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1.1 
1. OVERVIEW OF THE NATIONAL HEALTH AND 
NUTRITION EXAMINATION SURVEY  
This chapter provides a general description of the health examination surveys conducted by 
the National Center for Health Statistics (NCHS) and the current National Health and Nutrition 
Examination Survey (NHANES). It also provides an overview of the tasks that staff perform during the 
survey.  
History of the National Health and Nutrition Examination Programs 
This NHANES is the eighth in a series of national examination studies conducted in the 
United States since 1960. 
The National Health Survey Act, passed in 1956, gave the legislative authorization for a 
continuing survey to provide current statistical data on the amount, distribution, and effects of illness and 
disability in the United States. In order to fulfill the purposes of this act, it was recognized that data 
collection would involve at least three sources: (1) the people themselves by direct interview; (2) clinical 
tests, measurements, and physical examinations on sample persons; and (3) places where persons received 
medical care such as hospitals, clinics, and doctors’ offices.  
To comply with the 1956 act, between 1960 and 1984, the National Center for Health 
Statistics (NCHS), a branch of the U.S. Public Health Service in the U.S. Department of Health and 
Human Services, has conducted seven separate examination surveys to collect interview and physical 
examination data.  
The first three national health examination surveys were conducted in the 1960s: 
1. 1960-62 – National Health Examination Survey I (NHES I) 
2. 1963-65 – National Health Examination Survey II (NHES II) 
3. 1966-70 – National Health Examination Survey III (NHES III) 
1-1 (Revised January 2004) 
NHES I focused on selected chronic disease of adults aged 18-79. NHES II and NHES III 
focused on the growth and development of children. The NHES II sample included children aged 6-11, 
while NHES III focused on youths aged 12-17. All three surveys had an approximate sample size of 7,500 
individuals.  
Beginning in 1970 a new emphasis was introduced. The study of nutrition and its 
relationship to health status had become increasingly important as researchers began to discover links 
between dietary habits and disease. In response to this concern, under a directive from the Secretary of the 
Department of Health, Education and Welfare, the National Nutrition Surveillance System was instituted 
by NCHS. The purpose of this system was to measure the nutritional status of the U.S. population and 
monitor nutritional changes over time. A special task force recommended that a continuing surveillance 
system include clinical observation and professional assessment as well as the recording of dietary intake 
patterns. Thus, the National Nutrition Surveillance System was combined with the National Health 
Examination Survey to form the National Health and Nutrition Examination Survey (NHANES). Four 
surveys of this type have been conducted since 1970: 
1. 1971-75 – National Health and Nutrition Examination Survey I (NHANES I) 
2. 1976-80 – National Health and Nutrition Examination Survey II (NHANES II) 
3. 1982-84 – Hispanic Health and Nutrition Examination Survey (HHANES)  
4. 1988-94 – National Health and Nutrition Examination Survey (NHANES III)  
NHANES I, the first cycle of the NHANES studies, was conducted between 1971 and 1975. 
This survey was based on a national sample of about 28,000 persons between the ages of 1-74. Extensive 
data on health and nutrition were collected by interview, physical examination, and a battery of clinical 
measurements and tests from all members of the sample.  
NHANES II began in 1976 with the goal of interviewing and examining 28,000 persons 
between the ages of 6 months to 74 years. This survey was completed in 1980. To establish a baseline for 
assessing changes over time, data collection for NHANES II was made comparable to NHANES I. This 
means that in both surveys many of the same measurements were taken in the same way, on the same age 
segment of the U.S. population.  
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While the NHANES I and NHANES II studies provided extensive information about the 
health and nutritional status of the general U.S. population, comparable data were not available for many 
of the ethnic groups within the United States. Hispanic HANES (HHANES), conducted from 1982 to 
1984, produced estimates of health and nutritional status for the three largest Hispanic subgroups in the 
United States—Mexican Americans, Cuban Americans, and Puerto Ricans—that were comparable to the 
estimates available for the general population. HHANES was similar in design to the previous HANES 
studies, interviewing and examining about 16,000 people in various regions across the country with large 
Hispanic populations.  
NHANES III, conducted between 1988 and 1994, included about 40,000 people selected 
from households in 81 counties across the United States. As previously mentioned, the health status of 
minority groups is often different than the health status and characteristics of nonminority groups, so 
black Americans and Mexican Americans were selected in large proportions for NHANES III. Each 
group comprised 30 percent of the sample. NHANES III was the first survey to include infants as young 
as 2 months of age and to include adults with no upper age limit. To obtain generalizeable estimates, 
infants and young children (1-5 years) and older persons (60+ years) were sampled at a higher rate than 
previously. NHANES III also placed an additional emphasis on the effects of the environment upon 
health. Data were gathered to measure levels of pesticide exposure, presence of certain trace elements in 
the blood, and amounts of carbon monoxide present in the blood. A home examination was incorporated 
for those persons who were unable or unwilling to come to the exam center but would agree to an 
abbreviated examination in their homes. 
In addition to NHANES I, NHANES II, Hispanic HANES, and NHANES III, several other 
HANES projects have been underway since 1982. These projects have been a part of the HANES 
Epidemiologic Follow-up Survey, a multiphase survey conducting follow-up interviews with the 
NHANES I population in order to provide longitudinal data on the health of the U.S. population.  
Overview of the Current NHANES 
This NHANES follows in the tradition of past NHANES surveys, continuing to be a 
keystone in providing critical information on the health and nutritional status of the U.S. population.  
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1.2 
The major difference between the current NHANES and previous surveys is that the current 
NHANES is conducted as a continuous, annual survey. Each single year and any combination of 
consecutive years of data collection comprises a nationally representative sample of the U.S. population. 
This new design allows annual statistical estimates for broad groups and specific race-ethnicity groups as 
well as flexibility in the content of the questionnaires and exam components. New technologic 
innovations in computer-assisted interviewing and data processing result in rapid and accurate data 
collection, data processing, and publication of results. 
The number of people examined in a 12-month period will be about the same as in previous 
NHANES, about 5,000 a year from 15 different locations across the nation. The data from the NHANES 
are used by government agencies, state and community organizations, private researchers, consumer 
groups, companies, and health care providers.  
1.2.1 Data Collection 
Data collected on the current NHANES survey began early in 1999 and will continue for 
approximately 6 years at 88 locations (stands) across the United States. The survey was preceded by a 
pretest in the spring of 1998 and a dress rehearsal was conducted in early 1999. 
Approximately 40,000 individuals of all ages in households across the U.S. will be randomly 
selected to participate in the survey. The study respondents include whites as well as an oversample of 
blacks and Mexican-Americans. The study design also includes a representative sample of these groups 
by age, sex, and income level. Adolescents, older people, and pregnant women are also oversampled in 
the current NHANES. 
The overall goals of the NHANES are to: 
	 Estimate the number and percentage of persons in the U.S. population and designated 
subgroups with selected diseases and risk factor; 
	 Monitor trends in the prevalence, awareness, treatment, and control of selected 
diseases; 
	 Monitor trends in risk behaviors and environmental exposure; 
	 Analyze risk factors for selected diseases; 
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 Study the relationships between diet, nutrition, and health; and 
 Explore emerging public health issues and new technologies. 
Selected persons are invited to take part in the survey by first being interviewed in their 
homes. Household interview data are collected via computer-assisted personal interviewing (CAPI) and 
include demographic, socioeconomic, dietary, and health-related questions. Upon completion of the 
interview, respondents are asked to participate in a physical examination. The examination is conducted 
in a specially equipped and designed Mobile Examination Center (MEC), consisting of four trailers. The 
MEC houses the state-of-the-art exam equipment and is divided into rooms to assure the privacy of each 
study participant during the exams and interviews. The examination includes a physical and dental 
examination conducted by a physician and a dentist, laboratory tests, a variety of physical measurements, 
and other health interviews conducted by highly trained medical personnel.  
The household interviews and MEC exam combined will collect data in the following 
important health-related areas: 
 Cardiovascular and respiratory disease; 
 Vision; 
 Hearing; 
 Mental illness; 
 Growth; 
 Infectious diseases and immunization status in children; 
 Obesity; 
 Dietary intake and behavior; 
 Nutritional status; 
 Disability; 
 Skin diseases; 
 Environmental exposures; 
 Physical fitness; and 
 Other health-related topics. 
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1.3 Sample Selection 
A sample is defined as a representative part of a larger group. Since it is impossible to 
interview and examine everyone in the U.S. for NHANES, a representative sample is taken of the U.S. 
population. By studying a representative sample of the population, it is assumed that the findings would 
not have been too different had every person in the U.S. been studied. Because generalizations about the 
population will be made, it is extremely important that the sample be selected in a way that accurately 
represents the whole population. Statisticians calculate the size of the sample needed and take into 
consideration the geographic distribution and demographic characteristics of the population, such as age, 
gender, race, and income. 
An introductory letter is sent to each household in the sample. A few weeks after the letter 
goes out, interviewers visit each listed household and use carefully designed screening procedures to 
determine whether any residents are eligible for the survey. If eligible residents are present, the 
interviewer then proceeds to introduce the study, presents the Sample Person (SP) a survey brochure, and 
obtains a signed consent for the household interview. The brochure contains detailed information on the 
survey, the household interview, and the MEC examination. 
A signed consent form must be obtained from each eligible individual before the household 
interview can be conducted. A refusal to sign the consent form is considered a refusal to participate in the 
survey. After the interview is completed, the interviewer then explains the MEC exam, obtains another 
signed consent form for the MEC exam, and contacts the field office to schedule a MEC appointment for 
the SP. All SPs aged 12 years and older must sign the Examination Consent forms to participate in the 
MEC examination. Parental consent is also required for SPs under 18 years of age. SPs aged 7-11 years 
old are asked to sign the Examination Assent Form. An additional consent form is required for consent to 
future general research for both adults (ages 18+) and parents of children under 18 years. This consent 
form gives permission to store a small sample of blood and urine for future specimen testing. A refusal to 
sign the MEC consent or assent form is considered a refusal to participate in the examination phase of the 
survey. Examinations will not be performed on sample persons who do not sign a consent form. 
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1.4 Field Organization for NHANES 
There are two levels of field organization for this study - the home office staff and the field 
staff. 
	 Home Office Staff from Westat – Project staff from Westat are responsible for 
overseeing the field teams and field work.  
	 Field Office (FO) Staff – For this survey, an office will be opened at every survey 
location (stand). Each field office will have a Study Manager (SM), Office Manager 
(OM), a Field Manager (FM), and one Assistant Office Manager (AOM). 
- The Study Manager (SM) is responsible for the overall management of 
operations at a stand. 
- The Office Manager (OM) is responsible for the stand office operations and is 
the main conduit for the flow of work and information between the MEC and 
the household interviewing staff. S/he will supervise one or more local office 
clerks hired to assist with office activities. The OM reports to the SM. 
- The Field Manager (FM) has primary responsibility for the supervision of the 
household interviewers. The FM also assists the SM and supervises the 
activities of the Assistant Office Managers. S/he will deal with administrative 
issues, ISIS problems, and preparations for the next stand. 
- The Assistant Office Managers (AOMs) are primarily responsible for data 
entry into the Integrated Survey Information System (ISIS), editing data 
collection materials, and verification of interviewer work. The AOMs report to 
the FM and also work closely with the OM. 
	 Household Interviewers – This staff is primarily responsible for identifying and 
enrolling the survey participants, conducting the household interviews, and appointing 
the study participants for the MEC exam. Specifically, household interviewers will 
locate occupied residential dwelling units, administer the Screener to select eligible 
sample persons, obtain signed consents to the household interview, conduct the 
interviews, set up examination appointments, obtain consents for the MEC exam, 
conduct field reminders for MEC appointments, and assist in rescheduling broken, 
cancelled, and no-show appointments. 
Several times a week, household interviewers visit the field office and report to the 
field manager. During the course of the study, interviewers also interact on a daily 
basis with other field office staff and home office staff. 
	 MEC Staff – This staff of health professionals conducts the health exams. The survey 
includes two exam teams. 
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There are 16 individuals on each traveling team: 1 MEC manager, 1 MEC 
coordinator, 1 licensed physician, 1 licensed dentist, 3 medical technologists, 4 health 
technologists, 2 MEC interviewers, 2 dietary interviewers, and 1 phlebotomist. In 
addition, local assistants are recruited, trained, and employed at each stand to assist 
the exam staff. A data manager also travels with each team. 
The following section describes the steps that are always completed prior to the opening of a 
stand and an overview of the tasks that interviewers are expected to perform. Highlighted items are basic 
concepts critical to the conduct of the study. 
Steps completed prior to interviewing include: 
	 Statisticians scientifically select certain segments in the sampling area. A segment is 
an area with definite boundaries, such as a city block or group of blocks containing a 
cluster of households. 
	 Twelve weeks before data collection begins, NHANES staff list the segments. Listing 
is the systematic recording on special forms of the address of every dwelling unit 
(DU) located within the segment. Commercial buildings and other structures not 
intended as living quarters are not listed. 
	 A sample of dwelling units is selected from the listing forms. This sample is the group 
of addresses that interviewers visit in order to conduct interviews. 
	 Immediately before data collection begins, an advance letter is sent to each dwelling 
unit with a mailing address. This letter briefly describes the study and inform the 
household that an interviewer will contact them in the near future. 
The tasks interviewers perform when they arrive at a stand include: 
1.	 After the successful completion of training, interviewers are given an assignment of 
sampled dwelling units to contact. Each assignment consists of prelabeled Household 
Folders, prelabeled Neighbor Information Forms, and the appropriate Segment Folder.  
2.	 Using addresses on the Household Folders and listing/mapping materials in the 
Segment Folder, interviewers locate these dwelling units.  
3.	 If a selected address is not a dwelling unit or is not occupied, interviewers complete 
the “Vacant/Not a DU Section” on the Screener Non-Interview Form. 
4.	 In an occupied residential dwelling unit, interviewers contact an adult who lives in the 
selected household and administer the Screener using a laptop computer. 
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The Screener is an interview that lists all the individuals who live in the household, 
divides the household into families, and collects all the demographic characteristics 
necessary to immediately determine if there are persons in the household eligible for 
further interviewing. 
All instructions necessary to determine eligibility and to select sample persons (SPs) 
are programmed in the CAPI Screener.  
5.	 If all persons in a household are ineligible, no further work is done with the case. 
When eligible household members are identified, interviewers continue to conduct all 
the necessary tasks associated with the case.  
6.	 In eligible households, the interviewer obtains a signed interview consent form prior 
to completing the medical history and/or the family questionnaire. 
7.	 Next, the appropriate medical history CAPI interview is administered to eligible 
respondents. The questions asked depend on the age of the SP.  
8.	 In each household containing children aged 1-5, floor and window sill dust samples 
are obtained. These samples provide information on lead levels in the household 
environment. 
9.	 A Family questionnaire is also administered to one adult family member from each 
eligible family in the household. 
10.	 Next, an appointment is scheduled for each SP, coordinating the MEC schedule and 
the SP schedule. 
11.	 Interviewers then obtain signed consent form(s) for each SP for the examination, call 
the field office to confirm the examination appointment(s), and give each SP an 
appointment slip.  
12.	 If there is more than one eligible family in a household, this process is repeated with 
each additional family.  
13.	 Interviewers record the result of each contact or attempted contact with the household 
on the Call Record located in the Household Folder. 
14.	 Interviewers also support the survey by conducting field reminders prior to MEC 
appointments and reschedule broken, cancelled, or no-show MEC appointments. 
15.	 If an interviewer is unable to complete any of the questionnaires or procedures for any 
SP, an SP Card is completed. This card documents the problems encountered in 
completing one or more tasks.  
16.	 Interviewers check for missed DUs and/or structures when instructed to do so. If any 
are found, the Missed DU or Missed Structure Procedures is implemented and 
appropriate forms will be completed.  
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17.	 When an interview has been completed, interviewers edit their work, carefully 
reviewing all forms for completeness and legibility. 
18.	 Interviewers report in person to the FM at the stand office for regularly scheduled 
conferences, usually every other day. During these conferences, interviewers discuss 
completed cases, discuss problems with incomplete cases, receive new case 
assignments, and report time, expenses, and production.  
19.	 To insure the accuracy and completeness of the survey, all interviewer work is edited 
by the field office staff, and then validated by recontacting respondents. After this 
review, supervisors provide interviewers with feedback concerning the quality of the 
work. 
20.	 At the end of each stand field period, interviewers return all interviewing materials to 
the supervisor. 
1.5 Exams and Interviews in the Mobile Examination Center (MEC) 
Examinations and interviews are conducted in a mobile examination center (MEC), which is 
composed of four specially equipped trailers. Each trailer is approximately 48 feet long and 8 feet wide. 
The trailers are set up side-by-side and connected by enclosed passageways. During the main survey, 
detachable truck tractors drive the trailers from one geographic location to another. 
Exhibit 1-1 shows a floor plan for the MEC. The interior of the MEC is designed specifically 
for this survey. For example, the trailers are divided into specialized rooms to assure the privacy of each 
study participant during exams and interviews. Many customized features have been incorporated 
including an audiometry room that uses a soundproof booth, a wheelchair lift, and a wheelchair-accessible 
bathroom available to assist participants with mobility problems. Exhibit 1-2 shows the locations of the 
various exams within the MEC. 
1.5.1 Exam Sessions 
The MEC operates 5 days a week and includes weekday, evening, and weekend sessions. 
Two 4-hour sessions are scheduled each day with approximately 10-12 SPs per session. During a stand, 
work weeks rotate to offer a variety of MEC appointments on weekday mornings, afternoons, and 
evenings, and every weekend. 
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Exhibit 1-1. Floor plan of the MEC 
Exhibit 1-2. MEC exams and rooms 
Trailer Room	 Room Use 
Trailer 1 	 Reception area Welcoming and waiting area for SPs 
Vision room Vision tests 
Balance Balance test 
Fitness Cardiovascular fitness 
Trailer 2 	 Physician Physical examination  
MEC Interview Health interview 
MEC Interview Health interview 
Dietary Interview Dietary interview 
Dietary Interview Dietary interview 
Lower Extremity Disease Testing for lower extremity pulses and 
sensitivity 
Trailer 3 	 Venipuncture Drawing of blood samples, MRSA collection 
and physical activity monitor 
Laboratory Processing of urine and blood samples 
Label/shipping area Lab area for labeling and shipping specimens 
Staff lounge Staff area that houses main computer system 
Trailer 4 	 Total Body Composition Total body composition scans and 
bioimpedance 
Body Measures Body measurements and dermatology 
Dental Dental exam 
Audiometry/Tympanometry Hearing tests 
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1.5.2 Exam Team Responsibilities 
There are 16 individuals on each exam team. In addition, a local assistant will be hired to 
assist the staff in managing examinee flow. One data manager also travels with each team. The duties of 
the exam team members are summarized below: 
 One MEC manager supervises the exam staff, manages the facility, and supports exam 
operations. 
 One coordinator directs the flow of SPs through the MEC examination process. The 
coordinator manages all SP appointments, verifies that all components are completed 
for each SP, and exits SPs from the MEC. 
 One physician conducts the medical examination and records results, reviews the 
results of the complete blood count and pregnancy test, and serves as the safety officer 
for the MEC. 
 One dentist conducts the dental exam and calls the results to a health technologist who 
records the findings. 
 Two health (MEC) interviewers administer questionnaires for physical and mental 
health information. 
 Two dietary interviewers administer the dietary questionnaire. The interviewers 
record a 24-hour dietary recall of the types and amounts of foods consumed by the SP 
in the last 24 hours. 
 Four health technologists with radiologic technology or other health training take and 
record body measurements, perform balance tests, vision tests, cardiovascular fitness 
tests, muscle strength assessments, lower extremity measures, total body composition 
(DEXA) scans, bioimpedance (BIA) tests, administer hearing tests, and collect skin 
images. In addition, the technologists record findings for the dental examiner. 
 Three medical technologists conduct clinical laboratory tests on biological and 
environmental specimens, record the results of the tests, and prepare and ship 
specimens to various laboratories. 
 One phlebotomist administers the phlebotomy questionnaire draws blood from SPs, 
and recruits SPs for special studies. 
 The data manager (DM) assists in the setup and testing of computer systems and 
telecommunications hookups at the FO and MEC. S/he also coordinates the 
maintenance and repair of computer systems at the FO and MEC with the home office 
and external venders and acts as the FO and MEC systems “help desk” person. The 
data manager reports to the SM on administrative matters and the HO for ISIS-related 
matters. 
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Each staff member is part of a team of professional persons with specific assignments that 
must be completed in order to accomplish the overall objective of the survey. Each individual must be 
aware of and respect the job demands placed upon other staff members, maintain an attitude of tolerance 
and consideration for fellow members of the team, and willingly perform extra tasks that may be assigned 
to support other staff members in the performance of their duties. MEC staff members may be requested 
to perform tasks not directly related to their specific professional skills in order to implement the overall 
data collection plan. 
1.5.3 Examination Components 
The full examination for an adult takes approximately 3½ hours, but the actual length 
depends on the SP’s age. Some exams are done only on certain age groups so the exam profiles vary, 
even among adult SPs. The exam components are described briefly below and summarized in Exhibit 1-3: 
 Anthropometry 
The purpose of the anthropometry component is to provide: (1) nationally 
representative data on selected body measures, (2) estimates of the prevalence of 
overweight and obesity, (3) data to study the association between body measures and 
such health conditions and risk factors as cardiovascular disease, diabetes, 
hypertension, and activity and dietary patterns, and (4) data to monitor growth and 
development in children. A total of 11 body measurements are collected, but the 
number and type of measures varies with the age groups. 
 Balance 
Balance disorders, disequilibrium, and dizziness from vestibular disorders constitute a 
major public health problem. Primary disorders may be hidden by their consequences, 
such as falls, while subtle dysfunction may underlie difficulties in learning, writing, 
reading, and in everyday activities. The main objectives of the balance test are to 
obtain prevalence data, examine the relationship between balance disorders and other 
factors, and to characterize normal and disordered balance and spatial orientation. The 
standard Romberg test is used to measure postural sway. 
 Bioelectrical Impedance Analysis (BIA) 
The purpose of the BIA exam is to monitor secular trends in overweight prevalence, 
describe the prevalence of obesity, and examine the relationship between overweight 
and obesity and other examination measures. BIA measures the electrical impedance 
of body tissues and is used to assess fluid volumes, total body water, body cell mass, 
and fat-free body mass. 
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Exhibit 1-3. Examination components 
Component	 Ages 
Anthropometry 	All 
Audiometry/Tympanometry 	20-69 (half-sample) 
Balance 	40+ 
Bioimpedance (BIA) 	 8-49 
Cardiovascular Fitness	 12-49 
Dermatology 	20-59 
Dietary Interview 	 All 
Lower Extremity Disease	 40+ 
MEC Interview 	 8+ 
Mental Health	 8-19 years (also includes parents of 8-15-year­
olds); 20-39 years (half-sample) 
MRSA sample collection 	 1+ 
Oral Health 	 2+ 
Physical Activity Monitor	 6+ 
Physician Exam 	 All 
Total Body Composition 	 8+ 
Urine Collection 	 6+ 
Venipuncture 	1+ 
Vision 	12+ 
Volatile Organic Compounds (VOC) 	20-59 (random subsample) 
 Cardiovascular Fitness 
Evaluation of physical fitness provides nationally representative data on measures of 
physical fitness, and estimates of the prevalence of persons at risk due to sedentary 
habit and poor physical fitness. Cardiovascular fitness is assessed with a submaximal 
treadmill test on examinees aged 12 through 49 years.  
 Dermatology (Skin Disorders) 
The specific aims of this component are: (1) to monitor the prevalence, secular trends 
and impact of selected skin conditions that were last assessed in NHANES I (1971­
75); (2) to identify risk factors for selected skin conditions that can be used to increase 
understanding of disease etiology and prevention; and (3) to create a data resource that 
can be used to develop a CDC National Skin Cancer Prevention and Control Agenda. 
The MEC dermatology exam involves standardized photography of selected sites on 
the body. This component will focus on two specific skin diseases: psoriasis and hand 
dermatitis. The major goal is to determine the prevalence of these two conditions. 
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 Dietary Interview 
The goal of the dietary component is to estimate total intake of foods, food energy and 
nutrients, nonnutrient food components, and plain drinking water by the U.S. 
population; and assess dietary behaviors and the relationship of diet to health. 
Quantitative dietary intake data is obtained for all subjects by means of a 24-hour 
dietary recall interview using a computer-assisted dietary data entry system. A second 
24-hour recall will be conducted on all SPs by telephone through a phone center 
operation at the home office. In 2003, a self-administered form, the Food Frequency 
Questionnaire, will be offered to SPs who complete the MEC dietary interview. It will 
be mailed from and returned to the home office. 
 Hearing 
The goals of the hearing exam are to obtain normative data on the hearing status of the 
adult U.S. population, and to evaluate certain covariates that may be related to hearing 
loss, such as occupational exposure. The hearing component tests adults by 
performing pure tone audiometry and tympanometry. Because pure tone screening by 
itself may not be sensitive enough to detect middle ear disease, tympanometry is 
conducted to provide an estimate of tympanic membrane compliance. 
 Laboratory 
The laboratory component includes the collection and processing of various biological 
and environmental specimens including blood for subjects 1 year and older, urine for 
subjects 6 years and older. On-site pregnancy testing excludes pregnant women from 
other examination components such as DEXA, BIA, and cardiovascular fitness 
testing. Complete Blood Counts (CBCs) are also performed in the MEC laboratory. 
All other specimen testing is performed by Federal, private, and university-based 
laboratories under contract to NCHS. 
 Lower Extremity Disease (LED) 
The purpose of this component is to determine the prevalence of LED and its risk 
factors. Simple and reproducible measures of lower extremity arterial disease are 
obtained. Peripheral neuropathy is evaluated by measurement of cutaneous pressure 
sensation in the feet. Foot deformities permit the estimation of prevalence of those at 
high risk for the late-stage complications of LED. 
 MEC Interview 
The MEC Interview consists of questionnaire sections designed to obtain information 
on health behaviors, specific conditions, medical history, and risk factors. The 
information collected in the interview is intended to assist researchers in analyzing the 
data collected in the other examination components. The interview is administered to 
all age-eligible subjects, or a suitable proxy, using computer-assisted interviewing 
software. 
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 Mental Health 
The mental health assessment is used to estimate the prevalence of selected disorders 
in the U.S. and to describe the degree of comorbidity between mental health disorders 
and other medical conditions and biological risk factors. Assessments are made during 
the MEC Interview using relevant portions of the Diagnostic Interview Schedule for 
Children (DISC) and the Composite International Diagnostic Interview (CIDI) for 
adults. 
 Methicillin-Resistant S. Aureus (MRSA) Sample Collection 
A nasal swab specimen collection for Methicillin-Resistant Staphylococcus aureus 
(S. aureus) is obtained on SPs aged 1+ years for the purpose of estimating the 
prevalence of MRSA in the population. Antimicrobial resistance to S. aureus has 
increased so dramatically, particularly in the hospital setting, that currently only one 
treatment option exists for this organism. NHANES is the first population-based 
prevalence study of MRSA. No other population-based studies or national 
surveillance efforts are available to provide reliable national estimates for this 
problem. 
 Oral Health 
This component monitors oral health status, risk factors for disease, and access to 
preventive and treatment services. The exam consists of a series of subcomponents 
which assess dentition and periodontal disease.  
 Physical Activity Monitor 
The purpose of physical activity monitor component (PAM) is to assess the physical 
activity levels of NHANES examinees 6+ years of age. NHANES examinees wear a 
physical activity monitor (PAM) to examine physical activity patterns over a 7-day 
monitoring period and then mail it back to the home office. The monitors detect 
locomotion-type activities such as walking or jogging. The monitors provide a means 
of capturing non-structured activities that are often difficult for survey respondents 
(SPs) to self-report. Physical activity data are linked to other household interview and 
health component data and are used to track changes that occur in body weight, 
functional status, bone status, and health status over time. 
 Physician Exam 
Blood pressure assessment and discussion of testing for sexually transmitted disease 
are the primary elements of the physician’s exam. The purpose of assessment of blood 
pressure is to monitor prevalence and trends in major cardiovascular conditions and 
risk factors and to evaluate prevention and treatment programs targeting 
cardiovascular disease. The physician discusses the purpose of STD testing and 
arranges for SPs to select a unique password with which to phone NCHS and obtain 
test results. 
1-16 

 Total Body Composition 
This component is composed of the BIA and Dual Energy X-ray Absorptiometry 
(DEXA). The purpose of the DEXA scan is to gain insights into age, gender, and 
racial/ethnic differences in the skeleton relative to other measures of body 
composition such as total muscle and fat mass, as well as behavioral factors such as 
diet and activity. A total body scan using dual energy X-rays is performed to provide 
measures of bone mineral content, bone mineral density, muscle and fat mass. 
 Vision 
The vision examination consists of a near vision acuity test, a distance vision acuity 
test, an eyeglass prescription determination (when appropriate), and an automated 
refraction measurement. Information from the component may be used to estimate the 
prevalence of visual acuity impairment and distribution of refractive error in the U.S. 
population. Data are also used to evaluate screening strategies for visual impairment 
and eye disease, and evaluate functional impairment related to vision. 
 Volatile Organic Compounds (VOC) 
Information on levels of exposure to a selected group of volatile organic compounds is 
collected on a subsample of the survey population to assist in determining whether 
regulatory mechanisms are needed to reduce the levels of hazardous air pollutants to 
which the general population is exposed.  
1.5.4 Sample Person Remuneration 
All examinees receive remuneration for the MEC visit as well as payment for transportation 
expenses. The MEC visit remuneration is age-related and includes an extra incentive if the SP fasts prior 
to the exam. SPs who complete the physical activity monitoring component also receive an incentive. In 
addition, remunerations are offered to SPs who complete the dietary phone interview and the Food 
Frequency Questionnaire. 
1.5.5 Report of Exam Findings 
Examinees receive the results of many of the tests and exams conducted in the MEC, though 
some results are used only for research and are not reported.  
One report, a Preliminary Report of Findings, is produced for the SP on the day of their 
examination and includes results that are immediately available and require no further evaluation or 
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interpretation. Just prior to the examinee’s departure from the MEC, the coordinator prints a report that 
includes height, weight, and body mass index, complete blood count, blood pressure, and results from the 
audiometry, cardiovascular fitness, lower extremity disease, vision, and dental exams. The MEC 
physician reviews the blood pressure and complete blood count test results for abnormalities and 
discusses any problems with the SP (or their parent). The dentist also discusses the dental 
recommendations with the SP. Approximately 12-16 weeks after the exam, NCHS mails the remainder of 
the examination results to the SP after appropriate clinical or quality reviews are completed. Seriously 
abnormal results are reported to the SP via telephone by NCHS before the remaining findings are mailed.  
Certain tests, such as those for sexually transmitted diseases (chlamydia, gonorrhea, syphilis, 
Herpes simplex 1 and 2, bacterial vaginosis, and Trichomoniasis) and human immunodeficiency virus 
(HIV) are released only to the sample person using a specially devised procedure requiring a unique 
password. 
To further assist sample persons, an in-house NCHS survey response team is available to 
answer calls from NHANES participants regarding the results from the Report of Finding System. The 
response team effort works both as a triage mechanism and a surveillance system. A receipt and control 
record is kept on all sample person inquiries. Also available at no cost to sample persons is an 800 toll-
free telephone number which can be accessed during regular scheduled business hours. The response 
team members include a physician, a nurse with a doctorate degree, and other staff who are trained to 
answer specific questions. 
Tests and procedures conducted in the MEC are not considered diagnostic exams and are not 
a substitute for an evaluation by a medical professional. No clinical treatments or health interventions of 
any type are performed in the MEC. If a health problem is discovered during the course of the MEC 
exam, the physician offers to contact the examinee’s personal healthcare provider or recommend a local 
physician or clinic for follow-up care. If a sample person is found to have a serious condition requiring 
immediate attention, the local rescue squad may be summoned or the SP will be advised to seek 
immediate medical treatment.  
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1.5.6 Dry Run Day 
At the beginning of the examination period, one-half day is devoted to calibrating 
instruments, practicing MEC procedures, and collecting biological specimens that serve as blind quality 
control samples. A dry run day is scheduled immediately prior to the first exam day of every stand to 
make sure that all equipment is operational, supplies are adequate, and the facility is working properly. 
Any problems are corrected quickly before the “real” examinations begin. All procedures in the dry run 
are completed as though the actual exam session was being conducted. The only difference is that the 
examinees are actual volunteers who are not part of the sample for the survey. Volunteers may include 
local residents, local officials, or field employees or guests of NCHS. 
1.6 Integrated Survey Information System (ISIS) 
The Integrated Survey Information System (ISIS) is a computer-based infrastructure 
designed to support all survey operations including sample management, data collection, data editing, 
quality control, analysis, and delivery of NHANES data. With a collection of customized subsystems, the 
ISIS links the Field Office, Mobile Examination Center, Westat home office, and NCHS during field 
operations. Each component in NHANES such as Dietary Interview has a computer application for direct 
data entry. Data collected in the Dietary Interview room of the mobile examination center is directly 
entered in the ISIS system computers. In addition, data from biomedical equipment such as the blood 
pressure monitor in the CV Fitness room is directly downloaded to the ISIS system where it is displayed 
on the computer screen and stored in the system database.  
1.7 Confidentiality and Professional Ethics 
All information regarding this study must be kept strictly confidential except as required by 
law. This includes location of survey sites. Since this study is being conducted under a contract with the 
National Center for Health Statistics, the privacy of all information collected is protected by two public 
laws: Section 308(d) of the Public Health Service Act (42 U.S.C.242m) and the Privacy Act of 1974 (5 
U.S.C. 552a). 
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Each person working on the study must be continuously aware of the responsibility to 
safeguard the rights of all the individuals participating in the study. Each participant should be treated 
courteously, not as a sample number. Never divulge names or any other information about study 
participants except to the research team. Refrain from any discussions about study participants, in or out 
of the MEC, which might be overheard by people not on the survey staff. All of the members of the 
research team are under the same legal, moral, and ethical obligations to protect the privacy of the SPs 
participating in the survey. No participant names will be included in any reports prepared about the 
survey and neither NCHS nor the contractor is allowed to release information that would identify study 
participants without the consent of the participants. 
Cooperation from the public is essential to the success of survey research. A great deal of 
effort is expended in obtaining cooperation from many national, regional, state, and local officials and the 
general public. It is the responsibility of every field employee to build on the integrity of the survey to 
encourage continued access to study participants during current and future surveys. Professional conduct, 
both on and off the job, is extremely important. 
Each staff member has a responsibility for promoting good public relations. The Public 
Health Service and the contractor will be judged by the actions of the staff both on and off duty; 
consequently staff must be discreet in speech and action. Personal appearance and behavior must be 
governed by these same considerations. Please be aware of the audience at all times and avoid statements 
or actions that could shed an unfavorable light on the survey. 
Staff will be asked to sign a pledge of confidentiality before the survey begins. This pledge 
states that they are prohibited by law from disclosing any information while working on the survey to 
anyone except authorized staff of NCHS and the contractor, and that they agree to abide by the 
contractor’s Assurance of Confidentiality. 
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2.1
2. OVERVIEW TO THE ORAL HEALTH COMPONENT 
Introduction 
The oral health component of NHANES is sponsored by the following organizations: 
	 National Institute of Dental and Craniofacial Research (NIDCR); 
	 The Division of Oral Health of the Center for Chronic Disease Prevention and Health 
Promotion of the Centers for Disease Control and Prevention (CDC); and 
	 The National Center for Health Statistics (NCHS). 
The component was developed by the NIDCR, the Division of Oral Health, and the NCHS, 
with input from nationally recognized research scientists intramurally and extramurally, and public health 
leaders from the NIDCR, CDC, other U.S. Public Health Service agencies, universities, and state health 
departments.  
The purpose of the NHANES oral health component is to assess the prevalence of oral 
diseases and conditions, such as dental caries, periodontal disease, edentulism, denture use, sealants, 
fluorosis, and traumatic injury in a national sample. The periodic assessment includes evaluation of tooth 
wear, functional occlusal contacts, and perceived overall quality of oral health.  
Over the past four decades, oral and dental health characteristics collected in national 
surveys supported by the Federal Government have been critical for monitoring health status, risk factors 
for disease, access to preventive and treatment services, and other health characteristics among the 
general population and special subpopulations. These studies include the National Health and Nutrition 
Examination Surveys (NHANES), National Health Interview Surveys (NHIS), National Medical 
Expenditure Surveys (NMES), and special surveys such as the Hispanic Health and Nutrition 
Examination Survey.  
Oral and dental diseases affect many in the United States and constitute a major burden on 
the Nation. Dental caries, periodontal disease, and tooth loss are significant problems affecting the 
Nation’s oral health. Although average dental caries scores for school-aged children have declined, 50 
percent of children still have caries. In addition, 94 percent of adults in the United States have 
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2.2 
experienced caries. Dental sealants, an effective means of preventing caries, are underutilized in the 
United States, with only 19 percent of children aged 5-17 having them. In addition to caries, 15 percent of 
Americans have severe periodontal destruction and 11 percent have lost all their teeth.  
The oral health component of the current NHANES will meet a critical need by 
accomplishing the objectives listed below. The NHANES oral health component will: 
 Evaluate trends in oral and dental diseases; 
 Evaluate trends in tooth retention and replacement; 
 Estimate the burden of oral and dental diseases in the population as a whole; 
 Estimate the burden of oral and dental diseases in subgroups of the population; and 
 Assess progress in meeting national health objectives. 
This section provides a general overview of the oral health component and the Mobile 
Examination Center (MEC) operations. Specific procedures for conducting the oral examination are 
described in Chapter 4 of the Dental Examiners Procedures Manual while specific procedures for 
recording data are described in Chapter 4 of the Dental Recorders Procedures Manual. 
Data Collection 
The MEC contains an automated computer system referred to as ISIS, the Integrated Survey 
and Information System. This automated system is used to: 
	 Direct the flow of SPs through the MEC, keeping track of which parts of the 
examination have been completed; 
	 Record interview and examination data; 
	 Perform edits on collected data; and 
	 Enter quality control data for each component. 
The dental examiner “calls” his/her observations (codes for oral health indices) during the 
oral examination and the recorder enters these calls into ISIS. 
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2.3 Operations Overview 
This section summarizes the flow in the MEC and the responsibilities of the dental examiner 
and dental recorder. 
 The dental examiner arrives at the MEC prior to the session start. He/she needs to 
arrive early enough to complete the following tasks prior to the start of session: 
- Print and post the session schedule for the number of study participants (SPs) 
and their ages; 
- Set up the oral health work area (details will be provided later in this chapter); 
- Check all equipment; 
- Make sure enough supplies are available for the session. A full session is quite 
busy and there will be no time to resupply; 
- Complete the quality control for set-up in ISIS (details will be provided later); 
and 
 At the start of the session, each SP will check in with the coordinator at the 
workstation, just inside the MEC entrance. The coordinator will provide each SP with 
a bracelet with the SPs name, ID number, and corresponding bar code. 
 The examiner notifies the coordinator that the room set-up is complete and the 
examiner is ready to receive SPs. 
 The examiner or recorder checks the daily appointment schedule and goes to the 
coordinator station to meet the SP and bring him/her to the oral health room. 
 The recorder opens the SP’s record in ISIS and wands the bar code on the SP’s 
bracelet. 
 The examiner asks SPs 16 years and older medical exclusion questions, and responds 
to SP questions. SPs aged 13 to 15 years will have a proxy form that the MEC 
manager completed with the SP’s parent or guardian. 
 The examiner completes the oral health subcomponents while the recorder enters the 
data in the ISIS system. 
 The SP is escorted to the reception area or next examination by the dental examiner or 
recorder. 
 The examiner sets up the room for the next SP.  
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2.4 
 At the end of a session, the examiner does the following: 
- Cleans the oral health room; 
- Takes the biohazard trash bag to the collection area; and 
- Completes the End of Session quality control in ISIS. 
Conducting the Oral Examination and Recording Oral Examination Data 
Data for this component will be collected using a visual-tactile examination. This 
examination has several sections. The specific section a study participant receives is dependent on their 
age and medical exclusions. The specific examinations, with the appropriate age range are listed below. 
Medical Exclusions and Dental Condition Questions 
 Medical exclusion questions (13 years and older); and 

 Dental condition questions (16 years and older). 

Dentition 
 Denture questions (25 years and older); 

 Tooth count (2 years and older); 

 Coronal caries (2 years and older); 

 Root caries (18 years and older); 

 Dental sealants (2 to 34 years old); 

 Dental fluorosis (6 to 49 years); 

 Incisor trauma (6 to 29 years old) 

 Tooth wear (13 years and older); and 

 Functional occlusal contacts (25 years and older). 

Periodontal Assessment 
 Loss of attachment (13 years and older) 

 Bleeding from probing (13 years and older) 
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Recommendation for Care 
 Report of Findings (2 years and older); and 
 Referral letter (as needed). 
2.4.1 Exclusion for Medical Conditions 
SPs with certain medical conditions will not be permitted to participate in some components 
of the dental exam. The examiner must ask each SP 16 years or older if he/she has any of the conditions 
listed on the Medical Exclusion screen. The MEC manager obtains medical exclusion information for SPs 
13 to 15 years old from the SP’s parent or guardian. The MEC manager records the answers on a hard 
copy proxy questionnaire. The questionnaire accompanies the SP to the oral health room and is reviewed 
by the dental examiner. This information is then entered in ISIS by the dental recorder at the beginning of 
the examination. The responses to the medical exclusion questions along with the SP’s age determine 
which dental examination components can be performed. 
2.4.2 Documenting Incomplete and Omitted Examinations 
If a scheduled examination is partially completed or not done at all, the reason must be 
recorded in ISIS. The NHANES dental examination has several subcomponents and not every SP receives 
every subcomponent. The primary reasons SPs do not receive certain subcomponents relate to age and 
medical exclusions. However, there may be occasions when SPs are prevented from receiving the dental 
examination, or the dental examination begins but must be terminated prior to completion. Medical 
exclusions and these other unusual circumstances are recorded in ISIS. The age-dependent components 
are already accounted for by the system. 
Medical exclusions are recorded by a “yes” response to any of the medical conditions or 
circumstances listed in ISIS. This causes the system to automatically skip the excluded subcomponents.  
Specific reasons for terminating an examination or a subcomponent of an examination are 
recorded in ISIS, on the status screen for the whole examination or for the particular section of the 
examination. Section status screens are summary screens that appear at the end of each subcomponent 
section: medical exclusions and dental conditions, dentition, periodontal, and recommendation for care. If 
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the subcomponent is partially complete or not done, the following reasons are programmed into the ISIS 
system and appear at the status screen: 
 SP refused or uncooperative. An “uncooperative” SP is one who is unwilling to 
cooperate, e.g., an infant or small child who cannot be persuaded to get through the 
examination. 
 No time. 
 Physical limitation. An SP may complete part of the examination because of a 
physical limitation, e.g., the examiner may not be able to do part of an examination 
because an SP has braces. 
 SP unable to comply. SP who is willing but faces a barrier in complying with the 
protocol, e.g., a person who cannot sit in a position conducive to conducting the 
examination. 
 Equipment failure. A piece of equipment is not working, or the examiner does not 
have the supplies necessary to complete an exam. 
 Medical reasons. A circumstance where the SP’s safety or medical condition is of 
concern to the examiner due to pain, fainting, seizure, bleeding, etc. 
For example, if the SP experienced pain or fainted and the examiner elected not to complete 
certain exam portions, this would be treated as an aborted exam for medical reasons. 
 Safety Reasons. If an SP is excluded from certain subcomponents because of a 
medical exclusion question, but has otherwise gone through the exam, it is recorded as 
a partially completed exam for safety reasons not a termination for medical reasons. 
 Room not available. 
 Other reason. A reason not programmed in the ISIS system requires a comment. 
2.4.3 Report of Dental Exam Findings and Referral Letters  
The last portion of the examination is the Recommendation for Care screen. The information 
on this screen is used to create the Report of Oral Exam Findings and an Oral Health Referral Letter, if 
needed. The information on this screen is partially automated – based on the examination data, and 
partially examiner driven – based on information the examiner gives the recorder. The Report of Findings 
will be handed to the SP when he/she leaves the MEC. It will indicate whether the SP should continue 
his/her usual dental care, see a dentist at his/her earliest convenience, see a dentist within 2 weeks, or see 
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a dentist immediately. The Referral Letter is handed to those SPs whose oral health warranted a concern 
that they see a dentist within the next 2 weeks or earlier. The report, Referral Letter, and related 
procedures will be discussed in depth in Chapter 5. 
2.4.4 Returning the SP to the Coordinator’s Area 
After examination data are recorded and the examiner completes the Recommendation for 
Care screen, the examiner or recorder will escort the SP to the coordinator station or to another 
examination room. The examiner will then prepare the oral health room for the next SP. 
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3. EQUIPMENT AND SUPPLIES 

3.1 Dental Examination Area in MEC 
The oral health room is located in Trailer #4 of the mobile examination center (MEC). This 
room contains the equipment and supplies necessary to conduct the dental examinations. This 9' by 4' 9" 
room includes cabinets for storage, a counter top, and a sink with running water. (See Exhibit 3-1.) 
3.2 Description of Equipment and Supplies 
Exhibit 3-2 shows a list of equipment and supplies and the anticipated quantities for each of 
these items. The specific manuals for each piece of equipment are located in the bottom drawer of the oral 
health room. It is located in a blue folder labeled Oral Health Equipment. Use these as necessary if a 
problem arises. 
Each MEC was loaded with equipment and supplies necessary to perform examinations for 
the first stand. The home office ships supplies to the field prior to the start of each stand, and as needed. 
Remember to use older items first. 
The dental examiner should inform the MEC manager immediately if there is a problem 
with any dental equipment or supply. The home office will arrange to have the equipment repaired or 
replaced, if necessary. 
3.2.1 Inventory Procedures 
There are two inventories completed per stand. The first is done at the Start of Stand and 
requires verifying the End of Stand count from the previous MEC inventory and the amount shipped to 
the stand at the Start of Stand. The total for each item should be at par or above par. The second type of 
inventory is completed at the End of Stand. This inventory requires counting all supplies for your 
component. Remember to include everything in the oral health room and in the belly compartment. 
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Exhibit 3-1. Dental examination room 
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Exhibit 3-2. Equipment and supplies for dental component 
Supply Per MEC 
Per Stand 
(@ 6 weeks) Per SP 
Examination 
Dental Porta-Chair 
Back-up dental chair (kept in belly compartment of MEC) 
Adeck set screws 
Adjustable Deltube stools (for examiner and recorder) 
Air compressor 
Back-up air compressor (kept in belly of MEC) 
Air syringe 
Air compressor gasket (o-ring) 1/8” 
Air compressor gasket (o-ring) 1/16” 
Filter element replacement (cotton roll – spare) 
Cotton applicators 
Halogen light (with bulb and adapter) 
Replacement halogen light bulb 
Back-up light and replacement light bulb 
Replacement fuse for halogen light 
2x2 gauze, non-sterile (NuGauze) 
Denture adhesive 
Pillow (for elderly) 
Pillow covers 
Instrument set-up tray 
One-quart bottle (to mix Restore solution) 
Half-gallon bottle (to mix Speed Clean solution) 
Rubbermaid container, rectangle #10 (to soak instruments) 
Dental Release Forms  
Stickers (assorted cartoon for children) 
Instruments 
#23 Explorer 
Hu Friedy PCP-2 periodontal probe 
Mirrors (handles and heads) 
Endodontic ruler, 65 mm 
Curettes 
Sterilization 
Ritter SpeedClave Steam Sterilizer 
SpeedClean solution 
Attest incubator 
Attest (spore tests)  
Peelvue sterilizing pouches 
Sterigage indicator strips 
Door gasket (spare) 
1 
1 
1 set 
2 
1 
1 
1 
5 
5 
1 
1 bag 
1 
1 
1 
2 
1 tube 
1 
25 
1 
1 
1 
4 
10 English/ 
5 Spanish 
4 rolls 
60 
60 
60 
60 
5 
1 
1 
1 
8 oz 
12 vials 
12-18 
2 
1 
1 (SP 13+) 
1 
1 (SP 25+) 
1 
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Exhibit 3-2. Equipment and supplies for dental component (continued) 
Supply Per MEC 
Per Stand 
(@ 6 weeks) Per SP 
Sterilization (continued) 
Instrument brush with holder 
Utility gloves 
Hot pad mitt 
Distilled water 
Infection Control 
Safe-tips EZ, disposable 
Syringe covers
Barrier chair covers 
Coverall barrier with dispenser 
Disposable lab jackets 
Latex examination gloves, powder free 
Latex free examination gloves, powder free 
Face masks, ear loop and molded 
Safety glasses, plexiglas  
Side shields, disposable (for eyeglasses) 
Restore (to soak instruments) 
Germicidal wipes, disposable 
Liquid hand soap dispenser 
Waterless hand cleaner 
Waste basket, biohazard 
Trash bags, biohazard 
Sharps disposal container 
Non-Dental 
Containers, various (to hold miscellaneous items) 
Hand cream 
Small toothbrush 
Washcloth 
Sponge 
Scissors 
Masking tape 
Scotch tape 
Cleaning supplies: 409, window cleaner, softscrub 
Felt tip pens 
Clipboard 
Paper towels 
Clock 
CPR mask 
Liquid dish detergent (Dove only) 
Hand mirror 
Tool kit (screwdrivers, Allen wrenches, wrench, pliers) 
Cotton pliers 
1 
1 pr 
1 
1 
1 bottle 
1 bottle 
1 
6 
As needed 
1 
1 
1 
1 
2 rolls 
1 roll 
1 bottle each 
2 
1 
As needed 
1 
1 
1 bottle 
1 
1 
1 
3 gal 
6 
4 boxes 
60 
60 quarts 
5 cans 
60 
2 
1 
1 
2 
2 sheets 
1 pr 
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The following procedures should be followed when counting supplies for either inventory. 
	 Verify that you are counting in the correct units (e.g., box, bottle, case). 
	 Enter only one name in the “Counted By” field. This is the person responsible for 
taking and verifying the inventory count. 
	 Do not write any notes, comments, etc. on the count sheet. Only write your name in 
the “Counted By” field and place a number in the “Count” box. Do not redefine or re­
iterate the Unit of Measure. If you have any comments or concerns on the count sheets 
see your MEC manager. 
	 Do not count partial units. Record whole numbers only in the “Count” field. 
	 If the PAR for an item is more than 1 and the box or container is open, do not count 
that container (e.g., gloves – 12 boxes have not been opened, 1 box is opened, the 
count is 12). 
	 If the PAR for an item is only 1 unit – if it is more than ½ empty place a 0 in the count 
unit. Another way to look at it is can the next stand get by without needing more? If 
not, put a 0. 
	 Lot #’s and expiration dates – all active lot #’s and expiration dates show up on the 
count sheets if they are applicable for that item. If you see a lot # and expiration date 
you must put a count (even if it is 0) in this field. Please also remember to use items 
with older expiration dates first. 
	 Restocking Supplies – remember to use items you have on hand in the rooms and 
items in the belly compartment first. Do not restock your rooms unless necessary with 
items that were just shipped to the stand. Many items such as gloves, alcohol prep 
pads, electrodes, etc. deteriorate over time. 
3.2.1.1 Consumables vs. Non-Consumables 
Inventory items are broken out into two categories – consumable and non-consumable. 
Inventory both types of items at the end of each stand. The definition for a consumable item is anything 
that is typically consumed during an examination. Whereas some items may be used (consumed) in case 
of emergency, these are still considered non-consumables since they are not typically consumed during 
the course of an exam. 
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3.2.1.2 Shipping Excess Inventory Back to the Warehouse 
When shipping excess inventory back to the warehouse, please use the “Transfer Inventory 
to Warehouse Manifest” which is found on the Intraweb and can be printed by your MEC manager or data 
manager. This form will look similar to the “End of Stand Count Sheets.” Please enter your name in the 
“Count By” field and indicate next to each item how many units are being shipped back to the warehouse. 
This information will be entered into the system by the warehouse manager and will be used to adjust 
your stand inventory and usage information as well as increase the warehouse inventory counts. 
3.2.1.3 Tracking of Expired and Broken Inventory 
The “Delete Expired/Broken Inventory Report” should be completed whenever you have 
inventory that has expired and must be destroyed or has broken and is no longer usable. This report is also 
found on the Intraweb and should be completed and forwarded to the warehouse manager so that the 
expired or broken inventory can be removed from the stand inventory. 
Do not borrow any supplies from any other components. The warehouse tracks usage by 
stand and by component. You are responsible for ensuring that you have enough supplies to complete 
exams, notify you MEC manager as soon as possible when your supplies run low. 
3.3 Equipment Procedures and Maintenance 
The procedures for set-up and maintenance of equipment at the beginning of a stand, daily, 
weekly, mid-stand, and at the end of a stand will be listed below. Then this chapter will review specific 
procedures for use of equipment and supplies. 
3.3.1 Start of Stand 
It is very important the dental equipment and supplies are checked and set-up properly at the 
start of a stand. The specific directions for the equipment may seem complicated, but they will be 
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reviewed, demonstrated, and practiced during training sessions. The examiner has primary responsibility 
for setting up and taking down the dental equipment and supplies.  
The following is a list of all tasks the dental examiner completes at set-up or start-of-stand: 
 Complete inventory of supplies – Add new/additional items and check to make sure 
all items listed are present and in good working condition. 
 Clean the oral health room with 409 and/or soft scrub. Use the washcloth, then throw 
it out. Counters, blinds, cabinets, walls, and window should be cleaned. Disinfect the 
inside of the instrument drawers. 
 Clean and disinfect the biohazard can. 
 Check to make sure all equipment arrived without damage. 
 Check the back-up compressor to make sure it is in working order. 
 Stock cabinets with supplies per instructions in Chapter 6. 
 Pack excess supplies in the belly. 
 Hang clock and CPR mask. 
 Clean and set-up Porta-Chair. 
 Clean and set-up dental light. 
 Clean and set-up dental stools. 
 Set-up air compressor. 
 Check air syringe filter to make sure it is dry. 
 Clean and set-up Speedclave. 
 Check Speedclave gasket. 
 Make sure the dental reference sheets are secured on the wall. 
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3.3.2 Start of Exam Session 
There are a number of specific tasks the dental examiner needs to complete at the beginning 
of each exam session. These are listed below. 
	 Wash hands; 
	 Turn dental light on; and 
	 Visually check the following pieces of equipment: 
-	 The light; 
-	 The air compressor and air tank valves; 
-	 The sterilizer; 
	 Turn the air compressor on and close valve; 
	 Check airflow from air syringe; and 
	 Prepare the room for the examination – complete all infection control procedures; 
-	 Wipe all counters and chairs with sani-cloths; 
-	 Mix Restore solution daily (start of first session); 
-	 Place Restore solution in Rubbermaid containers to place used instruments. 
These should be on counter with lids on; and 
3.3.3 End of Exam Session 
There are a number of procedures the dental examiner will complete at the end of each 
session. These are as follows: 
	 Turn the dental light off; 
	 Purge the air tank (only needed at the last session of the day or after the AM session if 
the sessions are split – morning and evening) and turn the air compressor off; and 
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	 If instruments were sterilized, complete the information required in ISIS utilities for 
this (instruments must be washed and bagged with 1 mirror, explorer, perio-probe, 
ruler, and 2 gauze squares prior to sterilizing. One sterigage must be placed with each 
load). See instructions for proper sterilizing procedures later in this chapter. 
	 Clean room; 
	 Take biohazardous waste to the storage facility in the MEC taking the following steps: 
1.	 Seal the biohazard bag with tape; 
2.	 Wear gloves to transport the bag to the inside rear bay doors of the laboratory 
in Trailer #3; open the bay doors and drop the bag to the ground; 
3.	 Remove the gloves and discard them in a biohazard bag in the laboratory; 
4.	 Take a new pair of clean gloves from the laboratory and walk outside to the 
back of trailer #3; 
5.	 Open the belly compartment; 
6.	 Put on the clean gloves; 
7.	 Place the biohazard bag into the belly compartment; 
8.	 Remove the gloves and place them in the belly compartment; and 
9. Lock the belly compartment. 

 Exit the ISIS system. 

3.3.4 Weekly 
There are a number of procedures the dental examiner will complete each week during a 
stand. These are as follows: 
 Conduct a spore test; 

 Clean the exterior of the sterilizer; 

 Check water reservoir in the sterilizer; and 

 Check supply levels in cabinets; restock if necessary.
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3.3.5 Mid-Stand 
The following items need to be completed by the dental examiner during the middle of each 
stand: 
	 Drain and clean the sterilizer chamber; and 
	 Refill sterilizer chamber with distilled water. 
3.3.6 End of Stand  
Equipment and supplies must be packed at the end of each stand. Since the MEC may be 
moving long distances, the equipment must be packed and stored for distance travel. 
	 Disassemble the Porta-Chair and pack it in the carrying case. Place on the exam room 
floor in a flat position. 
	 Remove the light and light assembly from the wall. The light assembly should be 
placed in the specified plastic case lined with bubble wrap. Secure the case on the 
exam room floor. 
	 Turn the air compressor off and bleed the tank. Move the compressor to the back of 
the cabinet and secure it using the U hooks and bungee cord provided. Wrap the air 
syringe in bubble wrap, secure on the wall either with tape and velcro strips to the 
metal holder or in velcro strip on the wall. 
	 Flush the SpeedClave with SpeedClean, then flush 2 times with distilled water as per 
directions. Pack it and the Attest biological monitoring kit in the designated carrying 
case and secure on the floor. 
	 Remove the clock from the wall. Remove the batteries and tape to the back of the 
clock. Wrap in bubble wrap and place in bottom drawer. 
	 Remove the CPR mask from the wall. Wrap in bubble wrap and place in bottom 
drawer. 
	 Secure supplies in the cabinets. Bring supplies from upper cabinet shelves down to 
lower shelves. Pack securely on bottom shelf with heavier items on the bottom. Secure 
the cabinets, doors, and storage drawers with the designated Velcro strips and wood 
bars. 
	 Contact the data manager to secure the computer equipment and telephone. 
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 Close the window. 
 Close and secure the window blind. 
 Use the recorder and examiner stools, biohazardous containers, and other items not 
packed in carrying cases to secure the equipment and boxes in the room to prevent 
sliding and shifting during transport (refer to Appendix G). 
 Secure the door to the oral health room in the open position. 
 Pack supplies in the belly compartment in water resistant containers. Any items that 
are breakable or not stored in water resistant containers should be moved to the oral 
health room.  
 The back-up dental chair, soft cases for the primary and back-up dental chairs, and the 
plastic containers with supplies should remain in the belly compartment. 
 The back-up light and back-up compressor should be moved to the oral health room. 
3.4 Equipment 
3.4.1 Porta-Chair 
The Porta-Chair is the chair in which the SP will sit during the dental examination. 
Exhibit 3-3 on p. 3-12 shows the steps used in setting up the Porta-Chair. 
NOTE: The chair must be placed on its side when raising, collapsing, or adjusting the 
legs. Raising, collapsing, or adjusting the chair while it is upright could result in severe injury to the 
hands and wrists. 
3.4.1.1 Set-up 
1.	 Carefully place the chair on its side. The scissored legs have two screw knobs on each 
side which fasten into one of several notches underneath the base of the chair. The 
height of the base of the chair is determined by which notch is chosen. When 
determining the height, remember that it is difficult to change the height between SPs. 
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Exhibit 3-3. Illustration of Porta-Chair 
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2.	 The adjustable rod attaches to the chair in two places. The rod should be attached to 
the small assembly on the horizontal rod just underneath the chair. There is a small 
screw that secures the rod into the assembly. (It is often stripped because it is 
frequently forcibly removed.) It is important that this is secure as it can loosen and the 
chair back will fall. This is especially important if you intend to adjust the back of the 
chair during an examination. The rod can easily be connected and reconnected by 
depressing the button on the side of the T-pin, which fits into the bracket on the upper 
part of the backside of the chair. To assemble, align the holes of the assembly and the 
rod, then insert the T-pin. 
3.	 If using the backup Rolux light, the chair will have to be set-up with the light post 
bracket on the right side due to the layout of the dental room. To install the 25-inch 
light post, insert the post in the mounting bracket on the side of the chair and tighten 
the two screws with the supplied Allen wrench. 
3.4.1.2 Breakdown 
1.	 To detach the adjustable rod, remove the connecting T-pin from the upper portion rod 
that is attached into the bracket on the upper portion of the backside of the chair. 
Leave the rod attached to the assembly on the horizontal rod underneath the seat of the 
chair. Lower the rod and fold the chair back over the seat. 
2.	 Turn the chair on its side and loosen the screw knobs on the sides of the base of the 
chair to disconnect the scissored legs. 
3.	 The chair should be laid flat for storage. 
3.4.1.3 Cleaning 
A mild soap or foam-type upholstery cleaner (e.g., 409) may be used on the vinyl. All 
external metal surfaces may be cleaned using a detergent solution. Never use abrasive cleaners or 
scrubbing pads; they will damage the finishes. Be sure to clean the chair before returning it to its carrying 
bag. 
3.4.2 Dental Stool 
Since the examinations will be conducted with the examiner seated, the stool must be 
positioned next to the Porta-Chair. The dental stool can be raised to a comfortable height by using the 
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release lever under the seat. The stool is also equipped with a backrest that can be added for additional 
comfort. 
3.4.3 ProBrite Halogen Dental Light (Model HEINE HL 1200) 
The ProBrite Halogen dental light is pre-assembled and only needs to be mounted on the 
wall support in the oral health room and plugged into an electrical outlet. 
3.4.3.1 Set-up 
Remove the light from the plastic packing container and bubble wrap. Leave the bubble 
wrap in the container for tear down. The light mounting should be attached to the pole above the stainless 
steel tray and then the mounting screws should be tightened. 
3.4.3.2 Use 
The ProBrite Halogen light has a power switch to activate/deactivate the light and the 
distance to the SP controls the illumination area. For optimum use, turn the light off between exams. At 
the start of an exam, turn the light on and position the light head for maximum illumination of the area. 
3.4.3.3 Maintenance 
The following visual check should be performed at the start of each session: 
 Look for cracks on the power cable; 
 Look for cracks or splits on the bulb cowling and cover; 
 Look for cracks or scratches on the lens; and 
 Look for loose or missing items such as screws, nuts, or bolts. 
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3.4.3.4 Cleaning 
To clean the unit, first disconnect the power cord from the electrical source and wait until the 
unit is cool. Then clean the light with a soft cloth and soapy water or non-abrasive soap solution. 
3.4.3.5 Replacement of Light Bulb 
To replace the light bulb: 
1.	 Turn the light off and disconnect the power cable from the electrical source. 
2.	 Allow the bulb to cool. 
3.	 With thumb and forefinger, press the cap together at the two white marks and ease the 
cap off. 
4.	 When inserting the new bulb, ensure that the contact pins are not bent. 
5.	 To replace the cap, engage the clip in the opening marked (*) in the illumination head 
and press the cap until the second cap clicks in place.  
3.4.3.6 Changing the Fuse 
In order to change the fuse, first disconnect the power cord from the electrical source. The 
fuses are located in the fuse compartment next to the male outlet in the light assembly. Use a small 
screwdriver to open the fuse compartment. 
3.4.3.7 Pack-up 
To pack up the light, first disconnect the power cord from the electrical source and the light 
assembly. Then remove the light from the pole above the stainless steel tray. Re-tighten the screws so 
they do not get lost during transport. Wrap the light in bubble wrap and place in the long plastic storage 
container. The light must be kept in the oral health room during transport. 
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3.4.4 Air Compressor 
The ProAir Portable Air Compressor used in the current NHANES has been modified 
slightly to meet study-specific requirements. It is a 1/3 horsepower, oil-free, rocking piston compressor 
with sealed bearings. 
3.4.4.1 Set-up 
While travelling, the air compressor is secured to the back of the cabinet with U-hooks and a 
bungee cord. During set-up, move the air compressor back into position. Make sure the air compressor is 
sitting on a rug in the cabinet, the door is padded, and the air compressor is not resting against any of the 
cabinet walls. Then, check it for signs of mechanical damage such as split air lines, loose electrical wires, 
or connections, loose handles, and loose or missing nuts, bolts, and screws. 
3.4.4.2 Use 
Turn power source on. To turn the compressor on, there is a switch in the form of a knob. It 
is at the top of the compressor on the left. The air compressor will run until the air reservoir is filled and 
then automatically turn off. It will then cycle on and off to keep the reservoir charged at the appropriate 
pressure as air is used. 
3.4.4.3 Daily Maintenance 
Visual checks: Check for signs of mechanical damage such as split air lines, loose electrical 
wires, loose connections, loose handles, and loose or missing screws, nuts, or bolts. 
Purge/bleed air tank: Turn the air compressor off and open the screw valve on the bottom 
of the tank (it is a brass nut) at the end of each day. If there is a split session day, then purge the tank at 
the end of the morning session as well. Make sure the valves are closed and the compressor has been 
turned on before operating the compressor again. 
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3.4.4.4 Pack-up 
Turn the power source off and bleed the tank. Move the compressor to the back of the 
cabinet and secure with the U-hooks and bungee cord provided. 
3.4.5 Air Syringe 
3.4.5.1 Set-up 
Unwrap the air syringe (should be wrapped in bubble wrap), and check the connection with 
the air compressor. Visually check to make sure there has been no damage (cylinder is intact) and the 
cotton roll (filter element) is not damp. If needed, replace the cotton roll, filter, or filter tube. 
3.4.5.2 Changing the filter element (cotton roll) 
The filter element of the air syringe should be changed annually and also if it becomes damp. 
1.	 Turn off the air to the compressor and bleed off any air in the syringe by pressing the 
air button on the syringe until no air flows through it. 
2.	 Unscrew the handle of the syringe. 
3.	 Push on the supply tubing so that the clear filter tube containing the filter element is 
ejected from within the aluminum handle. 
4.	 Remove the used cotton roll from the tube using cotton pliers. 
5.	 Inspect the clear tube for any debris or moisture. If present, clean with soap and water 
and dry thoroughly. 
6.	 Install a clean cotton roll into the clear tube and position as shown below. 
7.	 Install a filter disc into the tube above the cotton roll. 
8.	 Apply silicone lube to the o-ring on the syringe head. 
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9. Reassemble the syringe handle to the head. 
10. Turn on the air and test the syringe. 
3.4.5.3 Pack-up 
Turn off the air to the compressor and bleed off any air in the syringe. Wrap the syringe in 
bubble wrap, and secure it to the air syringe holder using tape and velcro.  
3.4.6 Replacing Instruments 
The MEC will be equipped with 60 sets of dental instruments. One set of instruments will be 
used per SP. We are assuming about 20 SPs per day; so, the examiner will use about 20 sets each day. 
Since mirrors become scratched and explorers and probes become worn over time, defective 
instruments will be replaced annually during the field period. Mirror handles are not replaced during the 
study unless the need arises. 
New instruments will be shipped to the MEC as needed. Old instruments are to be sent back 
to the home office if they are in need of replacement. 
NOTE: Examiners should inspect instruments, equipment, and supplies daily. 
Damaged instruments, such as scratched mirrors should be returned to the home office and 
replaced. Completely unusable instruments, such as broken mirrors should be discarded in the 
sharps container. Remember: Instruments must be sterilized and the pointed edges carefully 
wrapped prior to sending back to the home office or disposing of them. 
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3.5
3.6 
 Examination Environment 
The instruments and dental supplies must be checked and organized at the start of each 
session. General guidelines for maintaining safety and efficiency in the dental examination room are: 
 Arrange equipment so that SPs can move easily and safely into and out of the room. 
 Electric cords must be under or behind the dental chair. 
 The SpeedClave is set up so as not to interfere with dental examinations. 
 Disinfecting solutions and other liquids must be covered and out of reach of SPs, 
particularly children. 
 The dental examination room must be kept clean. 
 The instrument sterilization packets are impervious to fluids and should be opened 
and placed in such a position that the packet becomes the instrument tray for the SP 
on which they are used. 
 Two plastic containers with lids for used instruments must be placed out of the 
examination environment. Used mirrors will be placed in one plastic container and 
used explorers, probes, rulers, and curettes in the other container. Other instruments 
must not be placed with the mirrors because they may scratch the mirrors. 
 The hazardous waste container lid must be closed except when depositing wastes. 
Infection Control 
The examiner is responsible for the infection control procedures described in this section; the 
recorder will not help with cleaning, sterilizing, or handling used instruments. The procedures for 
handling and sterilizing instruments and maintaining a safe examination environment are in compliance 
with regulations and recommendations of the Centers for Disease Control, U.S. Public Health Service, 
and the National Institute of Occupational Safety and Health.  
Appendix B presents infection control practices recommended for dentistry by the Centers 
for Disease Control and Prevention (CDC). The dentist is responsible for ensuring proper infection 
control practices in the dental examination room. 
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3.6.1 Prior to the Examination 
The following must be completed prior to the start of each session: 
	 Counter tops must be disinfected with an appropriate solution before arranging the 
instruments and supplies for daily use. 
	 Disposable barriers must be placed on the following items: chair cover, syringe, light 
head and controls, and mounted instrument tray. 
	 The examiner must wear a facemask, safety glasses with side shields, and a new pair 
of powder-free exam gloves for each SP examination.  
NOTE: If the examiner adjusts the dental stool or the mask or touches any object, 
other than ones that have been covered or disinfected during an examination, he or she must 
rescrub and put on a new pair of gloves. 
	 Examiners and recorders must wear neat and clean lab jackets or gowns in the MEC. 
Examiners are provided with disposable lab jacket which should be changed weekly, 
or more frequently if needed. Dental examiners should remove lab jackets before 
entering the staff lounge. 
	 Only properly sterilized instruments are to be used for dental examinations. 
	 The Restore holding solution should be prepared daily. 
3.6.2 After Each Examination 
The sequence of procedures for maintaining infection control between SP examinations is as 
follows: 
	 Used instruments will be deposited in the used instrument containers partially filled 
with the appropriately diluted solution of Restore. 
	 Soiled adhesive covers, syringe covers, chair covers, and instrument sterilization 
packets must be removed and thrown in the hazardous waste container prior to de­
gloving. 
	 Disposable air tips must be disposed of in the sharps container. 
	 Gloves should be turned inside out as they are removed and thrown into the hazardous 
waste container. 
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	 A disinfecting solution must be used on any surface that could have been 
contaminated during the examination. 
	 A disinfecting solution must also be used on the air syringe holder and the air syringe 
tubing. 
	 Hands must be washed with soap and water, and then be regloved. 
	 A clean chair cover should be placed on the mounted instrument tray with a new 
instrument packet. Do not set up the new instruments until the SP arrives in the room 
as the instruments may become contaminated if left out for a period of time. 
	 When not in use, instrument containers, utility gloves, instrument brushes, and any 
other supplies that come in contact with used instruments should be stored on the 
bottom shelf under the sink away from noncontaminated items. 
	 Examiners must remove their lab jackets when leaving the work area; lab jackets may 
not be worn in the staff lounge. 
3.6.3 After Each Session 
The biohazard bag needs to be taken to the MEC storage facility in the following manner: 
1.	 Seal the biohazard bag with tape; 
2.	 Wear gloves to transport the bag to the inside rear bay doors of the laboratory in 
trailer three; 
3.	 Open the bay doors and drop the bag to the ground; 
4.	 Remove the gloves and discard them in a biohazard bag in the laboratory; 
5.	 Take a new pair of clean gloves from the laboratory and walk outside to the back of 
trailer three; 
6.	 Open the belly compartment; 
7.	 Put on the clean gloves; 
8.	 Place the biohazard bag into the belly compartment; 
9.	 Remove the gloves and place them in the biohazard box in the belly compartment; and 
10.	 Lock the belly compartment. 
3-21	 (Revised January 2004) 
The chief medical technologist can address any questions about opening the inside rear bay 
doors in trailer three. 
3.6.4 Infection Control Supplies 
The infection control supplies and their specific uses are discussed in this section. This 
includes chemical solutions, disposable barriers, sterilization supplies, personal protection, and 
miscellaneous items. 
3.6.4.1 Chemical Solutions 
	 Surface disinfectants: Sani-cloths (1- to 5-minute exposure time); and 
	 Holding solution: Restore (10-minute exposure time; concentration of 1/4 oz. to 1 qt. 
water). 
3.6.4.2 Disposable Barriers 
 Disposable air syringe tips; 

 Chair covers;

 Instrument tray covers; 

 Syringe covers; and  

 Coverall adhesive barriers. 

3.6.4.3 Sterilization Supplies 
 Peelvue autoclave pouch; 

 Sterigage indicator; 

 Attest Biological Indicator Monitoring Kit; 

 SpeedClean autoclave cleaner; 
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 Distilled water; 

 Instrument brush; and 

 Dishwashing detergent. 

3.6.4.4 Personal Protection 
 Disposable lab jackets; 

 Masks; 

 Protective eyewear with side shields; 

 Gloves, latex or non-latex, one time use; and 

 Utility gloves (handling used instruments). 

3.6.4.5 Containers 
 Biohazardous waste container; and  

 Biohazardous sharps containers. 

3.6.4.6 Hand Washing 
 Paper towels; and 

 Liquid hand soap and/or waterless hand cleaner. 

The following list summarizes infection control supplies for use in the dental examination 
room: 
 Air syringe: plastic covers for syringe; disposable air tips; surface disinfectant for 
plastic tubing and the syringe holder; 
 Porta-Chair: plastic cover; surface disinfectant; 
 Light: adhesive barrier on head and controls; surface disinfectant; 
 Instrument tray: plastic chair cover; surface disinfectant; 
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	 Counter: surface disinfectant; 
	 Instruments: Restore holding solution; instrument brush; utility gloves; dishwashing 
detergent; paper towels; 
	 Sterilization: Peelvue autoclave pouches with sterigage indicator; spore test kit; 
SpeedClean; 
	 Waste: biohazard containers (waste and sharps); and 
	 Examiner: disposable lab jacket; mask; protective eyewear with side shields; single 
use gloves. 
3.6.5 Instruments 
All mirrors, explorers, probes, and endodontic rulers must be sterilized prior to first use and 
after each use. Having a sufficient number of sterilized instruments available for each examination 
session is the responsibility of the dental examiner. The examiner must wear Nitrile utility gloves 
whenever handling used instruments. 
To prepare instruments for sterilization: 
	 Remove the instruments from the holding solution. Discard the holding solution and 
rinse instruments in their container. Fill the containers with soapy water, using liquid 
dish soap. Place lids on containers and agitate. Scrub with a brush to remove any 
remaining blood or debris. Be careful to prevent cutting your hands while scrubbing 
contaminated instruments. 
	 Rinse instruments thoroughly to remove all foreign debris and soap. 
	 Pat instruments dry with paper towels. Thoroughly dry rulers and mirror heads with 
paper towels. Then set all instruments on the stainless steel tray to air dry overnight 
for complete drying before placing them in the Peelvue pouches. Endodontic rulers 
and mirror heads must be completely dry to prevent undue damage. 
3.6.6 SpeedClave 
Used instruments will be sterilized with a portable SpeedClave in the MEC. If the 
SpeedClave is not working properly, the examiner must inform the MEC manager immediately and, if 
necessary, a replacement SpeedClave will be sent to the field.  
3-24	 (Revised January 2004) 
3.6.6.1 Storage and Handling of Used Instruments 
	 Used instruments should be handled carefully to prevent transfer of microorganisms 
from the SP to the dental examiner. 
	 Immediately after instruments have been used, place them in a plastic container 
containing Restore. Keep the instruments in solution until you are ready to scrub them 
for sterilization. 
	 Instruments must be scrubbed and dried before they are packaged for sterilization in 
the SpeedClave. Extra care must be taken with the mirror heads and rulers. 
3.6.6.2 SpeedClave Set-up 
The SpeedClave should be placed on a level surface to ensure proper filling of water in the 
chamber. The far-left side of the counter in the dental room has been configured to properly hold the 
SpeedClave as follows: 
	 A minimum of a 2½" space must be available behind and on either side of the unit for 
proper air circulation. 
	 The wall cabinets have been built at least 25" above the top of the unit to provide 
space for filling the reservoir with water as well as for cooling processed trays. 
3.6.6.3 General Operation Information 
	 The pilot light blinks ON and OFF when the heater is in operation. If the light does 
not blink, check to make sure the timer is in the ON position. You may also need to 
check the electrical power supply line and the thermostat reset. 
	 The sterilizer is protected by an automatic low-water control, which will prevent the 
unit from operating without sufficient water. To return to operating conditions, add 
water and press the reset button. 
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3.6.6.4 Weekly Checks 
	 Check the water reservoir weekly. If the water level is below the FULL mark, fill the 
reservoir to this mark with distilled water. 
	 Adjust the temperature regulator during the setup operation by turning the temperature 
regulator knob fully counter-clockwise. This will give a maximum temperature of 
270° F. 
3.6.6.5 Placing Instruments in SpeedClave 
	 Self-seal paper bags for sterilizing the instruments will be used. Place one set of 
instruments and two pieces of gauze in each bag. Mirror heads and sharp points of 
instrument are placed at opposite ends of the bag, so that pointed instruments will not 
scratch the mirror head. By using this procedure you will keep sets of instruments 
sterile and can open bags of instruments as needed for the next day’s examinations. 
Gloves must be worn when handling sterilized instruments. 
	 Place bags on their sides on the tray. This will maximize steam circulation and 
facilitate drying. The diamond-shaped symbol on the paper bag changes color from 
blue to black to indicate that the sterilization process has been completed. 
	 Place one sterigage indicator strip on top of the instrument packs. 
NOTE: Several bags of instruments can be sterilized at once. Do not pack the bags too 
tightly on the tray since air circulation around each object is required for proper sterilization. 
3.6.6.6 Sterilization 
NOTE: The SpeedClave must never be left unattended while sterilization is in progress. 
	 With the door open, press the FILL/VENT lever down until the water level in the 
chamber is within ½" of the front rim. 
	 Place tray with the prepackaged instruments and the separate Sterigage indicator strip 
in the chamber. 
	 Close and latch door: swing the door assembly to the left until it stops in the almost 
closed position, then push the entire door to the right so that the right edge is fitted 
inside the chamber rim. The left side will follow. Swing the door handle all the way to 
the right to latch the door. 
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 Set the timer for 15 minutes to heat the water in the chamber. 
 When the pilot light goes out, and the gauge indicates that the sterilizing temperature 
has been met, reset the timer for 15 minutes. 
 An automatic timer will shut off the heater and a buzzer will sound for 1 minute when 
the cycle is complete. 
 Turn the timer knob counterclockwise to zero to turn the buzzer off. 
 Pull the door handle to the vent position, then hold the FILL/VENT lever down until 
the door pops inward and steam escapes. Release the FILL/VENT lever when the door 
pops inward. 
 Allow the sterilizer to remain in this position for 15 minutes to allow the instruments 
to dry thoroughly. 
 Open the door. NOTE: The instruments may require further drying at this point. 
They may be unloaded or kept in the chamber for further drying. 
 Allow at least 15 minutes before beginning the next cycle. 
3.6.6.7 Termination of Cycle Prior to Completion 
If the cycle is terminated before normal completion of the cycle, the red pilot light will go 
out and the temperature will drop. Usual causes for termination are (1) insufficient water in the chamber; 
(2) the door is opened during the cycle; (3) the proper temperature is not maintained; or (4) the circuit 
breaker is tripped. To correct the problem, test the system as follows: 
 Swing the door handle to the vent position and wait 15 minutes for the steam to 
dissipate. 
 Remove the load of instruments. 
 Check the water reservoir and fill it if necessary. 
 Check the water level in the chamber and fill it to ½" of the front rim, if necessary. 
 Close the door and press the reset button. 
If the test cycle completes without a malfunction, you can begin again to sterilize using new 
monitors and biologic indicator strips. 
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If the test cycle does not complete without a malfunction, rotate the timer to zero, which is 
the OFF position. Unplug the power cord. Do not open the door or attempt any other procedures. Inform 
the MEC manager. 
3.6.6.8 Maintenance 
3.6.6.8.1 Weekly 
Wipe all external surfaces with a soft, dry cloth. Wash them occasionally with a damp cloth 
and mild soap or detergent. Clean the door gasket and mating surface with a damp cloth. Examine the 
door gasket for possible damage that would prevent a good sealing surface. 
3.6.6.8.2 Mid-Stand 
Clean the sterilizing chamber. Drain the water from the reservoir. A petcock is located at the 
bottom of the unit to facilitate draining. Wash the inside of the chamber with mild soap and distilled 
water. Do not use abrasives or bleaching agents. Rinse with distilled water. Refill the reservoir with 
distilled water. 
3.6.6.8.3 End-of-Stand 
The system must be flushed at the end of each stand with SpeedClean Sterilizer Cleaner as 
follows: 
	 Mix 4 ounces of SpeedClean with 2 quarts of distilled water. 
	 Drain the reservoir and fill with the diluted cleaning solution. 
	 Run one 15-minute cycle at 250 degrees F. Instruments should not be sterilized at this 
time. 
	 Drain the cleaning solution from the chamber and reservoir. Fill the reservoir with 
clean distilled water and run two 15-minute cycles at 250 degrees F. 
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	 Drain the reservoir and allow the sterilizer to cool to room temperature. Remove the 
tray rack. Wipe out the inside of the chamber being careful not to damage the heating 
element. Wipe off the tray rack itself and replace in the chamber. 
	 Clean the gasket and channel. You may find a small brush helpful during this 
procedure. Clean and inspect the gasket for damage and replace if necessary. 
	 The gasket may need to be lubricated at the end of each stand. If this is necessary, the 
supplies and instructions will be forwarded to the examiners. 
	 Gaskets will be replaced twice a year. 
3.6.6.9 Repair 
If the SpeedClave needs repair, inform the MEC manager immediately. 
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3.6.6.10 Documentation 
Sterilization of instruments and maintenance of the autoclave must be documented in the 
ISIS quality control system. This is located in utilities. The information required is under the end of 
session QC. It should be filled out the day the instruments are sterilized. 
3.7 Spore Tests 
The dental examiner must conduct a spore test on the SpeedClave weekly using the Attest 
biological indicators. These indicators contain bacillus steraothermophilus spores, which are especially 
resistant to the steam sterilization process. Following the sterilization cycle, the vial is crushed which 
provides media to promote growth of any spores not killed during the sterilization. A color change on the 
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indicator will inform you whether the sterilization process was successful. Gloves and safety glasses 
should be used at all times when handling these indicators. Complete the weekly test by using the 
following procedures: 
3.7.1 Processing 
	 Place one Attest steam biological indicator in the center of an empty “test” Peelvue 
instrument bag. 
	 Place this test pack on a tray loaded with instruments. Placement should be in the 
most difficult area for steam to reach in the load; i.e., the middle of the tray.  
	 Process the load according to routine sterilization procedures. 
	 After the cycle is completed, wait a minimum of 5 minutes after the sterilizer door has 
been opened fully before removing the test pack.  
	 Remove the test pack from the sterilizer. Open it and allow the heat to dissipate prior 
to removing the biological indicator. 
	 Allow the biological indicator to cool outside the test pack for 10 minutes. 
	 Check the biological indicator label for a color change from rose to brown. Check the 
chemical integrator for an ACCEPT result. (An incomplete color change on the 
biological indicator label or a REJECT result on the chemical integrator may indicate 
an inadequate sterilization process.) 
	 Incubate the sterilized biological indicator along with the control indicator (see 
Section III) as soon as possible. Place the bottom of the indicator vial into the 
incubator at a 45-degree angle. Then push the vial straight back. This crushes the vial 
and activates the indicator. Push the “activated” indicator vial down until it is firmly 
set in the incubator. The cap should remain above the metal block. 
3.7.2 Interpretation 
	 Examine the biological indicator at the following intervals: 8, 12, 24, and 48 hours. A 
yellow color indicates an inadequate sterilization process. No color change indicates 
an adequate sterilization process. 
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	 The final determination of successful sterilization can be made at the 48-hour 
incubation mark. Be sure to time the incubation so that you are in the MEC at the 48­
hour time period. 
	 Record the results in the ISIS quality control system. 
3.7.3 Use of Controls 
	 Place a nonsterilized Attest biological indicator in the incubator at the same time you 
place the sterilized indicator into the incubator. This nonsterilized indicator acts as a 
“positive” control. 
	 Examine the positive control at the same intervals as the test indicator. In this case, a 
yellow color indicates correct incubation, viability of spores, and capability of the 
media to support rapid growth. 
	 Record the results in the ISIS quality control system. 
	 Dispose of used positive indicators by sterilizing them for at least 10 minutes at 270 
degrees and then discarding them in the biohazardous waste container. 
3.7.4 Reporting Results 
Results of the “test indicator” and the “positive control” incubations are to be recorded in the 
ISIS quality control system under the weekly tab. Include the following information: 
	 Load: Since the spore tests are done on a weekly basis but you will be sterilizing 
more than once per week, you must indicate the load in which the test was done. For 
example, if you performed the spore test on the first load that was sterilized that week, 
record “1”; if you performed the spore test on the second load that was sterilized that 
week, record “2”; and so on. 
	 Start Date: Record the day you began the test, which is the day you sterilized the test 
indicator. 
	 Start Time: Record the time of day you began the test in hours and minutes. Be sure 
to specify “a.m.” or “p.m.” Do not use military time. 
	 End Date: Record the day you ended the test, that is 48 hours after the test was 
completed OR the day the test indicator first indicated a problem. 
	 End Time: Record the time of day you ended the test in hours and minutes. Be sure to 
specify “a.m.” or “p.m.” Do not use military time. 
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	 Control: Record whether the result was “+” (yellow) or “-” (no color change) or 
“NA” (indeterminate-problem with the test). 
	 Test: Record whether the result was “+” (yellow) or “-” (no color change) or “NA” 
(indeterminate-problem with the test). 
	 Lot #: Record the lot number of the spore vials used during the test. 
	 Comments: Use this space to record any unusual circumstances, such as a problem 
with the test (i.e., the biological indicator on the test strip indicates that the test was 
rejected). 
NOTE: You must have a “+” control result and “-” test result to continue using the 
autoclave to sterilize instruments. 
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Inform the MEC manager immediately if the test indicator results are positive. Perform a 
second spore test if there is any problem with the initial test, i.e. the control indicator results are negative, 
using two control vials, one from the same lot and one from a different lot. This will help isolate whether 
there is a problem with the autoclave, incubator, or vials. Inform the MEC manager immediately if you 
are unable to obtain an acceptable test result, either negative or positive, after the second spore test. 
Unusual Occurrence 
Whenever an action is taken that is not documented elsewhere, it should be reported in the 
unusual occurrence log. This is a Word document on the computer. This document should be completed 
in the event of an unusual occurrence. Once completed, two copies will be printed—one to be left on the 
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3.8 
MEC and the other sent by facsimile to Westat. Examples of actions requiring the use of the unusual 
occurrence log include the following:  
 Maintenance or repair of dental instruments; 

 Maintenance or repair of dental equipment;  

 Replacement of dental instruments; 

 Replacement of dental equipment; and 

 Anything not recorded or reported elsewhere. 
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4. ORAL EXAMINATION METHODS 
The oral examination component consists of a questionnaire and clinical examination sub­
components. The dentist examiner and dental recorder work as a team in conducting this examination for 
each study participant (SP).  
Questionnaire and clinical examination data are entered by keyboard directly into computer 
terminals at the examination site. The procedures for recording into the Integrated Survey and 
Information System (ISIS) are discussed in the Dental Recorders Procedures Manual. 
4.1 Sequence of Oral Examination Components 
All SPs aged 2 years and older are eligible for some part of the examination.  
Exhibit 4-1 lists the oral examination subcomponents in the order they are conducted. 
Included on the table are the eligible ages of the SP for each examination component and whether the 
component triggers a referral for care. The examination procedures and methods are discussed in the 
following sections. 
The assessment sequences of the examination follow the sequences shown on the ISIS 
screen. Each examination component has its own sequence.  
4.2 Pre-examination Procedures 
1.	 The examiner or recorder will select the Dental Examination icon from the 
introductory window on the automated system at the start of a session.  
2.	 The examiner will enter his/her password when prompted. 
3.	 The recorder will open a new examination when a SP has been assigned to the room. 
4.	 The recorder will enter his/her tech password when prompted. 
5.	 The recorder will pass the optical scan wand across the SP’s identification bracelet 
and then verify the SP’s name and identification number displayed on the screen. 
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Exhibit 4-1. Guide to oral examination components 
Assessment Age Referral Match 
1- ELIGIBILITY AND 
DENTAL CONDITION 
Medical Exclusion Questions 13+ No 
Dental Condition Questions 16+ No 
2 – DENTITION 
Denture Questions 25+ No 
Tooth Count 2+ No 
Caries: Coronal Surface 2+ Yes 
Caries: Root Surface* 18+ Yes 
Sealants 2-34 No 
Fluorosis - Dean’s Index 6-49 Yes 
Incisor Trauma 6-29 Yes 
Tooth Wear Scores 13+ No 
Functional Occlusal Contacts Index 25+ No 
3 – PERIODONTAL 
Loss of Attachment* 13+ Yes 
Bleeding on Probing* 13+ Yes 
4 – RECOMMENDATION FOR CARE 
Instrument Packs 
#5 Reflecting Mirror 
#23 Explorer 
Hu Friedy PCP-2 (2-4-6-8-10-12) Periodontal Probe 
Endodontic Ruler 
* Not to be performed if there is a medical exclusion. 
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4.3 
6.	 The examiner will explain the process to the SP in his/her own words and include the 
following facts: 
- This dental examination is not a substitute for examinations performed by the 
SP’s dentist. 
-	 You will be looking at and lightly touching the SP’s teeth. 
- You will be calling numbers and letters to the technologist that only have 
meaning for this research project. 
-	 Some general results will be provided when the SP leaves the MEC. 
In conducting the examinations, each SP will be examined in the same manner. An examiner 
will avoid the temptation of examining an SP who appears to be highly susceptible to a condition more 
thoroughly than an SP who appears less susceptible. 
Answering Study Participant Questions 
It is very important that the dental examiner answer questions raised by the SPs. Some of 
their concerns about the dental exam and appropriate responses might be: 
	 Treatment. If the SP asks, assure him/her that the exam will not include treatment, 
X-rays, a drill, or anesthesia. The dentist will use only a mirror and dental hand 
instruments to examine the mouth. 
	 Qualifications of the examiner. The examiner is a licensed dentist. 
	 Existing dental work. The exam will not interfere with any existing dental work such 
as fillings, bridges, sealants, or orthodontic bands. The examiner may ask the SP to 
remove any complete or partial dentures for intra-oral inspection. 
	 AIDS (Acquired Immune Deficiency Syndrome). The Centers for Disease Control, 
part of the Public Health Service, has set up standard practices (universal precautions) 
for dentists to use to prevent the spread of diseases, viruses, and bacteria, and these 
procedures are strictly observed by the dentists on this study. The dentist will wear 
sterile gloves and a mask, and the dental instruments will be sterilized before 
examinations are preformed. The precautions used in the survey are the same as those 
maintained in dental offices. 
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4.4 Guide to the Integrated Survey and Information System (ISIS) 
The dental recorder is responsible for entering dental “calls” directly into ISIS during the 
examination. Detailed instructions for proceeding through each screen are provided in the Recorder’s 
Manual. The ISIS screens are organized as follows: 
	 Demographic Information: On the bar located at the top of the screen, the SP ID, 
name, age, gender, and the examination date and session time are displayed. 
	 Heads Up Display: This is a summary screen that is displayed in the upper portion of 
the screen after the Tooth Count is completed.  
Space for each surface of each tooth is provided and conditions, such as caries and 
restorations, are indicated with different symbols as entered by the recorder. The mouth diagram is shown 
as if the examiner is facing the SP with the central incisors of each quadrant in the middle of the diagram 
and the third molars at each end. Tooth surfaces are displayed in the pattern commonly used in diagnostic 
charts and are defined as follows:  
 Occlusal - top or biting surface; 

 Lingual - surface toward the tongue; 

 Facial (Buccal)- surface outside, toward the lips and cheeks; 

 Mesial - interproximal surface towards the midline of the arch; and 

 Distal - interproximal surface away from the midline of the arch. 

Tooth condition symbols are as follows: 
Circle, black = Permanent tooth 
Circle, small, black = Primary tooth 
Circle with slash, red = Missing tooth 
Circle with “I”, red = Implant 
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Surface condition symbols are: 
Bullet, red = Caries 
Shading, gray = Restoration 
	 Examination Data Entry: The various examination data entry screens have the 
following similarities: 
-	 Each row represents a quadrant or portion of a quadrant. 
- The quadrants are displayed in the following order: upper right, upper left, 
lower left, and lower right. 
- The data entry spaces correspond to the teeth being examined in that quadrant 
for that assessment. 
- The teeth are identified with codes along the top of the row to identify the teeth 
as follows: 
CI = Permanent Central Incisor/Primary Central Incisor 
LI = Permanent Lateral Incisor/Primary Lateral Incisor 
C = Permanent Cuspid/Primary Cuspid 
1B/1PM = 1st Bicuspid/1st Primary Molar 
2B/2PM = 2nd Bicuspid/2nd Primary Molar 
1M = 1st Permanent Molar 
2M = 2nd Permanent Molar 
3M = 3rd Permanent Molar 
4.4.1 General Data Entry Guidelines 
This section summarizes key data entry guidelines. Detailed instructions are available in the 
MEC Subsystem Overview Manual (see Appendix E). Directions regarding allowable codes, acceptable 
ways to move through a screen, allowable shortcuts, and mandatory QC checks by screen are provided in 
this chapter. 
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Movement within the dental examination program can be accomplished by using the mouse 
or the keyboard. In most instances, using the keyboard is easier and more efficient. The keys are to be 
used in the program as follows: 
TAB 	 Use this key to move forward from data entry field to data entry field 
within a screen whenever the program does not automatically move from 
field to field for you.  
Shift TAB 	 Use this key to move backwards from data entry field to data entry field 
within a screen. 
Backspace	 Use this key within a data entry field to erase an entry backwards, one digit 
at a time. 
Enter 	 Use this key to move to the next screen after all allowable entries are made 
on the current screen. 
F2 	 Use this key as a shortcut on two assessments, dental sealants and 
fluorosis. 
F11 	 Use this key to clear data on a screen and restart the assessment.  
F12 	 The F12 key allows you to skip one or more assessments but still complete 
the “Recommendation for Care” section. 
It is to be used only when you cannot collect data for a certain screen. It 
can be used for the following assessments; coronal caries, sealants, 
fluorosis, trauma, tooth wear, functional occlusal contacts, and periodontal 
assessment. 
The mouse is used in a variety of ways as follows: 
	 To move the cursor to any data entry field within a screen; 
	 To display a list of allowable responses on a “pick list” by clicking on the down arrow 
(∇) to the right of the data entry field; 
	 To activate shortcuts by clicking on a box which will trigger fields to be filled or 
shaded, as appropriate; 
	 To move to the next screen after all allowable entries are made on a screen by clicking 
on the right arrow button on the lower right portion of the screen. 
Improper entries will cause the system to beep, display an error message in the lower left 
portion of the screen, and prohibit movement within the screen until a valid response is entered. If 
necessary, the recorder should provide the examiner with the explanation of the error as defined in the 
error message. 
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In some instances, a “9” will appear in one or more shaded data entry fields on a screen 
when the screen is initially displayed. This code is termed a “hard 9” and is triggered by specific codes 
entered on the Tooth Count screen. The program does not allow the recorder to overwrite the “9” with 
any other code. ISIS will skip these fields and the cursor will move to the first blank field on the screen. 
To change this hard “9,” the tooth count code for that tooth must be changed on the Tooth Count Screen. 
4.4.2 Editing the Examination Record 
ISIS automatically edits responses as the recorder enters them. Below are a few of the edits 
that the system provides. 
 Range Edit Checks: The system checks to make sure that the value entered by the 
recorder is valid. 
 Tooth Count Edit Checks: The system checks against the tooth count calls during all 
subsequent assessments. This ensures calls are consistent across assessments, i.e., 
teeth coded as missing in the tooth count are not assessed in most of the subsequent 
assessments, and primary teeth are not assessed in subsequent assessments that only 
look at permanent teeth (i.e., incisor trauma). 
When the system determines that a tooth should not be assessed for a particular 
component based on the tooth count results, the tooth space on the screen is shaded 
and “hard coded” with a “9” (cannot be assessed) code. 
 “Hard” 9 Checks: The system does not allow the recorder to overwrite a “hard” 9 
code with another code. “Hard” 9 codes are determined by the system as a result of 
the tooth count. 
4.4.3 Section Status Screens 
After each component section (medical exclusions and dental conditions, dentition, 
periodontal, and recommendation for care), a status screen is displayed which is used to document the 
outcome of the section. The screen consists of two parts: The first one is used to record an overall 
completion code and the second is used to record the reasons for incomplete exams. 
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The overall completion code is automatically assigned by the system based on the data 
entered during the course of the dental examination. One of three outcomes is selected:  
 Complete; 

 Partial complete; and 

 Not done. 

Whenever a “partial complete” or “not done” outcome is assigned, ISIS prompts the recorder 
to enter a reason for the incomplete exam. There are nine choices the recorder can select from. These 
choices are standard throughout the survey and are listed below. 
1.	 Safety exclusion 
2.	 SP refusal 
3.	 No time 
4.	 Physical limitation 
5.	 Communication problem 
6.	 Equipment failure;  
7.	 SP ill/emergency; 
8.	 Interrupted; and 
9.	 Other (Specify) - If “Other specify” is chosen, the “Other text” field is enabled and the 
recorder must enter a comment in order to continue. 
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4.4.3.1 Sample Section Startup Screen 
4.4.4 Examination Break-offs 
There are several types of examination break-offs. In the first scenario, you may need to 
clear an assessment and restart it. In the second scenario, you may need to break-off during a particular 
assessment and still continue with the examination. In the third scenario, you may need to break-off 
during a particular assessment and cancel the rest of the examination. The procedures to be followed for 
these situations are provided in this section. 
4.4.4.1 Clearing a Screen 
There are various reasons for clearing a screen. For example, the examiner inadvertently 
calls the codes for one assessment while the recorder is entering data on another screen, or the examiner is 
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calling assessments for a particular tooth and the recorder is entering that call for a different tooth. If the 
situation cannot easily be resolved, the screen is cleared and the assessment is restarted using the F11 key. 
If the F11 key is used on any screen other than the Tooth Count screen, only the data on the 
selected screen is cleared. However, if the F11 key is used on the Tooth Count screen, all data on the 
Tooth Count screen as well as data on the following screens are cleared. This is because the tooth count 
calls drive subsequent assessments. 
4.4.4.2 Canceling an Assessment 
There are times when an assessment must be interrupted before it is completed but the 
examination can continue (for example, the SP experiences pain in gingival bleeding but is still eligible 
for loss of attachment). In these situations the recorder presses the F12 key to end the assessment, 
regardless of how much has been completed, and continues with the next assessment. All data entered on 
the screen prior to the use of the F12 key are saved. Specifications for using the F12 key are provided in 
the Recorders Manual (Section 3.3.1). 
4.4.4.3 Canceling an Examination 
There may be situations when an examination is terminated early i.e., the SP faints, the 
session ends, or the MEC shuts down for weather reasons. To cancel an examination before it is finished, 
the recorder uses the <CLOSE EXAM> button on the navigation bar as specified in the Recorders 
Manual. 
Note: All data entered up until the point you exited is saved. The “Open an Existing 
Examination” icon on the toolbar is used to reenter the examination. The Medical Exclusion 
Questionnaire is displayed to remind you of the pertinent exclusion information. Then the program 
requires the user to scroll forward through the screens until the first blank screen or partially 
blank screen, depending on how you exited, is displayed. The examination is continued from this 
point forward. 
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4.4.5 Exiting an Examination 
The <FINISH> button on the navigation bar is used to exit an examination once the SP 
specific assessments are completed. This button is only enabled when the Recommendation For Care 
status screen is completed; it is not enabled on any other screen. To exit the examination on any other 
screen, the <CLOSE EXAM> button is used as specified in the previous section. 
4.5 Medical Exclusion Questionnaire 
The medical exclusion questions will be asked of all SPs aged 13 years and older. The 
purpose of this questionnaire is to identify SPs who should be excluded from portions of the oral health 
examination for their personal safety. 
The Medical Exclusion Questionnaire (Exhibit 4-2) asks about medical conditions that may 
preclude the SP from participating in some components of the oral exam. If there are no medical 
exclusions for the SP, all questions were answered “No,” then all age-appropriate assessments are 
performed. However, if there is at least one “yes” answer to a medical condition that leads to a medical 
exclusion, then all of the age appropriate assessments are performed except the root caries and 
periodontal assessment. ISIS is designed to skip these assessments as appropriate. 
It is the examiner’s responsibility to ask the medical exclusion questions directly of all SPs 
aged 16 years and older. Medical exclusion information will be obtained from SPs aged 13-15 years via 
proxy interviews conducted by the MEC manager. The hard copy Proxy Questionnaire will accompany 
the SP to the dental room for the dental examiner to review and the recorder to enter in ISIS. 
Answers of “Don’t know” will be coded as “No” whenever “Don’t know” is prohibited as a 
valid data entry response. Answers of “Refused” will not be accepted. Probe all “Refused” responses until 
an acceptable answer (“Yes” or “No”) is obtained. 
NOTE: A positive response to Q2 does not indicate a medical exclusion; rather it 
indicates that Q3-Q6 must be asked. A positive response to any of the specific conditions asked 
about in Q3-Q6 will generate a medical exclusion based on a heart condition. 
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Exhibit 4-2. Medical Exclusion Questionnaire 
NOTE: The remainder of the Medical Exclusion Questionnaire is not asked once a 
positive response to a medical exclusion item is given. For example, if the SP answers “yes” to Q6, 
do not ask Q7-Q11. 
NOTE: The questions on hemophilia (Q9) and pacemakers (Q10) will not be asked here 
if the information is obtained elsewhere, such as in the household interview or other exam 
components. Answers provided elsewhere will appear on the screen when the screen is initially 
displayed. Therefore, only ask these questions if they are highlighted on the screen as this indicates 
that the information is still pending. Because these are “shared” medical exclusion items and 
“Don’t Know” responses are accepted in other components, acceptable answers for these items are 
“Yes,” “No,” and “Don’t Know.” Answers of “Don’t Know” will be treated as “No” by ISIS. 
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4.6 Dental Condition Questions 
Understanding the determinants that promote underutilization of dental care is important for 
promoting a community’s oral health status. This brief module of questions will provide information from 
perceived overall oral health status to ascertain existing dental conditions or problems to allow for future 
comparative research with clinical oral health status. 
4.6.1 Examination Procedure 
This Dental Condition Questionnaire is administered to all SPs aged 16 years or greater by 
the dental examiner. The purpose of this questionnaire is to ascertain a perceived general assessment of 
the condition of the mouth and reasons associated with utilization of dental care. A “good” or “poor” or 
“fair” response to the perceived overall condition of the mouth will lead to a question about perceived 
problems/reasons. A positive response to the inability to access care when needed leads to a question 
about reasons why care was not accessed. The dental examiner will read the questions to the SP and will 
relay the appropriate codes to the dental recorder. The sequence of the questions is as follows: 
The dental examiner states: 
“Now I have some questions about your teeth.” 
(Q1) How would you describe the condition of your teeth? Would you say… 
1 – Excellent,

2 – Very Good,  

3 – Good, 

4 – Fair, or 

5 – Poor?  

7 – Refused 

9 – Don’t Know 

{If response is “good” or “fair” or “poor” to Q1, go to Q2; if not skip to tooth count.} 
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(Q2) What specific problems do you have with your teeth?  
1 – Toothache 

2 – Sensitivity

3 – Cavities / Caries 

4 – Broken / Missing Fillings or Restorations 

5 – Broken / Fractured Teeth 

6 – Staining / Discoloration of Teeth 

7 – Crooked Teeth / Need Braces 

8 – Teeth Needing Extractions

9 – Missing Teeth 

10 – Denture Problems 

11 – Periodontal Related Problems 

12 – Unsatisfactory Prior Dental Experience 

13 – None / No Specific Problem 

14 – Other 

77 – Refused 

99 – Don’t Know 

4.6.2 Recording Procedures 
The dental examiner uses the Dental Condition Questionnaire crib sheet to read the questions 
to the SP. The dental examiner receives the SP responses and dictates the appropriate codes to the dental 
recorder for the questionnaire. The examiner will obtain this information directly from the SP. 
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4.7 Denture Questions 
SPs aged 25 years and older receive the denture questionnaire subcomponent. This 
component consists of a series of questions asked by the examiner to the SP regarding complete or partial 
denture use. Two questions relate to maxillary denture use and two questions relate to mandibular denture 
use. The objectives of the subcomponent are to: 
 Determine the prevalence of complete and partial dentures among adults including 
important sociodemographic subgroups. 
 Determine type of replacement with tooth loss patterns (in conjunction with the 
coronal caries assessment). 
 Determine the percentage of people who routinely use complete and partial dentures. 
 Provide a basis for comparisons with past and future national estimates for denture use 
in the United States. 
 Provide useful information for training programs specializing in dental prosthetics. 
With minor modifications, these denture questions have been used in several surveys, 
including NHANES III. Data were collected in NHANES III on complete denture prevalence, their 
conditions and their use. 
4.7.1 Examination Procedure 
After administering the dental condition questions, the examiner will read the following 
introductory text to the SP: 
“I am now going to ask you some questions about full and/or partial removable denture (i.e. 
plate or false teeth) use. A full denture (plate) is a replacement for either all of your upper or 
lower teeth. A partial denture replaces only some of your upper or lower teeth. Both a partial 
or a full (plate) denture can be removed from the mouth or placed in the mouth by yourself.” 
The examiner will then ask up to a series of four questions based upon the presence or 
history of denture wear. The first question (Q1) that the examiner will ask is “do you have an upper 
removable partial or full denture?” If the SP responds affirmatively, the examiner dictates a call of “yes” 
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to the recorder and asks the second question. If the SP responds with a “no,” the examiner dictates a call 
of “no” to the recorder and proceeds to the third question, skipping the second question. The second 
question (Q2) to be asked is “Do you usually wear it during the day?” 
The third question (Q3) that the examiner will ask is “Do you have a lower removable partial 
or full denture?” If the SP responds “yes,” the examiner dictates a call of “yes” to the recorder and asks 
the fourth question. If the SP responds with a “no,” the examiner dictates a call of “no,” and the denture 
question section is completed. The fourth question (Q4) to be asked is “Do you usually wear it during the 
day?” 
4.7.2 Scoring Codes 
The codes for each of the four denture questions are the same and are as follows: 
Y = Yes 
N = No 
R = Refused 
D = Don’t know 
4.7.3 Guide to Referral and Follow-up 
The examiner is to use his/her own professional judgment about referring SPs with apparent 
removable prosthetic needs. A recommendation for dental prosthetic referral is provided as a category (E) 
in the level of care and recommendation section, which is later described in this chapter. 
4.7.4 Recording Procedures 
The recorder uses the Denture Questionnaire screen to record the examiner’s calls as the SP 
responds to the questions. There may be two to four questions asked depending on previous answers 
provided by the SP to the examiner. 
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4.8 Tooth Count 
4.8.1 Examination Procedures 
SPs 2 years and older receive this examination which assesses the number of primary and 
permanent teeth, and the presence of surgical implants. Information on surgical implants is obtained from 
preliminary questions asked by the examiner. The dentist examines the SP utilizing any guidance 
provided during the questioning. 
The Tooth Count Assessment involves examining the maxillary arch and the mandibular 
arch to identify the presence or absence of permanent and/or primary teeth as well as the presence of 
permanent dental roots in each tooth position of the mouth. There are 32 tooth positions in the mouth, 
including the third molars. The maximum number of permanent tooth spaces that can be indicated is 32. 
The maximum number of primary tooth spaces that can be indicated is 20. Tooth spaces must be 
examined in the following order: Maxillary right quadrant, maxillary left quadrant, mandibular left 
quadrant, and mandibular right quadrant. Within each quadrant, the examiner should begin with the 
central incisor space and move posteriorly in order to the third molar space using the surface reflecting 
mirror and the #23 explorer. 
The codes used for the tooth count calls are listed below. Only one code per tooth is to be 
entered. 
1 = Primary tooth (deciduous) 
2 = Permanent tooth 
3 = Implant 
4 = Tooth not present 
5 = Permanent tooth root 
4.8.1.1 Surgical Implants 
Surgical implants are posts surgically placed through the gingival tissue into the jawbone 
and are typically capped by a prosthetic tooth. Implants may replace a single tooth or may replace 
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multiple teeth in longer segments of a dental arch. There may be more missing teeth restored with pontics 
than there are implants, similar to a traditional fixed bridge. The surgical implant question will be asked 
for SPs age 10 and older. 
Surgical implants may be used to replace specific teeth or to support fixed or removable 
appliances. Surgical implants may be difficult to detect without suitable radiographs. Therefore, in 
addition to the clinical assessment, questions must be posed to all SPs to determine whether implants are 
present. Information for children may be obtained from an adult responsible for the child being examined. 
The examiner should ask the question in the following way: 
“Do you/does does (SP name) have one or more teeth that are missing, or were 
removed, and have been replaced with a surgical implant?”  
If the SP responds, “Don’t know,” repeat the question and define implants as follows:  
“Surgical implants have a post surgically placed through your gum and into the bone 
and are often capped by an artificial tooth or bridge.”  
The answer to this question must be called to the recorder. If the SP’s, or responsible adult’s 
response to this question is “Yes,” the following questions will be asked: 
 Do you know how many surgical implants you/SP’s name have/has in your/his/her 
mouth? 
 Can you point to the area of your/(SP’s name) mouth where the surgical implant(s) 
was/were placed? 
The SP may be able to indicate the exact tooth position or the general location of the 
implant. If the SP or responsible adult indicates a “Yes” response, encourage the SP or responsible adult 
to indicate where in the mouth the surgical implants are. The dental examiner should then examine the 
whole mouth for implants. 
If the SP does not know whether they received a surgical implant or not, go over the fact that 
this is a procedure where the implant is surgically (emphasis on surgically) implanted into the bone. If 
they still do not know, then answer NO, and the Dental Examiner should do a thorough examination of 
the mouth with verbal probing to see if there is an implant. The implant box can be checked and 
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unchecked at any point in the tooth count. The Recorder cannot proceed if the implant box is checked and 
there is not at least one “3”. 
The location of the implant is called during the tooth count assessment along with the other 
codes. If a tooth space has been replaced with a surgical implant, a code of “3” is assigned for that space; 
otherwise, a code of “1,” “2,” or “4” is assigned to the tooth space, as appropriate. 
If through the examination the examiner determines no implants are present, then he/she 
should tell the recorder to uncheck the implant box on the tooth count screen. 
4.8.2 Guidelines for Scoring 
again. 
To assist with the guidelines listed below, the codes used in the tooth count are listed below, 
1 = Primary tooth (deciduous) 
2 = Permanent tooth 
3 = Implant 
4 = Tooth not present 
5 = Permanent tooth root 
1. A tooth is considered to be present if any part of its crown projects through the gum. 
2. If a permanent and a primary tooth are visible in the same tooth space, the permanent 
tooth is assigned to the tooth space. 
3. In instances of supernumerary teeth, the examiner must decide which tooth is the 
“legitimate” occupant of the space. 
4. Orthodontic extractions - First bicuspids are often extracted as part of orthodontic 
treatment. These teeth are coded as missing (“4”). For the sake of uniformity, all bicuspids extracted for 
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orthodontics are scored as first bicuspids. The examiner must make the determination that the teeth were 
in fact extracted for orthodontic reasons. This is usually not difficult to detect because of the symmetric 
pattern of orthodontic extractions. The examiner should confirm this with the SP prior to coding the teeth. 
5. When the primary tooth crown is destroyed by caries and only the roots remain, score the 
tooth as present (“1”). 
6. When the permanent tooth crown is destroyed by caries or trauma and only the roots 
remain, score the tooth as permanent root present (“5”). A permanent tooth that has a replacement for the 
appropriate coronal structure or serves as a support structure for an overdenture will also be scored as “5.” 
4.8.3 Recording Procedures 
The recorder first enters the code called by the examiner for the question about surgical 
implants. The recorder then uses the next screen, the Tooth Count screen, to enter the tooth count calls 
made by the examiner. 
NOTE: It is extremely important that the correct calls be made by the examiner and 
entered correctly by the recorder on this screen, as the outcome of this assessment determines how 
other assessments are performed and coded. For example, root caries, dental fluorosis, and 
traumatic injuries are assessed only on permanent teeth as defined in the tooth count. 
Whenever a call in the Tooth Count precludes a later assessment, such as primary teeth not 
eligible for The Incisor Trauma assessment, the program automatically shades the affected tooth in the 
subsequent assessment. A “Cannot be assessed” code is also automatically displayed in the shaded data 
entry space. This code is “9” and the shaded “9” code is termed a “hard 9.” The program does not allow 
the recorder to overwrite the “9” with any other code. In subsequent assessments, ISIS will skip these 
tooth positions and the cursor will move to the first blank tooth space. To change this hard “9,” the Tooth 
Count code for that tooth must be changed on the Tooth Count Screen. 
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In addition, the following apply to SPs who are edentulous or have implants: 
1.	 There is a variable on the screen labeled “Implant” which must be checked if the SP 
reports an implant. Simply recording a “3” on the tooth spaces will not suffice for 
coding the SP as having an implant. 
2.	 There is a variable on the screen labeled “Edentulous” which must be checked if the 
SP is edentulous. Simply recording all “3s” and “4s” in the tooth spaces will not 
suffice for coding the SP as edentulous. 
3.	 If an edentulous SP has an appliance supported by implants, the implant box and 
edentulous box must be checked on the screen. When the edentulous box is checked 
on a SP who answered yes to the implant question, the system will automatically enter 
“4” in all tooth spaces. Prompt the recorder to change the mandibular cuspids to “3” to 
record the presence of implants, regardless of the placement of the implants. 
4.	 Natural teeth used as an overdenture abutment would be coded as a “5” followed by a 
“T” for the coronal caries assessment. 
Root tips are classified as any permanent residual tooth structure that is predominately 
composed of dental root structure with less than 90 percent of the CEJ visible, with less than 90 percent of 
the coronal structure visible, and occupies a dental position within the dental arch. Because multi-rooted 
posterior teeth may present as multiple root tips, examiners will assign multiple root tips to the 
appropriate dental position in the arch and code accordingly. 
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4.9 Dental Caries 
The objectives of the dental caries component of the survey are to: 
 Establish age-specific data for the prevalence of dental caries, both coronal and root, 
in a national sample; 
 Provide a basis for comparisons with past and future national dental caries surveys; 
 Provide baseline data for possible follow-up of selected subsamples; 
 Provide a basis for the development of estimates of treatment needs; and  
 Provide a basis for studying the association between the prevalence of dental caries 
and risk factors. 
There are two parts to the dental caries assessment: coronal caries and root caries. With 
certain exceptions, diagnostic criteria for the coronal caries examinations are those developed by Radike, 
et al., as published in the Proceedings of the Conference on Clinical Testing of Cariostatic Agents, 
sponsored by the American Dental Association in 1968. With minor modifications, the diagnostic criteria 
for coronal caries have been used in several statewide surveys and in the following national surveys: 
 National Health and Nutrition Examination Survey I (NHANES I) (1970-74); 
 National Institute of Dental Research (NIDR) National Dental Caries Prevalence 
Survey in U.S. School Children (1979-80); 
 Hispanic Health and Nutrition Examination Survey (Hispanic HANES); 
 NIDR National Survey of Oral Health in U.S. Employed Adults and Seniors 
(1985-86); 
 NIDR National Survey of Oral Health in School Children (1986-87); and 
 National Health and Nutrition Examination Survey III (NHANES III) (1988-1994). 
The diagnostic criteria for root caries were used in the following surveys: 
	 NIDR National Survey of Oral Health in U.S. Employed Adults and Seniors 
(1985-86); and 
	 NHANES III. 
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4.9.1 Coronal Caries Assessment 
Each SP aged 2 years and older receives the coronal caries assessment. All teeth except the 
third molars are assessed. 
4.9.1.1 Examination Procedures 
Each quadrant is dried with air and examined with a surface reflecting mirror and a No. 23 
explorer. The examiner begins the assessment in the maxillary right quadrant with the right central incisor 
and continues distally through the second molar in the same quadrant. The same sequence is followed for 
the upper left, lower left, and lower right quadrants. Tooth surfaces are examined in the following order: 
lingual, facial (buccal), mesial, and distal for anterior teeth, and lingual, occlusal, facial, mesial, and distal 
for posterior teeth. It is not advisable to call out the individual tooth surface codes until the surfaces of the 
whole tooth are examined, as this can be confusing to the recorder. Thus, the examiner will mentally 
accumulate surface calls for a given tooth, then dictate the calls to the recorder. 
4.9.1.2 Scoring Codes 
The codes characterizing a whole tooth condition are referred to as “tooth calls.” The 
allowable codes are as follows: 
S = Sound permanent tooth (no decay or filling on any surface) 
Z = Permanent tooth with surface condition 
D = Sound primary (deciduous) tooth 
K = Primary tooth with surface condition 
U = Unerupted tooth 
E = Missing due to dental disease (caries/periodontal disease) 
M = Missing due to other causes (orthodontic/traumatic or other nondisease) 
R = Missing due to dental disease but replaced by a fixed restoration 
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X = Missing due to other causes but replaced by a fixed restoration 
P = Missing due to dental disease but replaced by a removable restoration 
Q = Missing due to other causes but replaced by a removable restoration 
J = Permanent root tip is present but no restorative replacement is present 
T = Permanent root tip is present but a restorative replacement is present 
Y = Tooth present, condition cannot be assessed 
The codes characterizing the surface condition are referred to as “surface codes.” The 
allowable codes are as follows: 
For caries, the allowable codes are as follows: 
0 = Lingual caries 

1 = Occlusal caries

2 = Facial caries 

3 = Mesial caries 

4 = Distal caries 

For filled teeth or restorations, the allowable surface codes are as follows: 
5 = Lingual restoration 

6 = Occlusal restoration 

7 = Facial restoration 

8 = Mesial restoration 

9 = Distal restoration 

C = Crown (short call for both primary and permanent teeth) 
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4.9.1.3 Assessment Diagnostic Criteria: Decayed, Missing, and Filled Surface Index (DMFS) 
4.9.1.3.1 Decayed Tooth Surfaces (the D Component of the DMFS Index) 
Frank lesions are detected as gross cavitation and thus present few problems in diagnosis. 
Incipient lesions captured in this survey, on the other hand, are more difficult to diagnose consistently. 
Incipient lesions may be subdivided into three categories according to location, each with the following 
special diagnostic considerations: 
1. Pits and fissures on occlusal, facial, and lingual surfaces  
These areas are classified as carious when the explorer catches after insertion with moderate, 
firm pressure, accompanied by either a softness at the base of the area and/or an opacity adjacent or the 
area providing evidence of undermining or demineralization. In other words, a deep pit or fissure in which 
the explorer catches is not sufficient evidence of decay without one or both of the following: 
 Softness at the base of the area; 
 Opacity adjacent to the area providing evidence of undermining or demineralization. 
2. Smooth areas on facial (labial or buccal) or lingual surfaces  
These areas are carious if they are (1) either decalcified or if there is a white spot as 
evidence of subsurface demineralization and (2) if the area is found to be soft by: 
 Penetration with the explorer, or 
 Scraping the area with the explorer. 
Visual evidence of demineralization is not enough to diagnose caries. 
3. Proximal surfaces 
 When areas are accessible to direct visual and tactile examination, i.e., when there is 
no adjacent tooth, the same criteria as that used for smooth areas on facial or lingual 
surfaces are used. 
(Revised February 2003) 
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	 When areas are not available to direct examination, other criteria must be applied.  
- On anterior teeth, trans-illumination can serve as a useful aid in discovering 
proximal lesions. Trans-illumination is achieved by placing a mirror lingually 
and positioning the examining light so that it passes through the teeth and 
reflects into the mirror. If a characteristic shadow or loss of translucency is seen 
on the proximal surface, then this is indicative of caries on the surface. Ideally, 
the actual diagnosis should be confirmed by detecting a break in the enamel 
surface with the explorer; however, clear visualization of a lesion by trans­
illumination can justify a positive diagnosis. 
- On posterior teeth, however, visual evidence alone, such as undermining under 
a marginal ridge, is not sufficient proof for diagnosing a proximal lesion. A 
positive diagnosis is made only if a break in the enamel surface can be 
detected with the explorer. 
4.9.1.3.2 Missing Teeth (the M Component of the DMFS Index) 
This criterion traditionally represented permanent teeth extracted only as a result of caries. 
However, because of the difficulty of correctly distinguishing between teeth extracted due to caries and 
those extracted for periodontal reasons, no attempt is made at the time of the examination to differentiate 
between these two causes of tooth loss. It is essential, however, to distinguish between teeth extracted 
because of caries or periodontal disease and those extracted or missing for other reasons.  
	 The code “E” is used to indicate teeth extracted because of caries or periodontal 
disease, 
	 The code “M” is used for teeth missing due to trauma, orthodontic treatment, or other 
nondisease related causes. 
	 The code “U” is used to identify unerupted or congenitally missing teeth. 
In order to determine whether an “E,” “M,” or “U” is called, the examiner will ask the SP 
about the reason for tooth loss. Separate codes are used when a missing tooth has been replaced by a fixed 
or removable prosthesis.  
	 “R” is used to designate a tooth that is missing due to dental disease, but has been 
replaced by a fixed restoration.  
	 “P” is used to designate a tooth that is missing due to dental disease, but has been 
replaced by a removable restoration. 
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	 “X” is used to designate a tooth that is missing due to other causes, but has been 
replaced by a fixed restoration. 
	 “Q” is used to designate a tooth that is missing due to other causes, but has been 
replaced by a removable restoration. 
A fixed or removable prosthetic replacement is considered to exist when it is visible in the 
mouth. If an appliance is not visible, the examiner should ask the SP if one exists. If the SP reports the 
existence of a removable appliance, the replacement is considered to exist if the SP reports he/she wears 
the appliance, no matter how infrequently. 
When a replacement exists, the examiner does not consider its condition or adequacy when 
making the call. When a replacement does not exist, the examiner does not attempt a clinical judgment of 
the need or adequacy of space for a replacement, even if tooth movement has closed the space. 
When more than one tooth has been replaced by a single pontic, each tooth space is scored 
as replaced. 
 Not Replaced Replaced 
Disease E R, P 
Nondisease M X, Q 
When an implant is identified in Tooth Count, a code of “3,” the appropriate restorative 
codes for Coronal Caries would either be “R,” “X,” “P,” or “Q.” The correct code is based on restorative 
replacement type and the self-reported reason for permanent tooth loss. 
4.9.1.3.3 Filled Tooth Surfaces (the F Component of the DMFS Index)  
The F component represents a tooth surface that has been filled with either a permanent or a 
temporary restoration as a result of caries. It is necessary to distinguish between surfaces restored because 
of caries and those restored for other reasons, such as trauma, hypoplasia, malformation, or bridge 
abutment. The examiner may question the SP as necessary to make the correct call. 
(Revised February 2003) 
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4.9.1.4 Scoring Permanent Teeth 
Sound permanent teeth (“S”) are distinguished from permanent teeth with restorations or 
caries (“Z). The “Z” code precedes any other legitimate diagnostic call for decayed or filled surfaces. For 
example, if a permanent molar has occlusal caries and is otherwise sound, the “Z” code is combined with 
the code for occlusal caries, i.e., “Z1.” If the permanent tooth is sound, the “S” code is used alone. For 
permanent teeth coded as a “5” in the tooth count, the “T” or “J” codes must be used. ISIS will not accept 
any other coronal caries codes. 
Any permanent root tip that has had a replacement made for the appropriate coronal 
structure or serves as a supporting structure for an overdenture will be coded as a “T.” This includes 
visible residual roots present under any type of removable complete or partial denture. If a visible residual 
root is present and no replacement has been made, the correct code will be a “J.” 
The specific codes for permanent teeth are listed below:  
S = Sound permanent tooth (no decay or filling on any surface) 
Z = Permanent tooth with surface condition 
J = Permanent root tip is present but no restorative replacement is present 
T = Permanent root tip is present but a restorative replacement is present 
4.9.1.5 Scoring Primary Teeth 
Decayed or filled surfaces of primary teeth are scored in the same manner as permanent 
teeth, using the same diagnostic criteria. However, because this survey is concerned with both primary 
and permanent teeth, it is necessary to call sound primary teeth with a “deciduous” score (“D”) to 
distinguish them from sound permanent teeth (“S”). The “K” code is used for primary teeth with 
restorations or caries to distinguish them from permanent teeth with restorations or caries (“Z”). The “K” 
code precedes any other legitimate diagnostic call for decayed or filled surfaces on primary teeth. For 
example, if a primary molar has occlusal caries and is otherwise sound, the “K” code is combined with 
the code for occlusal caries (i.e., “K1”). If the primary tooth is sound, the “D” code is used alone. 
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Missing primary teeth present potential problems in scoring because it is often not possible 
to distinguish exfoliated teeth from those extracted due to caries, especially during the period of mixed 
dentition. To avoid this problem, at the time of examination, all missing primary teeth are scored as 
unerupted permanent teeth (“U”). When data are analyzed, the age of the SPs can be used to determine 
the most likely reason for tooth loss. 
The specific codes for primary teeth are listed below:  
D = Sound primary (deciduous) tooth 
K = Primary tooth with surface condition 
Note again if both a permanent and a primary tooth are visible in the same tooth space, 
only the status of the permanent tooth is described and no score is assigned for the primary tooth. 
4.9.1.6 General Guidelines for Scoring 
The tooth and surface codes are listed again here for convenience. They are as follows: 
Tooth Codes 
S = Sound permanent tooth (no decay or filling on any surface) 
Z = Permanent tooth with surface condition 
D = Sound primary (deciduous) tooth 
K = Primary tooth with surface condition 
U = Unerupted tooth 
E = Missing due to dental disease (caries/periodontal disease) 
M = Missing due to other causes (orthodontic/traumatic or other non-disease) 
R = Missing due to dental disease but replaced by a fixed restoration 
X = Missing due to other causes but replaced by a fixed restoration 
P = Missing due to dental disease but replaced by a removable restoration 
Q = Missing due to other causes but replaced by a removable restoration 
J = Permanent root tip is present but no restorative replacement is present 
T = Permanent root tip is present but a restorative replacement is present 
Y = Tooth present, condition cannot be assessed 
Surface Codes 
For caries, the allowable codes are as follows: 
0 = Lingual caries 

1 = Occlusal caries

2 = Facial caries 

3 = Mesial caries

4 = Distal caries 
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For filled teeth or restorations, the allowable surface codes are as follows: 
5 = Lingual restoration 

6 = Occlusal restoration 

7 = Facial restoration 

8 = Mesial restoration 

9 = Distal restoration 

C = Crown (short call for both primary and permanent teeth) 

The following conventions have been adopted in the interest of achieving diagnostic 
consistency: 
1.	 Only one entry can be made for each tooth surface. In the event that a surface has 
both decay and a filling, only the decay is called. If the examiner gives two calls for 
the same surface, the ISIS system will beep and a message will be displayed in the 
lower right portion of the screen. Data entry is prohibited until an allowable response 
is entered. The recorder should bring this to the examiner’s attention immediately. 
2.	 If a tooth has rotated, surface calls should be assigned to the anatomical surface not to 
the current position of the surface. 
3.	 Incisal edges of anterior teeth are not considered to be separate surfaces. If a lesion or 
restoration is confined solely to the incisal edge, its score should be assigned to the 
nearest adjacent surface. If the lesion is equidistant from the surfaces, code lingual. 
4.	 Anterior teeth have four surfaces that are coded - facial, lingual, mesial, and distal. 
5.	 Posterior teeth have five surfaces that are coded – facial, lingual, mesial, distal, and 
occlusal. 
6.	 When a caries lesion extends beyond the line angle onto another surface, that surface 
is also scored as carious. For restorations, however, the following rules apply: 
- On anterior teeth, a proximal filling is not considered to involve the adjacent 
facial or lingual surface unless it extends at least one-third of the distance to the 
opposite proximal surface. The reason for this criterion is that the tooth 
structure on facial or lingual surfaces of anterior teeth must often be removed to 
provide access for the proximal restoration. 
- On posterior teeth, to guard against a similar possibility of overcalling, a 
proximal restoration should extend more than a millimeter past the line angle 
before it is considered to involve the adjacent facial or lingual surface. 
7.	 If a tooth has a full crown restoration placed because of caries, the tooth will be coded 
as “C,” which represents the maximum number of surfaces for the tooth type, i.e., four 
surfaces on anterior teeth and five surfaces on posterior teeth.  
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The following conventions apply: 
- All full crowns on posterior teeth, including abutment teeth for fixed or 
removable prostheses, will be considered to have been placed due to caries.  
- On anterior teeth, however, the examiner should make a determination of the 
reason for crown placement. If it can be determined that the crown was placed 
solely for a reason other than caries, such as fracture, malformation, or bridge 
abutment, the tooth is coded “Y.” 
For three-quarter crowns, the following rules apply: 
- In general, if a tooth has been restored with less than full coverage, each surface 
is examined and scored in the usual manner. However, when the crown 
coverage extends onto the facial (labial or buccal) or lingual surface for cusp 
protection, the surface is not scored as restored unless the coverage extends 
more than two millimeters cervically from the cusp tip or incisal edge. 
- For three-quarter crowns used as abutment teeth, all surfaces are scored in the 
usual manner if the abutment is a posterior tooth. On anterior teeth, if it can be 
determined that the crown was placed solely for purposes of abutment and not 
for caries, the restoration is not scored, but surfaces without crown coverage are 
examined and scored in the usual manner. 
8.	 Teeth that are banded or bracketed for orthodontic treatment are examined in the usual 
manner and all visible surfaces are scored. 
9.	 Certain teeth, notably first bicuspids, may have been extracted as part of orthodontic 
treatment. These teeth are coded “missing due to other causes” “M” and will be 
excluded from the DMFS analysis. The examiner must make the determination that 
the teeth were in fact extracted for orthodontic reasons. This is usually not difficult to 
determine because of the typically symmetric pattern of these extractions. For the sake 
of uniformity, all orthodontically extracted bicuspids are scored as first bicuspids. 
Teeth other than bicuspids may also be extracted for orthodontic reasons. In many 
cases the SP will have good recall of the reason for the extractions and can help in 
making the correct determination. 
10.	 Nonvital teeth are scored in the same manner as vital teeth. If, however, a restoration 
on a nonvital tooth was placed solely to seal a root canal and not for caries, that 
restoration is not scored. If no other lesions or restorations are present, the tooth will 
be called sound (“S”). 
11.	 Hypoplastic teeth are scored in the usual manner. However, if it can be determined 
that a restoration was placed solely for esthetic reasons and not for caries, that 
restoration is not scored. If a hypoplastic tooth is restored with a full crown, it is to be 
coded “Y”. 
12.	 Malformed teeth are scored in the usual manner except when they have been restored 
with a full crown for esthetic reasons, in which case they are coded “Y”. 
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13.	 When the primary tooth crown is destroyed by caries and only the roots remain, score 
all surfaces carious (5 surfaces on the posterior teeth – 0,1,2,3,4; and 4 surfaces on the 
anterior teeth – 0,2,3,4). 
14.	 When the same tooth surface is both carious and filled, only the caries is scored. 
15.	 Fractured or missing restorations are scored as if the restoration was intact unless 
caries is found to be present. In that case, the involved surface is scored as carious 
rather than restored. 
16.	 In the case of supernumerary teeth, only one tooth is scored for the tooth space. The 
examiner must decide which tooth is the “legitimate” occupant of the space. 
17.	 If both a deciduous and a permanent tooth occupy the same tooth space, only the 
permanent tooth is scored. 
18.	 Third molars are not scored. When examining second molars it is important to note 
that a drifted third molar may occupy the space of a missing second molar. In such 
cases, the diagnosis and score must relate to the status of the missing second molar, 
not the third molar. If the second molar, for example, was extracted due to caries and a 
sound third molar now occupies the space, the second molar is scored as extracted 
(“E”) and the third molar is not scored. 
19.	 A tooth is considered to be in eruption when any part of its crown projects through the 
gum. This criterion is easier to standardize than one based on a more advanced stage 
of eruption. 
20.	 Stain and pigmentation alone should not be regarded as evidence of caries as either 
can occur on sound teeth. 
If the tooth is permanent with no decay or filling on any surface, the examiner calls “S.” If 
the tooth is permanent and is not sound, the examiner calls “Z” and the appropriate surface condition 
codes as described below. “D” is entered for all sound primary calls while “K” and the appropriate 
surface condition codes are entered if the primary tooth has surface conditions (caries, restoration). If the 
tooth is missing and characterized by one of the other “tooth” calls, the examiner calls out the appropriate 
letter (U, E, M, R, X, P, or Q). 
The recorder records the appropriate tooth condition code in the first space for the tooth. 
After this first space, there is a separate block of data entry spaces to accommodate the surface calls for 
that tooth as necessary. 
If the tooth is permanent with decay or restorations on one or more surfaces (Z), the 
examiner calls the number(s) which correspond(s) to the surface(s) having decay or a restoration. Some 
examples are listed below. 
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	 If the examiner calls 0, 1, 2, 3, or 4, it means that there is decay on the surfaces of the 
tooth represented by those numbers.  
	 If the examiner calls 5, 6, 7, 8, or 9, it means that there is a filling on the surface(s) 
represented by the number(s) called.  
	 If the examiner calls “C,” it means that there is a crown on that tooth.  
	 Combinations of caries and restorations on different surfaces are allowed. For 
example, if the examiner calls “1, 8, 9” it means that there is a caries on the occlusal 
surface and a restoration on the mesial and distal surfaces.  
This procedure continues to the second molar for each of the four quadrants of the mouth.  
4.9.1.7 Guide for Referral and Followup  
Any caries call (0, 1, 2, 3, or 4) flags an ISIS recommendation telling the SP to see a dentist 
at his/her earliest convenience (Level 3 recommendation). Levels of recommendation are discussed in 
detail later in this chapter. 
4.9.1.8 Recording Procedures 
The Coronal Caries screen is divided into four rows, which correspond to the four quadrants 
of the mouth: upper right, upper left, lower left, and lower right. These quadrants are labeled on the left 
portion of the screen. The teeth are labeled across the top. Space to enter the overall caries tooth call and 
the individual surface caries is provided for each tooth except the third molars. There is space to enter 
codes for seven teeth per quadrant. No more than 28 permanent teeth can be scored for each SP. Third 
molars, or wisdom teeth, are not scored for dental caries. 
NOTE: The examiner and recorder are both responsible for making sure that the calls 
the examiner makes are being recorded in the correct tooth space on the screen. In order to do this 
consistently, each tooth position is to be referred to by its quadrant location and tooth location. For 
example, whenever a new quadrant is started or there is a long silence between calls, the recorder 
will prompt the examiner with the next blank tooth space, such as “upper left central incisor” 
(noted as “UL CI” on the screen). 
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NOTE: In instances where all teeth in the upper and/or lower jaws are missing for the 
same reason, it is imperative that the examiner prompt the recorder to use the “Upper” and 
“Lower” fields to indicate the caries code. By doing so, the system will fill all teeth in that half 
mouth with the same code and the SP will be scored with the appropriate half-mouth calls. 
4.9.1.9 Interaction with Heads-Up Display Screen 
As condition codes are entered on the Coronal Caries screen, the corresponding condition 
symbols are displayed on the Heads-Up Display screen. As mentioned earlier, red bullets symbolize 
caries, while restorations are symbolized by shading. No changes are made to implants (red circle with 
“I”) or missing teeth (red circle with slash) based on calls entered on this or subsequent screens. 
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4.9.2 Root Caries Assessment 
SPs aged 18 years and older receive this assessment to determine the prevalence of root 
caries and root restorations. 
4.9.2.1 Examination Procedures 
Only teeth that have recession should be assessed for the presence of root caries and root-
restorations. If recession is present but the root surfaces are sound, then the score is “2.” If recession is not 
present, the score is also a “2”. All exposed portions of a tooth’s root surface should be examined 
carefully in the following sequence: the examiner begins with the maxillary right quadrant with the right 
central incisor and continues distally through the second molar in the same quadrant. The same sequence 
is followed for the upper left, lower left, and lower right quadrants. 
Each quadrant with recession is dried with air and examined with a surface reflecting mirror 
and a No. 23 explorer. The most difficult areas to examine are approximal surfaces in posterior teeth, 
particularly those that contain approximal restorations. Subgingival inspection is not recommended 
because few lesions are confined subgingivally and it may produce bleeding. Data are captured as overall 
presence or absence of root caries and overall presence or absence of root restorations. 
4.9.2.2 Scoring Codes 
For this assessment, the presence of any root caries and any restorations will be recorded as 
“whole mouth” calls. Therefore, the exposed surfaces of individual teeth will be assessed, but not 
recorded as individual surfaces. The allowable “whole mouth” codes for root caries are as follows: 
 1 = Root caries detected 
 2 = No root caries detected 
 9 = Cannot be assessed 
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The allowable “whole mouth” codes for root restorations are as follows: 
	 1 = Root restoration detected 
	 2 = No root restoration detected 
	 9 = Cannot be assessed 
4.9.2.3 Diagnostic Criteria 
Caries occur on root surfaces of teeth only where there has been loss of normal gingival 
attachment, apical recession from the cemento-enamel junction (CEJ). Generally, caries on root surfaces 
occurs coronal to the present gingival margin but apical to the CEJ; very few lesions exist solely in the 
gingival pocket. Although all exposed root surfaces are susceptible, it has been reported that root caries 
predominantly occurs in approximal and facial aspects. 
Root caries starts at or just below the cemento-enamel junction. Most commonly, early root 
caries lesions are small and round. However, they may spread laterally along the cervical junction, 
sometimes coalescing with neighboring lesions to produce a collar of caries around the root. Caries that 
begins in a root surface does not tend to affect the adjacent coronal enamel surface directly. Rather, they 
may undermine the cervical enamel and invade coronal dentin, leaving a cervical enamel spur or ledge. If 
the carious process continues, pieces of this ledge may fracture, making it appear as if the caries had 
originated in the enamel as well as the cementum. The opposite sequence can occur as well, with cervical 
coronal caries spreading apically to involve the CEJ and then the root surface. Some scoring guidelines 
are listed below. 
	 When a single caries lesion that extends at least 1 mm past the CEJ in both incisal and 
apical directions affects both the coronal and root surfaces, both surfaces should be 
considered decayed, thus this lesion would be assessed for root and coronal caries. 
	 A lesion affecting both crown and root surfaces that extends less than 1 mm in either 
direction, the surface on the side of the CEJ that involves more than 50 percent of the 
area of the lesion should be scored.  
	 When it is impossible to apply the “>50 percent rule,” i.e., both coronal and root 
surfaces appear equally affected, both surfaces should be considered “decayed.” For 
restorations, the same rules apply. 
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Defective margins of fillings with suspicious carious areas should be checked with an 
explorer for recurrent decay and the criteria for assessing “decayed and filled” root surfaces should be the 
same as for coronal surfaces, that is, decay takes precedence over a filling. Full crown coverage is 
considered to have been placed for coronal caries even if the margin of the crown extends on to the root 
surface. Thus, a root surface with a crown margin free of recurrent decay should be considered sound. 
Areas of abrasion or erosion in root surfaces rarely become carious because they are 
generally kept clean and are free of plaque. Root caries frequently occur beneath plaque, but rarely 
beneath calculus. Accumulations of plaque, which obstruct the examination procedure, should be 
removed. Surfaces covered entirely by calculus are considered sound. 
Active caries lesions in root surfaces are yellow/orange, tan, or light brown in color. Lesions 
in remission may or may not be cavitated. They are hardened and tend to be darker, sometimes almost 
black. When root caries are covered by small amounts of plaque, the discoloration of the lesions usually 
shows through. 
In some incipient lesions the carious area of the root surface may merely be discolored 
without cavitation, but the area will be soft to exploration. Cavitation with jagged margins and a 
roughened, but soft floor or base usually occurs in advanced lesions. Normal cementum is softer than 
enamel, and frequently will yield to pressure from the tip of an explorer. Areas of root caries, however, 
are softer than surrounding cementum; therefore, it is possible to differentiate sound cementum from 
carious cementum based on tactile sense. In the presence of root caries, an explorer penetrates the tissue 
but usually can be removed easily. However, if the explorer penetrates but resists withdrawal or “sticks,” 
the surface is usually sound cementum. With experience and training, it is possible to develop a tactile 
sense to differentiate sound from carious cementum. Note that for areas without gross cavitation, visual 
criteria related to location, shape, and discoloration of the suspected area do not, in themselves, define 
root caries. The tactile criteria of softness to an explorer tip must be met for a definitive diagnosis of root 
caries to be made. 
4-43 

4.9.2.4 Guide for Referral and Follow-up  
Presence of any root caries flags an ISIS recommendation telling the SP to see a dentist at 
his/her earliest convenience (Level 3 recommendation). Levels of recommendation are discussed in detail 
later in this chapter. 
4.9.2.5 Recording Procedures 
A maximum of 28 permanent teeth will be examined for each SP. Third molars, or wisdom 
teeth, are not examined for root caries. 
The Root Caries screen consists of two “whole mouth” variables. Space has been provided to 
indicate whether any root caries or root restorations exist in the SP’s mouth.  
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4.10 Sealant Assessment 
4.10.1 Examination Procedures 
SPs aged 2-34 years receive the sealant assessment. The sequence of the exam is the same as 
that of the tooth count. However, only the pitted or grooved surfaces of the first and second 
bicuspid/primary molars, first and second molars, and the permanent maxillary lateral incisors are to be 
scored for the assessment. These surfaces in each quadrant are dried with air and examined with a surface 
reflecting mirror and a No. 23 explorer for the presence of sealant. 
Sealants are professionally applied plastic films used to occlude the pits and fissures on 
occlusal, facial (buccal), and lingual surfaces of teeth. Sealants are applied to the teeth as viscous liquids 
and polymerize (or “cure”) in a short period of time. The purpose of sealants is to provide a physical 
barrier to the collection of substrate for cariogenic bacteria in the pits and fissures, and thus prevent dental 
caries from initiating or developing further. It is important to be aware that sealant products may vary in 
appearance, from clear to colored, or white. Sealant should be scored as present on a surface when any 
part of the surface remains covered. If it appears that sealant material was used as a restoration rather than 
as a preventive procedure, score the surface as filled in the coronal caries section and do not record the 
presence of sealant on this screen. 
4.10.2 Scoring Codes 
The calls for the sealant assessment are as follows: 
0 = Sealant not present 
1 = Occlusal sealant present on permanent tooth 
2 = Facial sealant present on permanent tooth (mandibular only) 
3 = Lingual sealant present on permanent tooth (maxillary only) 
4 = Occlusal sealant present on primary tooth 
9 = Cannot be assessed 
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4.10.3 Scoring Guidelines 
	 “0”, “4,” and “9” are mutually exclusive calls.  
	 Combinations of “1, 2” and “1, 3” are allowed for permanent molars since more than 
one surface of these teeth may be sealed. 
	 Only “0,” “3,” or “9” are allowable codes for lateral incisors. 
	 Only “0,” “1,” “3,” or “9” are allowable codes for upper permanent molars. 
	 Only “0,” “1,” “2,” or “9” are allowable codes for lower permanent molars. 
4.10.4 Recording Procedures 
Sealant codes can be entered for the bicuspids/primary molars, first and second molars, and 
the permanent maxillary lateral incisors only. One code is permitted for primary teeth, bicuspids and 
permanent lateral incisors, while multiple codes are permitted for permanent molar teeth. Refer to the 
previous section for allowable codes. 
The recorder may use a designated shortcut key to record all “0s” if the SP has no sealants 
on the teeth to be assessed. In these instances, the examiner calls “All 0’s” instead of calling “0” for each 
individual tooth assessed. The recorder presses the F2 key to automatically fill “0” in all blank tooth 
spaces in each quadrant, thus pressing the F2 key four times will fill all four quadrants with “0s.” The 
examiner will call “All 0’s” by quadrant, or will call “All 0’s” for all four quadrants. The examiner 
will let the recorder know which he/she is doing. 
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4.11 Dental Fluorosis Assessment 
Dental fluorosis is a condition of tooth enamel and dentine that results from receiving 
excessive amounts of fluoride during the period of tooth development. Both primary and permanent teeth 
may have dental fluorosis, although the former generally is affected to a lesser extent. The degree of 
dental fluorosis can range from barely noticeable whitish opacities to confluent pitting of the enamel 
surface and unsightly dark brown staining, depending upon the amount of fluoride ingested and duration 
of exposure during tooth development. Enamel opacities in dental fluorosis are bilaterally symmetrical 
and affect multiple teeth. Staining, loss of enamel, and attrition are post-eruptive phenomena, therefore 
they may not be strictly bilateral. 
4.11.1 Classification and Scoring (Dean’s Fluorosis Index Criteria) 
The criteria for classifying and scoring dental fluorosis are modified from the system 
described by Dean in 1942. Each tooth is examined and assigned to one of six categories according to its 
degree of dental fluorosis. For analysis, classification of a person is based on the two teeth most affected 
by fluorosis. If the two teeth are not equally affected, the classification given to the person is the score for 
the less involved tooth. For the purpose of the dental examination in this study, each tooth is classified. 
The modified criteria and the corresponding scores described by Dean are provided in Exhibit 4-3. 
REFERENCES 
Dean H.T. (1942). The investigation of psychological effects by the epidemiological method. In: Fluorine 
and Dental Health, F.R. Moulton, (Ed.), AAAS, Pub. No. 19, Washington, DC, pp. 23-31. 
Rozier, R.G. (1994). Epidemiologic indices for measuring the clinical manifestations of dental fluorosis: 
Overview and critique. Advances in Dental Research, 8(1), 39-55. 
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Exhibit 4-3. Dean’s Fluorosis Index criteria (Modified for NHANES) 
Dean’s Classification 
(Score*) 
Criteria Operational Definition 
Normal - (0) The enamel presents the usual translucent semi­
vitriform type of structures. The surface is smooth, 
glossy, and usually of a pale creamy white color. 
Criteria that do not meet definitions below. 
Questionable- (0.5) The enamel shows slight aberrations from the 
translucency of normal enamel, ranging from a 
few white flecks to occasional white spots. This 
classification is utilized in those instances where a 
Occasional white spots. 
definite diagnosis of the very mild form of 
fluorosis is not warranted and a classification of 
“normal” is not justified. 
Very Mild - (1) Small, opaque, paper white areas scattered 
irregularly over the enamel but involving less than 
25 percent of the total surface area. Included in 
this category are teeth that show no more than 1-2 
mm of white opacity at the cusp tips of posterior 
teeth or incisal edges of anterior teeth. 
Paper white areas, scattered over 25 percent of the 
tooth surface or less. One should be confident of the 
diagnosis of fluorosis based on the pattern in the 
mouth and the type of lesions. The lesions are 
bilaterally symmetrical and the margin of lesion 
blends or is not clearly defined. Otherwise call it 
questionable. 
Mild - (2) The white opaque areas are more extensive but 
involve less than 50 percent of the total surface 
Greater than 25 percent, but less than 50 percent of 
any tooth surface is affected. 
area. 
Moderate - (3) 50 percent or greater of the tooth surface area is 
affected. All enamel surfaces of the teeth are 
affected, and surfaces subject to attrition show 
marked wear. Brown stain is frequently a 
disfiguring feature. 
50 percent or greater of the tooth is affected. All 
visible surfaces (occlusal, buccal, and lingual of 
posterior teeth; or facial and lingual surfaces of 
anterior teeth) must be involved. Posterior teeth 
typically show attrition because fluorosed surfaces 
wear easily. The area that has undergone attrition is 
considered as fluorosed for scoring purposes. If there 
is marked attrition, this has to be considered when 
determining the extent of involvement (consider this 
area as fluorosed). Anterior teeth out of occlusion 
may not show attrition. 
Severe - (4) All enamel surfaces are affected. The diagnostic 
sign required for this classification is discrete or 
confluent pitting of the enamel. With marked 
confluent pitting, the tooth often presents a 
corroded-like appearance. Brown stains of intact 
enamel are often present. 
A fluorosed tooth with discrete or confluent pitting. 
General form of the tooth may be affected. 
* NOTE: These are the scoring codes as defined by Dean. NHANES scoring codes are provided later in this chapter. 
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4.11.1.1 Special Diagnostic Considerations 
	 It is not uncommon to observe bilateral hypoplastic teeth especially with first molars. 
These should be distinguished from dental fluorosis. In dental fluorosis, all enamel 
surfaces are affected when pitting is present. In non-fluorosed hypoplastic teeth, part 
of the unaffected enamel will appear free of enamel opacities. 
	 A tooth is not scored if one-half or more of the visible enamel area is replaced with a 
restoration, is destroyed by caries, or is covered with an orthodontic band. For 
posterior teeth the visible enamel is composed of the buccal and lingual surfaces, 
extending from embrasure to embrasure, and the occlusal surface. For the anterior 
teeth, the visible area is composed of the labial and lingual surfaces, extending from 
embrasure to embrasure. 
	 Dental fluorosis in the milder classifications may be confined to particular areas of the 
enamel, or may occur irregularly over the entire enamel surface. The area affected is 
derived by visually coalescing all areas of the fluorosis and relating that area to the 
total area of all visible enamel. 
	 Staining of intact enamel is not a diagnostic criterion specific to any of the 
classifications and is not taken into consideration in scoring a tooth. 
	 A pit is defined as a discrete, focal loss of outermost enamel. Initially, the enamel wall 
is usually intact. With wear, however, the enamel wall can be abraded away, so that 
often only part of the wall can be detected. In contrast to intact enamel on which the 
explorer tip can be moved easily across the smooth surface, pitted areas demonstrate a 
definite physical defect in which the base of the defective area may be either carious 
or sound. If it is sound, the base of the pit is rough and offers resistance to the lateral 
movement of the explorer tip, and a scratchy sound is detected when the explorer is 
moved across it. If the base is carious, it demonstrates softness upon being probed 
with moderate pressure. The pitted area is usually stained or demonstrates a different 
color compared with the surrounding intact enamel. 
	 Confluent pitting of the enamel results from the coalescence of two or more discrete 
pits. The walls of pits at the occlusal or incisal edges can be abraded, so that only the 
walls on the gingival aspect remain intact, often leading to an irregular “ledging” 
effect. In some cases, confluent pitting may advance to a point where such large areas 
of enamel are corroded such that the anatomy of the tooth is altered. 
	 If the lingual and buccal surfaces of a posterior tooth have fluorosis from the occlusal 
surface to the middle third, but the occlusal surface shows marked attrition, call it 
moderate. 
	 If the lingual and buccal surfaces of a posterior tooth have fluorosis involving 
25 percent of each surface, but the occlusal surface shows attrition only on the cuspal 
tips and the rest of the occlusal surface appears normal, the call would be mild. This is 
because the total will not add up to 50 percent and there is no marked attrition. 
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	 If the lingual and buccal surfaces of a posterior tooth have fluorosis from the occlusal 
surface to the middle 3rd, and 100 percent of the occlusal surface has white opacities, 
it would be moderate. This is because 50 percent of the tooth is affected and the tooth 
probably has not been subjected to attrition. 
	 If the labial surface of an anterior tooth has fluorosis from incisal to cervical but the 
lingual is free, the code is mild because not all surfaces are affected. 
4.11.1.2 Differentiating Between Dental Fluorosis and Nonfluoride Opacities 
Opacities occurring in enamel may be due to a multitude of etiological factors in addition to 
excessive fluoride intake. In studies of dental fluorosis it is necessary to distinguish between fluoride and 
nonfluoride enamel changes. This distinction is generally most difficult when examining for the milder 
forms of fluorosis. To aid the examiner in making an appropriate decision, the set of criteria developed by 
Russell (Exhibit 4-4) are used. 
Exhibit 4-4. The differential diagnosis of fluoride and nonfluoride enamel opacities 
Characteristic 	 Milder Forms of Fluorosis Nonfluoride Enamel Opacities 
Area affected 	 Usually seen on or near tips of 
cusps or incisal edges. 
Shape of lesion 	 Resembles line shading in pencil 
sketch; lines follow incremental 
lines in enamel, form irregular 
caps on cusps. 
Demarcation 	Shades off imperceptibly into 
surrounding normal enamel. 
Color 	 Slightly more opaque than 
normal enamel; “paper-white.”
Incisal edges, tips of cusps may
have frosted appearance. Does 
not show stain at time of eruption
(in these milder degrees, rarely at 
any time). 
Gross hypoplasia 	 None. Pitting of enamel does not 
occur in the milder forms. 
Enamel surface has glazed
appearance, is smooth to point of
explorer. 
Detection 	 Often invisible under strong
light; most easily detected by line 
of sight tangential to tooth 
crown. 
Usually centered on smooth 
surface; may affect entire crown. 
Often round or oval. 
Clearly differentiated from 
adjacent normal enamel. 
Usually pigmented at time of 
eruption; often creamy yellow to 
dark reddish-orange. 
Absent to severe. Enamel surface 
may seem etched, be rough to
explorer. 
Seen most easily under strong
light on line of sight
perpendicular to tooth surface. 
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Russell, A.L. (1961). The differential diagnosis of fluoride and non-fluoride enamel opacities. Pub Health 
Dent, 21, 143-146.  
4.11.2 Examination Procedures 
All SPs aged 6-49 years old receive the dental fluorosis assessment, which utilizes a slightly 
modified Dean’s Fluorosis Index to assess the condition of the enamel. The index scores the entire tooth 
and is used for assessing fully erupted permanent teeth only (excluding third molars). Deciduous teeth, 
permanent teeth not in full eruption, and teeth in which more than one-half of the visible surface area is 
obscured by a restoration, caries, or an orthodontic appliance are not assessed. Code these teeth/spaces as 
cannot be assessed (“9”). 
Each tooth is examined using a surface reflecting mirror and a No. 23 explorer. No air is 
used for this assessment. Each tooth is scored as a unit according to Dean’s Fluorosis Index as follows: 
 0 = Normal (no fluorosis detected) 

 1 = Very mild (opaque, paper white areas involving less than ¼ of the tooth surface) 

 2 = Mild (opaque, paper white areas involving ¼ to less than ½ of the tooth surface) 

 3 = Moderate (opaque paper white areas involving ½ or more of the tooth surface) 

 4 = Severe (discrete or confluent pitting in involved areas) 

 5 = Questionable (slight aberration of normal enamel appearance including white 

flecks) 

 8 = Nonfluoride opacity

 9 = Cannot be assessed 

4-53 

The fluorosis assessment is conducted in the following order: 
1.	 As the exam proceeds tooth by tooth in the same convention as the caries 
examination, observe the enamel condition of the corresponding bilateral tooth. For 
example, if initially examining tooth #3, then #14 would be the examined bilateral 
tooth. 
2.	 If the bilateral tooth relatively exhibits comparable enamel opacities and/or anomalies, 
then a fluorosis score is appropriately called to the recorder for the initially examined 
tooth. The extent of fluorosis cannot vary widely from the initially examined tooth to 
the examined bilateral tooth. 
3.	 Proceed tooth by tooth until each quadrant is scored in the same order and sequence as 
in the caries examination 
4.	 Important notes: 
- Because fluorosis always occurs bilaterally in the same arch, dental fluorosis 
must be established bilaterally before scoring teeth individually. 
-	 There is only one score per tooth. 
- If the corresponding bilateral tooth cannot be assessed, then the initially 
examined tooth is scored as cannot be assessed (“9”). 
- If the corresponding bilateral tooth is normal, then the initially examined tooth 
is scored either as normal (‘0”), or nonfluoride opacity (“8”), or could not be 
assessed (“9”). 
- This survey will use a score of “5” for Dean’s “0.5” score as noted in 
Exhibit 4-3. Codes for nonfluoride opacity (‘8”) and nonassessment (“9”) have 
also been added. 
4.11.2.1 Scoring Guidelines 
These guidelines promote diagnostic consistency. Note that fluorosis is a condition that is 
generally bilateral. 
1.	 Only fully erupted permanent teeth are scored. 
2.	 Teeth are NOT dried with air prior to examination. 
3.	 A tooth is scored as “9” if it is crowned, missing, not fully erupted, or if one-half or 
more of the visible enamel is replaced with a restoration, covered with an orthodontic 
band, or destroyed by caries. 
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4.	 If fluorosis occurs irregularly on areas of the enamel surface, determination of the area 
affected is derived by visually coalescing all areas of fluorosis and relating that 
amount of area to the total visible surface area. 
5.	 For anterior teeth the visible enamel area is the labial and lingual surfaces extending 
from embrasure to embrasure. For posterior teeth, the visible enamel area is the facial 
and lingual surfaces extending from embrasure to embrasure and the occlusal surface. 
6.	 Scoring is based on the extent of fluoride opacities, attrition, and pitting. 
7.	 Staining of intact enamel is not a diagnostic criterion for any of the fluorosis 
classifications. Note that an area of severe fluorosis may not be stained, whereas, an 
area of moderate fluorosis may become stained.  
8.	 All nonfluoride opacities are to be scored as code “8” regardless of the suspected 
etiology. 
9.	 Mild nonfluoride opacities are difficult to distinguish from mild fluoride opacities. 
Mild nonfluoride opacities are more likely to be: 
- Centered on the surface; 
- Round or oval; 
- Clearly differentiated from adjacent enamel; and 
- Pigmented and/or glassy. 
10.	 Mild fluorosis is more difficult to detect under strong light than mild nonfluoride 
opacities. Tangential viewing improves the likelihood of detecting fluorosis. 
4.11.3 Guide for Referral and Followup 
A code of “4” in the Dean’s Index triggers a Level 3 recommendation for care flag in ISIS. 
This recommendation is telling the SP to see a dentist at his/her earliest convenience. Levels of 
recommendation are discussed in detail later in this chapter. 
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4.11.4 Recording Procedures 
The scores called by the examiner are entered in the appropriate fields for the Dean’s Index 
using the codes listed above. 
The recorder may use a designated shortcut key (F2 key) to record all “0s” whenever the SP 
has no fluorosis. In these instances, the examiner calls “All 0’s” instead of “0” for each individual tooth 
assessed. The recorder presses the F2 key to automatically fill “0” in each blank tooth space of a quadrant. 
Pressing the F2 four times will fill all four quadrants with “0’s.” The examiner will call “All 0’s” by 
quadrant, or “All 0’s” for all quadrants. The examiner will let the recorder know which he/she is 
calling. 
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4.11.5 Fluorosis Review: Questions and Answers* 
Questions: 
1.	 How do I score if #3 is affected but not #14? 
- There is no fluorosis. Usually many pairs of teeth are affected. 
2.	 Is the occurrence of fluorosis always bilateral or can one arch have it and another arch 
not have it? 
-	 Yes, always bilateral. Upper incisors can have fluorosis but not lower 
incisors. 
3.	 Can the degree of fluorosis vary considerably from arch to arch and bilaterally? 
-	 Can be very mild on #3 and mild on #14 but not very mild on #3 and 
moderate/severe on #14. 
4.	 Should the dentition with the fluorosis that has heavy staining and wear, but no pits, 
be classified always as moderate and not severe? 
-	 Yes. Confluent pitting is characteristic of severe. 
5.	 How do I score if the lingual and the buccal of tooth #14 has fluorosis from the 
occlusal to middle 3rd but the occlusal shows marked attrition. 
-	 Call it moderate. 
6.	 How do I score if the lingual and buccal of tooth #14 has fluorosis involving 25 
percent of each surface but the occlusal shows attrition only on the cuspal tips but the 
rest of the occlusal surfaces appears normal. 
-	 Call it mild because the total will not add up to 50 percent and there is no 
marked attrition. 
7.	 How do I score if the lingual and buccal of tooth #14 has fluorosis from occlusal to 
middle 3rd and 100 percent of the occlusal show as white opacities? 
-	 Call it moderate. Because 50 percent of the tooth is affected and probably 
the tooth has not been subjected to attrition. 
8.	 How do I score if the labial of tooth #8 has fluorosis from incisal to cervical but the 
lingual is normal? 
-	 Call it mild. Not all surfaces are affected (I have never seen a case like 
this). 
* Questions & answers have been provided by Dr. Kumar. 
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4.12 Incisor Trauma Assessment 
The objectives of the Incisor Trauma subcomponent of the survey are to: 
 Determine the prevalence of traumatic injuries to permanent incisor teeth in a national 
sample; 
 Provide a basis for comparison with past and future surveys; 
 Provide a basis for developing estimates of treatment needs; and 
 Provide a basis for developing strategies for the prevention of traumatic injuries to 
teeth. 
REFERENCES 
Andreason, J.O. (1972). Traumatic injuries to teeth. St. Louis: C.V. Mosby.

Basrani, E. (1985). Fractures of the teeth. Philadelphia: Lea & Febiger. 

Ferguson, F.S., and Ripa, L.W. (Fall 1979). Prevalency and type of traumatic injuries in the anterior teeth 

of preschool children. J Pedodont, 4(1), 3-8. 
4.12.1 Examination Procedures 
All SPs aged 6-29 years receive the Incisor Trauma assessment for the maxillary and 
mandibular permanent incisors only. The clinical assessment is described in this section.  
Ask the SP or a responsible adult, the following question: 
“Have you (SP name) ever had an injury to your (his/her) front teeth?”  
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If the SP indicates that one or more injuries have occurred, ask the following question: 
“Can you point to the area of your (SP name) mouth where the trauma occurred?” 
The SP or responsible adult may be able to indicate the quadrant of the mouth in which the 
trauma occurred, or the exact tooth positions where the trauma occurred.  
If the SP indicates where in the mouth the trauma occurred, this should be used for 
information only. Regardless of the answer, proceed to examine the SP.  
The eight permanent incisors should be examined carefully for evidence of traumatic injury. 
The teeth should be examined in the same sequence as for the caries examination. A positive history of 
trauma is required for codes “1” through “6.” One of the following scores is to be assigned for each 
permanent incisor tooth: 
0 	 A score of “0” indicates that a permanent tooth has no evidence of traumatic injury. 
1 	 A score of “1” indicates that an unrestored enamel fracture is present in a permanent 
tooth that does not involve the dentine.  
2 	 A score of “2” indicates an unrestored fracture in a permanent tooth that involves the 
dentine. 
3 	 A score of “3” indicates untreated pulpal damage to a permanent tooth as evidenced by 
one of the following:  
- dark discoloration, as compared with other teeth—a discoloration of one tooth, 
or adjacent teeth, that are otherwise healthy is considered a sign of pulpal injury 
or 
- swelling or a fistula in the labial or lingual vestibule adjacent to an otherwise 
healthy tooth. 
4 	 A score of “4” indicates that a fracture has been restored in a permanent tooth, either 
with a full crown or a less extensive restoration. It may be necessary to question the 
SP or responsible adult to ascertain the reason for the restoration. 
5 A score of “5” indicates the presence of a lingual restoration in a permanent tooth as a 
sign of endodontic therapy, and a positive history from the SP or responsible adult of 
root canal therapy following traumatic injury. 
6 A score of “6” indicates that a permanent tooth is missing due to trauma. 
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9 	 A score of “9” is assigned to any tooth or space that does not fall within the preceding 
categories; for example, a missing tooth due to a reason(s) other than trauma, a tooth 
having a full crown restoration as a treatment for dental caries, or a primary tooth. 
4.12.2 Guide for Referral and Follow-up 
The following codes trigger a recommendation for care flag:  
	 Code “2” on this assessment has ISIS flag a recommendation that says the SP should 
see a dentist within the next 2 weeks (Level 2 Recommendation). 
	 Code “3” on this assessment has ISIS flag a recommendation that says the SP should 
see a dentist immediately (Level 1 Recommendation). 
	 Code “6” on this assessment has ISIS flag a recommendation that says the SP should 
see a dentist at his/her earliest convenience (Level 3 Recommendation). 
4.12.3 Recording Procedures 
Findings for the traumatic injuries of permanent incisor teeth are recorded on the Incisor 
Trauma Injuries screen. Allowable codes range from “0” to “6” and “9” as listed above. Missing or 
implanted teeth are restricted to “6” and “9.” 
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4.13 Tooth Wear 
NHANES provides a unique opportunity to assess the prevalence of dental erosion and tooth 
wear across the lifespan and amongst varied population groups to discern if health disparities exist. In 
addition, many of the suggested etiologies of dental erosion including dietary factors, medications, health 
conditions, and socioeconomic status can be explored while adjusting for potential confounders. No other 
survey in the United States provides such an excellent opportunity to address the much discussed but little 
researched issue of dental erosion and tooth wear. The Tooth Wear Index is proposed for use in the 
NHANES because the index will allow for comparisons to be made with recently published reports from 
other countries. 
4.13.1 Description 
The exam is conducted on all SPs aged 13 years or greater. The dental examiner performs 
the exam with a surface-reflecting mirror. 
The Tooth Wear Index of Smith and Knight (1984), with modifications by Millward et al. 
(1994), has been used in the assessment of dental erosion in epidemiological surveys and studies. The 
Tooth Wear Index as described for use in the 1998 Adult Dental Health Survey conducted by the Social 
Survey Division of the Office of National Statistics, United Kingdom, will be used in the NHANES.  
4.13.1.1 Description of Index and Scoring System 
Visual examination of the facial, lingual, and incisal surfaces of the maxillary central and 
lateral incisors, and cuspids; the mandibular central and lateral incisors, and cuspids; and occlusal 
surfaces of the maxillary and mandibular first molars should be conducted using an examining light and a 
surface reflecting mirror with each tooth surface being dried. 
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For purposes of this assessment, the mouth is divided into segments as follows: 
Upper Right Segment 
Central Incisor, Lateral Incisor, Cuspid, and First Molar 
Upper Left Segment 
Central Incisor, Lateral Incisor, Cuspid, and First Molar 
Lower Left Segment 
Central Incisor, Lateral Incisor, Cuspid, and First Molar 
Lower Right Segment 
Central Incisor, Lateral Incisor, Cuspid, and First Molar 
4.13.1.2 Tooth Wear Scoring System 
Exhibit 4-5 presents the criteria for assessment for tooth wear. 
Exhibit 4-5. Criteria for assessment of tooth wear 
Score Surface Criteria 
0 All Sound natural tooth surface. 
Any wear is restricted to the enamel and does not extend into dentin. 
1 All Loss of enamel just exposing dentin. 
2 B, L Loss of enamel exposing dentin for more than an estimated one-third of the individual 
surface area (B,L). 
O, I Loss of enamel and extensive loss of dentin, but not exposing secondary dentin or 
pulp. On occlusal/incisal surfaces exposed dentin facets with a buccal-lingual 
dimension of 2mm or greater at the widest point will be seen. 
3 B, L Complete loss of enamel on a surface, pulp exposure or exposure of secondary dentin 
where the pulp used to be. Frank pulp exposure is most unlikely. 
O, I Pulp exposure or exposure of secondary dentin. 
8 All Fractured tooth. Clear evidence of traumatic loss of tooth substance rather than wear. 
9 All Cannot assess. More than 75% of surface is obscured and no remaining incisal edge/tip 
which can be coded. Includes missing teeth, crowns, and abutments. 
B = Buccal; L = Lingual; I – Incisal; O = Occlusal 
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4.13.2 Examination Procedures 
The general sequence of the exam is similar to the Tooth Count Exam. Each eligible tooth 
should be assessed looking at each coronal surface. The assessment begins with the upper right central 
incisor (#8) lingual surface, proceeds to the incisal surface, and concludes with the facial surface. The 
lateral incisor (#7) is examined next and is followed by the cuspid (#6). The Upper Right Segment is 
concluded with the examination of the upper right first maxillary molar occlusal surface (#3).  
Upon completion of the Upper Right Segment, the exam proceeds to the Upper Left 
Segment, then the Lower Left Segment, and concludes with the Lower Right Segment. 
4.13.3 Scoring Guidelines 
	 Only natural teeth surfaces are examined. If a crown, abutment, pontic, or other 
restorative materials cover a surface of the tooth eligible for examination, a “9” will 
be called. 
	 Partially erupted teeth will be excluded from all surface assessments and a “9” will be 
called. 
	 Teeth sustaining traumatic damage will be excluded from all surface assessments and 
an “8” will be called. The examiner should probe for a history of trauma to confirm a 
call of “8.” 
	 Missing teeth identified in the Tooth Count will be hard coded with a “9.” 
	 Code “2” is the most difficult one to judge. Use the periodontal probe (2mm band) to 
measure the diameter of any exposed dentin facet if necessary. 
	 Where wear is severe, it can often be contiguous from palatal onto incisal, such that it 
is difficult to distinguish the surfaces. In these instances, code both the same. 
	 Frank pulpal exposure is very rare, but exposure of secondary dentin (where the pulp 
used to be), usually appearing as a small translucent area in the center of a wide area 
of dentin exposure, is not uncommon in older people. 
	 Assess only the indexed permanent teeth. Retained primary teeth are not scored. 
(Revised February 2003) 
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4.13.4 Recording Procedures 
A Tooth Wear Score (TWS) can be entered for the central incisors, lateral incisors, cuspids, 
and first molars only. One code is permitted for each surface and each tooth has three surfaces. Allowable 
codes are listed in Table 2-1. The dental examiner will dictate codes to the dental recorder. 
If a code of “1,” “3,” “4,” or “5” from the Tooth Count has been recorded, a “9” is hard-
coded for the appropriate tooth for the TWS. 
4.13.5 References 
Al-Dlaigan, Y.H., Shaw, L., and Smith, A. (2001). Dietary erosion in a group of British 14-year-old 
school children Part II: Influence of dietary intake. British Dental Journal, 190, 258-261. 
Hinds, K., and Gregory, J.R. (1995). National Diet and Nutrition Survey: Children age 1.5 To 4.5 years, 
Vol 2: Report of the Dental Survey. London: HMSO. 
Millward, A., Shaw, L., Smith, A.J., Rippin, J.W., and Harrington, E. (1994). The distribution and 
severity of tooth wear and the relationship between erosion and dietary constituents in a group of 
children. International Journal of Paediatric Dentistry, 151-157. 
Smith, B.G.N., and Knight, J.K. (1984). An index for measuring the wear of teeth. British Dental Journal, 
156, 435-438. 
Kelly, M., Steele, J., Nuttall, N., Bradnock, G., Morris, J., Nunn, J., Pine, C., Pitts, N., Treasure, E., and 
White, D. (1998). Adult Dental Health Survey: Oral health in the United Kingdom. London: Office for 
National Statistics. 
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4.14 Functional Occlusal Contacts Index (FOCI) 
National epidemiological surveys conducted in the United States have historically focused 
on descriptions of the oral craniofacial complex largely from a disease perspective by quantifying such 
conditions as carious lesions, periodontal attachment loss, and oral mucosal pathologies. This supplement 
to the NHANES dental examination component would further enhance the dentition examination by 
adding a count of the numbers of functional occlusal contacts of teeth as quantified by an index of the 
same name (FOCI). The functional occlusal contacts supplement would respond to the need that dental 
researchers have identified for assessments that more fully describe the functional capacities of the 
dentition. Having a greater understanding of this feature of the functional capacity of the oral craniofacial 
complex is of importance to research related to the relationship of oral health status and general health, 
e.g., diet and nutritional status to health services research. It is integral to answering questions regarding 
the impact of dental status on oral health-related quality of life. 
Given that the range of incisal opening is a contributory factor to a functional occlusion, a 
maximal incisal opening measure also will be collected. 
4.14.1 Description 
The exam is conducted on all SPs aged 25 years or older. The dental examiner performs the 
exam with a surface-reflecting mirror. 
This exam will count the number of functional occlusal contacts in such a way to quantify an 
important aspect of the functional status of the dentition that simple counts of teeth and prostheses alone 
cannot provide. This is a visual examination that goes beyond counting the number of teeth to count how 
many of the teeth oppose each other and can function properly when eating.  
4.14.1.1 Description of Index and Scoring System 
For the purposes of this examination the participant closes together normally on the back 
teeth. Using a mouth mirror to hold back the cheek, the examiner looks at the lower arch from the side 
and records the distribution of contacts. If a contact is present for a natural tooth to natural tooth contact, a 
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code “1” is called. If a contact is present for a natural tooth to a fixed prosthesis or between two fixed 
prostheses is present, a code “1” is also called. For purposes of this assessment, a code of “1” is reflective 
of “tooth-borne” contacts. If a contact is present for a natural tooth or a fixed prosthesis and a removable 
prosthesis, a code “2” is called. If a contact between two removable prostheses is present, a code “3” is 
called. If however there is no contact, a code “0” (zero) is called.  
4.14.1.2 Methods and Scoring System 
The Functional Occlusal Contacts Index (FOCI) consists of (1) an assessment of the 
posterior (premolar and molar) regions, and then (2) a similar assessment for the sum of anterior tooth 
contacts. The right and then left posterior regions are assessed for (1) the number of contacts between 
natural teeth, (2) natural teeth and pontics of fixed prostheses, (3) natural teeth and removable prostheses, 
and (4) the number of contacts between denture teeth. As there are few anterior teeth missing without 
prostheses in the U.S. adult population, the anterior assessment is limited to a single assessment requiring 
at least one anterior mandibular tooth in contact with an opposing anterior tooth irrespective of the type of 
teeth involved.  
A contact is the same as an occlusal stop. For the purposes of this examination, the SP closes 
together normally on the back teeth. Using a mouth mirror to hold back the cheek, the examiner looks at 
the lower arch from the side and records the distribution of contacts. In a complete quadrant, there will be 
8 possible zones of contact in the posterior region (see diagrams in Section 4.14.4). Each of the premolars 
is a single zone, and each of the molars is about twice as wide, so they are counted as two zones each. 
4.14.1.3 Codes and Criteria of Occlusal Contact Zones 
Posterior functional occlusal contact zones: 
0 = No posterior functional contact 
1 = “Tooth-borne” functional contact present 
2 = Functional contact present between a natural tooth or a fixed prosthesis and a removable 
prosthesis 

3 = Functional contact between two removable prostheses  

9 = Cannot assess 

(Revised February 2003) 
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Anterior functional occlusal contact zone: 
0 = No anterior functional contact 
1 = “Tooth-borne” functional contact present 
2 = Functional contact present between a natural tooth or a fixed prosthesis and a removable 
prosthesis 

3 = Functional contact between two removable prostheses 

9 = Cannot assess 

4.14.2 Examination Procedures 
The Functional Occlusal Contact Exam begins with the Maximal Incisal Opening. 
With the SP lying down, in the position required for the intraoral exam, ask the 
SP to position his/her mandible in a comfortable position and open his/her 
mouth as wide as possible, even if pain is felt. Do not prompt the SP to “open 
wider” again. 
Examiners will ask the SP to: 
“Please rest your lower jaw into a comfortable position and open your mouth 
as wide as possible.” 
There is to be no additional prompting of the SP to open wider. Using the endodontic 
ruler, measure from the incisal edge of the most vertically oriented maxillary central incisor to the labio­
incisal edge of the opposing mandibular incisor. Place the edge of the endodontic ruler against the labio­
incisal edge of the mandibular central incisor and measure to the incisal edge of the most vertically 
oriented maxillary central incisor. Call the measurement to the recorder in whole millimeters. Fractional 
measurements are rounded down to the lower whole number. The allowable calls are as follows: 
0 – 65 = Measurement in mm (where 65 = 65 mm or greater)  
99 = Cannot be assessed. 
(Revised February 2003) 
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If a prosthetic device has replaced central incisors, measure from the incisal edge of the 
replacement tooth. If the SP is edentulous and does not have a prosthetic device, “99” for cannot be 
assessed is recorded. The completion code would then be partial, physical limitation.  
Following Maximal Incisal Opening measurement, the Functional Occlusal Contact Index 
exam is implemented. Scoring begins with the right side, distal to the canine, and counting the number of 
occlusal contacts distally. The left posterior region is scored next. If a contact is present for a natural tooth 
to natural tooth contact, a code “1” is called. If a contact is present for a natural tooth to a fixed prosthesis 
or between two fixed prostheses, a code “1” is also called. If a contact is present for a natural tooth or a 
fixed prostheses and a removable prosthesis, a code “2” is called. If a contact between two removable 
prostheses is present, a code “3” is called. If however there is no contact, a code “0” (zero) is called. The 
calls are made irrespective of which teeth are in contact. For example, if a first premolar has been lost and 
the second premolar has moved forward, the mesial cusp of the first molar may have taken up the second 
premolar position, and the second premolar may have taken the first premolar position. However, 
although it is the second premolar and the first molar that are making the contacts, the contacts will be 
scored as being in the zones that (in a full dentition) would be occupied by the first and second premolars. 
Several examples are provided in Section 4.14.4. 
For the assessment of anterior contacts, the examiner looks at the six lower anterior teeth and 
selects the one mandibular incisor and its opposing maxillary anterior tooth (either incisor or canine) that 
represents the following hierarchical relationship:  
1 = “Tooth-borne” functional contact present 
2 = Functional contact present between a natural tooth or a fixed prosthesis and a removable 
prosthesis 

3 = Functional contact between two removable prostheses 

0 = No anterior functional contact 

When people have a deep overbite, they may have difficulty in protrusively producing a true 
“end-to-end” contact. If so, then it may be difficult to observe a contact even in a more centric relation. 
Nevertheless, the assumption should be made that a contact exists. Where there is severe anterior open 
bite, or where lower teeth are missing, there clearly cannot be a contact. Nevertheless, an attempt should 
be made to assess for the potential of a functional occlusal contact in an anterior open bite condition. 
(Revised February 2003) 
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4.14.3 Scoring Guidelines 
	 A posterior functional contact is classified as present where the contact forms a 
vertical occlusal stop. This is recorded according to the lower even if the area of 
contact is small. In rare cases where there is contact but no occlusal stop (e.g., a 
scissors bite), a zero is recorded. Clearly there can be no contact if there is no lower 
tooth in the zone.  
	 In some cases it may be difficult to tell whether the teeth actually touch or not; if in 
doubt, the assumption should be made that the contact is present. 
	 Where there are small spaces in the lower arch and you cannot decide whether you 
should consider it as a whole zone, count the space as a full zone if the space is wider 
than a half a tooth; otherwise ignore it. 
	 Removable prosthesis contact must be a contact involving a denture tooth and not 
contact to an acrylic base plate alone. 
	 If contact is observed involving gross cavitation and caries, this type of contact is not 
considered to be “functional” and should be coded as “0.” 
	 If the SP presents with having left his/her removable denture(s) at home, the examiner 
cannot assess for functional contacts and the code of “9” should be used where 
appropriate. 
(Revised February 2003) 
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4.14.4 Examples of Scoring Contacts 
Right side: Several lower teeth are present but do not make contact, and the two molars 
have drifted forward into the distal half of the space where the first molar was. Starting distal to the 
canine and working back, the call for all natural teeth would be: 
0.1.0.1.1. 0.0.0  
C 
C 
Figure 4-1. Example 1 – Right side  
Left side: On this side there has been a fair amount of drifting, but this isn’t relevant to the 
numbers of functional occlusal contacts. The calls from the distal of the canine towards the distal of the 
left side of the mouth are: 
0.0.1.1.1.0.0.0 
C 
Figure 4-2. Example 2 – Left side  
(Revised April 2003) 
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Left side: All but one maxillary tooth has been lost and the one remaining tooth has drifted 
and tipped forward and makes a contact in about the fifth zone back (roughly where the mesial half of the 
second molar would be. Sometimes this position can be difficult to judge accurately. Whether the contact 
is actually in that position or one zone, either side is not critical. What is important is that it is in the 
middle of the molar region. The calls are: 
0.0.0.0.1.0.0.0 
C 
C 
Figure 4-3. Example 3 – Left side  
Right side: There are posterior teeth but they all miss each other. The upper first premolar 
has slipped down into the lower premolar space and although there may be contact between the lower 
molar and the upper premolar it is on the side of the tooth and does not constitute an occlusal stop. These 
are called out as: 
0.0.0.0.0.0.0.0 
C 
Figure 4-4. Example 4 – Right side  
(Revised April 2003) 
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Right side: This is a common situation where single upper and lower premolars have been 
removed for orthodontic purposes and all spaces have been closed. Once again it does not matter that 
there are no second premolars. What matters is that there is a contact in that position. The calls are: 
1.1.1.1.1.1.1.0 
C 
C 
Figure 4-5. Example 5 – Right side  
Right side: Maxillary and Mandibular partial tooth loss is present; however, only a 
Maxillary Removable Partial Denture (denture teeth are shaded) is worn at the time of the exam. Contact 
in Zone 1 is between the first premolars is defined as a lower natural tooth and an upper denture tooth to 
yield a call of a “2.” The calls are: 
2.1.0.1.1.2.2.0 
C 
C 
Figure 4-6. Example 6 – Right side  
(Revised April 2003) 
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Left side: Maxillary and Mandibular Partial Dentures are worn (denture teeth are shaded). 
Contact in Zone 1 is between a forward drifted lower second premolar and Maxillary denture teeth. The 
correct call would be a “2.” Contact in Zone 3 involves a lower partial denture tooth (premolar) and the 
mesial of an upper molar denture tooth. The correct call here is a “3.” The calls are: 
2.3.3.2.2.0.0.0 
Figure 4-7. Example 7 – Left side  
4.14.5 Recording Procedures 
One code is permitted for each posterior zone (16 zones in total) and one code is permitted 
for the anterior segment assessment. Allowable codes are listed in Section 4.14.1.3. The dental examiner 
will dictate codes to the dental recorder. 
4.14.6 References 
Steele, J.G., Sheiham, A., Marcenes, W., and Walls, A.W.G. (1998). National Diet and Nutrition Survey: 
People Aged 65 Years and Over. Volume 2: Report of the Oral Health Survey. London: The Stationery 
Office, 1-124. 
(Revised April 2003) 
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Screen shots: 
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4.15 Periodontal Assessments 
The periodontal section includes two parts: measurements to determine the loss of 
attachment and the identification of bleeding from probing. The objectives of the periodontal disease 
component of the survey are to: 
 Establish age-specific data for the prevalence of periodontal diseases in a national 
sample; 
 Provide a basis for comparisons with past and future national surveys; 
 Provide baseline data for possible followup of selected subsamples; 
  Provide a basis for the future development of estimates of treatment needs; and 
 Provide a basis for studying the association between periodontal diseases prevalence 
and risk factors. 
Periodontal assessments are conducted from posterior to anterior, beginning with the most 
distal tooth in a quadrant (excluding third molars) and proceeding toward the midline. With minor 
modifications, current diagnostic criteria were used in the following surveys: 
 NIDR National Survey of Oral Health in Employed Adults and Seniors (1985-86) 

 NIDR National Survey of Oral Health in School Children (1986-87) 

 NHANES III 

 Several statewide surveys. 

REFERENCES 
Löe, H. and Silness, J. (1963). Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odont 
Scand, 21, 533. 
Ramfjord, S.P. (1967). Periodontal disease index (PDI). J Periodont, 38, 585. 
Ramfjord, S.P. and Ash, M.N. (1979). Periodontology and Periodontics. Philadelphia: W.B. Saunders 
Co. 
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4.15.1 Participant Eligibility for the Periodontal Assessment 
The periodontal assessment is performed on all SPs aged 13 and older. Periodontal 
attachment losses and bleeding from probing are assessed in the same randomly selected quadrants—one 
maxillary and one mandibular. Only fully erupted permanent teeth are scored. Three sites from each tooth 
are assessed: the distal, the mid-facial, and the mesial. 
4.15.2 Selection of Quadrants to be Assessed 
The computer program automatically identifies the two random quadrants (one random 
upper quadrant and one random lower quadrant) to be selected for the periodontal assessment. The 
recorder tells the examiner which quadrants to examine. The computer program uses the following system 
to determine the two quadrants: 
	 The fifth digit of the ID number is used to select the upper quadrant. If this number is 
even, the right side is used. If this number is odd, the left side is used. 
	 Similarly, the sixth digit of the ID number is used to select the lower quadrant for the 
periodontal examination. If this number is even, the right side is used. If this number 
is odd, the left side is used. 
	 For example, if the SP’s ID number is 123456, this would represent a left upper (5) 
and right lower (6) designation for the SP. 
4.15.3 Examination Procedure 
Clinically and quantitatively the loss of attachment is the distance in millimeters (mm) from 
the cemento-enamel junction (CEJ) to the bottom of the sulcus. The computer program calculates loss of 
attachment. The examiner takes two measurements per site for use in this calculation. Bleeding on 
Probing (BOP) is the clinical observation of the presence of blood after a site has been probed to produce 
a sulcus (pocket) depth measurement. 
Each quadrant is dried with air and then each site in the quadrant is examined with a surface 
reflecting mirror and a periodontal probe. The periodontal probe is used to measure the distal-facial 
interproximal (D), mid-facial (B), and mescal-facial interproximal (M) sites. For each site, the distance 
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from the free gingival margin (FGM) to the CEJ is measured first, and then the distance from the FGM to 
the bottom of the pocket is measured. Where the gingival margin is subject to recession and the CEJ is 
exposed, the distance from the CEJ to the gingival margin is a called a negative value. 
The periodontal probe is color coded and graduated at 2, 4, 6, 8, 10, and 12 millimeters. The 
periodontal probe is to be held with a light grasp and pointed toward the apex of the tooth. Each 
measurement is rounded to the lowest whole millimeter. The probe is inserted from the facial aspect to 
measure all three sites – the distal interproximal, the mid-facial, and the mesial interproximal. 
For the interproximal sites, (M) and (D), the probe should be placed parallel to the long axis 
of the tooth and facially adjacent to the dental contact area. Angulating the probe into the interproximal 
area under the dental contact is not permitted. For the maxillary and mandibular molars the mid-facial 
assessment is always made mid-buccally at the location of mid-facial furcation area, keeping the probe 
parallel to the long axis of the tooth. 
The allowable range for the FGM to CEJ measurement is: 
-9 to 9 = Measurement in millimeters

+A = Measurement is +10 millimeters 

+B = Measurement is +11 millimeters 

+C = Measurement is +12 millimeters 

Y = Cannot be assessed 

The allowable range for the FGM to sulcus base measurement (pocket depth) is: 
0 - 9 = Measurement in millimeters

A = Measurement is 10 millimeters 

B = Measurement is 11 millimeters 

C = Measurement is 12 millimeters 

Y = Cannot be assessed 

The presence of bleeding is assessed after the probing measurements are made. The (D), (B), 
and (M) sites for each tooth are examined for bleeding points, and the appropriate score is called for each 
site at each tooth as follows: 
1 = Bleeding from probing detected 

2 = No evidence of bleeding 

9 = Cannot assess 
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The periodontal assessment is conducted in the following order: 
	 The examiner will identify the most distal tooth that is eligible in the appropriate 
quadrant and proceed tooth-by-tooth in a posterior to anterior direction. The examiner 
will make the distal FGM-CEJ measurement first followed by the distal FGM-pocket 
depth measurement. The examiner will proceed to the mid-facial aspect of the tooth 
and will make the FGM-CEJ measurement followed by the FGM-pocket depth 
measurement. The examiner will proceed to the mesial site of the same tooth and 
measure accordingly. The examiner will then proceed to the next tooth toward the 
anterior and repeat the same measures for attachment loss. This process continues 
until measurements are made and recorded for all teeth in the quadrant. 
	 Once the quadrant’s (D), (B), and (M) sites are probed for a tooth’s loss of attachment 
measurement, the dental examiner will assess for bleeding from probing. Following 
probing and recording of the (M) site of the most anterior tooth in that quadrant, the 
examiner will return to the most posterior tooth in the quadrant and will observe the 
distal site for any presence of blood. If blood is seen, the examiner calls a “1.” If the 
site is blood-free, the examiner calls a “2.” If the site cannot be assessed, the examiner 
calls a “9.” The examiner proceeds to the mid-facial aspect of the same tooth and 
repeats the procedure and makes the appropriate call. Then the examiner proceeds to 
the mesial site of the same tooth and records accordingly. The examiner will then 
proceed to the next tooth toward the anterior and repeat the same observations for 
bleeding from probing. This process continues until all the teeth in the quadrant are 
observed and recorded. This now completes the periodontal assessment for the first 
quadrant and the examiner moves on to the next quadrant for assessment. 
	 Therefore, the pattern of recording will be the (D), (B), and (M) loss of attachment 
measurements tooth-by-tooth for the quadrant, then the (D), (B), and (M) bleeding 
observations tooth-by-tooth for the same quadrant. Once the maxillary quadrant has 
been periodontally assessed, the recorder identifies the appropriate mandibular 
quadrant and the examiner repeats the periodontal assessment procedures. 
4.15.4 Special Considerations 
1.	 Calculus at mesiofacial or midfacial sites that obscures the CEJ or interferes with the 
correct placement of the probe is removed (using a curette, if necessary). 
2.	 When the margin of a restoration is below the CEJ, the position of the CEJ will be 
estimated using adjacent landmarks and dental anatomy. 
3.	 When the CEJ cannot be estimated, the examiner codes “Y” to exclude the site.  
4.	 When the natural tooth is missing, (i.e., space maintainers, implants, partial denture, or 
pontics), the tooth sites are automatically scored “Y” by the ISIS program.  
5.	 Mobile teeth should be examined with care. The CEJ should be estimated if possible.  
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6.	 Orthodontically banded teeth, splinted teeth, and hemisected teeth will be considered 
on an individual basis and should be examined if possible.  
7.	 Partially erupted teeth are excluded from all periodontal assessments. Retained roots 
are also excluded if the CEJ and part of the clinical crown are not present. The code of 
“Y” should be used for mesiofacial and midfacial sites of the excluded tooth. If the 
entire quadrant cannot be scored, the single code of “NS” (no score) should be called 
and the recorder will enter “Y” for each tooth present in that quadrant.  
8.	 Although bleeding from probing is a site-specific call, if blood has pooled from a 
previously probed site and covered any other site of the same tooth, that site is scored 
a “1” as well. 
9.	 When teeth are rotated or positioned out of arch alignment, eligible probing sites are 
to be determined by anatomical positioning. If a tooth is rotated distally 90 degrees 
and the mid-facial is in a position of relative contact with the mesial of the posterior 
tooth, the distal probing measure will be made at the anatomical distal of the rotated 
tooth and not the anatomical mid-facial location. The anatomical mid-facial of the 
rotated tooth in this example would most likely be coded as “YY.” The appropriate 
probe insertion site to ascertain a measure will always be relative to the anatomical 
location of the tooth. 
4.15.5 Guide to Referral and Follow-up 
A Level 3 (see your dentist at earliest convenience) recommendation for care flag is 
identified by the system under the following conditions: 
	 More than 2 sites have a sulcus depth >4mm; or  
	 More than 2 sites have a depth from FGM to CEJ < -4mm; or 
	 More than 1 site has a level of attachment loss > 4mm. 
If suppuration occurs as a result of the periodontal probing or if a periodontal abscess is 
observed during the clinical examination, the examiner must recommend a level 1 or 2 recommendation 
for care, based on the examiner’s professional judgement, and generate a referral letter for the SP. 
(Revised February 2003) 
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4.15.6 Recording Procedures 
Findings for the periodontal assessment are recorded on the Periodontal Assessment screen. 
Each screen view is reserved for one quadrant.  
NOTE: The second periodontal measurement must be equal to or greater than the first 
periodontal measurement and if one measurement cannot be assessed, then the other measurement 
must also be coded as a “Y” for cannot be assessed. 
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4.16 Recommendation For Care and Referrals 
The computer system generates a list of specific recommendations for follow-up care based 
on subcomponent evaluation. There are four levels of referrals defined in the system as follows: 
 Level 1 - SP should see a dentist immediately 
 Level 2 - SP should see a dentist within the next 2 weeks 
 Level 3 - SP should see a dentist at his/her earliest convenience 
 Level 4 - SP should continue with his/her regular routine dental care 
Recommendations for care levels are flagged for specific conditions. The dental examiner 
assigns an overall recommendation for the SP based on the care levels assigned to each subcomponent 
and his/her clinical judgement. 
An examination recommendation for care level must be assigned to each and every SP by 
the examiner. If the SP does not have a condition that triggers a Level 1, Level 2, or Level 3 
recommendation for any assessment, he/she will be flagged as a Level 4 recommendation for care 
referral. If the examiner finds any condition that warrants a different level of referral, he/she will override 
the system’s referral. 
4.16.1 Recommendation For Care Recording Procedure 
This section is comprised of two screens. The first screen is used to document the care level 
assigned by the examiner. The second screen is used to create the SP Referral Letter, if needed. 
4.16.2 Recommendation For Care Screen 
The Recommendation For Care screen is a multipart screen with a list of the assessments 
that may trigger a referral on the upper left side of the screen and a choice of referral levels on the upper 
right side of the screen. The system automatically pulls data from the assessments performed to aid the 
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examiner in determining which level of care should be recommended. The lower portion of the screen is 
an open-ended comment section used by the examiner to clarify the reason for the recommendation. 
The “Assessments” section will be prefilled by the system. If the codes entered for an 
assessment do not trigger a recommendation for care flag as defined in this chapter, the system 
automatically assigns a Level 4 to that assessment. If the codes entered for an assessment trigger a 
predetermined care level, the system automatically assigns that level. In the event that multiple codes are 
assigned within the assessment, the system automatically displays the code for the more severe 
recommendation. NOTE: Preassigned levels are provided as a guide for the examiner only. 
The “Overall Recommendation” section is to be based on the level of care determined by the 
examiner and entered by the recorder. It is the examiner’s responsibility to assign an overall 
examination recommendation for care level based on his/her best professional judgment and calls 
the level to the recorder. 
The “Other Conditions” section is located just below the “Overall Recommendation” 
section. The dental examiner will choose one or more of the following conditions to be printed on the 
Referral Letter and Report of Findings as follows. 
A = Decayed teeth 

B = Gum problems/disease 

C = Oral hygiene 

D = Clinical impression of soft tissue condition 

E = Denture/partial denture/plates 

F = No significant findings 

G = Other Finding (see comment) 

NOTE: “F” is mutually exclusive with all other calls and no other condition will be 
listed if selected. 
Section G is only used when a referral letter needs to be generated. The “Comments” section 
is for the examiner to write any open-ended comment up to 75 characters long. The purpose of this 
comment is to clarify the reason for the Level 1 or Level 2 referral, if necessary. The information 
recorded in this space is printed on the Referral Letter the SP receives. 
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Specific requirements for determining the recommendation of care level and recording 
conditions for the SP Referral Letter with regard to professional and ethical considerations are provided in 
Chapter 5. 
The “Referral Refused” and “Generate Referral Letter” buttons are enabled whenever a 
Level 1 or Level 2 overall recommendation for care level is assigned.  
When the “Referral Refused” button is selected, a comment must be entered in order to 
move on. This comment is the examiner’s assessment of the reason the referral was refused and any other 
important information he/she feels may need to be documented. The system will then proceed directly to 
the Recommendation For Care Status Screen without creating the SP Referral Letter.  
When the “Generate Referral Letter” button is selected, the system will proceed to the SP 
Referral Information Screen to create a SP Referral Letter as discussed in the next section. 
4.16.3 SP Referral Information Screen Recording Procedures 
The SP Referral Information screen is used to record the information necessary to create the 
SP Referral Letter. It is displayed whenever the “Generate Referral Letter” button is selected on the 
Recommendation For Care screen. 
To complete this screen, the examiner will obtain the name and address of the SP’s dentist or 
clinic to which the letter should be addressed. In addition, the examiner will inform the recorder of any 
statements that should be added regarding the nature of the explanation or the SP’s response. Then the 
screen is used to document to whom the referral was actually given—the SP or the SP’s guardian. 
If the SP does not have a specific dentist or clinic to whom the letter should be sent, the 
Clinic Pickup feature on the upper right hand portion of the screen is used to select one of the NHANES 
referral dentists/clinics. The examiner asks the SP to choose one of the facilities listed and that is the 
health care provider to whom the SP Referral Letter will be addressed. If the name of the clinic is very 
long, this will not appear on the referral letter screen. The recorder will need to type the name in.  
4-89 

All comments to be added in the “Description of Explanation” and “SP Response” dialog 
boxes are to be recorded verbatim by the recorder as the examiner dictates. In sensitive cases, the 
examiner may ask the recorder to leave the room and complete the screen him/herself with the SP still 
present. The examiner will then complete the examination or ask the recorder to come back and close the 
examination. 
After completing the SP Referral Information screen, the following functions may be 
performed by choosing the menu options on the lower right hand portion of the screen. Use the mouse to 
click on the appropriate button as follows:  
Print This button will trigger the referral letter to be printed in the Shipping Room. 
Only use this function when the examiner needs to review a hardcopy of this 
letter with the SP. However, do not provide the SP with a copy of this letter. 
He/she will receive a copy of the letter along with other related documents when 
he/she leaves the MEC. 
Preview This button is used to view the letter on the computer screen. You will be able to 
scroll through the letter to verify all items have been inserted properly: The 
dentist name and address, the SP name, and the conditions entered on the 
Recommendation For Care screen. Any changes that need to be made must be 
made on the appropriate referral screen; changes cannot be made on this preview 
screen. 
Save This button saves the letter. This must be done, so the letter will be printed and 
given to the SP at the coordinator stand when the SP leaves the MEC. It then 
closes the SP Referral Screen and returns the user to the Recommendation for 
Care Screen.  
Cancel This button is used to cancel the creation of the SP Referral Letter and returns to 
the Recommendation For Care Screen.  
After the SP Referral Screen is completed, the program returns to the Recommendation for 
Care screen. The <Enter> key is used to proceed with the rest of the examination; that is, the 
Recommendation For Care Section Status screen. 
NOTE: If an examination is not completed, for whatever reason (SP ill, MEC closes, 
equipment malfunction, etc.), but the examiner felt that an SP Referral Letter should be generated, 
the <CLOSE EXAM> button, not the <FINISH> button, must be selected on the section status 
screen. 
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Recommendation For Care Screens 
4-91 (Revised February 2003) 
4.16.4 Post-examination Procedures 
1. Complete the Dental Examination Screens. 
2. Return the SP to the coordinator for assignment to another component.  
3. Set the room up for the next SP.  
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5. RECOMMENDATION FOR CARE, REFERRALS, AND MISCELLANEOUS 
As stated earlier, each SP will receive some general results about the dental examination 
he/she received in the MEC. These general oral health results will be combined with general results from 
the other MEC examination components to create an overall Report of Findings for each SP. In addition, 
SPs who require immediate dental care will receive a separate Oral Health Referral Letter. Both these 
documents are discussed in this section. 
Some SPs may not be able to physically complete the oral health assessments in a recumbent 
position (i.e., lying down in the dental exam chair.) These individuals may be wheel-chair-bound and 
experience difficulty in transferring to the dental exam chair, or they may be very frail. Consequently, 
individuals who do not receive the entire oral health exam lying down in the dental chair are identified 
with a special tracking code. 
5.1 SP Exam Position Tracking Code 
Before the recommendation of care screen appears, ISIS displays a screen asking if the SP 
was in a recumbent (lying down) position for all eligible assessments of the oral health exam (including 
tooth count through loss of attachment measures.) The examiner will dictate a “yes” to the recorder if a 
“yes” is applicable. If not, the examiner will dictate a “no” to the recorder. Final discretion as to whether a 
SP should be examined on the dental chair in a recumbent position is left to the examiner’s professional 
judgment and the abilities/wishes of the SP. 
5.1.1 Scoring Codes 
The allowable codes for the SP exam position tracking variable are as follows: 
Y = Yes 
N = No 
C = Cannot assess 
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5.1.2 Guidelines for Scoring 
If a child was held by a parent or guardian during the exam, the child will be coded as a 
“no.” If the child was lying down on the dental exam chair with a parent or guardian sitting on the chair as 
well, the child will be coded as a “yes.” If, at any part during the oral health exam, a SP must sit up to 
complete any portion of an exam or to quit any exam component, the SP will be coded as a “no.” 
5.2 Report of Findings 
A Report of Findings document is printed for each SP who is examined in the MEC. The 
general results from each component completed by that SP are provided on the report. The oral health 
section of the report includes the level of recommendation for care assigned by the examiner and a list of 
the problem area(s) identified by the examiner. A Sample Report of Findings is provided in Exhibit 5-1. 
5.3 Completing the Recommendations for Dental Care 
The oral examination included in this survey does not take the place of a dental checkup, 
treatment by the SP’s own dentist, or routine dental care since no radiographs are taken and the SP’s 
history is not available to the examiner. Rather, the exam is designed to achieve the research objectives. 
Therefore, a procedure has been developed for alerting SPs to the need for followup care or the need to 
continue regular routine dental care that takes the limits of the exam into consideration. 
The report of dental findings called Recommendation For Care (Exhibit 5-2) should be 
completed for each SP. This report makes recommendations about the SP’s need for dental care. At the 
conclusion of the examination, the examiner determines which of four levels should be recorded on the 
Recommendations For Care screen. These boxes indicate whether the SP should: 
1. See a dentist immediately; 
2. See his/her dentist within 2 weeks;  
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Exhibit 5-1. SP Report of Findings 
SAMPLE REPORT #1 

SAMPLE REPORT #2 
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Exhibit 5-2. Recommendation For Care screen 
(Revised February 2003) 
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5.4 
See his/her dentist at the earliest convenience; or 
3. Continue his/her regular routine dental care. 
The Recommendation For Care screen will trigger the printing of a referral letter (Exhibit 5-
3) each time a Level 1 or Level 2 recommendation of care is given. The referral letter will print in the 
coordinator area and will be given to the SP when he/she leaves the MEC. 
When the SP requires immediate care or care within the next 2 weeks, several items enable 
on the Recommendation For Care screen which will allow the examiner to indicate the main reason for 
the referral. Select one of the approved descriptions and/or include a brief comment in the space allocated. 
Remember that any description provided will be printed on the Referral Letter the SP receives. The 
comments should not provide a detailed diagnosis. Avoid descriptions which are references to specific 
tooth surface, specific treatment needs, or statements indicating a specific diagnostic classification. The 
approved descriptions include: 
A. Decayed teeth (this is listed as cavities on the Report of Findings); 
B. Gum problem/disease; 
C. Oral hygiene problem; 
D. Clinical impression of soft tissue conditions; 
E. Denture/Partial Denture/Plates 
F. No significant findings, and 
G. Some other finding (see referral letter); 
Criteria for Referral 
This section is provided to help the examiner choose the appropriate level (Level 1, 2, 3, or 
4) on the “Recommendation For Care” screen. The guidelines in Exhibit 5-4 are offered to assist 
examiners with their choice of the appropriate recommendation for care level. 
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Exhibit 5-3. Oral health referral letter 
National Health and Nutrition Examination Survey IV 
Notification of Dental Examination Findings 
Dentist/Clinic Name 
Address 
Phone Number 
Dear Doctor: 
On <exam date>, <SP’s Name> was among those who had a voluntary examination at special mobile 
facilities operated by the U.S. Public Health Service. The oral examination of the National Health and 
Nutrition Examination Survey is not and is not intended to be a substitute for the examination usually 
given to persons seeking care from their own dentists. Our examination does not include a dental history 
or x-rays; therefore, the findings are solely the result of a limited oral examination. 
<SP’s Name> was referred to your office for immediate evaluation or followup in the following areas: 
 Other condition 1 
 Other condition 2 
 Etc. 
If you have any questions about the survey, please call Kathryn S. Porter, MD at <NCHS 800#> between 
9:00 AM and 6:00 PM EST, Monday – Friday. 
Cordially, 
<NHANES Dentist Name> 
5-6 

Exhibit 5-4. Guidelines for dental referral 
GUIDELINES FOR DENTAL REFERRAL 
Level 1	 Emergency dental condition: In the opinion of the examiner, a dental or 
oral condition exists which may require immediate services for the relief 
of symptoms and stabilization of the condition. Such conditions include 
but are not limited to: severe tooth pain, hemorrhage of the oral tissues, 
acute infectious processes of the oral cavity, traumatic injury to the teeth 
and surrounding tissues, unusual swelling of the face, gums, or other oral 
tissue, or oral conditions that obstruct the airway. 
Level 2 	 Urgent dental condition: In the opinion of the examiner, a dental or oral 
lesion or condition exists for which the SP should seek medical/dental 
services within a few week period for diagnosis, relief of symptoms 
and/or stabilization of the condition, counseling about the condition or 
other appropriate followup. Such conditions may include but are not 
limited to: tooth fracture, oral lesion or condition visible to the examiner 
or SP, lost restoration, chronic pain, or other condition that is unlikely to 
resolve without professional intervention. 
Level 3 	 Earliest convenience: In the opinion of the examiner, a need for oral 
hygiene services or nonemergency conditions exist which should be 
addressed prior to the next scheduled visit. Such nonemergency 
conditions may include incipient/early caries lesions or mild gingivitis. 
Level 4 	 Continue regular care: Applies when none of the above conditions exist. 
It is widely recognized by the American public that susceptibility to plaque-induced carious 
and/or periodontal lesions is both universal and continuous throughout the life of the dentition. A periodic 
examination by a professional is an effective means of averting the serious sequelae, which may develop 
due to failure to treat these lesions at the appropriate time. It is therefore justified, following any research-
oriented oral examination, to advise that SPs “continue regular routine dental check-ups” when nothing 
unusual is found. There is, however, a considerable proportion of our population that does not receive 
appropriate treatment at an appropriate time. It is the examiner’s ethical responsibility to advise these SPs 
to “see the dentist at their earliest convenience” when such advice is warranted. There will be a small 
number of SPs who should seek treatment immediately, and it is the examiner’s responsibility to inform 
the appropriate individuals about the urgency of the situation. 
The choice of referral for “routine care” or “within 2 weeks” or “at the earliest convenience” 
or “immediate care” requires careful consideration based first on the SP’s welfare but tempered by the 
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5.5 
realities of dental practice. For example, it is inappropriate to refer SPs for care at “the earliest 
convenience” for decayed primary teeth if it is likely that those teeth will exfoliate before developing into 
sources of pain or infection. An inquiry about current or pending treatment status should be made to 
avoid the inappropriate referral of SPs currently under care or scheduled for examination in the 
near future. 
The examiner should not identify the specific teeth or surfaces of concern, nor is it necessary 
to list the specific condition provided in the guidelines in Exhibit 5-4 on the Recommendation For Care 
screen. By doing so the examiner may inadvertently misdirect the SP’s dentist’s attention away from 
another problem. Since the NHANES exam is not diagnostic, the examiner does not want to discourage 
the SP’s dentist from making an independent evaluation. 
Recommendations for care for young children should be based on the recommendations of 
the American Dental Association and other organizations. These organizations recommend that children 
have their first dental visit by age 2. Children over 2 years who have never had a check-up should be 
encouraged to have one; children with no problems who have seen a dentist should be encouraged to 
“continue regular routine care.” 
If the situation warrants it, the examiner may ask the MEC physician to assume 
responsibility for the SP. This would be especially appropriate if an oral condition is discovered with 
significant medical ramifications (e.g., hairy cell leukoplakia). 
As mentioned above, the realities of dental practice must be kept in mind in making the final 
choice. 
SP Refusal of Referral Letter 
There may be times when an SP refuses to accept the referral for dental care the examiner 
has provided. These instances are documented manually using a Dental Release Form and documented 
electronically using the Recommendation For Care screen in the ISIS system. 
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Exhibit 5-5. Dental Release Form 
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Whenever an SP refuses the referral, the examiner is to obtain the reason for the refusal. The 
dental examiner must also have the SP complete the Dental Manual Release Form (Exhibit 5-5). The 
examiner should fill out the date and the stand in the SP’s presence. The SP or SP’s guardian is then 
asked to sign the form and indicate the relationship to the SP if the SP is a minor. The examiner then must 
sign as the witness. The form is printed on 3-part NCR paper. The SP’s copy of the form (pink copy) 
should be handed to the coordinator when the SP is returned to the coordinator area for distribution to the 
SP when he/she leaves the MEC. The original form and the yellow copy (for NCHS) should be sent to 
Westat with the next mail delivery.  
The Recommendation For Care screen has a box that is checked if the SP refuses the 
referral. If this box is checked, the ISIS system will require a comment. This comment is the examiner’s 
assessment of the reason the referral was refused and any other important information he/she feels may 
need to be documented. This comment section may also be used to indicate the examiner’s response to the 
refusal and/or any pertinent information that may be useful for the examiner or someone at NCHS who is 
contacted about the SP. 
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6. QUALITY CONTROL FOR ORAL HEALTH EQUIPMENT  
This chapter reviews the tasks required of the dental examiner during a stand. Some of these 
tasks require documentation in the quality control program in the ISIS system. All of the ISIS screens are 
printed at the end of the chapter. The ISIS QC system replaces the hard copy logs used at the beginning of 
the current NHANES. The data entered on the ISIS QC screens is accessible to Westat and NCHS staff 
daily. Maintenance of the oral health equipment and room is the responsibility of the dental examiner. 
Completing the quality control checks in ISIS is also the responsibility of the dental examiner. If the 
quality control checks are not completed in the ISIS system, a pop-up error message will appear prior to 
each examination. Quality control checks will be completed at the following intervals: 
 Start of stand 
 Start of session 
 End of session 
 Weekly 
 Mid-stand 
 End of stand 
6.1 ISIS Quality Control System 
6.1.1 Accessing the System 
	 The dental examiner will select the dental icon from the introductory window on the 
computer screen. 
	 The dental examiner will enter his or her password when prompted. 
	 The dental examiner will go to utilities at the top of the screen. 
	 Under utilities, the examiner will select the quality control option and the dental 
quality control checks, Exhibit 6-1, will appear on the screen. 
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6.1.2 Entering the Data 
The examiner will choose the correct tab (Start of Stand, Start of Session, End of Session, 
Weekly, Middle of Stand, End of Stand) and enter the required information. If a required item is not done, 
the reason should be listed in the Comment section. There are several items on the list that may not be 
required every time (e.g., instrument sterilization not done every session). These items still require a 
check, but ND should be added to the Comment section. 
Exhibit 6-1. Dental quality control checks 
There are four columns for each QC check. The columns are as follows: 
	 The first column lists the QC check. 
	 The second column requires a check (9). The examiner should use the left button of 
the mouse. The check is inserted by clicking the left button while the cursor is over 
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the box. If the examiner needs to uncheck an item, then he or she needs to click the 
left button again, while the cursor is over the box. 
 The third column is the Result column. This is not necessary for every item in the QC 
list. Each item is listed later in the chapter with the required information. 
 The fourth column is the Comment section. This should be used if an item is not 
completed or if there is a problem with the equipment/supplies. 
6.2 Start of Stand Procedures 
You will note that a great deal of detail is provided. Examiners are switching MECs 
approximately every 6 weeks. If each examiner stores dental equipment and supplies in different places, it 
will be difficult locating equipment and supplies when he or she arrives at a different MEC. Occasionally, 
back-up examiners are sent to the field. Because the back-up staff are not as familiar with the room set-up 
and location of specific items, it is particularly beneficial for the back-ups if all examiners follow the 
same procedures for storing supplies. 
6.2.1 Inventory 
	 Inventory the dental room and belly compartment. Be sure to add newly shipped items 
to the existing list before taking the inventory. 
	 Remove the dental equipment from the cases and unpack the supplies needed for the 
first few weeks of exams.  
	 Store all empty cases, back up equipment, and extra supplies in the belly 
compartment. Place those supplies needed during the stand towards the front of the 
compartment. When possible, store the extra supplies in the waterproof case provided.  
	 Check all waterproof containers and covers for cracks or breakage. Report problems 
to the home office so that arrangements can be made to send replacements.  
6.2.2 Cleaning and Disinfecting 
	 Clean cabinet shelves and doors, drawers, counter tops, walls, shelves, and computer 
area. 
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 Disinfect the top drawer where the sterile instruments are stored. Disinfect all handles 
and any area that is used for supplies that come into contact with SPs during the 
examination. 
 Clean and disinfect the biohazardous waste container. Insert a biohazardous waste bag 
into the container. Bags are stored in the third drawer. 
6.2.3 Set Up 
Set up the dental equipment using the specifications provided in Chapter 3. Exhibit 6-2 lists 
the QC checks that need to be completed in the ISIS system. The following tasks need to be completed as 
well. 
	 Set up the counter top as follows: 
- Place the sharps container above the sink. 
- Place miscellaneous non-SP supplies, such as pens, pencils, tape, and scissors 
in bin on the shelf located above the counter. 
	 The drawers should be organized as follows: 
- Drawer 1: Sterilized instrument sets 
- Drawer 2: Syringe covers; disposable air tips; stickers; denture adhesive; 
cotton tip applicators; alcohol squares 
- Drawer 3: Biohazard bags, masking tape, etc. 
- Drawer 4: Manuals; paper work; miscellaneous non-SP supplies; and tool kit  
 The cabinets should be organized as follows: 
- Upper left cabinet: Tissues and the spore test kit are located on the top 
shelves; adhesive coverings and sterilization supplies are located on the bottom 
shelf. 
- Upper right cabinet: Gloves and masks are located on the bottom shelf; extra 
gloves and masks are located on the top shelves along with the pillow and 
pillow cases. 
- Lower left cabinet: This cabinet houses the compressor. 
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- Lower right cabinet: Bottled cleaning and disinfecting supplies are located on 
the bottom shelf; all contaminated supplies, such as the used instrument 
containers, are located on the top shelf. 
	 All computer equipment should have been set up prior to your arrival. If there is a 
problem with the keyboard, monitor, or wand, contact the data manager. 
Exhibit 6-2. Quality control checks 
Check Done Result Comment 
Room cleaned  No required entry Comment on problem or issue 
Chair set-up  No required entry Comment on problem or issue 
Chair cleaned  No required entry Comment on problem or issue 
Light set-up  No required entry Comment on problem or issue 
Light cleaned  No required entry Comment on problem or issue 
Stool cleaned  No required entry Comment on problem or issue 
Compressor set-up  No required entry Comment on problem or issue 
Sterilizer cleaned  No required entry Comment on problem or issue 
6.3 Within Stand Tasks 
6.3.1 Start of Session Tasks 
	 Open the ISIS dental program after the coordinator has opened the system for the 
session. 
	 Complete all tasks necessary for the start of session quality control as listed in 
Exhibit 6-3. 
	 Prepare fresh holding solutions. 
	 Clean and disinfect the dental area as needed. 
	 Place the adhesive coverings on the light-head arm and the light controls. 
	 Place plastic coverings on the instrument tray, the chair, and the air syringe. Place a 
new disposable air tip on the air syringe.  
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Exhibit 6-3. Start of session quality control checks 
QC check Done Result Comment 
Visual light check  No required entry Comment on problem or issue 
Compressor visual check  No required entry Comment on problem or issue 
Close air tank valves  No required entry Comment on problem or issue 
Sterilizer exterior cleaned  No required entry Comment on problem or issue 
Sterilizer gasket and mating 
surface cleaned 
 No required entry Comment on problem or issue 
Sterilizer gasket visual check  No required entry Comment on problem or issue 
6.3.2 Between SPs 
	 Place the used instruments and mirrors into the containers with the appropriately 
diluted Restore holding solution. 
	 Dispose of air tips into the sharps container. 
	 Throw all other used disposable items and barriers into the biohazardous waste 
container. 
	 Replace all disposable barriers, including the headrest covers on the pillow if used.  
	 Wipe instrument tray, counter top, light head, air tip holder, chair head, etc., with 
disinfectant. 
6.3.3 End of Session 
	 Complete all tasks necessary for the end of session quality control as listed in 
Exhibit 6-4. 
	 Discard holding solutions at the end of the last session for the day. Fill instrument 
containers with soapy water and scrub instruments with the instrument brush. Dry 
instruments and prepare for packaging and sterilizing. 
	 Clean and disinfect dental area as needed. 
	 Bag the biohazardous waste and replace with a clean bag at the end of each session. 
Check with the lab for specific pickup dates. 
	 Close ISIS. 
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Exhibit 6-4. End of session quality control checks 
QC check Done Result Comment 
Purge air tank 
(not needed after AM session) 
 No required entry Comment on problem or issue 
Instrument sterilized exposure time (if 
sterilized instruments ) 
 Enter time Comment on problem or issue 
Instrument sterilized temperature (if 
sterilized instruments) 
 Enter temperature Comment on problem or issue 
6.3.4 Weekly Tasks 
 Complete all tasks necessary for the weekly quality control as listed in Exhibit 6-5. 
 Clean the inside of the SpeedClave with mild soap and distilled water and then rinse 
with distilled water. Drain the water from the reservoir and refill with fresh, distilled 
water. 
 Clean those areas not maintained on a daily basis (e.g., countertop under the 
autoclave; exterior of autoclave, computer; screen; walls; shelves), as needed.  
 Stock supplies, as needed. 
Exhibit 6-5. Weekly quality control checks 
QC check Done Result Comment 
Sterilizer water reservoir checked  No required entry Comment on problem or issue 
Spore Test (see below)  No required entry Comment on problem or issue 
Spore Test start time  Enter time Comment on problem or issue 
Spore Test end time  Enter time Comment on problem or issue 
Spore Test - control result  Enter result Comment on problem or issue 
Spore Test – test result  Enter result Comment on problem or issue 
Lot #  Enter lot # Comment on problem or issue 
Load #  Enter load # Comment on problem or issue 
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6.3.5 Mid-Stand Procedures 
 Complete all tasks necessary for the mid-stand quality control as listed in Exhibit 6-6. 
Exhibit 6-6. Mid-stand quality control checks 
QC Check Done Result Comment 
Sterilizer drained and refilled with 
distilled water 
 No required entry Comment on problem or issue 
Sterilizer chamber cleaned  No required entry Comment on problem or issue 
6.3.6 End-of-Stand Pack-Up Procedures 
	 Review end of stand QC prior to pack-up. 
	 Open ISIS system prior to the coordinator shutting down. Enter information as it is 
completed. 
	 Complete all tasks necessary for the end of stand quality control as listed in Exhibit 
6-7. 
	 Flush the SpeedClave with SpeedClean solution as described in Chapter 3. 
	 Inventory the dental room and belly compartment using the inventory form provided 
by the MEC manager. An inventory worksheet developed for the dental component is 
available to assist and track the stand inventories. 
	 Pack the equipment and supplies as specified in Chapter 3. 
	 Close ISIS QC session. 
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Exhibit 6-7. End of stand quality control checks 
QC Check Done Result Comment 
Chair cleaned  No required entry Comment on problem or issue 
Chair packed  No required entry Comment on problem or issue 
Light cleaned  No required entry Comment on problem or issue 
Stool cleaned  No required entry Comment on problem or issue 
Sterilizer flushed  No required entry Comment on problem or issue 
Sterilizer chamber cleaned  No required entry Comment on problem or issue 
Sterilizer interior tray wiped and 
replaced 
 No required entry Comment on problem or issue 
Sterilizer gasket cleaned and 
inspected 
 No required entry Comment on problem or issue 
Sterilizer packed  No required entry Comment on problem or issue 
Air tank bled  No required entry Comment on problem or issue 
Compressor secured  No required entry Comment on problem or issue 
Replace instruments  No required entry Date replaced or ND if not 
replaced 
Replace light bulb  No required entry Date replaced or ND if not 
replaced 
Change fuses  No required entry Date replaced or ND if not 
replaced 
Change syringe cotton roll (if wet 
or if annual replacement required) 
 No required entry Date replaced or ND if not 
replaced 
Sterilizer gasket replaced  No required entry Date replaced or ND if not 
replaced 
6.4 Shipping 
Instruments or supplies that are broken, defective, or no longer used can be shipped back to 
the NHANES warehouse manager at the Home Office. Place the instruments in a padded envelope and 
ask the MEC manager to ship directly to the warehouse. When shipping obsolete or broken inventory 
back to the warehouse, please complete the “Delete Expired/Broken Inventory Report” which is found on 
the Intraweb and can be printed by your MEC manager or Data Manager. 
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Start of Stand ISIS Screen 
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Start of Session ISIS Screen 
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End of Session ISIS Screens 
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Weekly ISIS Screens 
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Middle of Stand ISIS Screen 
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End of Stand ISIS Screens 
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7.1 
7. QUALITY CONTROL PROCEDURES 
Two primary concerns in all epidemiological surveys are to protect the survey from errors 
that may compromise the representativeness of the sample and from errors in measurement of the 
phenomena being studied. Dental teams and support staff in NHANES are responsible for protecting the 
accuracy and precision of the dental component of this survey by promoting maximum response rates and 
assuring the quality of data collected from the sample. 
This section of the manual presents a brief summary of quality control procedures for which 
the dental team and support staff will be accountable. 
Response Rates 
The precision of the sample design in this survey is based on a very small number of persons 
selected to represent very large numbers of people. Therefore, the examination team’s responsibility to 
achieve the highest possible examination response rate is a very important one. The examination response 
rate is actually a product of response rates achieved at three stages: (1) the screener response rates, (2) the 
interview response rates, and (3) the examination response rates. 
Obviously, the dental team is directly involved in only the third stage of developing high 
examination response rates. Appearance, demeanor, and attitude of professional personnel shape SPs’ 
feelings about the survey and help determine the degree to which they will be cooperative during the 
examination. SPs’ feelings toward project personnel also affect what they say about the survey after they 
leave the MEC and interact with other people in the community. Individual members of the dental team 
and support staff are to treat all SPs with respect and courtesy. Special attention must be devoted toward 
relieving fear in children and apprehensive adults. In addition to being pleasant and displaying a caring 
attitude toward the SPs, examiners must exercise great care in performing the assessments so that the SPs 
are comfortable during the examination. 
Although it is only the third stage of response rate development in which the dental team is 
directly involved, every effort should be made to cooperate with advance arrangement teams and 
interview teams to assist them in developing high response rates. Examiners must be willing to provide 
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them with information and advice on how to alleviate fear that the examination may be painful or 
embarrassing so they can deal with apprehension among SPs who are reluctant to make an appointment 
for the examination. 
7.2 Data Quality 
Each individual staff member is the first and best guarantor of the quality of the data being 
collected. Data quality is affected by every step of the survey including nonexam procedures leading to 
the examination, and nonexam procedures following the examination. The quality of data in this survey is 
controlled by (1) an intense training period for the dental teams with calibration of dental examiners prior 
to the beginning of the survey, (2) periodic monitoring and recalibration of dental examiners, and 
(3) periodic retraining of dental teams. 
7.2.1 Training and Calibration 
Training is divided into three phases as follows: 
	 The instructional phase in which examination team members are familiarized with 
research examination procedures and criteria for research assessments. 
	 The standardization phase in which they are trained to use standard procedures and 
apply standard criteria for the oral health assessments. 
	 The calibration phase in which the degree of correlation among the examiners and 
the standard examiner is measured. 
Instruction 
The instructional phase of the training sequence is conducted by nationally recognized 
research science experts in each type of oral health assessment and survey procedure with support and 
assistance from the standard examiner. The standard examiner is a specially trained dentist with a high 
level of experience in conducting oral health protocols in national surveys. The expert trainers present 
lectures on criteria for each of the oral health assessments to be used in the survey. Lectures are 
accompanied by slides depicting a wide variety of possible observations and illustrating application of 
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assessment criteria to those observations. The lecture-slide presentations on each assessment are followed 
by instructions on data recording and editing for that assessment. Although the instructional phase 
consists primarily of lectures and slide presentations, some demonstrations of examination technique and 
equipment use are conducted. 
 Standardization 
The second phase of training is devoted to standardization. During this phase of training, the 
standard examiner reviews examination procedures and techniques and the criteria for each assessment, 
stressing the importance of consistency and uniformity among all examiners and the standard examiner in 
performing the examination and in applying the criteria to observations. Rationale for differences between 
a research examination and a diagnostic examination are discussed and professional ethics of research 
examinations reviewed. A demonstration of the examination by the standard examiner and practice 
examinations by the examiners being trained is among the salient features of this phase. Standardization 
of all examiners is achieved by using replicate examinations with detailed discussion of observations. 
NIDCR scientists, project consultants, and the standard examiner monitor and referee examinations and 
discussion of observations during these sessions. 
Calibration 
The reliability of the assessments is measured by determining the degree to which examiners 
can produce uniform and consistent results when performing independent replicate examinations without 
discussion. In this phase of training, the standard examiner and all examiners in training perform 
components of the examination on a specified number of SPs while NIDCR examiners monitor the 
calibration session without discussing observations with any of the examiners or the standard examiner. 
Data from the calibration sessions are analyzed to measure correlation between each examiner and the 
standard examiner. If correlations between each of the examiners and the standard examiner are not 
within acceptable ranges, additional training sessions will be scheduled. 
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7.2.2 Monitoring and Recalibration 
Continual gathering of clean, reliable data in a consistent and uniform manner is the primary 
objective of the survey. Several quality control procedures will be carried out periodically to assure 
continuing quality of data gathered by the dental teams throughout the duration of the survey. 
Expert Replication and Monitoring Field Operations  
During the field operations, examiners and recorders should periodically review their 
training manuals to prevent deviation, or “drift” from the standards achieved during the training period. 
Particular attention should be devoted to uniform adherence to the criteria for making correct decisions 
about observations. Strict compliance with infection control procedures is another important consideration 
for dental teams. In order to help the dental teams maintain their standards, NIDCR and CDC Division of 
Oral Health scientists and various other project personnel will make periodic visits to field personnel to 
observe their performance and offer feedback on the results of their examinations. 
The standard examiner will visit each team three times per year to observe field operations 
and to replicate 20 to 25 dental examinations during each visit. The purpose of these so called “expert 
replications” is to determine whether the examiners are maintaining the examination standards achieved 
during training, and to measure the degree of deviation, if any, from those standards. If correlation 
between the standard examiner and the field examiner is not within acceptable limits, retraining will be 
conducted on site. 
Annual Retraining 
The long duration of the study (6 years) mandates the need for regularly scheduled retraining 
periods. In addition to the regularly scheduled recalibration sessions with the standard examiner, there 
will be an annual retraining session for each dental examiner, also conducted by the standard examiner. 
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Appendix A 

Backup Equipment 

APPENDIX A. BACKUP EQUIPMENT 
Backup equipment will be provided for the dental chair, dental light, air compressor, and 
SpeedClave. Procedures for the setup, care, and maintenance of the backup equipment are provided in this 
appendix. 
1. Porta-Chair 
The back up Porta-Chair is the same as the original. Procedures for set up, care and 
maintenance are provided in Section 3.3.1  
2. Light 
The ProBrite light is a portable light that is partially preassembled and needs only to be 
connected to the wall support and plugged into an electrical outlet. 
 Set-up 
The wall mount ProBrite light comes assembled with a horizontal supporting arm and a 
bushing designed for the light post. After unpacking, the male plug extending past the bushing is 
connected to the female receptacle in the light post and then the ProBrite Light is lowered to the light post 
until the bushing properly seats in the light post. Connect the power cord.  
 Use 
The ProBrite light is equipped with two intensity control systems. The infinitely variable 
selection switch regulates intensity from no illumination to maximum illumination. The lens system 
located at the end of the arm regulates focus from a wide to a narrow light beam. As the beam is 
narrowed, the light energy is concentrated for greater illumination. A few minutes of experimentation will 
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establish the optimum intensity and focus for each operator. To ensure maximum lamp life, the minimum 
intensity position should not be left on all day but used only for short durations when needed during an 
exam. 
The light is also designed to minimize the need to reposition SPs for the dental procedures. 
The light is equipped with a fully flexible arm that may be moved freely to eliminate shadows and to 
illuminate areas impossible to illuminate with conventional lights. The optimum distance from the light 
lens to the operating area is 8-12 inches. Certain dental procedures may require higher light intensity that 
can be accomplished, in part, by moving the light lens to within 4 inches of the operating area. 
Correct adjustment is accomplished when all arm angles are about equal. Do not straighten 
the arm more than 90o at any flexible joint or broken glass fibers may result in reduction of light 
transmission. 
 Maintenance 
Perform a visual check at the start of each session, before using the equipment. Be sure to 
look for mechanical damage such as cracks on the power cord or cable, cracks or splits on the bulb 
cowling and cover, and cracks or scratching of the lens. Also look for loose or missing items such as 
screws, nuts, and bolts. 
 Cleaning 
Always wear nonpowdered gloves when cleaning the light and be sure to disconnect the 
power cable from the power source before you begin. 
The light may be cleaned using a soft cloth and a mild soap solution as needed. The mirror 
and lenses may be cleaned using a cotton applicator in a circular motion. Do not spray disinfectant 
directly into the light adapter as this may cause damage to the bulb and reduce light transmission. 
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 Replace Light Bulb 
To replace the high-intensity light bulb, disconnect the power cable from the electrical 
source. Allow the projector to cool down. Open the side-flap and expose the bulb holder, which easily 
swings out of the compartment. Using a small screwdriver, pry the bulb from its socket. Insert the new 
bulb (without touching the glass) into the holder as far as it will go. The metal contacts of the bulb should 
not be bent. Close the flap. The bulb holder automatically returns to the correct working position. Be 
aware, the light bulb fits tightly in the socket and can be difficult to remove and replace. 
 Change Fuses 
Replacement fuses are found in the fuse compartment next to the male outlet in the light 
assembly. This is located underneath the projector. A screw driver is needed to open and close the fuse 
compartment. Be sure to disconnect the power cable from the electric source. 
 Pack-up 
The arm of the light is made of glass fibers, which transmit the light. If the fibers are broken, 
there will be less light transmission. For this reason, care must be taken with the light. At the end of a 
stand, the light head and light box must be packed in their designated storage boxes, and the light head 
should be wrapped in bubble wrap. 
3. Gomco Air Compressor 
The backup air compressor is the Gomco Air Compressor. 
 Operating Principle 
The negative and positive pressures of a diaphragm pump are developed by the 
reciprocating motion of the diaphragm inside the pump head. These pressures are 
maintained by the motion of the diaphragm and the pressure and suction flapper 
valves. On the up stroke, the pressure valve will open to allow air to flow through to 
the exhaust or pressure port. On the down stroke, the pressure valve closes and the 
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suction valve opens which draws a vacuum or creates a negative pressure at the 
suction side. 
	 Assembly 
The Gomco Air Compressor is used only for air drying the mouth and not for suction, 
therefore only three assembly items are applicable. 
1. 	 The black cord tubing for blowing air will already be attached to the air 
pressure valve and does not need to be removed when moving the equipment.  
2.	 Check all tubing to make sure that connections are secure. 
3.	 Plug the electrical cord into a three-pronged outlet. If the outlet is two-pronged, 
use a three-pronged adapter.  
	 Safety Overflow Valve 
The valve operates on the principle that a chamois disc permits the flow of air through 
it when dry. Any fluid striking and saturating the chamois causes the pores to swell 
and, thereby, stops the passage of air. When the chamois becomes moist (restricting 
the air flow), the vacuum of the pump causes the chamois to push against the formed 
spring which shuts off the air flow through the pump. The unit may be used without a 
chamois disc in emergencies, but there will be no overflow protection. 
When the valve closes, the pump should immediately be shut off and the felt filter and 
chamois disc replaced. 
The felt filter is replaced into the head of the safety overflow valve to collect any 
moisture droplets that may get drawn into the intake tube. 
	 To Replace the Felt Filter 
1.	 Shut off pump. 
2.	 Remove cover on valve back. 
3.	 Take out three screws and filter window. 
4.	 Remove gasket. 
5.	 Remove felt filter and discard. 
6.	 Wipe clean and dry all parts. 
7.	 Put in new filter and attach gasket and window making sure that the window is 
tight. 
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	 To Replace Chamois Disc 
1.	 Remove cover of valve while pump is running.  
2.	 With chamois removed and spring in closed position, wipe out the moisture 
from valve back.  
3.	 Shut off pump and note that the spring releases from valve back.  
4.	 Press spring to back of valve and remove any moisture in lower portion of 
valve back. 
5.	 Start pump and note that the spring will remain open permitting air to enter 
pump.  
6.	 Gently insert new chamois in place of the old one with pump running and 
fasten on overflow valve cover.  
7.	 Remove moisture from vacuum regulating valve and tubing attached to 
overflow valve.  
8.	 Attach tubing from short bottle tube to valve and check to make sure suction is 
present. NOTE: The valve function should be checked in the collection bottle 
and in the vacuum system or premature shutoff may occur.  
If the valve closes after reassembly when the motor is running, this is an 
indication that moisture may be reaching the chamois disc. The valve should be 
disassembled and dried more thoroughly or replaced. Replace chamois disc. 
There is a chance that the valve may close by itself if the tubing is compressed 
and released suddenly--stop the pump for three seconds and it will reopen. 
If no moisture is reaching the valve and it still closes, the difficulty may be that 
the spring has been bent in a convex condition or the legs of the spring may 
have been bent too flat. Should this condition occur, the spring must be 
replaced. Refer servicing to qualified personnel.  
CAUTION: If flooding occurs, do not attempt to operate the pump. Refer 
servicing to qualified personnel. Do not at any time lubricate any of the parts 
with oil, grease, or petroleum products. The pump and motor are permanently 
lubricated and require no oiling or greasing.  
4. SpeedClave 
Problems with the SpeedClave should be reported to your MEC manager who will notify the 
Home Office of the need for a replacement as necessary.  
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Summary 
This report consolidates previous recommendations and adds new ones for infection control in dental settings. Recommendations 
are provided regarding 1) educating and protecting dental health-care personnel; 2) preventing transmission of bloodborne patho­
gens; 3) hand hygiene; 4) personal protective equipment; 5) contact dermatitis and latex hypersensitivity; 6) sterilization and 
disinfection of patient-care items; 7) environmental infection control; 8) dental unit waterlines, biofilm, and water quality; and 
9) special considerations (e.g., dental handpieces and other devices, radiology, parenteral medications, oral surgical procedures, and 
dental laboratories). These recommendations were developed in collaboration with and after review by authorities on infection 
control from CDC and other public agencies, academia, and private and professional organizations. 
Introduction	 • hand-hygiene products and surgical hand antisepsis; 
•	 contact dermatitis and latex hypersensitivity;
This report consolidates recommendations for preventing 
•	 sterilization of unwrapped instruments; 
and controlling infectious diseases and managing personnel 
•	 dental water-quality concerns (e.g., dental unit waterline
health and safety concerns related to infection control in den­
biofilms; delivery of water of acceptable biological quality 
tal settings. This report 1) updates and revises previous CDC 
for patient care; usefulness of flushing waterlines; use of
recommendations regarding infection control in dental set-
sterile irrigating solutions for oral surgical procedures; 
tings (1,2); 2) incorporates relevant infection-control measures 
handling of community boil-water advisories);
from other CDC guidelines; and 3) discusses concerns not 
•	 dental radiology;
addressed in previous recommendations for dentistry. These 
•	 aseptic technique for parenteral medications; 
updates and additional topics include the following: 
•	 preprocedural mouth rinsing for patients; 
•	 application of standard precautions rather than universal 
• oral surgical procedures;

precautions;

•	 laser/electrosurgery plumes; 
•	 work restrictions for health-care personnel (HCP) infected 
• tuberculosis (TB);

with or occupationally exposed to infectious diseases;

•	 Creutzfeldt-Jakob disease (CJD) and other prion-related 
•	 management of occupational exposures to bloodborne 
diseases;
pathogens, including postexposure prophylaxis (PEP) for 
•	 infection-control program evaluation; and 
work exposures to hepatitis B virus (HBV), hepatitis C 
•	 research considerations. 
virus (HCV); and human immunodeficiency virus (HIV); 
These guidelines were developed by CDC staff members in 
•	 selection and use of devices with features designed to pre-
collaboration with other authorities on infection control. Draft 
vent sharps injury; 
documents were reviewed by other federal agencies and profes­
sional organizations from the fields of dental health care, public 
The material in this report originated in the National Center for Chronic health, and hospital epidemiology and infection control. A Fed-
Disease Prevention and Health Promotion, James S. Marks, M.D., eral Register notice elicited public comments that were consid-
M.P.H., Director; and the Division of Oral Health, William R. Maas, 
ered in the decision-making process. Existing guidelines and D.D.S., M.P.H., Director. 
published research pertinent to dental infection-control prin­
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ciples and practices were reviewed. Wherever possible, recom­
mendations are based on data from well-designed scientific stud­
ies. However, only a limited number of studies have characterized 
risk factors and the effectiveness of prevention measures for 
infections associated with dental health-care practices. 
Some infection-control practices routinely used by health-
care practitioners cannot be rigorously examined for ethical or 
logistical reasons. In the absence of scientific evidence for such 
practices, certain recommendations are based on strong theo­
retical rationale, suggestive evidence, or opinions of respected 
authorities based on clinical experience, descriptive studies, or 
committee reports. In addition, some recommendations are 
derived from federal regulations. No recommendations are 
offered for practices for which insufficient scientific evidence 
or lack of consensus supporting their effectiveness exists. 
Background 
In the United States, an estimated 9 million persons work in 
health-care professions, including approximately 168,000 den­
tists, 112,000 registered dental hygienists, 218,000 dental 
assistants (3), and 53,000 dental laboratory technicians (4). 
In this report, dental health-care personnel (DHCP) refers to 
all paid and unpaid personnel in the dental health-care setting 
who might be occupationally exposed to infectious materials, 
including body substances and contaminated supplies, equip­
ment, environmental surfaces, water, or air. DHCP include 
dentists, dental hygienists, dental assistants, dental laboratory 
technicians (in-office and commercial), students and trainees, 
contractual personnel, and other persons not directly involved 
in patient care but potentially exposed to infectious agents (e.g., 
administrative, clerical, housekeeping, maintenance, or vol­
unteer personnel). Recommendations in this report are 
designed to prevent or reduce potential for disease transmis­
sion from patient to DHCP, from DHCP to patient, and from 
patient to patient. Although these guidelines focus mainly on 
outpatient, ambulatory dental health-care settings, the recom­
mended infection-control practices are applicable to all set­
tings in which dental treatment is provided. 
Dental patients and DHCP can be exposed to pathogenic 
microorganisms including cytomegalovirus (CMV), HBV, 
HCV, herpes simplex virus types 1 and 2, HIV, Mycobacte­
rium tuberculosis, staphylococci, streptococci, and other viruses 
and bacteria that colonize or infect the oral cavity and respira­
tory tract. These organisms can be transmitted in dental set­
tings through 1) direct contact with blood, oral fluids, or other 
patient materials; 2) indirect contact with contaminated 
objects (e.g., instruments, equipment, or environmental sur­
faces); 3) contact of conjunctival, nasal, or oral mucosa with 
droplets (e.g., spatter) containing microorganisms generated 
from an infected person and propelled a short distance (e.g., 
by coughing, sneezing, or talking); and 4) inhalation of air­
borne microorganisms that can remain suspended in the air 
for long periods (5). 
Infection through any of these routes requires that all of the 
following conditions be present: 
•	 a pathogenic organism of sufficient virulence and in 
adequate numbers to cause disease; 
•	 a reservoir or source that allows the pathogen to survive 
and multiply (e.g., blood); 
•	 a mode of transmission from the source to the host; 
•	 a portal of entry through which the pathogen can enter 
the host; and 
• a susceptible host (i.e., one who is not immune). 
Occurrence of these events provides the chain of infection (6). 
Effective infection-control strategies prevent disease transmis­
sion by interrupting one or more links in the chain. 
Previous CDC recommendations regarding infection con­
trol for dentistry focused primarily on the risk of transmission 
of bloodborne pathogens among DHCP and patients and use 
of universal precautions to reduce that risk (1,2,7,8). Univer­
sal precautions were based on the concept that all blood and 
body fluids that might be contaminated with blood should be 
treated as infectious because patients with bloodborne infec­
tions can be asymptomatic or unaware they are infected (9,10). 
Preventive practices used to reduce blood exposures, particu­
larly percutaneous exposures, include 1) careful handling of 
sharp instruments, 2) use of rubber dams to minimize blood 
spattering; 3) handwashing; and 4) use of protective barriers 
(e.g., gloves, masks, protective eyewear, and gowns). 
The relevance of universal precautions to other aspects of 
disease transmission was recognized, and in 1996, CDC 
expanded the concept and changed the term to standard pre­
cautions. Standard precautions integrate and expand the ele­
ments of universal precautions into a standard of care designed 
to protect HCP and patients from pathogens that can be spread 
by blood or any other body fluid, excretion, or secretion (11). 
Standard precautions apply to contact with 1) blood; 2) all 
body fluids, secretions, and excretions (except sweat), regard­
less of whether they contain blood; 3) nonintact skin; and 4) 
mucous membranes. Saliva has always been considered a 
potentially infectious material in dental infection control; thus, 
no operational difference exists in clinical dental practice 
between universal precautions and standard precautions. 
In addition to standard precautions, other measures (e.g., 
expanded or transmission-based precautions) might be neces­
sary to prevent potential spread of certain diseases (e.g., TB, 
influenza, and varicella) that are transmitted through airborne, 
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droplet, or contact transmission (e.g., sneezing, coughing, and 
contact with skin) (11). When acutely ill with these diseases, 
patients do not usually seek routine dental outpatient care. 
Nonetheless, a general understanding of precautions for dis­
eases transmitted by all routes is critical because 1) some DHCP 
are hospital-based or work part-time in hospital settings; 
2) patients infected with these diseases might seek urgent treat­
ment at outpatient dental offices; and 3) DHCP might 
become infected with these diseases. Necessary transmission-
based precautions might include patient placement (e.g., iso­
lation), adequate room ventilation, respiratory protection (e.g., 
N-95 masks) for DHCP, or postponement of nonemergency 
dental procedures. 
DHCP should be familiar also with the hierarchy of con­
trols that categorizes and prioritizes prevention strategies (12). 
For bloodborne pathogens, engineering controls that elimi­
nate or isolate the hazard (e.g., puncture-resistant sharps con­
tainers or needle-retraction devices) are the primary strategies 
for protecting DHCP and patients. Where engineering con­
trols are not available or appropriate, work-practice controls 
that result in safer behaviors (e.g., one-hand needle recapping 
or not using fingers for cheek retraction while using sharp 
instruments or suturing), and use of personal protective equip­
ment (PPE) (e.g., protective eyewear, gloves, and mask) can 
prevent exposure (13). In addition, administrative controls 
(e.g., policies, procedures, and enforcement measures targeted 
at reducing the risk of exposure to infectious persons) are a 
priority for certain pathogens (e.g., M. tuberculosis), particu­
larly those spread by airborne or droplet routes. 
Dental practices should develop a written infection-control 
program to prevent or reduce the risk of disease transmission. 
Such a program should include establishment and implemen­
tation of policies, procedures, and practices (in conjunction 
with selection and use of technologies and products) to pre­
vent work-related injuries and illnesses among DHCP as well 
as health-care–associated infections among patients. The pro­
gram should embody principles of infection control and 
occupational health, reflect current science, and adhere to rel­
evant federal, state, and local regulations and statutes. An 
infection-control coordinator (e.g., dentist or other DHCP) 
knowledgeable or willing to be trained should be assigned 
responsibility for coordinating the program. The effectiveness 
of the infection-control program should be evaluated on a day-
to-day basis and over time to help ensure that policies, proce­
dures, and practices are useful, efficient, and successful (see 
Program Evaluation). 
Although the infection-control coordinator remains respon­
sible for overall management of the program, creating and main­
taining a safe work environment ultimately requires the 
commitment and accountability of all DHCP. This report is 
designed to provide guidance to DHCP for preventing disease 
transmission in dental health-care settings, for promoting a safe 
working environment, and for assisting dental practices in 
developing and implementing infection-control programs. These 
programs should be followed in addition to practices and pro­
cedures for worker protection required by the Occupational 
Safety and Health Administration’s (OSHA) standards for 
occupational exposure to bloodborne pathogens (13), 
including instituting controls to protect employees from 
exposure to blood or other potentially infectious materials 
(OPIM), and requiring implementation of a written exposure-
control plan, annual employee training, HBV vaccinations, and 
postexposure follow-up (13). Interpretations and enforcement 
procedures are available to help DHCP apply this OSHA stan­
dard in practice (14). Also, manufacturer’s Material Safety Data 
Sheets (MSDS) should be consulted regarding correct proce­
dures for handling or working with hazardous chemicals (15). 
Previous Recommendations 
This report includes relevant infection-control measures from 
the following previously published CDC guidelines and rec­
ommendations: 
•	 CDC. Guideline for disinfection and sterilization in 
health-care facilities: recommendations of CDC and the 
Healthcare Infection Control Practices Advisory Commit­
tee (HICPAC). MMWR (in press). 
•	 CDC. Guidelines for environmental infection control in 
health-care facilities: recommendations of CDC and the 
Healthcare Infection Control Practices Advisory Commit­
tee (HICPAC). MMWR 2003;52(No. RR-10). 
•	 CDC. Guidelines for the prevention of intravascular 
catheter-related infections. MMWR 2002;51(No. RR-10). 
•	 CDC. Guideline for hand hygiene in health-care settings: 
recommendations of the Healthcare Infection Control 
Practices Advisory Committee and the HICPAC/SHEA/ 
APIC/IDSA Hand Hygiene Task Force. MMWR 2002;51 
(No. RR-16). 
•	 CDC. Updated U.S. Public Health Service guidelines for 
the management of occupational exposures to HBV, HCV, 
and HIV and recommendations for postexposure prophy­
laxis. MMWR 2001;50(No. RR-11). 
•	 Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis 
WR, Hospital Infection Control Practices Advisory Com­
mittee. Guideline for prevention of surgical site infection, 
1999. Infect Control Hosp Epidemiol 1999;20:250–78. 
•	 Bolyard EA, Tablan OC, Williams WW, Pearson ML, 
Shapiro CN, Deitchman SD, Hospital Infection Control 
Practices Advisory Committee. Guideline for infection 
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control in health care personnel, 1998. Am J Infect Con­
trol 1998;26:289–354. 
•	 CDC. Immunization of health-care workers: recommen­
dations of the Advisory Committee on Immunization Prac­
tices (ACIP) and the Hospital Infection Control Practices 
Advisory Committee (HICPAC). MMWR 1997;46(No. 
RR-18). 
•	 Rutala WA, Association for Professionals in Infection 
Control and Epidemiology, Inc. APIC guideline for selec­
tion and use of disinfectants. Am J Infect Control 
1996;24:313–42. 
•	 Garner JS, Hospital Infection Control Practices Advisory 
Committee. Guideline for isolation precautions in hospi­
tals. Infect Control Hosp Epidemiol 1996;17:53–80. 
•	 Larson EL, 1992, 1993, and 1994 Guidelines Committee. 
APIC guideline for handwashing and hand antisepsis in 
health-care settings. Am J Infect Control 1995;23:251–69. 
•	 CDC. Guidelines for preventing the transmission of 
Mycobacterium tuberculosis in health-care facilities, 1994. 
MMWR 1994;43(No. RR-13). 
•	 CDC. Recommendations for preventing transmission of 
human immunodeficiency virus and hepatitis B virus to 
patients during exposure-prone invasive procedures. 
MMWR 1991;40(No. RR-8). 
•	 Garner JS. CDC guideline for prevention of surgical 
wound infections, 1985. Supersedes guideline for preven­
tion of surgical wound infections published in 1982. 
(Originally published in November 1985). Revised. 
Infect Control 1986;7:193–200. 
•	 Garner JS, Favero MS. CDC guideline for handwashing 
and hospital environmental control, 1985. Infect Control 
1986;7:231–43. 
Selected Definitions 
Alcohol-based hand rub: An alcohol-containing preparation 
designed for reducing the number of viable microorganisms 
on the hands. 
Antimicrobial soap: A detergent containing an antiseptic agent. 
Antiseptic: A germicide used on skin or living tissue for the 
purpose of inhibiting or destroying microorganisms (e.g., 
alcohols, chlorhexidine, chlorine, hexachlorophene, iodine, 
chloroxylenol [PCMX], quaternary ammonium compounds, 
and triclosan). 
Bead sterilizer: A device using glass beads 1.2–1.5 mm 
diameter and temperatures 217ºC–232ºC for brief exposures 
(e.g., 45 seconds) to inactivate microorganisms. (This term is 
actually a misnomer because it has not been cleared by the 
Food and Drug Administration [FDA] as a sterilizer). 
Bioburden: Microbiological load (i.e., number of viable 
organisms in or on an object or surface) or organic material on 
a surface or object before decontamination, or sterilization. 
Also known as bioload or microbial load. 
Colony-forming unit (CFU): The minimum number (i.e., 
tens of millions) of separable cells on the surface of or in semi­
solid agar medium that give rise to a visible colony of progeny. 
CFUs can consist of pairs, chains, clusters, or as single cells 
and are often expressed as colony-forming units per milliliter 
(CFUs/mL). 
Decontamination: Use of physical or chemical means to 
remove, inactivate, or destroy pathogens on a surface or item 
so that they are no longer capable of transmitting infectious 
particles and the surface or item is rendered safe for handling, 
use, or disposal. 
Dental treatment water: Nonsterile water used during dental 
treatment, including irrigation of nonsurgical operative sites 
and cooling of high-speed rotary and ultrasonic instruments. 
Disinfectant: A chemical agent used on inanimate objects 
(e.g., floors, walls, or sinks) to destroy virtually all recognized 
pathogenic microorganisms, but not necessarily all microbial 
forms (e.g., bacterial endospores). The U.S. Environmental 
Protection Agency (EPA) groups disinfectants on the basis of 
whether the product label claims limited, general, or hospital 
disinfectant capabilities. 
Disinfection: Destruction of pathogenic and other kinds of 
microorganisms by physical or chemical means. Disinfection 
is less lethal than sterilization, because it destroys the majority 
of recognized pathogenic microorganisms, but not necessarily 
all microbial forms (e.g., bacterial spores). Disinfection does 
not ensure the degree of safety associated with sterilization 
processes. 
Droplet nuclei: Particles <5 µm in diameter formed by dehy­
dration of airborne droplets containing microorganisms that 
can remain suspended in the air for long periods of time. 
Droplets: Small particles of moisture (e.g., spatter) generated 
when a person coughs or sneezes, or when water is converted 
to a fine mist by an aerator or shower head. These particles, 
intermediate in size between drops and droplet nuclei, can 
contain infectious microorganisms and tend to quickly settle 
from the air such that risk of disease transmission is usually 
limited to persons in close proximity to the droplet source. 
Endotoxin: The lipopolysaccharide of gram-negative bacte­
ria, the toxic character of which resides in the lipid protein. 
Endotoxins can produce pyrogenic reactions in persons 
exposed to their bacterial component. 
Germicide: An agent that destroys microorganisms, especially 
pathogenic organisms. Terms with the same suffix (e.g., viru­
cide, fungicide, bactericide, tuberculocide, and sporicide) indi­
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cate agents that destroy the specific microorganism identified 
by the prefix. Germicides can be used to inactivate microor­
ganisms in or on living tissue (i.e., antiseptics) or on environ­
mental surfaces (i.e., disinfectants). 
Hand hygiene: General term that applies to handwashing, 
antiseptic handwash, antiseptic hand rub, or surgical hand 
antisepsis. 
Health-care–associated infection: Any infection associated with 
a medical or surgical intervention. The term health-care– 
associated replaces nosocomial, which is limited to adverse 
infectious outcomes occurring in hospitals. 
Hepatitis B immune globulin (HBIG): Product used for pro­
phylaxis against HBV infection. HBIG is prepared from plasma 
containing high titers of hepatitis B surface antibody (anti-
HBs) and provides protection for 3–6 mos. 
Hepatitis B surface antigen (HBsAg): Serologic marker on the 
surface of HBV detected in high levels during acute or chronic 
hepatitis. The body normally produces antibodies to surface 
antigen as a normal immune response to infection. 
Hepatitis B e antigen (HBeAg): Secreted product of the nucleo­
capsid gene of HBV found in serum during acute and chronic 
HBV infection. Its presence indicates that the virus is replicat­
ing and serves as a marker of increased infectivity. 
Hepatitis B surface antibody (anti-HBs): Protective antibody 
against HBsAg. Presence in the blood can indicate past infec­
tion with, and immunity to, HBV, or immune response from 
hepatitis B vaccine. 
Heterotrophic bacteria: Those bacteria requiring an organic 
carbon source for growth (i.e., deriving energy and carbon from 
organic compounds). 
High-level disinfection: Disinfection process that inactivates 
vegetative bacteria, mycobacteria, fungi, and viruses but not 
necessarily high numbers of bacterial spores. FDA further 
defines a high-level disinfectant as a sterilant used for a shorter 
contact time. 
Hospital disinfectant: Germicide registered by EPA for use 
on inanimate objects in hospitals, clinics, dental offices, and 
other medical-related facilities. Efficacy is demonstrated against 
Salmonella choleraesuis, Staphylococcus aureus, and Pseudomo­
nas aeruginosa. 
Iatrogenic: Induced inadvertently by HCP, medical (includ­
ing dental) treatment, or diagnostic procedures. Used particu­
larly in reference to an infectious disease or other complication 
of treatment. 
Immunization: Process by which a person becomes immune, 
or protected against a disease. Vaccination is defined as the 
process of administering a killed or weakened infectious 
organism or a toxoid; however, vaccination does not always 
result in immunity. 
Implantable device: Device placed into a surgically or natu­
rally formed cavity of the human body and intended to 
remain there for >30 days. 
Independent water reservoir: Container used to hold water or 
other solutions and supply it to handpieces and air and water 
syringes attached to a dental unit. The independent reservoir, 
which isolates the unit from the public water system, can be 
provided as original equipment or as a retrofitted device. 
Intermediate-level disinfection: Disinfection process that 
inactivates vegetative bacteria, the majority of fungi, myco­
bacteria, and the majority of viruses (particularly enveloped 
viruses) but not bacterial spores. 
Intermediate-level disinfectant: Liquid chemical germicide 
registered with EPA as a hospital disinfectant and with a label 
claim of potency as tuberculocidal (Appendix A). 
Latex: Milky white fluid extracted from the rubber tree 
Hevea brasiliensis that contains the rubber material cis-1,4 
polyisoprene. 
Low-level disinfection: Process that inactivates the majority 
of vegetative bacteria, certain fungi, and certain viruses, but 
cannot be relied on to inactivate resistant microorganisms (e.g., 
mycobacteria or bacterial spores). 
Low-level disinfectant: Liquid chemical germicide registered 
with EPA as a hospital disinfectant. OSHA requires low-level 
hospital disinfectants also to have a label claim for potency 
against HIV and HBV if used for disinfecting clinical contact 
surfaces (Appendix A). 
Microfilter: Membrane filter used to trap microorganisms 
suspended in water. Filters are usually installed on dental unit 
waterlines as a retrofit device. Microfiltration commonly 
occurs at a filter pore size of 0.03–10 µm. Sediment filters 
commonly found in dental unit water regulators have pore 
sizes of 20–90 µm and do not function as microbiological 
filters. 
Nosocomial: Infection acquired in a hospital as a result of 
medical care. 
Occupational exposure: Reasonably anticipated skin, eye, 
mucous membrane, or parenteral contact with blood or OPIM 
that can result from the performance of an employee’s duties. 
OPIM: Other potentially infectious materials. OPIM is an 
OSHA term that refers to 1) body fluids including semen, 
vaginal secretions, cerebrospinal fluid, synovial fluid, pleural 
fluid, pericardial fluid, peritoneal fluid, amniotic fluid, saliva 
in dental procedures; any body fluid visibly contaminated with 
blood; and all body fluids in situations where differentiating 
between body fluids is difficult or impossible; 2) any unfixed 
tissue or organ (other than intact skin) from a human (living 
or dead); and 3) HIV-containing cell or tissue cultures, organ 
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cultures; HIV- or HBV-containing culture medium or other 
solutions; and blood, organs, or other tissues from experimen­
tal animals infected with HIV or HBV. 
Parenteral: Means of piercing mucous membranes or skin 
barrier through such events as needlesticks, human bites, cuts, 
and abrasions. 
Persistent activity: Prolonged or extended activity that pre­
vents or inhibits proliferation or survival of microorganisms 
after application of a product. This activity can be demon­
strated by sampling a site minutes or hours after application 
and demonstrating bacterial antimicrobial effectiveness when 
compared with a baseline level. Previously, this property was 
sometimes termed residual activity. 
Prion: Protein particle lacking nucleic acid that has been 
implicated as the cause of certain neurodegenerative diseases 
(e.g., scrapie, CJD, and bovine spongiform encephalopathy 
[BSE]). 
Retraction: Entry of oral fluids and microorganisms into 
waterlines through negative water pressure. 
Seroconversion: The change of a serological test from nega­
tive to positive indicating the development of antibodies in 
response to infection or immunization. 
Sterile: Free from all living microorganisms; usually described 
as a probability (e.g., the probability of a surviving microor­
ganism being 1 in 1 million). 
Sterilization: Use of a physical or chemical procedure to 
destroy all microorganisms including substantial numbers of 
resistant bacterial spores. 
Surfactants: Surface-active agents that reduce surface tension 
and help cleaning by loosening, emulsifying, and holding soil 
in suspension, to be more readily rinsed away. 
Ultrasonic cleaner: Device that removes debris by a process 
called cavitation, in which waves of acoustic energy are propa­
gated in aqueous solutions to disrupt the bonds that hold par­
ticulate matter to surfaces. 
Vaccination: See immunization. 
Vaccine: Product that induces immunity, therefore protect­
ing the body from the disease. Vaccines are administered 
through needle injections, by mouth, and by aerosol. 
Washer-disinfector: Automatic unit that cleans and thermally 
disinfects instruments, by using a high-temperature cycle rather 
than a chemical bath. 
Wicking: Absorption of a liquid by capillary action along a 
thread or through the material (e.g., penetration of liquids 
through undetected holes in a glove). 
Review of Science Related 
to Dental Infection Control 
Personnel Health Elements 
of an Infection-Control Program 
A protective health component for DHCP is an integral part 
of a dental practice infection-control program. The objectives 
are to educate DHCP regarding the principles of infection 
control, identify work-related infection risks, institute preven­
tive measures, and ensure prompt exposure management and 
medical follow-up. Coordination between the dental practice’s 
infection-control coordinator and other qualified health-care 
professionals is necessary to provide DHCP with appropriate 
services. Dental programs in institutional settings, (e.g., hos­
pitals, health centers, and educational institutions) can coor­
dinate with departments that provide personnel health services. 
However, the majority of dental practices are in ambulatory, 
private settings that do not have licensed medical staff and 
facilities to provide complete on-site health service programs. 
In such settings, the infection-control coordinator should 
establish programs that arrange for site-specific infection-
control services from external health-care facilities and pro­
viders before DHCP are placed at risk for exposure. Referral 
arrangements can be made with qualified health-care profes­
sionals in an occupational health program of a hospital, with 
educational institutions, or with health-care facilities that 
offer personnel health services. 
Education and Training 
Personnel are more likely to comply with an infection-
control program and exposure-control plan if they understand 
its rationale (5,13,16). Clearly written policies, procedures, 
and guidelines can help ensure consistency, efficiency, and 
effective coordination of activities. Personnel subject to occu­
pational exposure should receive infection-control training on 
initial assignment, when new tasks or procedures affect their 
occupational exposure, and at a minimum, annually (13). 
Education and training should be appropriate to the assigned 
duties of specific DHCP (e.g., techniques to prevent cross-
contamination or instrument sterilization). For DHCP who 
perform tasks or procedures likely to result in occupational 
exposure to infectious agents, training should include 1) a 
description of their exposure risks; 2) review of prevention strat­
egies and infection-control policies and procedures; 3) discus­
sion regarding how to manage work-related illness and injuries, 
including PEP; and 4) review of work restrictions for the 
exposure or infection. Inclusion of DHCP with minimal 
exposure risks (e.g., administrative employees) in education 
and training programs might enhance facilitywide understand­
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ing of infection-control principles and the importance of the 
program. Educational materials should be appropriate in con­
tent and vocabulary for each person’s educational level, lit­
eracy, and language, as well as be consistent with existing federal, 
state, and local regulations (5,13). 
Immunization Programs 
DHCP are at risk for exposure to, and possible infection 
with, infectious organisms. Immunizations substantially 
reduce both the number of DHCP susceptible to these dis­
eases and the potential for disease transmission to other DHCP 
and patients (5,17). Thus, immunizations are an essential part 
of prevention and infection-control programs for DHCP, and 
a comprehensive immunization policy should be implemented 
for all dental health-care facilities (17,18). The Advisory Com­
mittee on Immunization Practices (ACIP) provides national 
guidelines for immunization of HCP, which includes DHCP 
(17). Dental practice immunization policies should incorpo­
rate current state and federal regulations as well as recommen­
dations from the U.S. Public Health Service and professional 
organizations (17) (Appendix B). 
On the basis of documented health-care–associated trans­
mission, HCP are considered to be at substantial risk for 
acquiring or transmitting hepatitis B, influenza, measles, 
mumps, rubella, and varicella. All of these diseases are vac­
cine-preventable. ACIP recommends that all HCP be vacci­
nated or have documented immunity to these diseases (5,17). 
ACIP does not recommend routine immunization of HCP 
against TB (i.e., inoculation with bacille Calmette-Guérin vac­
cine) or hepatitis A (17). No vaccine exists for HCV. ACIP 
guidelines also provide recommendations regarding immuni­
zation of HCP with special conditions (e.g., pregnancy, HIV 
infection, or diabetes) (5,17). 
Immunization of DHCP before they are placed at risk for 
exposure remains the most efficient and effective use of vac­
cines in health-care settings. Some educational institutions and 
infection-control programs provide immunization schedules 
for students and DHCP. OSHA requires that employers make 
hepatitis B vaccination available to all employees who have 
potential contact with blood or OPIM. Employers are also 
required to follow CDC recommendations for vaccinations, 
evaluation, and follow-up procedures (13). Nonpatient-care 
staff (e.g., administrative or housekeeping) might be included, 
depending on their potential risk of coming into contact with 
blood or OPIM. Employers are also required to ensure that 
employees who decline to accept hepatitis B vaccination sign 
an appropriate declination statement (13). DHCP unable or 
unwilling to be vaccinated as required or recommended should 
be educated regarding their exposure risks, infection-control 
policies and procedures for the facility, and the management 
of work-related illness and work restrictions (if appropriate) 
for exposed or infected DHCP. 
Exposure Prevention and Postexposure 
Management 
Avoiding exposure to blood and OPIM, as well as protec­
tion by immunization, remain primary strategies for reducing 
occupationally acquired infections, but occupational exposures 
can still occur (19). A combination of standard precautions, 
engineering, work practice, and administrative controls is the 
best means to minimize occupational exposures. Written poli­
cies and procedures to facilitate prompt reporting, evaluation, 
counseling, treatment, and medical follow-up of all occupa­
tional exposures should be available to all DHCP. Written 
policies and procedures should be consistent with federal, state, 
and local requirements addressing education and training, 
postexposure management, and exposure reporting (see Pre­
venting Transmission of Bloodborne Pathogens). 
DHCP who have contact with patients can also be exposed 
to persons with infectious TB, and should have a baseline tu­
berculin skin test (TST), preferably by using a two-step test, 
at the beginning of employment (20). Thus, if an unprotected 
occupational exposure occurs, TST conversions can be distin­
guished from positive TST results caused by previous expo­
sures (20,21). The facility’s level of TB risk will determine the 
need for routine follow-up TSTs (see Special Considerations). 
Medical Conditions, Work-Related Illness, 
and Work Restrictions 
DHCP are responsible for monitoring their own health sta­
tus. DHCP who have acute or chronic medical conditions 
that render them susceptible to opportunistic infection should 
discuss with their personal physicians or other qualified 
authority whether the condition might affect their ability to 
safely perform their duties. However, under certain circum­
stances, health-care facility managers might need to exclude 
DHCP from work or patient contact to prevent further trans­
mission of infection (22). Decisions concerning work restric­
tions are based on the mode of transmission and the period of 
infectivity of the disease (5) (Table 1). Exclusion policies should 
1) be written, 2) include a statement of authority that defines 
who can exclude DHCP (e.g., personal physicians), and 3) be 
clearly communicated through education and training. Poli­
cies should also encourage DHCP to report illnesses or expo­
sures without jeopardizing wages, benefits, or job status. 
With increasing concerns regarding bloodborne pathogens and 
introduction of universal precautions, use of latex gloves among 
HCP has increased markedly (7,23). Increased use of these gloves 
has been accompanied by increased reports of allergic reactions 
to natural rubber latex among HCP, DHCP, and patients 
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TABLE 1. Suggested work restrictions for health-care personnel infected with or exposed to major infectious diseases in health-
care settings, in the absence of state and local regulations* 
Disease/problem Work restriction Duration 
Conjunctivitis 
Cytomegalovirus infection 
Diarrheal disease 
Acute stage (diarrhea with other symptoms) 
Convalescent stage, Salmonella species 
Enteroviral infection 
Hepatitis A 
Hepatitis B 
Personnel with acute or chronic hepatitis B 
surface antigenemia who do not perform 
exposure-prone procedures 
Personnel with acute or chronic hepatitis B 
e antigenemia who perform exposure-prone 
procedures 
Hepatitis C 
Herpes simplex 
Genital 
Hands (herpetic whitlow) 
Orofacial 
Human immunodeficiency virus; personnel who 
perform exposure-prone procedures 
Measles 
Active 
Postexposure (susceptible personnel) 
Meningococcal infection 
Mumps 
Active 
Postexposure (susceptible personnel) 
Restrict from patient contact and contact with patient’s 
environment. 
No restriction 
Restrict from patient contact, contact with patient’s 
environment, and food-handling. 
Restrict from care of patients at high risk. 
Restrict from care of infants, neonates, and 
immunocompromised patients and their environments. 
Restrict from patient contact, contact with patient’s 
environment, and food-handing. 
No restriction†; refer to state regulations. Standard 
precautions should always be followed. 
Do not perform exposure-prone invasive procedures until 
counsel from a review panel has been sought; panel 
should review and recommend procedures that personnel 
can perform, taking into account specific procedures as 
well as skill and technique. Standard precautions should 
always be observed. Refer to state and local regulations 
or recommendations. 
No restrictions on professional activity.† HCV-positive 
health-care personnel should follow aseptic technique 
and standard precautions. 
No restriction 
Restrict from patient contact and contact with patient’s 
environment. 
Evaluate need to restrict from care of patients at high risk. 
Do not perform exposure-prone invasive procedures until 
counsel from an expert review panel has been sought; 
panel should review and recommend procedures that 
personnel can perform, taking into account specific 
procedures as well as skill and technique. Standard 
precautions should always be observed. Refer to state 
and local regulations or recommendations. 
Exclude from duty 
Exclude from duty 
Exclude from duty 
Exclude from duty 
Exclude from duty 
Until discharge ceases 
Until symptoms resolve 
Until symptoms resolve; consult with local and state health 
authorities regarding need for negative stool cultures 
Until symptoms resolve 
Until 7 days after onset of jaundice 
Until hepatitis B e antigen is negative 
Until lesions heal 
Until 7 days after the rash appears 
From fifth day after first exposure through twenty-first day 
after last exposure, or 4 days after rash appears 
Until 24 hours after start of effective therapy 
Until 9 days after onset of parotitis 
From twelfth day after first exposure through twenty-sixth 
day after last exposure, or until 9 days after onset of 
parotitis 
Source: Adapted from Bolyard EA, Hospital Infection Control Practices Advisory Committee. Guidelines for infection control in health care personnel, 1998. Am J Infect Control 
1998;26:289–354. 
* Modified from recommendations of the Advisory Committee on Immunization Practices (ACIP).† Unless epidemiologically linked to transmission of infection. § Those susceptible to varicella and who are at increased risk of complications of varicella (e.g., neonates and immunocompromised persons of any age). ¶ Patients at high risk as defined by ACIP for complications of influenza. 
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TABLE 1. (Continued) Suggested work restrictions for health-care personnel infected with or exposed to major infectious diseases 
in health-care settings, in the absence of state and local regulations* 
Disease/problem Work restriction Duration 
Pediculosis 
Pertussis 
Active 
Postexposure (asymptomatic personnel) 
Postexposure (symptomatic personnel) 
Rubella 
Active 
Postexposure (susceptible personnel) 
Staphylococcus aureus infection 
Active, draining skin lesions 
Carrier state 
Streptococcal infection, group A 
Tuberculosis 
Active disease 
PPD converter 
Varicella (chicken pox) 
Active 
Postexposure (susceptible personnel) 
Zoster (shingles) 
Localized, in healthy person 
Generalized or localized in immunosup­
pressed person

Postexposure (susceptible personnel)

Viral respiratory infection, acute febrile 
Restrict from patient contact 
Exclude from duty 
No restriction, prophylaxis recommended 
Exclude from duty 
Exclude from duty 
Exclude from duty 
Restrict from contact with patients and patient’s 
environment or food handling. 
No restriction unless personnel are epidemiologically 
linked to transmission of the organism 
Restrict from patient care, contact with patient’s 
environment, and food-handling. 
Exclude from duty 
No restriction 
Exclude from duty 
Exclude from duty 
Cover lesions, restrict from care of patients§ at high risk 
Restrict from patient contact 
Restrict from patient contact 
Consider excluding from the care of patients at high risk¶ 
or contact with such patients’ environments during 
community outbreak of respiratory syncytial virus and 
influenza 
Until treated and observed to be free of adult and 
immature lice 
From beginning of catarrhal stage through third week 
after onset of paroxysms, or until 5 days after start of 
effective antibiotic therapy 
Until 5 days after start of effective antibiotic therapy 
Until 5 days after rash appears 
From seventh day after first exposure through twenty-first 
day after last exposure 
Until lesions have resolved 
Until 24 hours after adequate treatment started 
Until proved noninfectious 
Until all lesions dry and crust 
From tenth day after first exposure through twenty-first 
day (twenty-eighth day if varicella-zoster immune globulin 
[VZIG] administered) after last exposure. 
Until all lesions dry and crust 
Until all lesions dry and crust 
From tenth day after first exposure through twenty-first day 
(twenty-eighth day if VZIG administered) after last exposure; 
or, if varicella occurs, when lesions crust and dry 
Until acute symptoms resolve 
Source: Adapted from Bolyard EA, Hospital Infection Control Practices Advisory Committee. Guidelines for infection control in health care personnel, 1998. Am J Infect Control 
1998;26:289–354. 
* Modified from recommendations of the Advisory Committee on Immunization Practices (ACIP).† Unless epidemiologically linked to transmission of infection. § Those susceptible to varicella and who are at increased risk of complications of varicella (e.g., neonates and immunocompromised persons of any age). ¶ Patients at high risk as defined by ACIP for complications of influenza. 
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(24–30), as well as increased reports of irritant and allergic con­
tact dermatitis from frequent and repeated use of hand-hygiene 
products, exposure to chemicals, and glove use. 
DHCP should be familiar with the signs and symptoms of 
latex sensitivity (5,31–33). A physician should evaluate DHCP 
exhibiting symptoms of latex allergy, because further exposure 
could result in a serious allergic reaction. A diagnosis is made 
through medical history, physical examination, and diagnos­
tic tests. Procedures should be in place for minimizing latex-
related health problems among DHCP and patients while 
protecting them from infectious materials. These procedures 
should include 1) reducing exposures to latex-containing 
materials by using appropriate work practices, 2) training and 
educating DHCP, 3) monitoring symptoms, and 4) substitut­
ing nonlatex products where appropriate (32) (see Contact 
Dermatitis and Latex Hypersensitivity). 
Maintenance of Records, Data Management, 
and Confidentiality 
The health status of DHCP can be monitored by maintain­
ing records of work-related medical evaluations, screening tests, 
immunizations, exposures, and postexposure management. 
Such records must be kept in accordance with all applicable 
state and federal laws. Examples of laws that might apply 
include the Privacy Rule of the Health Insurance Portability 
and Accountability Act (HIPAA) of 1996, 45 CFR 160 and 
164, and the OSHA Occupational Exposure to Bloodborne 
Pathogens; Final Rule 29 CFR 1910.1030(h)(1)(i–iv) (34,13). 
The HIPAA Privacy Rule applies to covered entities, includ­
ing certain defined health providers, health-care clearinghouses, 
and health plans. OSHA requires employers to ensure that 
certain information contained in employee medical records is 
1) kept confidential; 2) not disclosed or reported without the 
employee’s express written consent to any person within or 
outside the workplace except as required by the OSHA stan­
dard; and 3) maintained by the employer for at least the dura­
tion of employment plus 30 years. Dental practices that 
coordinate their infection-control program with off-site pro­
viders might consult OSHA’s Bloodborne Pathogen standard 
and employee Access to Medical and Exposure Records stan­
dard, as well as other applicable local, state, and federal laws, 
to determine a location for storing health records (13,35). 
Preventing Transmission 
of Bloodborne Pathogens 
Although transmission of bloodborne pathogens (e.g., HBV, 
HCV, and HIV) in dental health-care settings can have seri­
ous consequences, such transmission is rare. Exposure to 
infected blood can result in transmission from patient to 
DHCP, from DHCP to patient, and from one patient to 
another. The opportunity for transmission is greatest from 
patient to DHCP, who frequently encounter patient blood and 
blood-contaminated saliva during dental procedures. 
Since 1992, no HIV transmission from DHCP to patients 
has been reported, and the last HBV transmission from DHCP 
to patients was reported in 1987. HCV transmission from 
DHCP to patients has not been reported. The majority of 
DHCP infected with a bloodborne virus do not pose a risk to 
patients because they do not perform activities meeting the 
necessary conditions for transmission. For DHCP to pose a 
risk for bloodborne virus transmission to patients, DHCP must 
1) be viremic (i.e., have infectious virus circulating in the blood­
stream); 2) be injured or have a condition (e.g., weeping der­
matitis) that allows direct exposure to their blood or other 
infectious body fluids; and 3) enable their blood or infectious 
body fluid to gain direct access to a patient’s wound, trauma­
tized tissue, mucous membranes, or similar portal of entry. 
Although an infected DHCP might be viremic, unless the sec­
ond and third conditions are also met, transmission cannot 
occur. 
The risk of occupational exposure to bloodborne viruses is 
largely determined by their prevalence in the patient popula­
tion and the nature and frequency of contact with blood and 
body fluids through percutaneous or permucosal routes of 
exposure. The risk of infection after exposure to a bloodborne 
virus is influenced by inoculum size, route of exposure, and 
susceptibility of the exposed HCP (12). The majority of 
attention has been placed on the bloodborne pathogens HBV, 
HCV, and HIV, and these pathogens present different levels 
of risk to DHCP. 
Hepatitis B Virus 
HBV is a well-recognized occupational risk for HCP (36,37). 
HBV is transmitted by percutaneous or mucosal exposure to 
blood or body fluids of a person with either acute or chronic 
HBV infection. Persons infected with HBV can transmit the 
virus for as long as they are HBsAg-positive. The risk of HBV 
transmission is highly related to the HBeAg status of the source 
person. In studies of HCP who sustained injuries from needles 
contaminated with blood containing HBV, the risk of devel­
oping clinical hepatitis if the blood was positive for both HBsAg 
and HBeAg was 22%–31%; the risk of developing serologic 
evidence of HBV infection was 37%–62% (19). By compari­
son, the risk of developing clinical hepatitis from a needle con­
taminated with HBsAg-positive, HBeAg-negative blood was 
1%–6%, and the risk of developing serologic evidence of HBV 
infection, 23%–37% (38). 
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Blood contains the greatest proportion of HBV infectious 
particle titers of all body fluids and is the most critical vehicle 
of transmission in the health-care setting. HBsAg is also found 
in multiple other body fluids, including breast milk, bile, cere­
brospinal fluid, feces, nasopharyngeal washings, saliva, semen, 
sweat, and synovial fluid. However, the majority of body flu­
ids are not efficient vehicles for transmission because they con­
tain low quantities of infectious HBV, despite the presence of 
HBsAg (19). The concentration of HBsAg in body fluids can 
be 100–1,000-fold greater than the concentration of infec­
tious HBV particles (39). 
Although percutaneous injuries are among the most effi­
cient modes of HBV transmission, these exposures probably 
account for only a minority of HBV infections among HCP. 
In multiple investigations of nosocomial hepatitis B outbreaks, 
the majority of infected HCP could not recall an overt percu­
taneous injury (40,41), although in certain studies, approxi­
mately one third of infected HCP recalled caring for a patient 
who was HBsAg-positive (42,43). In addition, HBV has been 
demonstrated to survive in dried blood at room temperature 
on environmental surfaces for <1 week (44). Thus, HBV 
infections that occur in HCP with no history of nonoccupa­
tional exposure or occupational percutaneous injury might have 
resulted from direct or indirect blood or body fluid exposures 
that inoculated HBV into cutaneous scratches, abrasions, 
burns, other lesions, or on mucosal surfaces (45–47). The 
potential for HBV transmission through contact with envi­
ronmental surfaces has been demonstrated in investigations of 
HBV outbreaks among patients and HCP in hemodialysis units 
(48–50). 
Since the early 1980s, occupational infections among HCP 
have declined because of vaccine use and adherence to univer­
sal precautions (51). Among U.S. dentists, >90% have been 
vaccinated, and serologic evidence of past HBV infection 
decreased from prevaccine levels of 14% in 1972 to approxi­
mately 9% in 1992 (52). During 1993–2001, levels remained 
relatively unchanged (Chakwan Siew, Ph.D., American Den­
tal Association, Chicago, Illinois, personal communication, 
June 2003). Infection rates can be expected to decline further 
as vaccination rates remain high among young dentists and as 
older dentists with lower vaccination rates and higher rates of 
infection retire. 
Although the potential for transmission of bloodborne 
infections from DHCP to patients is considered limited 
(53–55), precise risks have not been quantified by carefully 
designed epidemiologic studies (53,56,57). Reports published 
during 1970–1987 describe nine clusters in which patients 
were thought to be infected with HBV through treatment by 
an infected DHCP (58–67). However, transmission of HBV 
from dentist to patient has not been reported since 1987, pos­
sibly reflecting such factors as 1) adoption of universal precau­
tions, 2) routine glove use, 3) increased levels of immunity as 
a result of hepatitis B vaccination of DHCP, 4) implementa­
tion of the 1991 OSHA bloodborne pathogen standard (68), 
and 5) incomplete ascertainment and reporting. Only one case 
of patient-to-patient transmission of HBV in the dental set­
ting has been documented (CDC, unpublished data, 2003). 
In this case, appropriate office infection-control procedures 
were being followed, and the exact mechanism of transmis­
sion was undetermined. 
Because of the high risk of HBV infection among HCP, 
DHCP who perform tasks that might involve contact with 
blood, blood-contaminated body substances, other body flu­
ids, or sharps should be vaccinated (2,13,17,19,69). Vaccina­
tion can protect both DHCP and patients from HBV infection 
and, whenever possible, should be completed when dentists 
or other DHCP are in training and before they have contact 
with blood. 
Prevaccination serological testing for previous infection is 
not indicated, although it can be cost-effective where preva­
lence of infection is expected to be high in a group of potential 
vacinees (e.g., persons who have emigrated from areas with 
high rates of HBV infection). DHCP should be tested for anti-
HBs 1–2 months after completion of the 3-dose vaccination 
series (17). DHCP who do not develop an adequate antibody 
response (i.e., anti-HBs <10 mIU/mL) to the primary vaccine 
series should complete a second 3-dose vaccine series or be 
evaluated to determine if they are HBsAg-positive (17). 
Revaccinated persons should be retested for anti-HBs at the 
completion of the second vaccine series. Approximately half 
of nonresponders to the primary series will respond to a sec­
ond 3-dose series. If no antibody response occurs after the 
second series, testing for HBsAg should be performed (17). 
Persons who prove to be HBsAg-positive should be counseled 
regarding how to prevent HBV transmission to others and 
regarding the need for medical evaluation. Nonresponders to 
vaccination who are HBsAg-negative should be considered 
susceptible to HBV infection and should be counseled regard­
ing precautions to prevent HBV infection and the need to 
obtain HBIG prophylaxis for any known or probable parenteral 
exposure to HBsAg-positive blood. 
Vaccine-induced antibodies decline gradually over time, and 
60% of persons who initially respond to vaccination will lose 
detectable antibodies over 12 years. Even so, immunity con­
tinues to prevent clinical disease or detectable viral infection 
(17). Booster doses of vaccine and periodic serologic testing to 
monitor antibody concentrations after completion of the vac­
cine series are not necessary for vaccine responders (17). 
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Hepatitis D Virus 
An estimated 4% of persons with acute HBV infection are 
also infected with hepatitis Delta virus (HDV). Discovered in 
1977, HDV is a defective bloodborne virus requiring the pres­
ence of HBV to replicate. Patients coinfected with HBV and 
HDV have substantially higher mortality rates than those 
infected with HBV alone. Because HDV infection is depen­
dent on HBV for replication, immunization to prevent HBV 
infection, through either pre- or postexposure prophylaxis, can 
also prevent HDV infection (70). 
Hepatitis C Virus 
Hepatitis C virus appears not to be transmitted efficiently 
through occupational exposures to blood. Follow-up studies 
of HCP exposed to HCV-infected blood through percutane­
ous or other sharps injuries have determined a low incidence 
of seroconversion (mean: 1.8%; range, 0%–7%) (71–74). One 
study determined transmission occurred from hollow-bore 
needles but not other sharps (72). Although these studies have 
not documented seroconversion associated with mucous mem­
brane or nonintact skin exposure, at least two cases of HCV 
transmission from a blood splash to the conjunctiva (75,76) 
and one case of simultaneous transmission of HCV and HIV 
after nonintact skin exposure have been reported (77). 
Data are insufficient to estimate the occupational risk of 
HCV infection among HCP, but the majority of studies indi­
cate the prevalence of HCV infection among dentists, sur­
geons, and hospital-based HCP is similar to that among the 
general population, approximately 1%–2% (78–86). In a study 
that evaluated risk factors for infection, a history of uninten­
tional needlesticks was the only occupational risk factor inde­
pendently associated with HCV infection (80). 
No studies of transmission from HCV-infected DHCP to 
patients have been reported, and the risk for such transmis­
sion appears limited. Multiple reports have been published 
describing transmission from HCV-infected surgeons, which 
apparently occurred during performance of invasive procedures; 
the overall risk for infection averaged 0.17% (87–90). 
Human Immunodeficiency Virus 
In the United States, the risk of HIV transmission in dental 
settings is extremely low. As of December 2001, a total of 57 
cases of HIV seroconversion had been documented among 
HCP, but none among DHCP, after occupational exposure to 
a known HIV-infected source (91). Transmission of HIV to 
six patients of a single dentist with AIDS has been reported, 
but the mode of transmission could not be determined 
(2,92,93). As of September 30, 1993, CDC had information 
regarding test results of >22,000 patients of 63 HIV-infected 
HCP, including 33 dentists or dental students (55,93). No 
additional cases of transmission were documented. 
Prospective studies worldwide indicate the average risk of 
HIV infection after a single percutaneous exposure to 
HIV-infected blood is 0.3% (range: 0.2%–0.5%) (94). After 
an exposure of mucous membranes in the eye, nose, or mouth, 
the risk is approximately 0.1% (76). The precise risk of trans­
mission after skin exposure remains unknown but is believed 
to be even smaller than that for mucous membrane exposure. 
Certain factors affect the risk of HIV transmission after an 
occupational exposure. Laboratory studies have determined if 
needles that pass through latex gloves are solid rather than 
hollow-bore, or are of small gauge (e.g., anesthetic needles 
commonly used in dentistry), they transfer less blood (36). In 
a retrospective case-control study of HCP, an increased risk 
for HIV infection was associated with exposure to a relatively 
large volume of blood, as indicated by a deep injury with a 
device that was visibly contaminated with the patient’s blood, 
or a procedure that involved a needle placed in a vein or artery 
(95). The risk was also increased if the exposure was to blood 
from patients with terminal illnesses, possibly reflecting the 
higher titer of HIV in late-stage AIDS. 
Exposure Prevention Methods 
Avoiding occupational exposures to blood is the primary 
way to prevent transmission of HBV, HCV, and HIV, to HCP 
in health-care settings (19,96,97). Exposures occur through 
percutaneous injury (e.g., a needlestick or cut with a sharp 
object), as well as through contact between potentially infec­
tious blood, tissues, or other body fluids and mucous mem­
branes of the eye, nose, mouth, or nonintact skin (e.g., exposed 
skin that is chapped, abraded, or shows signs of dermatitis). 
Observational studies and surveys indicate that percutane­
ous injuries among general dentists and oral surgeons occur 
less frequently than among general and orthopedic surgeons 
and have decreased in frequency since the mid-1980s (98–102). 
This decline has been attributed to safer work practices, safer 
instrumentation or design, and continued DHCP education 
(103,104). Percutaneous injuries among DHCP usually 
1) occur outside the patient’s mouth, thereby posing less risk 
for recontact with patient tissues; 2) involve limited amounts 
of blood; and 3) are caused by burs, syringe needles, labora­
tory knives, and other sharp instruments (99–102,105,106). 
Injuries among oral surgeons might occur more frequently 
during fracture reductions using wires (104,107). Experience, 
as measured by years in practice, does not appear to affect the 
risk of injury among general dentists or oral surgeons 
(100,104,107). 
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The majority of exposures in dentistry are preventable, and 
methods to reduce the risk of blood contacts have included 
use of standard precautions, use of devices with features engi­
neered to prevent sharp injuries, and modifications of work 
practices. These approaches might have contributed to the 
decrease in percutaneous injuries among dentists during 
recent years (98–100,103). However, needlesticks and other 
blood contacts continue to occur, which is a concern because 
percutaneous injuries pose the greatest risk of transmission. 
Standard precautions include use of PPE (e.g., gloves, masks, 
protective eyewear or face shield, and gowns) intended to pre­
vent skin and mucous membrane exposures. Other protective 
equipment (e.g., finger guards while suturing) might also 
reduce injuries during dental procedures (104). 
Engineering controls are the primary method to reduce 
exposures to blood and OPIM from sharp instruments and 
needles. These controls are frequently technology-based and 
often incorporate safer designs of instruments and devices (e.g., 
self-sheathing anesthetic needles and dental units designed to 
shield burs in handpieces) to reduce percutaneous injuries 
(101,103,108). 
Work-practice controls establish practices to protect DHCP 
whose responsibilities include handling, using, assembling, or 
processing sharp devices (e.g., needles, scalers, laboratory util­
ity knives, burs, explorers, and endodontic files) or sharps dis­
posal containers. Work-practice controls can include removing 
burs before disassembling the handpiece from the dental unit, 
restricting use of fingers in tissue retraction or palpation dur­
ing suturing and administration of anesthesia, and minimiz­
ing potentially uncontrolled movements of such instruments 
as scalers or laboratory knives (101,105). 
As indicated, needles are a substantial source of percutane­
ous injury in dental practice, and engineering and work-
practice controls for needle handling are of particular 
importance. In 2001, revisions to OSHA’s bloodborne patho­
gens standard as mandated by the Needlestick Safety and Pre­
vention Act of 2000 became effective. These revisions clarify 
the need for employers to consider safer needle devices as they 
become available and to involve employees directly respon­
sible for patient care (e.g., dentists, hygienists, and dental 
assistants) in identifying and choosing such devices (109). Safer 
versions of sharp devices used in hospital settings have become 
available (e.g., blunt suture needles, phlebotomy devices, and 
butterfly needles), and their impact on reducing injuries has 
been documented (110–112). Aspirating anesthetic syringes 
that incorporate safety features have been developed for den­
tal procedures, but the low injury rates in dentistry limit 
assessment of their effect on reducing injuries among DHCP. 
Work-practice controls for needles and other sharps include 
placing used disposable syringes and needles, scalpel blades, 
and other sharp items in appropriate puncture-resistant con­
tainers located as close as feasible to where the items were used 
(2,7,13,113–115). In addition, used needles should never be 
recapped or otherwise manipulated by using both hands, or 
any other technique that involves directing the point of a needle 
toward any part of the body (2,7,13,97,113,114). A one-
handed scoop technique, a mechanical device designed for 
holding the needle cap to facilitate one-handed recapping, or 
an engineered sharps injury protection device (e.g., needles 
with resheathing mechanisms) should be employed for recap­
ping needles between uses and before disposal 
(2,7,13,113,114). DHCP should never bend or break needles 
before disposal because this practice requires unnecessary 
manipulation. Before attempting to remove needles from 
nondisposable aspirating syringes, DHCP should recap them 
to prevent injuries. For procedures involving multiple injec­
tions with a single needle, the practitioner should recap the 
needle between injections by using a one-handed technique or 
use a device with a needle-resheathing mechanism. Passing a 
syringe with an unsheathed needle should be avoided because 
of the potential for injury. 
Additional information for developing a safety program and 
for identifying and evaluating safer dental devices is available at 
•	 http://www.cdc.gov/OralHealth/infectioncontrol/ 
forms.htm (forms for screening and evaluating safer den­
tal devices), and 
•	 http://www.cdc.gov/niosh/topics/bbp (state legislation on 
needlestick safety). 
Postexposure Management and Prophylaxis 
Postexposure management is an integral component of a 
complete program to prevent infection after an occupational 
exposure to blood. During dental procedures, saliva is pre­
dictably contaminated with blood (7,114). Even when blood 
is not visible, it can still be present in limited quantities and 
therefore is considered a potentially infectious material by 
OSHA (13,19). A qualified health-care professional should 
evaluate any occupational exposure incident to blood or OPIM, 
including saliva, regardless of whether blood is visible, in den­
tal settings (13). 
Dental practices and laboratories should establish written, 
comprehensive programs that include hepatitis B vaccination 
and postexposure management protocols that 1) describe the 
types of contact with blood or OPIM that can place DHCP at 
risk for infection; 2) describe procedures for promptly report­
ing and evaluating such exposures; and 3) identify a health­
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care professional who is qualified to provide counseling and 
perform all medical evaluations and procedures in accordance 
with current recommendations of the U.S. Public Health Ser­
vice (PHS), including PEP with chemotherapeutic drugs when 
indicated. DHCP, including students, who might reasonably 
be considered at risk for occupational exposure to blood or 
OPIM should be taught strategies to prevent contact with blood 
or OPIM and the principles of postexposure management, 
including PEP options, as part of their job orientation and 
training. Educational programs for DHCP and students should 
emphasize reporting all exposures to blood or OPIM as soon 
as possible, because certain interventions have to be initiated 
promptly to be effective. Policies should be consistent with 
the practices and procedures for worker protection required 
by OSHA and with current PHS recommendations for man­
aging occupational exposures to blood (13,19). 
After an occupational blood exposure, first aid should be 
administered as necessary. Puncture wounds and other inju­
ries to the skin should be washed with soap and water; 
mucous membranes should be flushed with water. No evidence 
exists that using antiseptics for wound care or expressing fluid 
by squeezing the wound further reduces the risk of bloodborne 
pathogen transmission; however, use of antiseptics is not con­
traindicated. The application of caustic agents (e.g., bleach) 
or the injection of antiseptics or disinfectants into the wound 
is not recommended (19). Exposed DHCP should immedi­
ately report the exposure to the infection-control coordinator 
or other designated person, who should initiate referral to the 
qualified health-care professional and complete necessary 
reports. Because multiple factors contribute to the risk of 
infection after an occupational exposure to blood, the follow­
ing information should be included in the exposure report, 
recorded in the exposed person’s confidential medical record, 
and provided to the qualified health-care professional: 
•	 Date and time of exposure. 
•	 Details of the procedure being performed, including where 
and how the exposure occurred and whether the exposure 
involved a sharp device, the type and brand of device, and 
how and when during its handling the exposure occurred. 
•	 Details of the exposure, including its severity and the type 
and amount of fluid or material. For a percutaneous injury, 
severity might be measured by the depth of the wound, 
gauge of the needle, and whether fluid was injected; for a 
skin or mucous membrane exposure, the estimated vol­
ume of material, duration of contact, and the condition 
of the skin (e.g., chapped, abraded, or intact) should be 
noted. 
•	 Details regarding whether the source material was known 
to contain HIV or other bloodborne pathogens, and, if 
the source was infected with HIV, the stage of disease, 
history of antiretroviral therapy, and viral load, if known. 
•	 Details regarding the exposed person (e.g., hepatitis B vac­
cination and vaccine-response status). 
•	 Details regarding counseling, postexposure management, 
and follow-up. 
Each occupational exposure should be evaluated individually 
for its potential to transmit HBV, HCV, and HIV, based on 
the following: 
•	 The type and amount of body substance involved. 
•	 The type of exposure (e.g., percutaneous injury, mucous 
membrane or nonintact skin exposure, or bites resulting 
in blood exposure to either person involved). 
•	 The infection status of the source. 
• The susceptibility of the exposed person (19). 
All of these factors should be considered in assessing the risk 
for infection and the need for further follow-up (e.g., PEP). 
During 1990–1998, PHS published guidelines for PEP and 
other management of health-care worker exposures to HBV, 
HCV, or HIV (69,116–119). In 2001, these recommenda­
tions were updated and consolidated into one set of PHS guide­
lines (19). The new guidelines reflect the availability of new 
antiretroviral agents, new information regarding the use and 
safety of HIV PEP, and considerations regarding employing 
HIV PEP when resistance of the source patient’s virus to 
antiretroviral agents is known or suspected. In addition, the 
2001 guidelines provide guidance to clinicians and exposed 
HCP regarding when to consider HIV PEP and recommen­
dations for PEP regimens (19). 
Hand Hygiene 
Hand hygiene (e.g., handwashing, hand antisepsis, or surgi­
cal hand antisepsis) substantially reduces potential pathogens 
on the hands and is considered the single most critical mea­
sure for reducing the risk of transmitting organisms to 
patients and HCP (120–123). Hospital-based studies have 
demonstrated that noncompliance with hand hygiene prac­
tices is associated with health-care–associated infections and 
the spread of multiresistant organisms. Noncompliance also 
has been a major contributor to outbreaks (123). The preva­
lence of health-care–associated infections decreases as adher­
ence of HCP to recommended hand hygiene measures 
improves (124–126). 
The microbial flora of the skin, first described in 1938, con­
sist of transient and resident microorganisms (127). Transient 
flora, which colonize the superficial layers of the skin, are easier 
to remove by routine handwashing. They are often acquired 
by HCP during direct contact with patients or contaminated 
environmental surfaces; these organisms are most frequently 
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associated with health-care–associated infections. Resident flora 
attached to deeper layers of the skin are more resistant to 
removal and less likely to be associated with such infections. 
The preferred method for hand hygiene depends on the type 
of procedure, the degree of contamination, and the desired 
persistence of antimicrobial action on the skin (Table 2). For 
routine dental examinations and nonsurgical procedures, 
handwashing and hand antisepsis is achieved by using either a 
plain or antimicrobial soap and water. If the hands are not 
visibly soiled, an alcohol-based hand rub is adequate. 
The purpose of surgical hand antisepsis is to eliminate tran­
sient flora and reduce resident flora for the duration of a pro­
cedure to prevent introduction of organisms in the operative 
wound, if gloves become punctured or torn. Skin bacteria can 
rapidly multiply under surgical gloves if hands are washed with 
soap that is not antimicrobial (127,128). Thus, an antimicro­
bial soap or alcohol hand rub with persistent activity should 
be used before surgical procedures (129–131). 
Agents used for surgical hand antisepsis should substantially 
reduce microorganisms on intact skin, contain a nonirritating 
antimicrobial preparation, have a broad spectrum of activity, 
be fast-acting, and have a persistent effect (121,132–135). 
Persistence (i.e., extended antimicrobial activity that prevents 
or inhibits survival of microorganisms after the product is 
TABLE 2. Hand-hygiene methods and indications 
applied) is critical because microorganisms can colonize on 
hands in the moist environment underneath gloves (122). 
Alcohol hand rubs are rapidly germicidal when applied to 
the skin but should include such antiseptics as chlorhexidine, 
quaternary ammonium compounds, octenidine, or triclosan 
to achieve persistent activity (130). Factors that can influence 
the effectiveness of the surgical hand antisepsis in addition to 
the choice of antiseptic agent include duration and technique 
of scrubbing, as well as condition of the hands, and techniques 
used for drying and gloving. CDC’s 2002 guideline on hand 
hygiene in health-care settings provides more complete infor­
mation (123). 
Selection of Antiseptic Agents 
Selecting the most appropriate antiseptic agent for hand 
hygiene requires consideration of multiple factors. Essential 
performance characteristics of a product (e.g., the spectrum 
and persistence of activity and whether or not the agent is fast-
acting) should be determined before selecting a product. 
Delivery system, cost per use, reliable vendor support and sup­
ply are also considerations. Because HCP acceptance is a 
major factor regarding compliance with recommended hand 
hygiene protocols (122,123,147,148), considering DHCP 
needs is critical and should include possible chemical allergies, 
Method Agent Purpose Duration (minimum) Indication* 
Routine handwash Water and nonantimicrobial soap (e.g., 
plain soap†) 
Remove soil and transient 
microorganisms 
15 seconds§ Before and after treating each patient 
(e.g., before glove placement and after 
Antiseptic handwash Water and antimicrobial soap (e.g., Remove or destroy 15 seconds§ 
glove removal). After barehanded 
touching of inanimate objects likely to be 
chlorhexidine, iodine and iodophors, transient microorganisms contaminated by blood or saliva. Before 
Antiseptic hand rub 
chloroxylenol [PCMX], triclosan) 
Alcohol-based hand rub¶ 
and reduce resident flora 
Remove or destroy 
transient microorganisms 
Rub hands until the 
agent is dry¶ 
leaving the dental operatory or the dental 
laboratory. When visibly soiled.¶ Before 
regloving after removing gloves that are 
torn, cut, or punctured. 
and reduce resident flora 
Surgical antisepsis Water and antimicrobial soap (e.g., 
chlorhexidine, iodine and iodophors, 
Remove or destroy 
transient microorganisms 
2–6 minutes Before donning sterile surgeon’s gloves 
for surgical procedures†† 
chloroxylenol [PCMX], triclosan) and reduce resident flora Follow manufacturer 
(persistent effect) instructions for 
Water and non-antimicrobial soap (e.g., 
plain soap†) followed by an alcohol-based 
surgical hand-scrub product with 
surgical hand-scrub 
product with 
persistent activity¶** 
persistent activity 
* (7,9,11,13,113,120–123,125,126,136–138). 
† Pathogenic organisms have been found on or around bar soap during and after use (139). Use of liquid soap with hands-free dispensing controls is preferable. 
§ Time reported as effective in removing most transient flora from the skin. For most procedures, a vigorous rubbing together of all surfaces of premoistened lathered hands and 
fingers for >15 seconds, followed by rinsing under a stream of cool or tepid water is recommended (9,120,123,140,141). Hands should always be dried thoroughly before 
donning gloves. 
¶ Alcohol-based hand rubs should contain 60%–95% ethanol or isopropanol and should not be used in the presence of visible soil or organic material. If using an alcohol-based 
hand rub, apply adequate amount to palm of one hand and rub hands together, covering all surfaces of the hands and fingers, until hands are dry. Follow manufacturer’s 
recommendations regarding the volume of product to use. If hands feel dry after rubbing them together for 10–15 seconds, an insufficient volume of product likely was applied. 
The drying effect of alcohol can be reduced or eliminated by adding 1%–3% glycerol or other skin-conditioning agents (123). 
**	 After application of alcohol-based surgical hand-scrub product with persistent activity as recommended, allow hands and forearms to dry thoroughly and immediately don sterile 
surgeon’s gloves (144,145). Follow manufacturer instructions (122,123,137,146). 
††	 Before beginning surgical hand scrub, remove all arm jewelry and any hand jewelry that may make donning gloves more difficult, cause gloves to tear more readily (142,143), 
or interfere with glove usage (e.g., ability to wear the correct-sized glove or altered glove integrity). 
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skin integrity after repeated use, compatibility with lotions used, 
and offensive agent ingredients (e.g., scent). Discussing spe­
cific preparations or ingredients used for hand antisepsis is 
beyond the scope of this report. DHCP should choose from 
commercially available HCP handwashes when selecting agents 
for hand antisepsis or surgical hand antisepsis. 
Storage and Dispensing of Hand Care 
Products 
Handwashing products, including plain (i.e., non-
antimicrobial) soap and antiseptic products, can become con­
taminated or support the growth of microorganisms (122). 
Liquid products should be stored in closed containers and dis­
pensed from either disposable containers or containers that 
are washed and dried thoroughly before refilling. Soap should 
not be added to a partially empty dispenser, because this prac­
tice of topping off might lead to bacterial contamination 
(149,150). Store and dispense products according to manu­
facturers’ directions. 
Lotions 
The primary defense against infection and transmission of 
pathogens is healthy, unbroken skin. Frequent handwashing 
with soaps and antiseptic agents can cause chronic irritant con­
tact dermatitis among DHCP. Damage to the skin changes 
skin flora, resulting in more frequent colonization by staphy­
lococci and gram-negative bacteria (151,152). The potential 
of detergents to cause skin irritation varies considerably, but 
can be reduced by adding emollients. Lotions are often rec­
ommended to ease the dryness resulting from frequent 
handwashing and to prevent dermatitis from glove use 
(153,154). However, petroleum-based lotion formulations can 
weaken latex gloves and increase permeability. For that reason, 
lotions that contain petroleum or other oil emollients should 
only be used at the end of the work day (122,155). Dental 
practitioners should obtain information from lotion manu­
facturers regarding interaction between lotions, gloves, dental 
materials, and antimicrobial products. 
Fingernails and Artificial Nails 
Although the relationship between fingernail length and 
wound infection is unknown, keeping nails short is consid­
ered key because the majority of flora on the hands are found 
under and around the fingernails (156). Fingernails should be 
short enough to allow DHCP to thoroughly clean underneath 
them and prevent glove tears (122). Sharp nail edges or bro­
ken nails are also likely to increase glove failure. Long artificial 
or natural nails can make donning gloves more difficult and 
can cause gloves to tear more readily. Hand carriage of gram-
negative organisms has been determined to be greater among 
wearers of artificial nails than among nonwearers, both before 
and after handwashing (157–160). In addition, artificial fin­
gernails or extenders have been epidemiologically implicated 
in multiple outbreaks involving fungal and bacterial infections 
in hospital intensive-care units and operating rooms (161– 
164). Freshly applied nail polish on natural nails does not 
increase the microbial load from periungual skin if fingernails 
are short; however, chipped nail polish can harbor added bac­
teria (165,166). 
Jewelry 
Studies have demonstrated that skin underneath rings is more 
heavily colonized than comparable areas of skin on fingers 
without rings (167–170). In a study of intensive-care nurses, 
multivariable analysis determined rings were the only substan­
tial risk factor for carriage of gram-negative bacilli and Staphy­
lococcus aureus, and the concentration of organisms correlated 
with the number of rings worn (170). However, two other 
studies demonstrated that mean bacterial colony counts on 
hands after handwashing were similar among persons wearing 
rings and those not wearing rings (169,171). Whether wear­
ing rings increases the likelihood of transmitting a pathogen is 
unknown; further studies are needed to establish whether rings 
result in higher transmission of pathogens in health-care set­
tings. However, rings and decorative nail jewelry can make 
donning gloves more difficult and cause gloves to tear more 
readily (142,143). Thus, jewelry should not interfere with glove 
use (e.g., impair ability to wear the correct-sized glove or alter 
glove integrity). 
Personal Protective Equipment 
PPE is designed to protect the skin and the mucous mem­
branes of the eyes, nose, and mouth of DHCP from exposure 
to blood or OPIM. Use of rotary dental and surgical instru­
ments (e.g., handpieces or ultrasonic scalers) and air-water 
syringes creates a visible spray that contains primarily large-
particle droplets of water, saliva, blood, microorganisms, and 
other debris. This spatter travels only a short distance and settles 
out quickly, landing on the floor, nearby operatory surfaces, 
DHCP, or the patient. The spray also might contain certain 
aerosols (i.e., particles of respirable size, <10 µm). Aerosols can 
remain airborne for extended periods and can be inhaled. How­
ever, they should not be confused with the large-particle spat­
ter that makes up the bulk of the spray from handpieces and 
ultrasonic scalers. Appropriate work practices, including use of 
dental dams (172) and high-velocity air evacuation, should 
minimize dissemination of droplets, spatter, and aerosols (2). 
Primary PPE used in oral health-care settings includes gloves, 
surgical masks, protective eyewear, face shields, and protective 
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clothing (e.g., gowns and jackets). All PPE should be removed 
before DHCP leave patient-care areas (13). Reusable PPE (e.g., 
clinician or patient protective eyewear and face shields) should 
be cleaned with soap and water, and when visibly soiled, dis­
infected between patients, according to the manufacturer’s 
directions (2,13). Wearing gloves, surgical masks, protective 
eyewear, and protective clothing in specified circumstances to 
reduce the risk of exposures to bloodborne pathogens is man­
dated by OSHA (13). General work clothes (e.g., uniforms, 
scrubs, pants, and shirts) are neither intended to protect against 
a hazard nor considered PPE. 
Masks, Protective Eyewear, Face Shields 
A surgical mask that covers both the nose and mouth and 
protective eyewear with solid side shields or a face shield should 
be worn by DHCP during procedures and patient-care activi­
ties likely to generate splashes or sprays of blood or body flu­
ids. Protective eyewear for patients shields their eyes from 
spatter or debris generated during dental procedures. A surgi­
cal mask protects against microorganisms generated by the 
wearer, with >95% bacterial filtration efficiency, and also pro­
tects DHCP from large-particle droplet spatter that might 
contain bloodborne pathogens or other infectious microor­
ganisms (173). The mask’s outer surface can become contami­
nated with infectious droplets from spray of oral fluids or from 
touching the mask with contaminated fingers. Also, when a 
mask becomes wet from exhaled moist air, the resistance to 
airflow through the mask increases, causing more airflow to 
pass around edges of the mask. If the mask becomes wet, it 
should be changed between patients or even during patient 
treatment, when possible (2,174). 
When airborne infection isolation precautions (expanded 
or transmission-based) are necessary (e.g., for TB patients), a 
National Institute for Occupational Safety and Health 
(NIOSH)-certified particulate-filter respirator (e.g., N95, N99, 
or N100) should be used (20). N95 refers to the ability to 
filter 1-µm particles in the unloaded state with a filter effi­
ciency of >95% (i.e., filter leakage <5%), given flow rates of 
<50 L/min (i.e., approximate maximum airflow rate of HCP 
during breathing). Available data indicate infectious droplet 
nuclei measure 1–5 µm; therefore, respirators used in health-
care settings should be able to efficiently filter the smallest 
particles in this range. 
The majority of surgical masks are not NIOSH-certified as 
respirators, do not protect the user adequately from exposure 
to TB, and do not satisfy OSHA requirements for respiratory 
protection (174,175). However, certain surgical masks (i.e., 
surgical N95 respirator) do meet the requirements and are cer­
tified by NIOSH as respirators. The level of protection a res­
pirator provides is determined by the efficiency of the filter 
material for incoming air and how well the face piece fits or 
seals to the face (e.g., qualitatively or quantitatively tested in a 
reliable way to obtain a face-seal leakage of <10% and to fit 
the different facial sizes and characteristics of HCP). 
When respirators are used while treating patients with dis­
eases requiring airborne-transmission precautions (e.g., TB), 
they should be used in the context of a complete respiratory 
protection program (175). This program should include train­
ing and fit testing to ensure an adequate seal between the edges 
of the respirator and the wearer’s face. Detailed information 
regarding respirator programs, including fit-test procedures are 
available at http://www.cdc.gov/niosh/99-143.html (174,176). 
Protective Clothing 
Protective clothing and equipment (e.g., gowns, lab coats, 
gloves, masks, and protective eyewear or face shield) should be 
worn to prevent contamination of street clothing and to pro­
tect the skin of DHCP from exposures to blood and body 
substances (2,7,10,11,13,137). OSHA bloodborne pathogens 
standard requires sleeves to be long enough to protect the fore­
arms when the gown is worn as PPE (i.e., when spatter and 
spray of blood, saliva, or OPIM to the forearms is anticipated) 
(13,14). DHCP should change protective clothing when it 
becomes visibly soiled and as soon as feasible if penetrated by 
blood or other potentially infectious fluids (2,13,14,137). All 
protective clothing should be removed before leaving the work 
area (13). 
Gloves and Gloving 
DHCP wear gloves to prevent contamination of their hands 
when touching mucous membranes, blood, saliva, or OPIM, 
and also to reduce the likelihood that microorganisms present 
on the hands of DHCP will be transmitted to patients during 
surgical or other patient-care procedures (1,2,7,10). Medical 
gloves, both patient examination and surgeon’s gloves, are 
manufactured as single-use disposable items that should be 
used for only one patient, then discarded. Gloves should be 
changed between patients and when torn or punctured. 
Wearing gloves does not eliminate the need for handwashing. 
Hand hygiene should be performed immediately before don­
ning gloves. Gloves can have small, unapparent defects or can 
be torn during use, and hands can become contaminated dur­
ing glove removal (122,177–187). These circumstances increase 
the risk of operative wound contamination and exposure of 
the DHCP’s hands to microorganisms from patients. In addi­
tion, bacteria can multiply rapidly in the moist environments 
underneath gloves, and thus, the hands should be dried thor­
oughly before donning gloves and washed again immediately 
after glove removal. 
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Types of Gloves 
Because gloves are task-specific, their selection should be 
based on the type of procedure to be performed (e.g., surgery 
or patient examination) (Table 3). Sterile surgeon’s gloves must 
meet standards for sterility assurance established by FDA and 
are less likely than patient examination gloves to harbor patho­
gens that could contaminate an operative wound (188). 
Appropriate gloves in the correct size should be readily acces­
sible (13). 
Glove Integrity 
Limited studies of the penetrability of different glove mate­
rials under conditions of use have been conducted in the den­
tal environment. Consistent with observations in clinical 
medicine, leakage rates vary by glove material (e.g., latex, vinyl, 
and nitrile), duration of use, and type of procedure performed 
(182,184,186,189–191), as well as by manufacturer (192– 
194). The frequency of perforations in surgeon’s gloves used 
during outpatient oral surgical procedures has been determined 
to range from 6% to 16% (181,185,195,196). 
Studies have demonstrated that HCP and DHCP are fre­
quently unaware of minute tears in gloves that occur during 
use (186,190,191,197). These studies determined that gloves 
TABLE 3. Glove types and indications 
developed defects in 30 minutes–3 hours, depending on type 
of glove and procedure. Investigators did not determine an 
optimal time for changing gloves during procedures. 
During dental procedures, patient examination and surgeon’s 
gloves commonly contact multiple types of chemicals and 
materials (e.g., disinfectants and antiseptics, composite resins, 
and bonding agents) that can compromise the integrity of 
latex as well as vinyl, nitrile, and other synthetic glove materi­
als (198–206). In addition, latex gloves can interfere with the 
setting of vinyl polysiloxane impression materials (207–209), 
although the setting is apparently not adversely affected by 
synthetic vinyl gloves (207,208). Given the diverse selection 
of dental materials on the market, dental practitioners should 
consult glove manufacturers regarding the chemical compat­
ibility of glove materials. 
If the integrity of a glove is compromised (e.g., punctured), 
it should be changed as soon as possible (13,210,211). Wash­
ing latex gloves with plain soap, chlorhexidine, or alcohol can 
lead to the formation of glove micropunctures (177,212,213) 
and subsequent hand contamination (138). Because this con­
dition, known as wicking, can allow penetration of liquids 
through undetected holes, washing gloves is not recommended. 
After a hand rub with alcohol, the hands should be thoroughly 
Commercially available glove materials*

Glove Indication Comment Material Attributes†

Patient 
examination 
gloves§ 
Surgeon’s 
gloves§ 
Nonmedical 
gloves 
Patient care, examinations, 
other nonsurgical proce­
dures involving contact with 
mucous membranes, and 
laboratory procedures 
Surgical procedures 
Housekeeping procedures 
(e.g., cleaning and 
disinfection) 
Handling contaminated 
sharps or chemicals 
Not for use during patient 
care 
Medical device regulated by the Food and Drug 
Administration (FDA). 
Nonsterile and sterile single-use disposable. Use 
for one patient and discard appropriately. 
Medical device regulated by the FDA. 
Sterile and single-use disposable. Use for one 
patient and discard appropriately. 
Not a medical device regulated by the FDA. 
Commonly referred to as utility, industrial, or 
general purpose gloves. Should be puncture- or 
chemical-resistant, depending on the task. Latex 
gloves do not provide adequate chemical 
protection. 
Sanitize after use. 
Natural-rubber latex (NRL) 1, 2 
Nitrile 2, 3 
Nitrile and chloroprene (neoprene) blends 2, 3 
Nitrile & NRL blends 1, 2, 3 
Butadiene methyl methacrylate 2, 3 
Polyvinyl chloride (PVC, vinyl) 4 
Polyurethane 4 
Styrene-based copolymer 4, 5 
NRL 1, 2 
Nitrile 2, 3 
Chloroprene (neoprene) 2, 3 
NRL and nitrile or chloroprene blends 2, 3 
Synthetic polyisoprene 2 
Styrene-based copolymer 4, 5 
Polyurethane 4 
NRL and nitrile or chloroprene blends 2, 3 
Chloroprene (neoprene) 2, 3 
Nitrile 2, 3 
Butyl rubber 2, 3 
Fluoroelastomer 3, 4, 6 
Polyethylene and ethylene vinyl alcohol copolymer 3, 4, 6 
* Physical properties can vary by material, manufacturer, and protein and chemical composition.† 1 contains allergenic NRL proteins.

2 vulcanized rubber, contains allergenic rubber processing chemicals.

3 likely to have enhanced chemical or puncture resistance.

4 nonvulcanized and does not contain rubber processing chemicals.

5 inappropriate for use with methacrylates.

6 resistant to most methacrylates.
§ Medical or dental gloves include patient-examination gloves and surgeon’s (i.e., surgical) gloves and are medical devices regulated by the FDA. Only FDA-cleared medical or 
dental patient-examination gloves and surgical gloves can be used for patient care. 
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dried before gloving, because hands still wet with an alcohol-
based hand hygiene product can increase the risk of glove per­
foration (192). 
FDA regulates the medical glove industry, which includes 
gloves marketed as sterile surgeon’s and sterile or nonsterile 
patient examination gloves. General-purpose utility gloves are 
also used in dental health-care settings but are not regulated 
by FDA because they are not promoted for medical use. More 
rigorous standards are applied to surgeon’s than to examina­
tion gloves. FDA has identified acceptable quality levels (e.g., 
maximum defects allowed) for glove manufacturers (214), but 
even intact gloves eventually fail with exposure to mechanical 
(e.g., sharps, fingernails, or jewelry) and chemical (e.g., 
dimethyacrylates) hazards and over time. These variables can 
be controlled, ultimately optimizing glove performance, by 
1) maintaining short fingernails, 2) minimizing or eliminat­
ing hand jewelry, and 3) using engineering and work-practice 
controls to avoid injuries with sharps. 
Sterile Surgeon’s Gloves and Double-Gloving 
During Oral Surgical Procedures 
Certain limited studies have determined no difference in 
postoperative infection rates after routine tooth extractions 
when surgeons wore either sterile or nonsterile gloves 
(215,216). However, wearing sterile surgeon’s gloves during 
surgical procedures is supported by a strong theoretical ratio­
nale (2,7,137). Sterile gloves minimize transmission of micro­
organisms from the hands of surgical DHCP to patients and 
prevent contamination of the hands of surgical DHCP with 
the patient’s blood and body fluids (137). In addition, sterile 
surgeon’s gloves are more rigorously regulated by FDA and 
therefore might provide an increased level of protection for 
the provider if exposure to blood is likely. 
Although the effectiveness of wearing two pairs of gloves in 
preventing disease transmission has not been demonstrated, 
the majority of studies among HCP and DHCP have demon­
strated a lower frequency of inner glove perforation and vis­
ible blood on the surgeon’s hands when double gloves are worn 
(181,185,195,196,198,217–219). In one study evaluating 
double gloves during oral surgical and dental hygiene proce­
dures, the perforation of outer latex gloves was greater during 
longer procedures (i.e., >45 minutes), with the highest rate 
(10%) of perforation occurring during oral surgery procedures 
(196). Based on these studies, double gloving might provide 
additional protection from occupational blood contact (220). 
Double gloving does not appear to substantially reduce either 
manual dexterity or tactile sensitivity (221–223). Additional 
protection might also be provided by specialty products (e.g., 
orthopedic surgical gloves and glove liners) (224). 
Contact Dermatitis and Latex 
Hypersensitivity 
Occupationally related contact dermatitis can develop from 
frequent and repeated use of hand hygiene products, exposure 
to chemicals, and glove use. Contact dermatitis is classified as 
either irritant or allergic. Irritant contact dermatitis is com­
mon, nonallergic, and develops as dry, itchy, irritated areas on 
the skin around the area of contact. By comparison, allergic 
contact dermatitis (type IV hypersensitivity) can result from 
exposure to accelerators and other chemicals used in the manu­
facture of rubber gloves (e.g., natural rubber latex, nitrile, and 
neoprene), as well as from other chemicals found in the dental 
practice setting (e.g., methacrylates and glutaraldehyde). 
Allergic contact dermatitis often manifests as a rash beginning 
hours after contact and, similar to irritant dermatitis, is usu­
ally confined to the area of contact. 
Latex allergy (type I hypersensitivity to latex proteins) can 
be a more serious systemic allergic reaction, usually beginning 
within minutes of exposure but sometimes occurring hours 
later and producing varied symptoms. More common reac­
tions include runny nose, sneezing, itchy eyes, scratchy throat, 
hives, and itchy burning skin sensations. More severe symp­
toms include asthma marked by difficult breathing, coughing 
spells, and wheezing; cardiovascular and gastrointestinal ail­
ments; and in rare cases, anaphylaxis and death (32,225). The 
American Dental Association (ADA) began investigating the 
prevalence of type I latex hypersensitivity among DHCP at 
the ADA annual meeting in 1994. In 1994 and 1995, 
approximately 2,000 dentists, hygienists, and assistants vol­
unteered for skin-prick testing. Data demonstrated that 6.2% 
of those tested were positive for type I latex hypersensitivity 
(226). Data from the subsequent 5 years of this ongoing cross-
sectional study indicated a decline in prevalence from 8.5% to 
4.3% (227). This downward trend is similar to that reported 
by other studies and might be related to use of latex gloves 
with lower allergen content (228–230). 
Natural rubber latex proteins responsible for latex allergy 
are attached to glove powder. When powdered latex gloves are 
worn, more latex protein reaches the skin. In addition, when 
powdered latex gloves are donned or removed, latex protein/ 
powder particles become aerosolized and can be inhaled, con­
tacting mucous membranes (231). As a result, allergic patients 
and DHCP can experience cutaneous, respiratory, and con­
junctival symptoms related to latex protein exposure. DHCP 
can become sensitized to latex protein with repeated exposure 
(232–236). Work areas where only powder-free, low-allergen 
latex gloves are used demonstrate low or undetectable amounts 
of latex allergy-causing proteins (237–239) and fewer symp­
toms among HCP related to natural rubber latex allergy. 
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Because of the role of glove powder in exposure to latex pro­
tein, NIOSH recommends that if latex gloves are chosen, HCP 
should be provided with reduced protein, powder-free gloves 
(32). Nonlatex (e.g., nitrile or vinyl) powder-free and low-
protein gloves are also available (31,240). Although rare, 
potentially life-threatening anaphylactic reactions to latex can 
occur; dental practices should be appropriately equipped and 
have procedures in place to respond to such emergencies. 
DHCP and dental patients with latex allergy should not have 
direct contact with latex-containing materials and should be 
in a latex-safe environment with all latex-containing products 
removed from their vicinity (31). Dental patients with histo­
ries of latex allergy can be at risk from dental products (e.g., 
prophylaxis cups, rubber dams, orthodontic elastics, and medi­
cation vials) (241). Any latex-containing devices that cannot 
be removed from the treatment environment should be 
adequately covered or isolated. Persons might also be allergic 
to chemicals used in the manufacture of natural rubber latex 
and synthetic rubber gloves as well as metals, plastics, or other 
materials used in dental care. Taking thorough health histories 
for both patients and DHCP, followed by avoidance of con­
tact with potential allergens can minimize the possibility of 
adverse reactions. Certain common predisposing conditions 
for latex allergy include previous history of allergies, a history 
of spina bifida, urogenital anomalies, or allergies to avocados, 
kiwis, nuts, or bananas. The following precautions should be 
considered to ensure safe treatment for patients who have pos­
sible or documented latex allergy: 
•	 Be aware that latent allergens in the ambient air can cause

respiratory or anaphylactic symptoms among persons with

latex hypersensitivity. Patients with latex allergy can be

scheduled for the first appointment of the day to mini­

mize their inadvertent exposure to airborne latex particles.

•	 Communicate with other DHCP regarding patients with

latex allergy (e.g., by oral instructions, written protocols,

and posted signage) to prevent them from bringing latex-

containing materials into the treatment area.

•	 Frequently clean all working areas contaminated with

latex powder or dust.

TABLE 4. Infection-control categories of patient-care instruments 
•	 Have emergency treatment kits with latex-free products 
available at all times. 
•	 If latex-related complications occur during or after a pro­
cedure, manage the reaction and seek emergency assistance 
as indicated. Follow current medical emergency response 
recommendations for management of anaphylaxis (32). 
Sterilization and Disinfection 
of Patient-Care Items 
Patient-care items (dental instruments, devices, and equip­
ment) are categorized as critical, semicritical, or noncritical, 
depending on the potential risk for infection associated with 
their intended use (Table 4) (242). Critical items used to pen­
etrate soft tissue or bone have the greatest risk of transmitting 
infection and should be sterilized by heat. Semicritical items 
touch mucous membranes or nonintact skin and have a lower 
risk of transmission; because the majority of semicritical items 
in dentistry are heat-tolerant, they also should be sterilized by 
using heat. If a semicritical item is heat-sensitive, it should, at 
a minimum, be processed with high-level disinfection (2). 
Noncritical patient-care items pose the least risk of trans­
mission of infection, contacting only intact skin, which can 
serve as an effective barrier to microorganisms. In the majority 
of cases, cleaning, or if visibly soiled, cleaning followed by disin­
fection with an EPA-registered hospital disinfectant is adequate. 
When the item is visibly contaminated with blood or OPIM, 
an EPA-registered hospital disinfectant with a tuberculocidal 
claim (i.e., intermediate-level disinfectant) should be used 
(2,243,244). Cleaning or disinfection of certain noncritical 
patient-care items can be difficult or damage the surfaces; there­
fore, use of disposable barrier protection of these surfaces might 
be a preferred alternative. 
FDA-cleared sterilant/high-level disinfectants and EPA-
registered disinfectants must have clear label claims for intended 
use, and manufacturer instructions for use must be followed 
(245). A more complete description of the regulatory frame­
work in the United States by which liquid chemical germi­
cides are evaluated and regulated is included (Appendix A). 
Category Definition Dental instrument or item 
Critical Penetrates soft tissue, contacts bone, enters into or contacts the blood­
stream or other normally sterile tissue. 
Surgical instruments, periodontal scalers, scalpel blades, surgical dental 
burs 
Semicritical Contacts mucous membranes or nonintact skin; will not penetrate soft 
tissue, contact bone, enter into or contact the bloodstream or other 
normally sterile tissue. 
Dental mouth mirror, amalgam condenser, reusable dental impression 
trays, dental handpieces* 
Noncritical Contacts intact skin. Radiograph head/cone, blood pressure cuff, facebow, pulse oximeter 
* Although dental handpieces are considered a semicritical item, they should always be heat-sterilized between uses and not high-level disinfected (246). See Dental Handpieces 
and Other Devices Attached to Air or Waterlines for detailed information. 
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Three levels of disinfection, high, intermediate, and low, are 
used for patient-care devices that do not require sterility and 
two levels, intermediate and low, for environmental surfaces 
(242). The intended use of the patient-care item should deter­
mine the recommended level of disinfection. Dental practices 
should follow the product manufacturer’s directions regarding 
concentrations and exposure time for disinfectant activity rela­
tive to the surface to be disinfected (245). A summary of ster­
ilization and disinfection methods is included (Appendix C). 
Transporting and Processing Contaminated 
Critical and Semicritical Patient-Care Items 
DHCP can be exposed to microorganisms on contaminated 
instruments and devices through percutaneous injury, contact 
with nonintact skin on the hands, or contact with mucous 
membranes of the eyes, nose, or mouth. Contaminated 
instruments should be handled carefully to prevent exposure 
to sharp instruments that can cause a percutaneous injury. 
Instruments should be placed in an appropriate container at 
the point of use to prevent percutaneous injuries during trans­
port to the instrument processing area (13). 
Instrument processing requires multiple steps to achieve ster­
ilization or high-level disinfection. Sterilization is a complex 
process requiring specialized equipment, adequate space, quali­
fied DHCP who are provided with ongoing training, and regu­
lar monitoring for quality assurance (247). Correct cleaning, 
packaging, sterilizer loading procedures, sterilization methods, 
or high-level disinfection methods should be followed to 
ensure that an instrument is adequately processed and safe for 
reuse on patients. 
Instrument Processing Area 
DHCP should process all instruments in a designated cen­
tral processing area to more easily control quality and ensure 
safety (248). The central processing area should be divided 
into sections for 1) receiving, cleaning, and decontamination; 
2) preparation and packaging; 3) sterilization; and 4) storage. 
Ideally, walls or partitions should separate the sections to con­
trol traffic flow and contain contaminants generated during 
processing. When physical separation of these sections cannot 
be achieved, adequate spatial separation might be satisfactory 
if the DHCP who process instruments are trained in work 
practices to prevent contamination of clean areas (248). Space 
should be adequate for the volume of work anticipated and 
the items to be stored (248). 
Receiving, Cleaning, and Decontamination 
Reusable instruments, supplies, and equipment should be 
received, sorted, cleaned, and decontaminated in one section 
of the processing area. Cleaning should precede all disinfection 
and sterilization processes; it should involve removal of debris 
as well as organic and inorganic contamination. Removal of 
debris and contamination is achieved either by scrubbing with 
a surfactant, detergent, and water, or by an automated process 
(e.g., ultrasonic cleaner or washer-disinfector) using chemical 
agents. If visible debris, whether inorganic or organic matter, is 
not removed, it will interfere with microbial inactivation and 
can compromise the disinfection or sterilization process 
(244,249–252). After cleaning, instruments should be rinsed 
with water to remove chemical or detergent residue. Splashing 
should be minimized during cleaning and rinsing (13). Before 
final disinfection or sterilization, instruments should be handled 
as though contaminated. 
Considerations in selecting cleaning methods and equipment 
include 1) efficacy of the method, process, and equipment; 
2) compatibility with items to be cleaned; and 3) occupational 
health and exposure risks. Use of automated cleaning equip­
ment (e.g., ultrasonic cleaner or washer-disinfector) does not 
require presoaking or scrubbing of instruments and can 
increase productivity, improve cleaning effectiveness, and 
decrease worker exposure to blood and body fluids. Thus, 
using automated equipment can be safer and more efficient 
than manually cleaning contaminated instruments (253). 
If manual cleaning is not performed immediately, placing 
instruments in a puncture-resistant container and soaking them 
with detergent, a disinfectant/detergent, or an enzymatic 
cleaner will prevent drying of patient material and make clean­
ing easier and less time-consuming. Use of a liquid chemical 
sterilant/high-level disinfectant (e.g., glutaraldehyde) as a hold­
ing solution is not recommended (244). Using work-practice 
controls (e.g., long-handled brush) to keep the scrubbing hand 
away from sharp instruments is recommended (14). To avoid 
injury from sharp instruments, DHCP should wear puncture-
resistant, heavy-duty utility gloves when handling or manu­
ally cleaning contaminated instruments and devices (6). 
Employees should not reach into trays or containers holding 
sharp instruments that cannot be seen (e.g., sinks filled with 
soapy water in which sharp instruments have been placed). 
Work-practice controls should include use of a strainer-type 
basket to hold instruments and forceps to remove the items. 
Because splashing is likely to occur, a mask, protective eyewear 
or face shield, and gown or jacket should be worn (13). 
Preparation and Packaging 
In another section of the processing area, cleaned instru­
ments and other dental supplies should be inspected, assembled 
into sets or trays, and wrapped, packaged, or placed into con­
tainer systems for sterilization. Hinged instruments should be 
processed open and unlocked. An internal chemical indicator 
should be placed in every package. In addition, an external 
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chemical indicator (e.g., chemical indicator tape) should be 
used when the internal indicator cannot be seen from outside 
the package. For unwrapped loads, at a minimum, an internal 
chemical indicator should be placed in the tray or cassette with 
items to be sterilized (254) (see Sterilization of Unwrapped 
Instruments). Dental practices should refer to the 
manufacturer’s instructions regarding use and correct place­
ment of chemical indicators (see Sterilization Monitoring). 
Critical and semicritical instruments that will be stored should 
be wrapped or placed in containers (e.g., cassettes or organiz­
ing trays) designed to maintain sterility during storage 
(2,247,255–257). 
Packaging materials (e.g., wraps or container systems) allow 
penetration of the sterilization agent and maintain sterility of 
the processed item after sterilization. Materials for maintain­
ing sterility of instruments during transport and storage 
include wrapped perforated instrument cassettes, peel pouches 
of plastic or paper, and sterilization wraps (i.e., woven and 
nonwoven). Packaging materials should be designed for the 
type of sterilization process being used (256–259). 
Sterilization 
The sterilization section of the processing area should 
include the sterilizers and related supplies, with adequate space 
for loading, unloading, and cool down. The area can also 
include incubators for analyzing spore tests and enclosed stor­
age for sterile items and disposable (single-use) items (260). 
Manufacturer and local building code specifications will 
determine placement and room ventilation requirements. 
Sterilization Procedures. Heat-tolerant dental instruments 
usually are sterilized by 1) steam under pressure (autoclaving), 
2) dry heat, or 3) unsaturated chemical vapor. All sterilization 
should be performed by using medical sterilization equipment 
cleared by FDA. The sterilization times, temperatures, and 
other operating parameters recommended by the manufac­
turer of the equipment used, as well as instructions for correct 
use of containers, wraps, and chemical or biological indica­
tors, should always be followed (243,247). 
Items to be sterilized should be arranged to permit free cir­
culation of the sterilizing agent (e.g., steam, chemical vapor, 
or dry heat); manufacturer’s instructions for loading the steril­
izer should be followed (248,260). Instrument packs should 
be allowed to dry inside the sterilizer chamber before remov­
ing and handling. Packs should not be touched until they are 
cool and dry because hot packs act as wicks, absorbing mois­
ture, and hence, bacteria from hands (247). The ability of 
equipment to attain physical parameters required to achieve 
sterilization should be monitored by mechanical, chemical, 
and biological indicators. Sterilizers vary in their types of 
indicators and their ability to provide readings on the mechani­
cal or physical parameters of the sterilization process (e.g., time, 
temperature, and pressure). Consult with the sterilizer manu­
facturer regarding selection and use of indicators. 
Steam Sterilization. Among sterilization methods, steam 
sterilization, which is dependable and economical, is the most 
widely used for wrapped and unwrapped critical and 
semicritical items that are not sensitive to heat and moisture 
(260). Steam sterilization requires exposure of each item to 
direct steam contact at a required temperature and pressure 
for a specified time needed to kill microorganisms. Two basic 
types of steam sterilizers are the gravity displacement and the 
high-speed prevacuum sterilizer. 
The majority of tabletop sterilizers used in a dental practice 
are gravity displacement sterilizers, although prevacuum ster­
ilizers are becoming more widely available. In gravity displace­
ment sterilizers, steam is admitted through steam lines, a steam 
generator, or self-generation of steam within the chamber. 
Unsaturated air is forced out of the chamber through a vent in 
the chamber wall. Trapping of air is a concern when using 
saturated steam under gravity displacement; errors in packag­
ing items or overloading the sterilizer chamber can result in 
cool air pockets and items not being sterilized. 
Prevacuum sterilizers are fitted with a pump to create a 
vacuum in the chamber and ensure air removal from the ster­
ilizing chamber before the chamber is pressurized with steam. 
Relative to gravity displacement, this procedure allows faster 
and more positive steam penetration throughout the entire 
load. Prevacuum sterilizers should be tested periodically for 
adequate air removal, as recommended by the manufacturer. 
Air not removed from the chamber will interfere with steam 
contact. If a sterilizer fails the air removal test, it should not be 
used until inspected by sterilizer maintenance personnel and 
it passes the test (243,247). Manufacturer’s instructions, with 
specific details regarding operation and user maintenance 
information, should be followed. 
Unsaturated Chemical-Vapor Sterilization. Unsaturated 
chemical-vapor sterilization involves heating a chemical solu­
tion of primarily alcohol with 0.23% formaldehyde in a closed 
pressurized chamber. Unsaturated chemical vapor sterilization 
of carbon steel instruments (e.g., dental burs) causes less cor­
rosion than steam sterilization because of the low level of 
water present during the cycle. Instruments should be dry 
before sterilizing. State and local authorities should be con­
sulted for hazardous waste disposal requirements for the steril­
izing solution. 
Dry-Heat Sterilization. Dry heat is used to sterilize mate­
rials that might be damaged by moist heat (e.g., burs and cer­
tain orthodontic instruments). Although dry heat has the 
advantages of low operating cost and being noncorrosive, it is 
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a prolonged process and the high temperatures required are 
not suitable for certain patient-care items and devices (261). 
Dry-heat sterilizers used in dentistry include static-air and 
forced-air types. 
•	 The static-air type is commonly called an oven-type steril­
izer. Heating coils in the bottom or sides of the unit cause hot 
air to rise inside the chamber through natural convection. 
•	 The forced-air type is also known as a rapid heat-transfer 
sterilizer. Heated air is circulated throughout the chamber 
at a high velocity, permitting more rapid transfer of 
energy from the air to the instruments, thereby reducing 
the time needed for sterilization. 
Sterilization of Unwrapped Instruments. An unwrapped 
cycle (sometimes called flash sterilization) is a method for ster­
ilizing unwrapped patient-care items for immediate use. The 
time required for unwrapped sterilization cycles depends on 
the type of sterilizer and the type of item (i.e., porous or non­
porous) to be sterilized (243). The unwrapped cycle in table­
top sterilizers is preprogrammed by the manufacturer to a 
specific time and temperature setting and can include a drying 
phase at the end to produce a dry instrument with much of 
the heat dissipated. If the drying phase requirements are unclear, 
the operation manual or manufacturer of the sterilizer should 
be consulted. If the unwrapped sterilization cycle in a steam 
sterilizer does not include a drying phase, or has only a mini­
mal drying phase, items retrieved from the sterilizer will be 
hot and wet, making aseptic transport to the point of use more 
difficult. For dry-heat and chemical-vapor sterilizers, a drying 
phase is not required. 
Unwrapped sterilization should be used only under certain 
conditions: 1) thorough cleaning and drying of instruments 
precedes the unwrapped sterilization cycle; 2) mechanical 
monitors are checked and chemical indicators used for each 
cycle; 3) care is taken to avoid thermal injury to DHCP or 
patients; and 4) items are transported aseptically to the point 
of use to maintain sterility (134,258,262). Because all implant­
able devices should be quarantined after sterilization until the 
results of biological monitoring are known, unwrapped or flash 
sterilization of implantable items is not recommended (134). 
Critical instruments sterilized unwrapped should be trans­
ferred immediately by using aseptic technique, from the steril­
izer to the actual point of use. Critical instruments should not 
be stored unwrapped (260). Semicritical instruments that are 
sterilized unwrapped on a tray or in a container system should 
be used immediately or within a short time. When sterile items 
are open to the air, they will eventually become contaminated. 
Storage, even temporary, of unwrapped semicritical instruments 
is discouraged because it permits exposure to dust, airborne 
organisms, and other unnecessary contamination before use 
on a patient (260). A carefully written protocol for minimiz­
ing the risk of contaminating unwrapped instruments should 
be prepared and followed (260). 
Other Sterilization Methods. Heat-sensitive critical and 
semicritical instruments and devices can be sterilized by 
immersing them in liquid chemical germicides registered by 
FDA as sterilants. When using a liquid chemical germicide for 
sterilization, certain poststerilization procedures are essential. 
Items need to be 1) rinsed with sterile water after removal to 
remove toxic or irritating residues; 2) handled using sterile 
gloves and dried with sterile towels; and 3) delivered to the 
point of use in an aseptic manner. If stored before use, the 
instrument should not be considered sterile and should be ster­
ilized again just before use. In addition, the sterilization pro­
cess with liquid chemical sterilants cannot be verified with 
biological indicators (263). 
Because of these limitations and because liquid chemical ste­
rilants can require approximately 12 hours of complete 
immersion, they are almost never used to sterilize instruments. 
Rather, these chemicals are more often used for high-level dis­
infection (249). Shorter immersion times (12–90 minutes) are 
used to achieve high-level disinfection of semicritical instru­
ments or items. These powerful, sporicidal chemicals (e.g., glu­
taraldehyde, peracetic acid, and hydrogen peroxide) are highly 
toxic (244,264,265). Manufacturer instructions (e.g., regard­
ing dilution, immersion time, and temperature) and safety 
precautions for using chemical sterilants/high-level disinfec­
tants must be followed precisely (15,245). These chemicals 
should not be used for applications other than those indicated 
in their label instructions. Misapplications include use as an 
environmental surface disinfectant or instrument-holding 
solution. 
When using appropriate precautions (e.g., closed contain­
ers to limit vapor release, chemically resistant gloves and aprons, 
goggles, and face shields), glutaraldehyde-based products can 
be used without tissue irritation or adverse health effects. How­
ever, dermatologic, eye irritation, respiratory effects, and skin 
sensitization have been reported (266–268). Because of their 
lack of chemical resistance to glutaraldehydes, medical gloves 
are not an effective barrier (200,269,270). Other factors might 
apply (e.g., room exhaust ventilation or 10 air exchanges/hour) 
to ensure DHCP safety (266,271). For all of these reasons, 
using heat-sensitive semicritical items that must be processed 
with liquid chemical germicides is discouraged; heat-tolerant 
or disposable alternatives are available for the majority of such 
items. 
Low-temperature sterilization with ethylene oxide gas (ETO) 
has been used extensively in larger health-care facilities. Its 
primary advantage is the ability to sterilize heat- and mois­
ture-sensitive patient-care items with reduced deleterious 
effects. However, extended sterilization times of 10–48 hours 
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and potential hazards to patients and DHCP requiring strin­
gent health and safety requirements (272–274) make this 
method impractical for private-practice settings. Handpieces 
cannot be effectively sterilized with this method because of 
decreased penetration of ETO gas flow through a small lumen 
(250,275). Other types of low-temperature sterilization (e.g., 
hydrogen peroxide gas plasma) exist but are not yet practical 
for dental offices. 
Bead sterilizers have been used in dentistry to sterilize small 
metallic instruments (e.g., endodontic files). FDA has deter­
mined that a risk of infection exists with these devices because 
of their potential failure to sterilize dental instruments and has 
required their commercial distribution cease unless the manu­
facturer files a premarket approval application. If a bead steril­
izer is employed, DHCP assume the risk of employing a 
dental device FDA has deemed neither safe nor effective (276). 
Sterilization Monitoring. Monitoring of sterilization pro­
cedures should include a combination of process parameters, 
including mechanical, chemical, and biological (247,248,277). 
These parameters evaluate both the sterilizing conditions and 
the procedure’s effectiveness. 
Mechanical techniques for monitoring sterilization include 
assessing cycle time, temperature, and pressure by observing 
the gauges or displays on the sterilizer and noting these 
parameters for each load (243,248). Some tabletop sterilizers 
have recording devices that print out these parameters. Cor­
rect readings do not ensure sterilization, but incorrect read­
ings can be the first indication of a problem with the 
sterilization cycle. 
Chemical indicators, internal and external, use sensitive 
chemicals to assess physical conditions (e.g., time and tem­
perature) during the sterilization process. Although chemical 
indicators do not prove sterilization has been achieved, they 
allow detection of certain equipment malfunctions, and they 
can help identify procedural errors. External indicators applied 
to the outside of a package (e.g., chemical indicator tape or 
special markings) change color rapidly when a specific param­
eter is reached, and they verify that the package has been 
exposed to the sterilization process. Internal chemical indica­
tors should be used inside each package to ensure the steriliz­
ing agent has penetrated the packaging material and actually 
reached the instruments inside. A single-parameter internal 
chemical indicator provides information regarding only one 
sterilization parameter (e.g., time or temperature). Multipa­
rameter internal chemical indicators are designed to react to 
>2 parameters (e.g., time and temperature; or time, tempera­
ture, and the presence of steam) and can provide a more reli­
able indication that sterilization conditions have been met 
(254). Multiparameter internal indicators are available only 
for steam sterilizers (i.e., autoclaves). 
Because chemical indicator test results are received when the 
sterilization cycle is complete, they can provide an early indi­
cation of a problem and where in the process the problem 
might exist. If either mechanical indicators or internal or 
external chemical indicators indicate inadequate processing, 
items in the load should not be used until reprocessed (134). 
Biological indicators (BIs) (i.e., spore tests) are the most 
accepted method for monitoring the sterilization process 
(278,279) because they assess it directly by killing known highly 
resistant microorganisms (e.g., Geobacillus or Bacillus species), 
rather than merely testing the physical and chemical condi­
tions necessary for sterilization (243). Because spores used in 
BIs are more resistant and present in greater numbers than the 
common microbial contaminants found on patient-care equip­
ment, an inactivated BI indicates other potential pathogens in 
the load have been killed (280). 
Correct functioning of sterilization cycles should be verified 
for each sterilizer by the periodic use (at least weekly) of BIs 
(2,9,134,243,278,279). Every load containing implantable 
devices should be monitored with such indicators (248), and 
the items quarantined until BI results are known. However, in 
an emergency, placing implantable items in quarantine until 
spore tests are known to be negative might be impossible. 
Manufacturer’s directions should determine the placement 
and location of BI in the sterilizer. A control BI, from the 
same lot as the test indicator and not processed through the 
sterilizer, should be incubated with the test BI; the control BI 
should yield positive results for bacterial growth. 
In-office biological monitoring is available; mail-in steril­
ization monitoring services (e.g., from private companies or 
dental schools) can also be used to test both the BI and the 
control. Although some DHCP have expressed concern that 
delays caused by mailing specimens might cause false-negatives, 
studies have determined that mail delays have no substantial 
effect on final test results (281,282). 
Procedures to follow in the event of a positive spore test 
have been developed (243,247). If the mechanical (e.g., time, 
temperature, and pressure) and chemical (i.e., internal or 
external) indicators demonstrate that the sterilizer is function­
ing correctly, a single positive spore test probably does not 
indicate sterilizer malfunction. Items other than implantable 
devices do not necessarily need to be recalled; however the 
spore test should be repeated immediately after correctly load­
ing the sterilizer and using the same cycle that produced the 
failure. The sterilizer should be removed from service, and all 
records reviewed of chemical and mechanical monitoring since 
the last negative BI test. Also, sterilizer operating procedures 
should be reviewed, including packaging, loading, and spore 
testing, with all persons who work with the sterilizer to deter­
mine whether operator error could be responsible (9,243,247). 
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Overloading, failure to provide adequate package separation, 
and incorrect or excessive packaging material are all common 
reasons for a positive BI in the absence of mechanical failure 
of the sterilizer unit (260). A second monitored sterilizer in 
the office can be used, or a loaner from a sales or repair com­
pany obtained, to minimize office disruption while waiting 
for the repeat BI. 
If the repeat test is negative and chemical and mechanical 
monitoring indicate adequate processing, the sterilizer can be 
put back into service. If the repeat BI test is positive, and pack­
aging, loading, and operating procedures have been confirmed 
as performing correctly, the sterilizer should remain out of ser­
vice until it has been inspected, repaired, and rechallenged with 
BI tests in three consecutive empty chamber sterilization cycles 
(9,243). When possible, items from suspect loads dating back 
to the last negative BI should be recalled, rewrapped, and 
resterilized (9,283). 
A more conservative approach has been recommended (247) 
in which any positive spore test is assumed to represent steril­
izer malfunction and requires that all materials processed in 
that sterilizer, dating from the sterilization cycle having the 
last negative biologic indicator to the next cycle indicating sat­
isfactory biologic indicator results, should be considered 
nonsterile and retrieved, if possible, and reprocessed or held in 
quarantine until the results of the repeat BI are known. This 
approach is considered conservative because the margin of 
safety in steam sterilization is sufficient enough that infection 
risk, associated with items in a load indicating spore growth, is 
minimal, particularly if the item was properly cleaned and the 
temperature was achieved (e.g., as demonstrated by accept­
able chemical indicator or temperature chart) (243). Published 
studies are not available that document disease transmission 
through a nonretrieved surgical instrument after a steam ster­
ilization cycle with a positive biological indicator (243). This 
more conservative approach should always be used for steril­
ization methods other than steam (e.g., dry heat, unsaturated 
chemical vapor, ETO, or hydrogen peroxide gas plasma) (243). 
Results of biological monitoring should be recorded and ster­
ilization monitoring records (i.e., mechanical, chemical, and 
biological) retained long enough to comply with state and 
local regulations. Such records are a component of an overall 
dental infection-control program (see Program Evaluation). 
Storage of Sterilized Items and Clean Dental 
Supplies 
The storage area should contain enclosed storage for sterile 
items and disposable (single-use) items (173). Storage prac­
tices for wrapped sterilized instruments can be either date- or 
event-related. Packages containing sterile supplies should be 
inspected before use to verify barrier integrity and dryness. 
Although some health-care facilities continue to date every 
sterilized package and use shelf-life practices, other facilities 
have switched to event-related practices (243). This approach 
recognizes that the product should remain sterile indefinitely, 
unless an event causes it to become contaminated (e.g., torn 
or wet packaging) (284). Even for event-related packaging, 
minimally, the date of sterilization should be placed on the 
package, and if multiple sterilizers are used in the facility, the 
sterilizer used should be indicated on the outside of the pack­
aging material to facilitate the retrieval of processed items in 
the event of a sterilization failure (247). If packaging is com­
promised, the instruments should be recleaned, packaged in 
new wrap, and sterilized again. 
Clean supplies and instruments should be stored in closed 
or covered cabinets, if possible (285). Dental supplies and 
instruments should not be stored under sinks or in other loca­
tions where they might become wet. 
Environmental Infection Control 
In the dental operatory, environmental surfaces (i.e., a sur­
face or equipment that does not contact patients directly) can 
become contaminated during patient care. Certain surfaces, 
especially ones touched frequently (e.g., light handles, unit 
switches, and drawer knobs) can serve as reservoirs of micro­
bial contamination, although they have not been associated 
directly with transmission of infection to either DHCP or 
patients. Transfer of microorganisms from contaminated 
environmental surfaces to patients occurs primarily through 
DHCP hand contact (286,287). When these surfaces are 
touched, microbial agents can be transferred to instruments, 
other environmental surfaces, or to the nose, mouth, or eyes 
of workers or patients. Although hand hygiene is key to mini­
mizing this transferal, barrier protection or cleaning and dis­
infecting of environmental surfaces also protects against 
health-care–associated infections. 
Environmental surfaces can be divided into clinical contact 
surfaces and housekeeping surfaces (249). Because housekeep­
ing surfaces (e.g., floors, walls, and sinks) have limited risk of 
disease transmission, they can be decontaminated with less rig­
orous methods than those used on dental patient-care items 
and clinical contact surfaces (244). Strategies for cleaning and 
disinfecting surfaces in patient-care areas should consider the 
1) potential for direct patient contact; 2) degree and frequency 
of hand contact; and 3) potential contamination of the sur­
face with body substances or environmental sources of micro­
organisms (e.g., soil, dust, or water). 
Cleaning is the necessary first step of any disinfection pro­
cess. Cleaning is a form of decontamination that renders the 
environmental surface safe by removing organic matter, salts, 
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and visible soils, all of which interfere with microbial inactiva­
tion. The physical action of scrubbing with detergents and 
surfactants and rinsing with water removes substantial num­
bers of microorganisms. If a surface is not cleaned first, the 
success of the disinfection process can be compromised. 
Removal of all visible blood and inorganic and organic matter 
can be as critical as the germicidal activity of the disinfecting 
agent (249). When a surface cannot be cleaned adequately, it 
should be protected with barriers (2). 
Clinical Contact Surfaces 
Clinical contact surfaces can be directly contaminated from 
patient materials either by direct spray or spatter generated 
during dental procedures or by contact with DHCP’s gloved 
hands. These surfaces can subsequently contaminate other 
instruments, devices, hands, or gloves. Examples of such sur­
faces include 
• light handles, 
• switches, 
• dental radiograph equipment, 
• dental chairside computers, 
• reusable containers of dental materials, 
• drawer handles, 
• faucet handles, 
• countertops, 
• pens, 
• telephones, and 
• doorknobs. 
Barrier protection of surfaces and equipment can prevent 
contamination of clinical contact surfaces, but is particularly 
effective for those that are difficult to clean. Barriers include 
clear plastic wrap, bags, sheets, tubing, and plastic-backed 
paper or other materials impervious to moisture (260,288). 
Because such coverings can become contaminated, they should 
be removed and discarded between patients, while DHCP are 
still gloved. After removing the barrier, examine the surface to 
make sure it did not become soiled inadvertently. The surface 
needs to be cleaned and disinfected only if contamination is 
evident. Otherwise, after removing gloves and performing hand 
hygiene, DHCP should place clean barriers on these surfaces 
before the next patient (1,2,288). 
If barriers are not used, surfaces should be cleaned and dis­
infected between patients by using an EPA-registered hospital 
disinfectant with an HIV, HBV claim (i.e., low-level disinfec­
tant) or a tuberculocidal claim (i.e., intermediate-level disin­
fectant). Intermediate-level disinfectant should be used when 
the surface is visibly contaminated with blood or OPIM 
(2,244). Also, general cleaning and disinfection are recom­
mended for clinical contact surfaces, dental unit surfaces, and 
countertops at the end of daily work activities and are required 
if surfaces have become contaminated since their last cleaning 
(13). To facilitate daily cleaning, treatment areas should be 
kept free of unnecessary equipment and supplies. 
Manufacturers of dental devices and equipment should pro­
vide information regarding material compatibility with liquid 
chemical germicides, whether equipment can be safely 
immersed for cleaning, and how it should be decontaminated 
if servicing is required (289). Because of the risks associated 
with exposure to chemical disinfectants and contaminated sur­
faces, DHCP who perform environmental cleaning and disin­
fection should wear gloves and other PPE to prevent 
occupational exposure to infectious agents and hazardous 
chemicals. Chemical- and puncture-resistant utility gloves 
offer more protection than patient examination gloves when 
using hazardous chemicals. 
Housekeeping Surfaces 
Evidence does not support that housekeeping surfaces (e.g., 
floors, walls, and sinks) pose a risk for disease transmission in 
dental health-care settings. Actual, physical removal of micro­
organisms and soil by wiping or scrubbing is probably as criti­
cal, if not more so, than any antimicrobial effect provided by 
the agent used (244,290). The majority of housekeeping sur­
faces need to be cleaned only with a detergent and water or an 
EPA-registered hospital disinfectant/detergent, depending on 
the nature of the surface and the type and degree of contami­
nation. Schedules and methods vary according to the area (e.g., 
dental operatory, laboratory, bathrooms, or reception rooms), 
surface, and amount and type of contamination. 
Floors should be cleaned regularly, and spills should be 
cleaned up promptly. An EPA-registered hospital disinfectant/ 
detergent designed for general housekeeping purposes should 
be used in patient-care areas if uncertainty exists regarding the 
nature of the soil on the surface (e.g., blood or body fluid 
contamination versus routine dust or dirt). Unless contami­
nation is reasonably anticipated or apparent, cleaning or dis­
infecting walls, window drapes, and other vertical surfaces is 
unnecessary. However, when housekeeping surfaces are visibly 
contaminated by blood or OPIM, prompt removal and sur­
face disinfection is appropriate infection-control practice and 
required by OSHA (13). 
Part of the cleaning strategy is to minimize contamination 
of cleaning solutions and cleaning tools (e.g., mop heads or 
cleaning cloths). Mops and cloths should be cleaned after use 
and allowed to dry before reuse, or single-use, disposable mop 
heads and cloths should be used to avoid spreading contami­
nation. Cost, safety, product-surface compatibility, and accept­
ability by housekeepers can be key criteria for selecting a 
cleaning agent or an EPA-registered hospital disinfectant/ 
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detergent. PPE used during cleaning and housekeeping proce­
dures followed should be appropriate to the task. 
In the cleaning process, another reservoir for microorgan­
isms can be dilute solutions of detergents or disinfectants, 
especially if prepared in dirty containers, stored for long peri­
ods of time, or prepared incorrectly (244). Manufacturers’ 
instructions for preparation and use should be followed. Mak­
ing fresh cleaning solution each day, discarding any remaining 
solution, and allowing the container to dry will minimize bac­
terial contamination. Preferred cleaning methods produce 
minimal mists and aerosols or dispersion of dust in patient-
care areas. 
Cleaning and Disinfection Strategies 
for Blood Spills 
The majority of blood contamination events in dentistry 
result from spatter during dental procedures using rotary or 
ultrasonic instrumentation. Although no evidence supports 
that HBV, HCV, or HIV have been transmitted from a house­
keeping surface, prompt removal and surface disinfection of 
an area contaminated by either blood or OPIM are appropri­
ate infection-control practices and required by OSHA (13,291). 
Strategies for decontaminating spills of blood and other body 
fluids differ by setting and volume of the spill (113,244). Blood 
spills on either clinical contact or housekeeping surfaces should 
be contained and managed as quickly as possible to reduce the 
risk of contact by patients and DHCP (244,292). The person 
assigned to clean the spill should wear gloves and other PPE as 
needed. Visible organic material should be removed with 
absorbent material (e.g., disposable paper towels discarded in 
a leak-proof, appropriately labeled container). Nonporous sur­
faces should be cleaned and then decontaminated with either 
an EPA-registered hospital disinfectant effective against HBV 
and HIV or an EPA-registered hospital disinfectant with a 
tuberculocidal claim (i.e., intermediate-level disinfectant). If 
sodium hypochlorite is chosen, an EPA-registered sodium 
hypochlorite product is preferred. However, if such products 
are unavailable, a 1:100 dilution of sodium hypochlorite (e.g., 
approximately ¼ cup of 5.25% household chlorine bleach to 
1 gallon of water) is an inexpensive and effective disinfecting 
agent (113). 
Carpeting and Cloth Furnishings 
Carpeting is more difficult to clean than nonporous hard-
surface flooring, and it cannot be reliably disinfected, espe­
cially after spills of blood and body substances. Studies have 
documented the presence of diverse microbial populations, 
primarily bacteria and fungi, in carpeting (293–295). Cloth 
furnishings pose similar contamination risks in areas of direct 
patient care and places where contaminated materials are man­
aged (e.g., dental operatory, laboratory, or instrument process­
ing areas). For these reasons, use of carpeted flooring and fab­
ric-upholstered furnishings in these areas should be avoided. 
Nonregulated and Regulated Medical Waste 
Studies have compared microbial load and diversity of 
microorganisms in residential waste with waste from multiple 
health-care settings. General waste from hospitals or other 
health-care facilities (e.g., dental practices or clinical/research 
laboratories) is no more infective than residential waste 
(296,297). The majority of soiled items in dental offices are 
general medical waste and thus can be disposed of with ordi­
nary waste. Examples include used gloves, masks, gowns, lightly 
soiled gauze or cotton rolls, and environmental barriers (e.g., 
plastic sheets or bags) used to cover equipment during treat­
ment (298). 
Although any item that has had contact with blood, exu­
dates, or secretions might be infective, treating all such waste 
as infective is neither necessary nor practical (244). Infectious 
waste that carries a substantial risk of causing infection during 
handling and disposal is regulated medical waste. A complete 
definition of regulated waste is included in OSHA’s bloodborne 
pathogens standard (13). 
Regulated medical waste is only a limited subset of waste: 
9%–15% of total waste in hospitals and 1%–2% of total waste 
in dental offices (298,299). Regulated medical waste requires 
special storage, handling, neutralization, and disposal and is 
covered by federal, state, and local rules and regulations 
(6,297,300,301). Examples of regulated waste found in den­
tal-practice settings are solid waste soaked or saturated with 
blood or saliva (e.g., gauze saturated with blood after surgery), 
extracted teeth, surgically removed hard and soft tissues, and 
contaminated sharp items (e.g., needles, scalpel blades, and 
wires) (13). 
Regulated medical waste requires careful containment for 
treatment or disposal. A single leak-resistant biohazard bag is 
usually adequate for containment of nonsharp regulated medi­
cal waste, provided the bag is sturdy and the waste can be 
discarded without contaminating the bag’s exterior. Exterior 
contamination or puncturing of the bag requires placement in 
a second biohazard bag. All bags should be securely closed for 
disposal. Puncture-resistant containers with a biohazard label, 
located at the point of use (i.e., sharps containers), are used as 
containment for scalpel blades, needles, syringes, and unused 
sterile sharps (13). 
Dental health-care facilities should dispose of medical waste 
regularly to avoid accumulation. Any facility generating regu­
lated medical waste should have a plan for its management 
that complies with federal, state, and local regulations to 
ensure health and environmental safety. 
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Discharging Blood or Other Body Fluids 
to Sanitary Sewers or Septic Tanks 
All containers with blood or saliva (e.g., suctioned fluids) 
can be inactivated in accordance with state-approved treat­
ment technologies, or the contents can be carefully poured 
down a utility sink, drain, or toilet (6). Appropriate PPE (e.g., 
gloves, gown, mask, and protective eyewear) should be worn 
when performing this task (13). No evidence exists that 
bloodborne diseases have been transmitted from contact with 
raw or treated sewage. Multiple bloodborne pathogens, par­
ticularly viruses, are not stable in the environment for long 
periods (302), and the discharge of limited quantities of blood 
and other body fluids into the sanitary sewer is considered a 
safe method for disposing of these waste materials (6). State 
and local regulations vary and dictate whether blood or other 
body fluids require pretreatment or if they can be discharged 
into the sanitary sewer and in what volume. 
Dental Unit Waterlines, Biofilm, 
and Water Quality 
Studies have demonstrated that dental unit waterlines (i.e., 
narrow-bore plastic tubing that carries water to the high-speed 
handpiece, air/water syringe, and ultrasonic scaler) can become 
colonized with microorganisms, including bacteria, fungi, and 
protozoa (303–309). Protected by a polysaccharide slime layer 
known as a glycocalyx, these microorganisms colonize and rep­
licate on the interior surfaces of the waterline tubing and form 
a biofilm, which serves as a reservoir that can amplify the num­
ber of free-floating (i.e., planktonic) microorganisms in water 
used for dental treatment. Although oral flora (303,310,311) 
and human pathogens (e.g., Pseudomonas aeruginosa 
[303,305,312,313], Legionella species [303,306,313], and 
nontuberculous Mycobacterium species [303,304]), have been 
isolated from dental water systems, the majority of organisms 
recovered from dental waterlines are common heterotrophic 
water bacteria (305,314,315). These exhibit limited patho­
genic potential for immunocompetent persons. 
Clinical Implications 
Certain reports associate waterborne infections with dental 
water systems, and scientific evidence verifies the potential for 
transmission of waterborne infections and disease in hospital 
settings and in the community (306,312,316). Infection or 
colonization caused by Pseudomonas species or nontuberculous 
mycobacteria can occur among susceptible patients through 
direct contact with water (317–320) or after exposure to 
residual waterborne contamination of inadequately reprocessed 
medical instruments (321–323). Nontuberculous mycobac­
teria can also be transmitted to patients from tap water aero­
sols (324). Health-care–associated transmission of pathogenic 
agents (e.g., Legionella species) occurs primarily through inha­
lation of infectious aerosols generated from potable water 
sources or through use of tap water in respiratory therapy equip­
ment (325–327). Disease outbreaks in the community have 
also been reported from diverse environmental aerosol-
producing sources, including whirlpool spas (328), swimming 
pools (329), and a grocery store mist machine (330). Although 
the majority of these outbreaks are associated with species of 
Legionella and Pseudomonas  (329), the fungus Cladosporium 
(331) has also been implicated. 
Researchers have not demonstrated a measurable risk of 
adverse health effects among DHCP or patients from expo­
sure to dental water. Certain studies determined DHCP had 
altered nasal flora (332) or substantially greater titers of 
Legionella antibodies in comparisons with control populations; 
however, no cases of legionellosis were identified among 
exposed DHCP (333,334). Contaminated dental water might 
have been the source for localized Pseudomonas aeruginosa 
infections in two immunocompromised patients (312). 
Although transient carriage of P. aeruginosa was observed in 
78 healthy patients treated with contaminated dental treat­
ment water, no illness was reported among the group. In this 
same study, a retrospective review of dental records also failed 
to identify infections (312). 
Concentrations of bacterial endotoxin <1,000 endotoxin 
units/mL from gram-negative water bacteria have been detected 
in water from colonized dental units (335). No standards exist 
for an acceptable level of endotoxin in drinking water, but the 
maximum level permissible in United States Pharmacopeia 
(USP) sterile water for irrigation is only 0.25 endotoxin units/ 
mL (336). Although the consequences of acute and chronic 
exposure to aerosolized endotoxin in dental health-care set­
tings have not been investigated, endotoxin has been associ­
ated with exacerbation of asthma and onset of hypersensitivity 
pneumonitis in other occupational settings (329,337). 
Dental Unit Water Quality 
Research has demonstrated that microbial counts can reach 
<200,000 colony-forming units (CFU)/mL within 5 days 
after installation of new dental unit waterlines (305), and lev­
els of microbial contamination <106 CFU/mL of dental unit 
water have been documented (309,338). These counts can 
occur because dental unit waterline factors (e.g., system design, 
flow rates, and materials) promote both bacterial growth and 
development of biofilm. 
Although no epidemiologic evidence indicates a public health 
problem, the presence of substantial numbers of pathogens in 
dental unit waterlines generates concern. Exposing patients or 
DHCP to water of uncertain microbiological quality, despite 
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the lack of documented adverse health effects, is inconsistent 
with accepted infection-control principles. Thus in 1995, ADA 
addressed the dental water concern by asking manufacturers 
to provide equipment with the ability to deliver treatment water 
with <200 CFU/mL of unfiltered output from waterlines (339). 
This threshold was based on the quality assurance standard 
established for dialysate fluid, to ensure that fluid delivery sys­
tems in hemodialysis units have not been colonized by indig­
enous waterborne organisms (340). 
Standards also exist for safe drinking water quality as estab­
lished by EPA, the American Public Health Association 
(APHA), and the American Water Works Association 
(AWWA); they have set limits for heterotrophic bacteria of 
<500 CFU/mL of drinking water (341,342). Thus, the num­
ber of bacteria in water used as a coolant/irrigant for nonsur­
gical dental procedures should be as low as reasonably 
achievable and, at a minimum, <500 CFU/mL, the regulatory 
standard for safe drinking water established by EPA and APHA/ 
AWWA. 
Strategies To Improve Dental 
Unit Water Quality 
In 1993, CDC recommended that dental waterlines be 
flushed at the beginning of the clinic day to reduce the micro­
bial load (2). However, studies have demonstrated this prac­
tice does not affect biofilm in the waterlines or reliably improve 
the quality of water used during dental treatment 
(315,338,343). Because the recommended value of <500 CFU/ 
mL cannot be achieved by using this method, other strategies 
should be employed. Dental unit water that remains untreated 
or unfiltered is unlikely to meet drinking water standards (303– 
309). Commercial devices and procedures designed to improve 
the quality of water used in dental treatment are available (316); 
methods demonstrated to be effective include self-contained 
water systems combined with chemical treatment, in-line 
microfilters, and combinations of these treatments. Simply 
using source water containing <500 CFU/mL of bacteria (e.g., 
tap, distilled, or sterile water) in a self-contained water system 
will not eliminate bacterial contamination in treatment water 
if biofilms in the water system are not controlled. Removal or 
inactivation of dental waterline biofilms requires use of chemi­
cal germicides. 
Patient material (e.g., oral microorganisms, blood, and saliva) 
can enter the dental water system during patient treatment 
(311,344). Dental devices that are connected to the dental 
water system and that enter the patient’s mouth (e.g., 
handpieces, ultrasonic scalers, or air/water syringes) should be 
operated to discharge water and air for a minimum of 20–30 
seconds after each patient (2). This procedure is intended to 
physically flush out patient material that might have entered 
the turbine, air, or waterlines. The majority of recently manu­
factured dental units are engineered to prevent retraction of 
oral fluids, but some older dental units are equipped with 
antiretraction valves that require periodic maintenance. Users 
should consult the owner’s manual or contact the manufac­
turer to determine whether testing or maintenance of 
antiretraction valves or other devices is required. Even with 
antiretraction valves, flushing devices for a minimum of 20– 
30 seconds after each patient is recommended. 
Maintenance and Monitoring 
of Dental Unit Water 
DHCP should be trained regarding water quality, biofilm 
formation, water treatment methods, and appropriate main­
tenance protocols for water delivery systems. Water treatment 
and monitoring products require strict adherence to mainte­
nance protocols, and noncompliance with treatment regimens 
has been associated with persistence of microbial contamina­
tion in treated systems (345). Clinical monitoring of water 
quality can ensure that procedures are correctly performed and 
that devices are working in accordance with the manufacturer’s 
previously validated protocol. 
Dentists should consult with the manufacturer of their dental 
unit or water delivery system to determine the best method for 
maintaining acceptable water quality (i.e., <500 CFU/mL) and 
the recommended frequency of monitoring. Monitoring of den­
tal water quality can be performed by using commercial self-
contained test kits or commercial water-testing laboratories. 
Because methods used to treat dental water systems target the 
entire biofilm, no rationale exists for routine testing for such 
specific organisms as Legionella or Pseudomonas, except when 
investigating a suspected waterborne disease outbreak (244). 
Delivery of Sterile Surgical Irrigation 
Sterile solutions (e.g., sterile saline or sterile water) should be 
used as a coolant/irrigation in the performance of oral surgical 
procedures where a greater opportunity exists for entry of 
microorganisms, exogenous and endogenous, into the vascular 
system and other normally sterile areas that support the oral 
cavity (e.g., bone or subcutaneous tissue) and increased poten­
tial exists for localized or systemic infection (see Oral Surgical 
Procedures). Conventional dental units cannot reliably deliver 
sterile water even when equipped with independent water res­
ervoirs because the water-bearing pathway cannot be reliably 
sterilized. Delivery devices (e.g., bulb syringe or sterile, single-
use disposable products) should be used to deliver sterile water 
(2,121). Oral surgery and implant handpieces, as well as ultra­
sonic scalers, are commercially available that bypass the dental 
unit to deliver sterile water or other solutions by using single-
use disposable or sterilizable tubing (316). 
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Boil-Water Advisories 
A boil-water advisory is a public health announcement that 
the public should boil tap water before drinking it. When 
issued, the public should assume the water is unsafe to drink. 
Advisories can be issued after 1) failure of or substantial inter­
ruption in water treatment processes that result in increased 
turbidity levels or particle counts and mechanical or equip­
ment failure; 2) positive test results for pathogens (e.g., 
Cryptosporidium, Giardia, or Shigella) in water; 3) violations 
of the total coliform rule or the turbidity standard of the sur­
face water treatment rule; 4) circumstances that compromise 
the distribution system (e.g., watermain break) coupled with 
an indication of a health hazard; or 5) a natural disaster (e.g., 
flood, hurricane, or earthquake) (346). In recent years, 
increased numbers of boil-water advisories have resulted from 
contamination of public drinking water systems with water­
borne pathogens. Most notable was the outbreak of 
cryptosporidiosis in Milwaukee, Wisconsin, where the 
municipal water system was contaminated with the protozoan 
parasite Cryptosporidium parvum. An estimated 403,000 per­
sons became ill (347,348). 
During a boil-water advisory, water should not be delivered 
to patients through the dental unit, ultrasonic scaler, or other 
dental equipment that uses the public water system. This 
restriction does not apply if the water source is isolated from 
the municipal water system (e.g., a separate water reservoir or 
other water treatment device cleared for marketing by FDA). 
Patients should rinse with bottled or distilled water until the 
boil-water advisory has been cancelled. During these advisory 
periods, tap water should not be used to dilute germicides or 
for hand hygiene unless the water has been brought to a roll­
ing boil for >1 minute and cooled before use (346,349–351). 
For hand hygiene, antimicrobial products that do not require 
water (e.g., alcohol-based hand rubs) can be used until the 
boil-water notice is cancelled. If hands are visibly contami­
nated, bottled water and soap should be used for handwashing; 
if bottled water is not immediately available, an antiseptic 
towelette should be used (13,122). 
When the advisory is cancelled, the local water utility should 
provide guidance for flushing of waterlines to reduce residual 
microbial contamination. All incoming waterlines from the 
public water system inside the dental office (e.g., faucets, water­
lines, and dental equipment) should be flushed. No consensus 
exists regarding the optimal duration for flushing procedures 
after cancellation of the advisory; recommendations range from 
1 to 5 minutes (244,346,351,352). The length of time needed 
can vary with the type and length of the plumbing system lead­
ing to the office. After the incoming public water system lines 
are flushed, dental unit waterlines should be disinfected accord­
ing to the manufacturer’s instructions (346). 
Special Considerations 
Dental Handpieces and Other Devices 
Attached to Air and Waterlines 
Multiple semicritical dental devices that touch mucous mem­
branes are attached to the air or waterlines of the dental unit. 
Among these devices are high- and low-speed handpieces, pro­
phylaxis angles, ultrasonic and sonic scaling tips, air abrasion 
devices, and air and water syringe tips. Although no epide­
miologic evidence implicates these instruments in disease trans­
mission (353), studies of high-speed handpieces using dye 
expulsion have confirmed the potential for retracting oral flu­
ids into internal compartments of the device (354–358). This 
determination indicates that retained patient material can be 
expelled intraorally during subsequent uses. Studies using labo­
ratory models also indicate the possibility for retention of viral 
DNA and viable virus inside both high-speed handpieces and 
prophylaxis angles (356,357,359). The potential for contami­
nation of the internal surfaces of other devices (e.g., low-speed 
handpieces and ultrasonic scalers), has not been studied, but 
restricted physical access limits their cleaning. Accordingly, any 
dental device connected to the dental air/water system that 
enters the patient’s mouth should be run to discharge water, 
air, or a combination for a minimum of 20–30 seconds after 
each patient (2). This procedure is intended to help physically 
flush out patient material that might have entered the turbine 
and air and waterlines (2,356,357). 
Heat methods can sterilize dental handpieces and other in­
traoral devices attached to air or waterlines (246,275,356, 
357,360). For processing any dental device that can be 
removed from the dental unit air or waterlines, neither surface 
disinfection nor immersion in chemical germicides is an 
acceptable method. Ethylene oxide gas cannot adequately ster­
ilize internal components of handpieces (250,275). In clinical 
evaluations of high-speed handpieces, cleaning and lubrica­
tion were the most critical factors in determining performance 
and durability (361–363). Manufacturer’s instructions for 
cleaning, lubrication, and sterilization should be followed 
closely to ensure both the effectiveness of the process and the 
longevity of handpieces. 
Some components of dental instruments are permanently 
attached to dental unit waterlines and although they do not 
enter the patient’s oral cavity, they are likely to become con­
taminated with oral fluids during treatment procedures. Such 
components (e.g., handles or dental unit attachments of saliva 
ejectors, high-speed air evacuators, and air/water syringes) 
should be covered with impervious barriers that are changed 
after each use. If the item becomes visibly contaminated dur­
ing use, DHCP should clean and disinfect with an EPA­
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registered hospital disinfectant (intermediate-level) before use 
on the next patient. 
Saliva Ejectors
 Backflow from low-volume saliva ejectors occurs when the 
pressure in the patient’s mouth is less than that in the evacua­
tor. Studies have reported that backflow in low-volume suc­
tion lines can occur and microorganisms be present in the lines 
retracted into the patient’s mouth when a seal around the 
saliva ejector is created (e.g., by a patient closing lips around 
the tip of the ejector, creating a partial vacuum) (364–366). 
This backflow can be a potential source of cross-contamina­
tion; occurrence is variable because the quality of the seal 
formed varies between patients. Furthermore, studies have dem­
onstrated that gravity pulls fluid back toward the patient’s 
mouth whenever a length of the suction tubing holding the 
tip is positioned above the patient’s mouth, or during simulta­
neous use of other evacuation (high-volume) equipment (364– 
366). Although no adverse health effects associated with the 
saliva ejector have been reported, practitioners should be aware 
that in certain situations, backflow could occur when using a 
saliva ejector. 
Dental Radiology 
When taking radiographs, the potential to cross-contami­
nate equipment and environmental surfaces with blood or 
saliva is high if aseptic technique is not practiced. Gloves should 
be worn when taking radiographs and handling contaminated 
film packets. Other PPE (e.g., mask, protective eyewear, and 
gowns) should be used if spattering of blood or other body 
fluids is likely (11,13,367). Heat-tolerant versions of intraoral 
radiograph accessories are available and these semicritical items 
(e.g., film-holding and positioning devices) should be heat-
sterilized before patient use. 
After exposure of the radiograph and before glove removal, 
the film should be dried with disposable gauze or a paper towel 
to remove blood or excess saliva and placed in a container (e.g., 
disposable cup) for transport to the developing area. Alterna­
tively, if FDA-cleared film barrier pouches are used, the film 
packets should be carefully removed from the pouch to avoid 
contamination of the outside film packet and placed in the 
clean container for transport to the developing area. 
Various methods have been recommended for aseptic trans­
port of exposed films to the developing area, and for removing 
the outer film packet before exposing and developing the film. 
Other information regarding dental radiography infection 
control is available (260,367,368). However, care should be 
taken to avoid contamination of the developing equipment. 
Protective barriers should be used, or any surfaces that 
become contaminated should be cleaned and disinfected with 
an EPA-registered hospital disinfectant of low- (i.e., HIV and 
HBV claim) to intermediate-level (i.e., tuberculocidal claim) 
activity. Radiography equipment (e.g., radiograph tubehead 
and control panel) should be protected with surface barriers 
that are changed after each patient. If barriers are not used, 
equipment that has come into contact with DHCP’s gloved 
hands or contaminated film packets should be cleaned and 
then disinfected after each patient use. 
Digital radiography sensors and other high-technology 
instruments (e.g., intraoral camera, electronic periodontal 
probe, occlusal analyzers, and lasers) come into contact with 
mucous membranes and are considered semicritical devices. 
They should be cleaned and ideally heat-sterilized or high-
level disinfected between patients. However, these items vary 
by manufacturer or type of device in their ability to be steril­
ized or high-level disinfected. Semicritical items that cannot 
be reprocessed by heat sterilization or high-level disinfection 
should, at a minimum, be barrier protected by using an FDA-
cleared barrier to reduce gross contamination during use. Use 
of a barrier does not always protect from contamination (369– 
374). One study determined that a brand of commercially 
available plastic barriers used to protect dental digital radiog­
raphy sensors failed at a substantial rate (44%). This rate 
dropped to 6% when latex finger cots were used in conjunc­
tion with the plastic barrier (375). To minimize the potential 
for device-associated infections, after removing the barrier, the 
device should be cleaned and disinfected with an EPA-
registered hospital disinfectant (intermediate-level) after each 
patient. Manufacturers should be consulted regarding appro­
priate barrier and disinfection/sterilization procedures for digi­
tal radiography sensors, other high-technology intraoral devices, 
and computer components. 
Aseptic Technique for Parenteral 
Medications 
Safe handling of parenteral medications and fluid infusion 
systems is required to prevent health-care–associated infections 
among patients undergoing conscious sedation. Parenteral 
medications can be packaged in single-dose ampules, vials or 
prefilled syringes, usually without bacteriostatic/preservative 
agents, and intended for use on a single patient. Multidose 
vials, used for more than one patient, can have a preservative, 
but both types of containers of medication should be handled 
with aseptic techniques to prevent contamination. 
Single-dose vials should be used for parenteral medications 
whenever possible (376,377). Single-dose vials might pose a 
risk for contamination if they are punctured repeatedly. The 
leftover contents of a single-dose vial should be discarded and 
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never combined with medications for use on another patient 
(376,377). Medication from a single-dose syringe should not 
be administered to multiple patients, even if the needle on the 
syringe is changed (378). 
The overall risk for extrinsic contamination of multidose 
vials is probably minimal, although the consequences of con­
tamination might result in life-threatening infection (379). If 
necessary to use a multidose vial, its access diaphragm should 
be cleansed with 70% alcohol before inserting a sterile device 
into the vial (380,381). A multidose vial should be discarded 
if sterility is compromised (380,381). 
Medication vials, syringes, or supplies should not be carried 
in uniform or clothing pockets. If trays are used to deliver 
medications to individual patients, they should be cleaned 
between patients. To further reduce the chance of contamina­
tion, all medication vials should be restricted to a centralized 
medication preparation area separate from the treatment area 
(382). 
All fluid infusion and administration sets (e.g., IV bags, tub­
ing, and connections) are single-patient use because sterility 
cannot be guaranteed when an infusion or administration set 
is used on multiple patients. Aseptic technique should be used 
when preparing IV infusion and administration sets, and 
entry into or breaks in the tubing should be minimized (378). 
Single-Use or Disposable Devices 
A single-use device, also called a disposable device, is 
designed to be used on one patient and then discarded, not 
reprocessed for use on another patient (e.g., cleaned, disin­
fected, or sterilized) (383). Single-use devices in dentistry are 
usually not heat-tolerant and cannot be reliably cleaned. 
Examples include syringe needles, prophylaxis cups and 
brushes, and plastic orthodontic brackets. Certain items (e.g., 
prophylaxis angles, saliva ejectors, high-volume evacuator tips, 
and air/water syringe tips) are commonly available in a dispos­
able form and should be disposed of appropriately after each 
use. Single-use devices and items (e.g., cotton rolls, gauze, and 
irrigating syringes) for use during oral surgical procedures 
should be sterile at the time of use. 
Because of the physical construction of certain devices (e.g., 
burs, endodontic files, and broaches) cleaning can be difficult. 
In addition, deterioration can occur on the cutting surfaces of 
some carbide/diamond burs and endodontic files during pro­
cessing (384) and after repeated processing cycles, leading to 
potential breakage during patient treatment (385–388). These 
factors, coupled with the knowledge that burs and endodon­
tic instruments exhibit signs of wear during normal use, might 
make it practical to consider them as single-use devices. 
Preprocedural Mouth Rinses 
Antimicrobial mouth rinses used by patients before a dental 
procedure are intended to reduce the number of microorgan­
isms the patient might release in the form of aerosols or spat­
ter that subsequently can contaminate DHCP and equipment 
operatory surfaces. In addition, preprocedural rinsing can 
decrease the number of microorganisms introduced in the 
patient’s bloodstream during invasive dental procedures 
(389,390). 
No scientific evidence indicates that preprocedural mouth 
rinsing prevents clinical infections among DHCP or patients, 
but studies have demonstrated that a preprocedural rinse with 
an antimicrobial product (e.g., chlorhexidine gluconate, 
essential oils, or povidone-iodine) can reduce the level of oral 
microorganisms in aerosols and spatter generated during rou­
tine dental procedures with rotary instruments (e.g., dental 
handpieces or ultrasonic scalers) (391–399). Preprocedural 
mouth rinses can be most beneficial before a procedure that 
requires using a prophylaxis cup or ultrasonic scaler because 
rubber dams cannot be used to minimize aerosol and spatter 
generation and, unless the provider has an assistant, high-
volume evacuation is not commonly used (173). 
The science is unclear concerning the incidence and nature 
of bacteremias from oral procedures, the relationship of these 
bacteremias to disease, and the preventive benefit of antimi­
crobial rinses. In limited studies, no substantial benefit has 
been demonstrated for mouth rinsing in terms of reducing 
oral microorganisms in dental-induced bacteremias (400,401). 
However, the American Heart Association’s recommendations 
regarding preventing bacterial endocarditis during dental pro­
cedures (402) provide limited support concerning 
preprocedural mouth rinsing with an antimicrobial as an 
adjunct for patients at risk for bacterial endocarditis. Insuffi­
cient data exist to recommend preprocedural mouth rinses to 
prevent clinical infections among patients or DHCP. 
Oral Surgical Procedures 
The oral cavity is colonized with numerous microorganisms. 
Oral surgical procedures present an opportunity for entry of 
microorganisms (i.e., exogenous and endogenous) into the 
vascular system and other normally sterile areas of the oral 
cavity (e.g., bone or subcutaneous tissue); therefore, an 
increased potential exists for localized or systemic infection. 
Oral surgical procedures involve the incision, excision, or 
reflection of tissue that exposes the normally sterile areas of 
the oral cavity. Examples include biopsy, periodontal surgery, 
apical surgery, implant surgery, and surgical extractions of teeth 
(e.g., removal of erupted or nonerupted tooth requiring eleva­
tion of mucoperiosteal flap, removal of bone or section of tooth, 
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and suturing if needed) (see Hand Hygiene, PPE, Single Use 
or Disposable Devices, and Dental Unit Water Quality). 
Handling of Biopsy Specimens 
To protect persons handling and transporting biopsy speci­
mens, each specimen must be placed in a sturdy, leakproof 
container with a secure lid for transportation (13). Care should 
be taken when collecting the specimen to avoid contaminat­
ing the outside of the container. If the outside of the container 
becomes visibly contaminated, it should be cleaned and disin­
fected or placed in an impervious bag (2,13). The container 
must be labeled with the biohazard symbol during storage, 
transport, shipment, and disposal (13,14). 
Handling of Extracted Teeth 
Disposal 
Extracted teeth that are being discarded are subject to the 
containerization and labeling provisions outlined by OSHA’s 
bloodborne pathogens standard (13). OSHA considers 
extracted teeth to be potentially infectious material that should 
be disposed in medical waste containers. Extracted teeth sent 
to a dental laboratory for shade or size comparisons should be 
cleaned, surface-disinfected with an EPA-registered hospital 
disinfectant with intermediate-level activity (i.e., tuberculocidal 
claim), and transported in a manner consistent with OSHA 
regulations. However, extracted teeth can be returned to 
patients on request, at which time provisions of the standard 
no longer apply (14). Extracted teeth containing dental amal­
gam should not be placed in a medical waste container that 
uses incineration for final disposal. Commercial metal-
recycling companies also might accept extracted teeth with 
metal restorations, including amalgam. State and local regula­
tions should be consulted regarding disposal of the amalgam. 
Educational Settings 
Extracted teeth are occasionally collected for use in preclini­
cal educational training. These teeth should be cleaned of vis­
ible blood and gross debris and maintained in a hydrated state 
in a well-constructed closed container during transport. The 
container should be labeled with the biohazard symbol (13,14). 
Because these teeth will be autoclaved before clinical exercises 
or study, use of the most economical storage solution (e.g., 
water or saline) might be practical. Liquid chemical germi­
cides can also be used but do not reliably disinfect both exter­
nal surface and interior pulp tissue (403,404). 
Before being used in an educational setting, the teeth should 
be heat-sterilized to allow safe handling. Microbial growth can 
be eliminated by using an autoclave cycle for 40 minutes (405), 
but because preclinical educational exercises simulate clinical 
experiences, students enrolled in dental programs should still 
follow standard precautions. Autoclaving teeth for preclinical 
laboratory exercises does not appear to alter their physical prop­
erties sufficiently to compromise the learning experience 
(405,406). However, whether autoclave sterilization of 
extracted teeth affects dentinal structure to the point that the 
chemical and microchemical relationship between dental 
materials and the dentin would be affected for research pur­
poses on dental materials is unknown (406). 
Use of teeth that do not contain amalgam is preferred in 
educational settings because they can be safely autoclaved 
(403,405). Extracted teeth containing amalgam restorations 
should not be heat-sterilized because of the potential health 
hazard from mercury vaporization and exposure. If extracted 
teeth containing amalgam restorations are to be used, immer­
sion in 10% formalin solution for 2 weeks should be effective 
in disinfecting both the internal and external structures of the 
teeth (403). If using formalin, manufacturer MSDS should be 
reviewed for occupational safety and health concerns and to 
ensure compliance with OSHA regulations (15). 
Dental Laboratory 
Dental prostheses, appliances, and items used in their fabri­
cation (e.g., impressions, occlusal rims, and bite registrations) 
are potential sources for cross-contamination and should be 
handled in a manner that prevents exposure of DHCP, patients, 
or the office environment to infectious agents. Effective com­
munication and coordination between the laboratory and den­
tal practice will ensure that appropriate cleaning and 
disinfection procedures are performed in the dental office or 
laboratory, materials are not damaged or distorted because of 
disinfectant overexposure, and effective disinfection procedures 
are not unnecessarily duplicated (407,408). 
When a laboratory case is sent off-site, DHCP should pro­
vide written information regarding the methods (e.g., type of 
disinfectant and exposure time) used to clean and disinfect 
the material (e.g., impression, stone model, or appliance) 
(2,407,409). Clinical materials that are not decontaminated 
are subject to OSHA and U.S. Department of Transportation 
regulations regarding transportation and shipping of infectious 
materials (13,410). 
Appliances and prostheses delivered to the patient should 
be free of contamination. Communication between the labo­
ratory and the dental practice is also key at this stage to deter­
mine which one is responsible for the final disinfection process. 
If the dental laboratory staff provides the disinfection, an EPA-
registered hospital disinfectant (low to intermediate) should 
be used, written documentation of the disinfection method 
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provided, and the item placed in a tamper-evident container 
before returning it to the dental office. If such documentation 
is not provided, the dental office is responsible for final disin­
fection procedures. 
Dental prostheses or impressions brought into the labora­
tory can be contaminated with bacteria, viruses, and fungi 
(411,412). Dental prostheses, impressions, orthodontic 
appliances, and other prosthodontic materials (e.g., occlusal 
rims, temporary prostheses, bite registrations, or extracted 
teeth) should be thoroughly cleaned (i.e., blood and bioburden 
removed), disinfected with an EPA-registered hospital disin­
fectant with a tuberculocidal claim, and thoroughly rinsed 
before being handled in the in-office laboratory or sent to an 
off-site laboratory (2,244,249,407). The best time to clean 
and disinfect impressions, prostheses, or appliances is as soon 
as possible after removal from the patient’s mouth before dry­
ing of blood or other bioburden can occur. Specific guidance 
regarding cleaning and disinfecting techniques for various 
materials is available (260,413–416). DHCP are advised to 
consult with manufacturers regarding the stability of specific 
materials during disinfection. 
In the laboratory, a separate receiving and disinfecting area 
should be established to reduce contamination in the produc­
tion area. Bringing untreated items into the laboratory increases 
chances for cross infection (260). If no communication has 
been received regarding prior cleaning and disinfection of a 
material, the dental laboratory staff should perform cleaning 
and disinfection procedures before handling. If during 
manipulation of a material or appliance a previously undetec­
ted area of blood or bioburden becomes apparent, cleaning 
and disinfection procedures should be repeated. Transfer of 
oral microorganisms into and onto impressions has been docu­
mented (417–419). Movement of these organisms onto den­
tal casts has also been demonstrated (420). Certain microbes 
have been demonstrated to remain viable within gypsum cast 
materials for <7 days (421). Incorrect handling of contami­
nated impressions, prostheses, or appliances, therefore, offers 
an opportunity for transmission of microorganisms (260). 
Whether in the office or laboratory, PPE should be worn until 
disinfection is completed (1,2,7,10,13). 
If laboratory items (e.g., burs, polishing points, rag wheels, or 
laboratory knives) are used on contaminated or potentially con­
taminated appliances, prostheses, or other material, they should 
be heat-sterilized, disinfected between patients, or discarded (i.e., 
disposable items should be used) (260,407). Heat-tolerant items 
used in the mouth (e.g., metal impression tray or face bow fork) 
should be heat-sterilized before being used on another patient 
(2,407). Items that do not normally contact the patient, pros­
thetic device, or appliance but frequently become contaminated 
and cannot withstand heat-sterilization (e.g., articulators, case 
pans, or lathes) should be cleaned and disinfected between 
patients and according to the manufacturer’s instructions. Pres­
sure pots and water baths are particularly susceptible to con­
tamination with microorganisms and should be cleaned and 
disinfected between patients (422). In the majority of instances, 
these items can be cleaned and disinfected with an EPA-
registered hospital disinfectant. Environmental surfaces should 
be barrier-protected or cleaned and disinfected in the same man­
ner as in the dental treatment area. 
Unless waste generated in the dental laboratory (e.g., dis­
posable trays or impression materials) falls under the category 
of regulated medical waste, it can be discarded with general 
waste. Personnel should dispose of sharp items (e.g., burs, dis­
posable blades, and orthodontic wires) in puncture-resistant 
containers. 
Laser/Electrosurgery Plumes 
or Surgical Smoke 
During surgical procedures that use a laser or electrosurgical 
unit, the thermal destruction of tissue creates a smoke 
byproduct. Laser plumes or surgical smoke represent another 
potential risk for DHCP (423–425). Lasers transfer electro­
magnetic energy into tissues, resulting in the release of a heated 
plume that includes particles, gases (e.g., hydrogen cyanide, 
benzene, and formaldehyde), tissue debris, viruses, and offen­
sive odors. One concern is that aerosolized infectious material 
in the laser plume might reach the nasal mucosa of the laser 
operator and adjacent DHCP. Although certain viruses (e.g., 
varicella-zoster virus and herpes simplex virus) appear not to 
aerosolize efficiently (426,427), other viruses and various bac­
teria (e.g., human papilloma virus, HIV, coagulase-negative 
Staphylococcus, Corynebacterium species, and Neisseria species) 
have been detected in laser plumes (428–434). However, the 
presence of an infectious agent in a laser plume might not be 
sufficient to cause disease from airborne exposure, especially if 
the agent’s normal mode of transmission is not airborne. No 
evidence indicates that HIV or HBV have been transmitted 
through aerosolization and inhalation (435). Although con­
tinuing studies are needed to evaluate the risk for DHCP of 
laser plumes and electrosurgery smoke, following NIOSH rec­
ommendations (425) and practices developed by the Associa­
tion of periOperative Registered Nurses (AORN) might be 
practical (436). These practices include using 1) standard pre­
cautions (e.g., high-filtration surgical masks and possibly full 
face shields) (437); 2) central room suction units with in-line 
filters to collect particulate matter from minimal plumes; and 
3) dedicated mechanical smoke exhaust systems with a high-
efficiency filter to remove substantial amounts of laser plume 
particles. Local smoke evacuation systems have been recom­
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mended by consensus organizations, and these systems can 
improve the quality of the operating field. Employers should 
be aware of this emerging problem and advise employees of 
the potential hazards of laser smoke (438). However, this con­
cern remains unresolved in dental practice and no recommen­
dation is provided here. 
M. tuberculosis 
Patients infected with M. tuberculosis occasionally seek 
urgent dental treatment at outpatient dental settings. Under­
standing the pathogenesis of the development of TB will help 
DHCP determine how to manage such patients. 
M. tuberculosis is a bacterium carried in airborne infective 
droplet nuclei that can be generated when persons with pul­
monary or laryngeal TB sneeze, cough, speak, or sing (439). 
These small particles (1–5 µm) can stay suspended in the air 
for hours (440). Infection occurs when a susceptible person 
inhales droplet nuclei containing M. tuberculosis, which then 
travel to the alveoli of the lungs. Usually within 2–12 weeks 
after initial infection with M. tuberculosis, immune response 
prevents further spread of the TB bacteria, although they can 
remain alive in the lungs for years, a condition termed latent 
TB infection. Persons with latent TB infection usually exhibit 
a reactive tuberculin skin test (TST), have no symptoms of 
active disease, and are not infectious. However, they can 
develop active disease later in life if they do not receive treat­
ment for their latent infection. 
Approximately 5% of persons who have been recently 
infected and not treated for latent TB infection will progress 
from infection to active disease during the first 1–2 years after 
infection; another 5% will develop active disease later in life. 
Thus, approximately 90% of U.S. persons with latent TB 
infection do not progress to active TB disease. Although both 
latent TB infection and active TB disease are described as TB, 
only the person with active disease is contagious and presents 
a risk of transmission. Symptoms of active TB disease include 
a productive cough, night sweats, fatigue, malaise, fever, and 
unexplained weight loss. Certain immunocompromising medi­
cal conditions (e.g., HIV) increase the risk that TB infection 
will progress to active disease at a faster rate (441). 
Overall, the risk borne by DHCP for exposure to a patient 
with active TB disease is probably low (20,21). Only one report 
exists of TB transmission in a dental office (442), and TST con­
versions among DHCP are also low (443,444). However, in 
certain cases, DHCP or the community served by the dental 
facility might be at relatively high risk for exposure to TB. 
Surgical masks do not prevent inhalation of M. tuberculosis 
droplet nuclei, and therefore, standard precautions are not 
sufficient to prevent transmission of this organism. Recom­
mendations for expanded precautions to prevent transmission 
of M. tuberculosis and other organisms that can be spread by 
airborne, droplet, or contact routes have been detailed in other 
guidelines (5,11,20). 
TB transmission is controlled through a hierarchy of mea­
sures, including administrative controls, environmental con­
trols, and personal respiratory protection. The main 
administrative goals of a TB infection-control program are early 
detection of a person with active TB disease and prompt isola­
tion from susceptible persons to reduce the risk of transmis­
sion. Although DHCP are not responsible for diagnosis and 
treatment of TB, they should be trained to recognize signs and 
symptoms to help with prompt detection. Because potential 
for transmission of M. tuberculosis exists in outpatient settings, 
dental practices should develop a TB control program appro­
priate for their level of risk (20,21). 
•	 A community risk assessment should be conducted peri­
odically, and TB infection-control policies for each dental 
setting should be based on the risk assessment. The poli­
cies should include provisions for detection and referral 
of patients who might have undiagnosed active TB; man­
agement of patients with active TB who require urgent 
dental care; and DHCP education, counseling, and TST 
screening. 
•	 DHCP who have contact with patients should have a 
baseline TST, preferably by using a two-step test at the 
beginning of employment. The facility’s level of TB risk 
will determine the need for routine follow-up TST. 
•	 While taking patients’ initial medical histories and at 
periodic updates, dental DHCP should routinely ask all 
patients whether they have a history of TB disease or symp­
toms indicative of TB. 
•	 Patients with a medical history or symptoms indicative of 
undiagnosed active TB should be referred promptly for 
medical evaluation to determine possible infectiousness. 
Such patients should not remain in the dental-care facil­
ity any longer than required to evaluate their dental con­
dition and arrange a referral. While in the dental 
health-care facility, the patient should be isolated from 
other patients and DHCP, wear a surgical mask when not 
being evaluated, or be instructed to cover their mouth and 
nose when coughing or sneezing. 
•	 Elective dental treatment should be deferred until a phy­
sician confirms that a patient does not have infectious TB, 
or if the patient is diagnosed with active TB disease, until 
confirmed the patient is no longer infectious. 
•	 If urgent dental care is provided for a patient who has, or 
is suspected of having active TB disease, the care should 
be provided in a facility (e.g., hospital) that provides air­
borne infection isolation (i.e., using such engineering con­
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trols as TB isolation rooms, negatively pressured relative 
to the corridors, with air either exhausted to the outside 
or HEPA-filtered if recirculation is necessary). Standard 
surgical face masks do not protect against TB transmis­
sion; DHCP should use respiratory protection (e.g., fit-
tested, disposable N-95 respirators). 
•	 Settings that do not require use of respiratory protection 
because they do not treat active TB patients and do not 
perform cough-inducing procedures on potential active 
TB patients do not need to develop a written respiratory 
protection program. 
•	 Any DHCP with a persistent cough (i.e., lasting >3 weeks), 
especially in the presence of other signs or symptoms com­
patible with active TB (e.g., weight loss, night sweats, 
fatigue, bloody sputum, anorexia, or fever), should be 
evaluated promptly. The DHCP should not return to the 
workplace until a diagnosis of TB has been excluded or 
the DHCP is on therapy and a physician has determined 
that the DHCP is noninfectious. 
Creutzfeldt-Jakob Disease and Other 
Prion Diseases
 Creutzfeldt-Jakob disease (CJD) belongs to a group of rap­
idly progressive, invariably fatal, degenerative neurological dis­
orders, transmissible spongiform encephalopathies (TSEs) that 
affect both humans and animals and are thought to be caused 
by infection with an unusual pathogen called a prion. Prions 
are isoforms of a normal protein, capable of self-propagation 
although they lack nucleic acid. Prion diseases have an incu­
bation period of years and are usually fatal within 1 year of 
diagnosis. 
Among humans, TSEs include CJD, Gerstmann-Straussler-
Scheinker syndrome, fatal familial insomnia, kuru, and vari­
ant CJD (vCJD). Occurring in sporadic, familial, and acquired 
(i.e., iatrogenic) forms, CJD has an annual incidence in the 
United States and other countries of approximately 1 case/ 
million population (445–448). In approximately 85% of 
affected patients, CJD occurs as a sporadic disease with no 
recognizable pattern of transmission. A smaller proportion of 
patients (5%–15%) experience familial CJD because of inher­
ited mutations of the prion protein gene (448). 
vCJD is distinguishable clinically and neuropathologically 
from classic CJD, and strong epidemiologic and laboratory 
evidence indicates a causal relationship with bovine spongiform 
encephalopathy (BSE), a progressive neurological disorder of 
cattle commonly known as mad cow disease (449–451). vCJD, 
was reported first in the United Kingdom in 1996 (449) and 
subsequently in other European countries (452). Only one 
case of vCJD has been reported in the United States, in an 
immigrant from the United Kingdom (453). Compared with 
CJD patients, those with vCJD are younger (28 years versus 
68 years median age at death), and have a longer duration of 
illness (13 months versus 4.5 months). Also, vCJD patients 
characteristically exhibit sensory and psychiatric symptoms that 
are uncommon with CJD. Another difference includes the ease 
with which the presence of prions is consistently demonstrated 
in lymphoreticular tissues (e.g., tonsil) in vCJD patients by 
immunohistochemistry (454). 
CJD and vCJD are transmissible diseases, but not through 
the air or casual contact. All known cases of iatrogenic CJD 
have resulted from exposure to infected central nervous tissue 
(e.g., brain and dura mater), pituitary, or eye tissue. Studies in 
experimental animals have determined that other tissues have 
low or no detectable infectivity (243,455,456). Limited 
experimental studies have demonstrated that scrapie (a TSE in 
sheep) can be transmitted to healthy hamsters and mice by 
exposing oral tissues to infectious homogenate (457,458). 
These animal models and experimental designs might not be 
directly applicable to human transmission and clinical den­
tistry, but they indicate a theoretical risk of transmitting prion 
diseases through perioral exposures. 
According to published reports, iatrogenic transmission of 
CJD has occurred in humans under three circumstances: after 
use of contaminated electroencephalography depth electrodes 
and neurosurgical equipment (459); after use of extracted 
pituitary hormones (460,461); and after implant of contami­
nated corneal (462) and dura mater grafts (463,464) from 
humans. The equipment-related cases occurred before the rou­
tine implementation of sterilization procedures used in health-
care facilities. 
Case-control studies have found no evidence that dental 
procedures increase the risk of iatrogenic transmission of TSEs 
among humans. In these studies, CJD transmission was not 
associated with dental procedures (e.g., root canals or extrac­
tions), with convincing evidence of prion detection in human 
blood, saliva, or oral tissues, or with DHCP becoming occu­
pationally infected with CJD (465–467). In 2000, prions were 
not found in the dental pulps of eight patients with 
neuropathologically confirmed sporadic CJD by using elec­
trophoresis and a Western blot technique (468). 
Prions exhibit unusual resistance to conventional chemical 
and physical decontamination procedures. Considering this 
resistance and the invariably fatal outcome of CJD, procedures 
for disinfecting and sterilizing instruments potentially con­
taminated with the CJD prion have been controversial for years. 
Scientific data indicate the risk, if any, of sporadic CJD trans­
mission during dental and oral surgical procedures is low to 
nil. Until additional information exists regarding the trans­
missibility of CJD or vCJD, special precautions in addition to 
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standard precautions might be indicated when treating known 
CJD or vCJD patients; the following list of precautions is pro­
vided for consideration without recommendation 
(243,249,277,469): 
•	 Use single-use disposable items and equipment whenever 
possible. 
•	 Consider items difficult to clean (e.g., endodontic files, 
broaches, and carbide and diamond burs) as single-use 
disposables and discard after one use. 
•	 To minimize drying of tissues and body fluids on a device, 
keep the instrument moist until cleaned and decontaminated. 
• Clean instruments thoroughly and steam-autoclave at 134ºC 
for 18 minutes. This is the least stringent of sterilization 
methods offered by the World Health Organization. The 
complete list (469) is available at http://www.who.int/emc­
documents/tse/whocdscsraph2003c.html. 
•	 Do not use flash sterilization for processing instruments 
or devices. 
Potential infectivity of oral tissues in CJD or vCJD patients is 
an unresolved concern. CDC maintains an active surveillance 
program on CJD. Additional information and resources are 
available at http://www.cdc.gov/ncidod/diseases/cjd/cjd.htm. 
Program Evaluation 
The goal of a dental infection-control program is to provide 
a safe working environment that will reduce the risk of health-
care–associated infections among patients and occupational 
exposures among DHCP. Medical errors are caused by faulty 
systems, processes, and conditions that lead persons to make 
mistakes or fail to prevent errors being made by others (470). 
Effective program evaluation is a systematic way to ensure pro­
cedures are useful, feasible, ethical, and accurate. Program evalu­
ation is an essential organizational practice; however, such 
evaluation is not practiced consistently across program areas, 
nor is it sufficiently well-integrated into the day-to-day man­
agement of the majority of programs (471). 
A successful infection-control program depends on develop­
ing standard operating procedures, evaluating practices, routinely 
documenting adverse outcomes (e.g., occupational exposures 
to blood) and work-related illnesses in DHCP, and monitoring 
health-care–associated infections in patients. Strategies and tools 
to evaluate the infection-control program can include periodic 
observational assessments, checklists to document procedures, 
and routine review of occupational exposures to bloodborne 
pathogens. Evaluation offers an opportunity to improve the 
effectiveness of both the infection-control program and dental-
practice protocols. If deficiencies or problems in the implemen­
tation of infection-control procedures are identified, further 
evaluation is needed to eliminate the problems. Examples of 
infection-control program evaluation activities are provided 
(Table 5). 
TABLE 5. Examples of methods for evaluating infection-control programs 
Program element	 Evaluation activity 
Appropriate immunization of dental health-care personnel (DHCP). 
Assessment of occupational exposures to infectious agents. 
Comprehensive postexposure management plan and medical follow-up program 
after occupational exposures to infectious agents. 
Adherence to hand hygiene before and after patient care. 
Proper use of personal protective equipment to prevent occupational exposures to 
infectious agents.

Routine and appropriate sterilization of instruments using a biologic monitoring

system.

Evaluation and implementation of safer medical devices.

Compliance of water in routine dental procedures with current drinking U.S. 
Environmental Protection Agency water standards (fewer than 500 CFU of 
heterotrophic water bacteria). 
Proper handling and disposal of medical waste. 
Health-care–associated infections. 
Conduct annual review of personnel records to ensure up-to-date immunizations. 
Report occupational exposures to infectious agents. Document the steps that 
occurred around the exposure and plan how such exposure can be prevented in 
the future. 
Ensure the postexposure management plan is clear, complete, and available at all 
times to all DHCP. All staff should understand the plan, which should include toll-
free phone numbers for access to additional information. 
Observe and document circumstances of appropriate or inappropriate 
handwashing. Review findings in a staff meeting. 
Observe and document the use of barrier precautions and careful handling of 
sharps. Review findings in a staff meeting. 
Monitor paper log of steam cycle and temperature strip with each sterilization load, 
and examine results of weekly biologic monitoring. Take appropriate action when 
failure of sterilization process is noted. 
Conduct an annual review of the exposure control plan and consider new 
developments in safer medical devices. 
Monitor dental water quality as recommended by the equipment manufacturer, 
using commercial self-contained test kits, or commercial water-testing laboratories. 
Observe the safe disposal of regulated and nonregulated medical waste and take 
preventive measures if hazardous situations occur. 
Assess the unscheduled return of patients after procedures and evaluate them for 
an infectious process. A trend might require formal evaluation. 
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Infection-Control Research 
Considerations 
Although the number of published studies concerning den­
tal infection control has increased in recent years, questions 
regarding infection-control practices and their effectiveness 
remain unanswered. Multiple concerns were identified by the 
working group for this report, as well as by others during the 
BOX. Dental infection-control research considerations 
public comment period (Box). This list is not exhaustive and 
does not represent a CDC research agenda, but rather is an 
effort to identify certain concerns, stimulate discussion, and 
provide direction for determining future action by clinical, 
basic science, and epidemiologic investigators, as well as health 
and professional organizations, clinicians, and policy makers. 
Education and promotion 
•	 Design strategies to communicate, to the public and providers, the risk of disease transmission in dentistry. 
•	 Promote use of protocols for recommended postexposure management and follow-up. 
•	 Educate and train dental health-care personnel (DHCP) to screen and evaluate safer dental devices by using tested design 
and performance criteria. 
Laboratory-based research 
•	 Develop animal models to determine the risk of transmitting organisms through inhalation of contaminated aerosols (e.g., 
influenza) produced from rotary dental instruments. 
•	 Conduct studies to determine the effectiveness of gloves (i.e., material compatibility and duration of use). 
•	 Develop devices with passive safety features to prevent percutaneous injuries. 
•	 Study the effect of alcohol-based hand-hygiene products on retention of latex proteins and other dental allergens (e.g., 
methylmethacrylate, glutaraldehyde, thiurams) on the hands of DHCP after latex glove use. 
•	 Investigate the applicability of other types of sterilization procedures (e.g., hydrogen peroxide gas plasma) in dentistry. 
•	 Encourage manufacturers to determine optimal methods and frequency for testing dental-unit waterlines and maintaining 
dental-unit water-quality standards. 
•	 Determine the potential for internal contamination of low-speed handpieces, including the motor, and other devices con­
nected to dental air and water supplies, as well as more efficient ways to clean, lubricate, and sterilize handpieces and other 
devices attached to air or waterlines. 
•	 Investigate the infectivity of oral tissues in Creutzfeldt-Jakob disease (CJD) or variant CJD patients. 
•	 Determine the most effective methods to disinfect dental impression materials. 
•	 Investigate the viability of pathogenic organisms on dental materials (e.g., impression materials, acrylic resin, or gypsum 
materials) and dental laboratory equipment. 
•	 Determine the most effective methods for sterilization or disinfection of digital radiology equipment. 
•	 Evaluate the effects of repetitive reprocessing cycles on burs and endodontic files. 
•	 Investigate the potential infectivity of vapors generated from the various lasers used for oral procedures. 
Clinical and population-based epidemiologic research and development 
•	 Continue to characterize the epidemiology of blood contacts, particularly percutaneous injuries, and the effectiveness of 
prevention measures. 
•	 Further assess the effectiveness of double gloving in preventing blood contact during routine and surgical dental procedures. 
•	 Continue to assess the stress placed on gloves during dental procedures and the potential for developing defects during 
different procedures. 
•	 Develop methods for evaluating the effectiveness and cost-effectiveness of infection-control interventions. 
•	 Determine how infection-control guidelines affect the knowledge, attitudes, and practices of DHCP. 
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Recommendations 
Each recommendation is categorized on the basis of existing 
scientific data, theoretical rationale, and applicability. Rankings 
are based on the system used by CDC and the Healthcare 
Infection Control Practices Advisory Committee (HICPAC) 
to categorize recommendations: 
Category IA. Strongly recommended for implementation 
and strongly supported by well-designed experimental, clini­
cal, or epidemiologic studies. 
Category IB. Strongly recommended for implementation 
and supported by experimental, clinical, or epidemiologic stud­
ies and a strong theoretical rationale. 
Category IC. Required for implementation as mandated 
by federal or state regulation or standard. When IC is used, a 
second rating can be included to provide the basis of existing 
scientific data, theoretical rationale, and applicability. Because 
of state differences, the reader should not assume that the 
absence of a IC implies the absence of state regulations. 
Category II. Suggested for implementation and supported 
by suggestive clinical or epidemiologic studies or a theoretical 
rationale. 
Unresolved issue. No recommendation. Insufficient evi­
dence or no consensus regarding efficacy exists. 
I.	 Personnel Health Elements of an Infection-Control 
Program 
A. General Recommendations 
1.	 Develop a written health program for DHCP 
that includes policies, procedures, and guidelines 
for education and training; immunizations; 
exposure prevention and postexposure manage­
ment; medical conditions, work-related illness, 
and associated work restrictions; contact derma­
titis and latex hypersensitivity; and maintenance 
of records, data management, and confidential­
ity (IB) (5,16–18,22). 
2.	 Establish referral arrangements with qualified 
health-care professionals to ensure prompt and 
appropriate provision of preventive services, 
occupationally related medical services, and 
postexposure management with medical follow-
up (IB, IC) (5,13,19,22). 
B. Education and Training 
1.	 Provide DHCP 1) on initial employment, 
2) when new tasks or procedures affect the 
employee’s occupational exposure, and 3) at a 
minimum, annually, with education and train­
ing regarding occupational exposure to poten­
tially infectious agents and infection-control 
procedures/protocols appropriate for and spe­
cific to their assigned duties (IB, IC) (5,11,13, 
14,16,19,22). 
2.	 Provide educational information appropriate in 
content and vocabulary to the educational level, 
literacy, and language of DHCP (IB, IC) (5,13). 
C. Immunization Programs 
1.	 Develop a written comprehensive policy regard­
ing immunizing DHCP, including a list of all 
required and recommended immunizations (IB) 
(5,17,18). 
2.	 Refer DHCP to a prearranged qualified health-
care professional or to their own health-care pro­
fessional to receive all appropriate immunizations 
based on the latest recommendations as well as 
their medical history and risk for occupational 
exposure (IB) (5,17). 
D. Exposure Prevention and Postexposure Manage­
ment 
1.	 Develop a comprehensive postexposure manage­
ment and medical follow-up program (IB, IC) 
(5,13,14,19). 
a.	 Include policies and procedures for prompt 
reporting, evaluation, counseling, treatment, 
and medical follow-up of occupational 
exposures. 
b.	 Establish mechanisms for referral to a quali­
fied health-care professional for medical 
evaluation and follow-up. 
c.	 Conduct a baseline TST, preferably by 
using a two-step test, for all DHCP who 
might have contact with persons with sus­
pected or confirmed infectious TB, regard­
less of the risk classification of the setting 
(IB) (20). 
E.	 Medical Conditions, Work-Related Illness, and 
Work Restrictions 
1.	 Develop and have readily available to all DHCP 
comprehensive written policies regarding work 
restriction and exclusion that include a statement 
of authority defining who can implement such 
policies (IB) (5,22). 
2.	 Develop policies for work restriction and exclu­
sion that encourage DHCP to seek appropriate 
preventive and curative care and report their 
illnesses, medical conditions, or treatments that 
can render them more susceptible to opportu­
nistic infection or exposures; do not penalize 
DHCP with loss of wages, benefits, or job sta­
tus (IB) (5,22). 
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3.	 Develop policies and procedures for evaluation, 
diagnosis, and management of DHCP with sus­
pected or known occupational contact dermati­
tis (IB) (32). 
4.	 Seek definitive diagnosis by a qualified health-
care professional for any DHCP with suspected 
latex allergy to carefully determine its specific 
etiology and appropriate treatment as well as 
work restrictions and accommodations (IB) (32). 
F.	 Records Maintenance, Data Management, and 
Confidentiality 
1.	 Establish and maintain confidential medical 
records (e.g., immunization records and docu­
mentation of tests received as a result of occupa­
tional exposure) for all DHCP (IB, IC) (5,13). 
2.	 Ensure that the practice complies with all appli­
cable federal, state, and local laws regarding 
medical recordkeeping and confidentiality (IC) 
(13,34). 
II.	 Preventing Transmission of Bloodborne Pathogens 
A. HBV Vaccination 
1.	 Offer the HBV vaccination series to all DHCP 
with potential occupational exposure to blood 
or other potentially infectious material (IA, IC) 
(2,13,14,19). 
2.	 Always follow U.S. Public Health Service/CDC 
recommendations for hepatitis B vaccination, 
serologic testing, follow-up, and booster dosing 
(IA, IC) (13,14,19). 
3.	 Test DHCP for anti-HBs 1–2 months after 
completion of the 3-dose vaccination series (IA, 
IC) (14,19). 
4.	 DHCP should complete a second 3-dose vac­
cine series or be evaluated to determine if they 
are HBsAg-positive if no antibody response 
occurs to the primary vaccine series (IA, IC) 
(14,19). 
5.	 Retest for anti-HBs at the completion of the sec­
ond vaccine series. If no response to the second 
3-dose series occurs, nonresponders should be 
tested for HBsAg (IC) (14,19). 
6.	 Counsel nonresponders to vaccination who are 
HBsAg-negative regarding their susceptibility to 
HBV infection and precautions to take (IA, IC) 
(14,19). 
7.	 Provide employees appropriate education regard­
ing the risks of HBV transmission and the avail­
ability of the vaccine. Employees who decline 
the vaccination should sign a declination form 
to be kept on file with the employer (IC) (13). 
B. Preventing Exposures to Blood and OPIM 
1.	 General recommendations 
a.	 Use standard precautions (OSHA’s blood-
borne pathogen standard retains the term 
universal precautions) for all patient encoun­
ters (IA, IC) (11,13,19,53). 
b.	 Consider sharp items (e.g., needles, scalers, 
burs, lab knives, and wires) that are contami­
nated with patient blood and saliva as 
potentially infective and establish engineer­
ing controls and work practices to prevent 
injuries (IB, IC) (6,13,113). 
c.	 Implement a written, comprehensive pro­
gram designed to minimize and manage 
DHCP exposures to blood and body fluids 
(IB, IC). (13,14,19,97). 
2.	 Engineering and work-practice controls 
a.	 Identify, evaluate, and select devices with 
engineered safety features at least annually 
and as they become available on the market 
(e.g., safer anesthetic syringes, blunt suture 
needle, retractable scalpel, or needleless IV 
systems) (IC) (13,97,110–112). 
b.	 Place used disposable syringes and needles, 
scalpel blades, and other sharp items in 
appropriate puncture-resistant containers 
located as close as feasible to the area in which 
the items are used (IA, IC) (2,7,13,19,113, 
115). 
c.	 Do not recap used needles by using both 
hands or any other technique that involves 
directing the point of a needle toward any 
part of the body. Do not bend, break, or 
remove needles before disposal (IA, IC) 
(2,7,8,13,97,113). 
d.	 Use either a one-handed scoop technique or 
a mechanical device designed for holding the 
needle cap when recapping needles (e.g., 
between multiple injections and before 
removing from a nondisposable aspirating 
syringe) (IA, IC) (2,7,8,13,14,113). 
3. Postexposure management and prophylaxis 
a.	 Follow CDC recommendations after percu­
taneous, mucous membrane, or nonintact 
skin exposure to blood or other potentially 
infectious material (IA, IC) (13,14,19). 
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III. Hand Hygiene 
A. General Considerations 
6. Do not wear hand or nail jewelry if it makes 
donning gloves more difficult or compromises 
1. Perform hand hygiene with either a the fit and integrity of the glove (II) (123,142, 
nonantimicrobial or antimicrobial soap and 
water when hands are visibly dirty or contami­
nated with blood or other potentially infectious 
IV. 
143). 
PPE 
A. Masks, Protective Eyewear, and Face Shields 
material. If hands are not visibly soiled, an alco­ 1. Wear a surgical mask and eye protection with 
hol-based hand rub can also be used. Follow the solid side shields or a face shield to protect 
manufacturer’s instructions (IA) (123). mucous membranes of the eyes, nose, and mouth 
2. Indications for hand hygiene include during procedures likely to generate splashing 
a. when hands are visibly soiled (IA, IC); or spattering of blood or other body fluids (IB, 
b. after barehanded touching of inanimate IC) (1,2,7,8,11,13,137). 
objects likely to be contaminated by blood, 2. Change masks between patients or during 
saliva, or respiratory secretions (IA, IC); patient treatment if the mask becomes wet (IB) 
c. before and after treating each patient (IB); (2). 
d. before donning gloves (IB); and 3. Clean with soap and water, or if visibly soiled, 
e. immediately after removing gloves (IB, IC) clean and disinfect reusable facial protective 
(7–9,11,13,113,120–123,125,126,138). equipment (e.g., clinician and patient protec­
3. For oral surgical procedures, perform surgical tive eyewear or face shields) between patients (II) 
hand antisepsis before donning sterile surgeon’s 
gloves. Follow the manufacturer’s instructions by 
(2). 
B. Protective Clothing 
using either an antimicrobial soap and water, or 1. Wear protective clothing (e.g., reusable or dis­
soap and water followed by drying hands and posable gown, laboratory coat, or uniform) that 
application of an alcohol-based surgical hand- covers personal clothing and skin (e.g., forearms) 
scrub product with persistent activity (IB) (121– likely to be soiled with blood, saliva, or OPIM 
123,127–133,144,145). (IB, IC) (7,8,11,13,137). 
4. Store liquid hand-care products in either dispos­ 2. Change protective clothing if visibly soiled (134); 
able closed containers or closed containers that change immediately or as soon as feasible if pen-
can be washed and dried before refilling. Do not etrated by blood or other potentially infectious 
add soap or lotion to (i.e., top off ) a partially fluids (IB, IC) (13). 
empty dispenser (IA) (9,120,122,149,150). 
B. Special Considerations for Hand Hygiene and 
Glove Use 
3. Remove barrier protection, including gloves, 
mask, eyewear, and gown before departing work 
area (e.g., dental patient care, instrument pro­
1. Use hand lotions to prevent skin dryness associ­
ated with handwashing (IA) (153,154). 
cessing, or laboratory areas) (IC) (13). 
C. Gloves 
2. Consider the compatibility of lotion and anti­ 1. Wear medical gloves when a potential exists for 
septic products and the effect of petroleum or contacting blood, saliva, OPIM, or mucous 
other oil emollients on the integrity of gloves membranes (IB, IC) (1,2,7,8,13). 
during product selection and glove use (IB) 2. Wear a new pair of medical gloves for each 
(2,14,122,155). patient, remove them promptly after use, and 
3. Keep fingernails short with smooth, filed edges wash hands immediately to avoid transfer of 
to allow thorough cleaning and prevent glove microorganisms to other patients or environ­
tears (II) (122,123,156). ments (IB) (1,7,8,123). 
4. Do not wear artificial fingernails or extenders 3. Remove gloves that are torn, cut, or punctured 
when having direct contact with patients at high as soon as feasible and wash hands before 
risk (e.g., those in intensive care units or operat­ regloving (IB, IC) (13,210,211). 
ing rooms) (IA) (123,157–160). 4. Do not wash surgeon’s or patient examination 
5. Use of artificial fingernails is usually not recom­ gloves before use or wash, disinfect, or sterilize 
mended (II) (157–160). gloves for reuse (IB, IC) (13,138,177,212,213). 
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5.	 Ensure that appropriate gloves in the correct size 
are readily accessible (IC) (13). 
6.	 Use appropriate gloves (e.g., puncture- and 
chemical-resistant utility gloves) when cleaning 
instruments and performing housekeeping tasks 
involving contact with blood or OPIM (IB, IC) 
(7,13,15). 
7.	 Consult with glove manufacturers regarding the 
chemical compatibility of glove material and 
dental materials used (II). 
D. Sterile Surgeon’s Gloves and Double Gloving 
During Oral Surgical Procedures 
1.	 Wear sterile surgeon’s gloves when performing 
oral surgical procedures (IB) (2,8,137). 
2.	 No recommendation is offered regarding the 
effectiveness of wearing two pairs of gloves to 
prevent disease transmission during oral surgi­
cal procedures. The majority of studies among 
HCP and DHCP have demonstrated a lower fre­
quency of inner glove perforation and visible 
blood on the surgeon’s hands when double gloves 
are worn; however, the effectiveness of wearing 
two pairs of gloves in preventing disease trans­
mission has not been demonstrated (Unresolved 
issue). 
V. Contact Dermatitis and Latex Hypersensitivity 
A. General Recommendations 
1.	 Educate DHCP regarding the signs, symptoms, 
and diagnoses of skin reactions associated with fre­
quent hand hygiene and glove use (IB) (5,31,32). 
2.	 Screen all patients for latex allergy (e.g., take 
health history and refer for medical consulta­
tion when latex allergy is suspected) (IB) (32). 
3.	 Ensure a latex-safe environment for patients and 
DHCP with latex allergy (IB) (32). 
4.	 Have emergency treatment kits with latex-free 
products available at all times (II) (32). 
VI. Sterilization and Disinfection of Patient-Care Items 
A. General Recommendations 
1.	 Use only FDA-cleared medical devices for ster­
ilization and follow the manufacturer’s instruc­
tions for correct use (IB) (248). 
2.	 Clean and heat-sterilize critical dental instru­
ments before each use (IA) (2,137,243,244, 
246,249,407). 
3.	 Clean and heat-sterilize semicritical items before 
each use (IB) (2,249,260,407). 
4.	 Allow packages to dry in the sterilizer before they 
are handled to avoid contamination (IB) (247). 
5.	 Use of heat-stable semicritical alternatives is 
encouraged (IB) (2). 
6.	 Reprocess heat-sensitive critical and semi-criti­
cal instruments by using FDA-cleared sterilant/ 
high-level disinfectants or an FDA-cleared low-
temperature sterilization method (e.g., ethylene 
oxide). Follow manufacturer’s instructions for use 
of chemical sterilants/high-level disinfectants 
(IB) (243). 
7.	 Single-use disposable instruments are acceptable 
alternatives if they are used only once and dis­
posed of correctly (IB, IC) (243,383). 
8.	 Do not use liquid chemical sterilants/high-level 
disinfectants for environmental surface disinfec­
tion or as holding solutions (IB, IC) (243,245). 
9.	 Ensure that noncritical patient-care items are 
barrier-protected or cleaned, or if visibly soiled, 
cleaned and disinfected after each use with an 
EPA-registered hospital disinfectant. If visibly 
contaminated with blood, use an EPA-registered 
hospital disinfectant with a tuberculocidal claim 
(i.e., intermediate level) (IB) (2,243,244). 
10. Inform DHCP of all OSHA guidelines for 
exposure to chemical agents used for disinfec­
tion and sterilization. Using this report, identify 
areas and tasks that have potential for exposure 
(IC) (15). 
B. Instrument Processing Area 
1.	 Designate a central processing area. Divide the 
instrument processing area, physically or, at a 
minimum, spatially, into distinct areas for 
1) receiving, cleaning, and decontamination; 
2) preparation and packaging; 3) sterilization; 
and 4) storage. Do not store instruments in an 
area where contaminated instruments are held 
or cleaned (II) (173,247,248). 
2.	 Train DHCP to employ work practices that pre­
vent contamination of clean areas (II). 
C. Receiving, Cleaning, and Decontamination Work 
Area 
1.	 Minimize handling of loose contaminated 
instruments during transport to the instrument 
processing area. Use work-practice controls (e.g., 
carry instruments in a covered container) to 
minimize exposure potential (II). Clean all vis­
ible blood and other contamination from den­
tal instruments and devices before sterilization 
or disinfection procedures (IA) (243,249–252). 
2.	 Use automated cleaning equipment (e.g., ultra­
sonic cleaner or washer-disinfector) to remove 
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debris to improve cleaning effectiveness and 7. Do not store critical instruments unwrapped (IB) 
decrease worker exposure to blood (IB) (2,253). (248). 
3. Use work-practice controls that minimize con- F. Sterilization Monitoring 
tact with sharp instruments if manual cleaning 1. Use mechanical, chemical, and biological moni­
is necessary (e.g., long-handled brush) (IC) (14). tors according to the manufacturer’s instructions 
4. Wear puncture- and chemical-resistant/heavy­ to ensure the effectiveness of the sterilization 
duty utility gloves for instrument cleaning and process (IB) (248,278,279). 
decontamination procedures (IB) (7). 2. Monitor each load with mechanical (e.g., time, 
5. Wear appropriate PPE (e.g., mask, protective temperature, and pressure) and chemical indi­
eyewear, and gown) when splashing or spraying cators (II) (243,248). 
is anticipated during cleaning (IC) (13). 3. Place a chemical indicator on the inside of each 
D. Preparation and Packaging package. If the internal indicator is not visible 
1. Use an internal chemical indicator in each pack- from the outside, also place an exterior chemi­
age. If the internal indicator cannot be seen from cal indicator on the package (II) (243,254,257). 
outside the package, also use an external indica­ 4. Place items/packages correctly and loosely into 
tor (II) (243,254,257). the sterilizer so as not to impede penetration of 
2. Use a container system or wrapping compatible the sterilant (IB) (243). 
with the type of sterilization process used and 5. Do not use instrument packs if mechanical or 
that has received FDA clearance (IB) (243,247, chemical indicators indicate inadequate process­
256). ing (IB) (243,247,248). 
3. Before sterilization of critical and semicritical 6. Monitor sterilizers at least weekly by using a bio­
instruments, inspect instruments for cleanliness, logical indicator with a matching control (i.e., 
then wrap or place them in containers designed biological indicator and control from same lot 
to maintain sterility during storage (e.g., cassettes number) (IB) (2,9,243,247,278,279). 
and organizing trays) (IA) (2,247,255,256). 7. Use a biological indicator for every sterilizer load 
E. Sterilization of Unwrapped Instruments that contains an implantable device. Verify 
1. Clean and dry instruments before the unwrapped results before using the implantable device, 
sterilization cycle (IB) (248). whenever possible (IB) (243,248). 
2. Use mechanical and chemical indicators for each 8. The following are recommended in the case of a 
unwrapped sterilization cycle (i.e., place an positive spore test: 
internal chemical indicator among the instru­ a. Remove the sterilizer from service and 
ments or items to be sterilized) (IB) (243,258). review sterilization procedures (e.g., work 
3. Allow unwrapped instruments to dry and cool practices and use of mechanical and chemi­
in the sterilizer before they are handled to avoid cal indicators) to determine whether opera-
contamination and thermal injury (II) (260). tor error could be responsible (II) (8). 
4. Semicritical instruments that will be used b. Retest the sterilizer by using biological, 
immediately or within a short time can be ster­ mechanical, and chemical indicators after 
ilized unwrapped on a tray or in a container sys­ correcting any identified procedural prob­
tem, provided that the instruments are handled lems (II). 
aseptically during removal from the sterilizer and c. If the repeat spore test is negative, and 
transport to the point of use (II). mechanical and chemical indicators are 
5. Critical instruments intended for immediate within normal limits, put the sterilizer back 
reuse can be sterilized unwrapped if the instru­ in service (II) (9,243). 
ments are maintained sterile during removal from 9. The following are recommended if the repeat 
the sterilizer and transport to the point of use spore test is positive: 
(e.g., transported in a sterile covered container) a. Do not use the sterilizer until it has been 
(IB) (258). inspected or repaired or the exact reason for 
6. Do not sterilize implantable devices unwrapped the positive test has been determined (II) 
(IB) (243,247). (9,243). 
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b.	 Recall, to the extent possible, and reprocess 
all items processed since the last negative 
spore test (II) (9,243,283). 
c.	 Before placing the sterilizer back in service, 
rechallenge the sterilizer with biological 
indicator tests in three consecutive empty 
chamber sterilization cycles after the cause 
of the sterilizer failure has been determined 
and corrected (II) (9,243,283). 
10. Maintain sterilization records (i.e., mechanical, 
chemical, and biological) in compliance with 
state and local regulations (IB) (243). 
G.	 Storage Area for Sterilized Items and Clean 
Dental Supplies 
1.	 Implement practices on the basis of date- or 
event-related shelf-life for storage of wrapped, 
sterilized instruments and devices (IB) (243, 
284). 
2.	 Even for event-related packaging, at a minimum, 
place the date of sterilization, and if multiple 
sterilizers are used in the facility, the sterilizer 
used, on the outside of the packaging material 
to facilitate the retrieval of processed items in 
the event of a sterilization failure (IB) (243,247). 
3.	 Examine wrapped packages of sterilized instru­
ments before opening them to ensure the bar­
rier wrap has not been compromised during 
storage (II) (243,284). 
4.	 Reclean, repack, and resterilize any instrument 
package that has been compromised (II). 
5.	 Store sterile items and dental supplies in cov­
ered or closed cabinets, if possible (II) (285). 
VII. Environmental Infection Control 
A. General Recommendations 
1.	 Follow the manufacturers’ instructions for cor­
rect use of cleaning and EPA-registered hospital 
disinfecting products (IB, IC) (243–245). 
2.	 Do not use liquid chemical sterilants/high-level 
disinfectants for disinfection of environmental 
surfaces (clinical contact or housekeeping) (IB, 
IC) (243–245). 
3.	 Use PPE, as appropriate, when cleaning and dis­
infecting environmental surfaces. Such equip­
ment might include gloves (e.g., puncture- and 
chemical-resistant utility), protective clothing 
(e.g., gown, jacket, or lab coat), and protective 
eyewear/face shield, and mask (IC) (13,15). 
B. Clinical Contact Surfaces 
1.	 Use surface barriers to protect clinical contact 
surfaces, particularly those that are difficult to 
clean (e.g., switches on dental chairs) and change 
surface barriers between patients (II) (1,2,260, 
288). 
2.	 Clean and disinfect clinical contact surfaces that 
are not barrier-protected, by using an EPA-
registered hospital disinfectant with a low- (i.e., 
HIV and HBV label claims) to intermediate-level 
(i.e., tuberculocidal claim) activity after each 
patient. Use an intermediate-level disinfectant 
if visibly contaminated with blood (IB) 
(2,243,244). 
C. Housekeeping Surfaces 
1.	 Clean housekeeping surfaces (e.g., floors, walls, 
and sinks) with a detergent and water or an EPA-
registered hospital disinfectant/detergent on a 
routine basis, depending on the nature of the 
surface and type and degree of contamination, 
and as appropriate, based on the location in the 
facility, and when visibly soiled (IB) (243,244). 
2.	 Clean mops and cloths after use and allow to 
dry before reuse; or use single-use, disposable 
mop heads or cloths (II) (243,244). 
3.	 Prepare fresh cleaning or EPA-registered disin­
fecting solutions daily and as instructed by the 
manufacturer. (II) (243,244). 
4.	 Clean walls, blinds, and window curtains in 
patient-care areas when they are visibly dusty or 
soiled (II) (9,244). 
D. Spills of Blood and Body Substances 
1.	 Clean spills of blood or OPIM and decontami­
nate surface with an EPA-registered hospital dis­
infectant with low- (i.e., HBV and HIV label 
claims) to intermediate-level (i.e., tuberculocidal 
claim) activity, depending on size of spill and 
surface porosity (IB, IC) (13,113). 
E.	 Carpet and Cloth Furnishings 
1.	 Avoid using carpeting and cloth-upholstered 
furnishings in dental operatories, laboratories, 
and instrument processing areas (II) (9,293– 
295). 
F.	 Regulated Medical Waste 
1.	 General Recommendations 
a.	 Develop a medical waste management pro­
gram. Disposal of regulated medical waste 
must follow federal, state, and local regula­
tions (IC) (13,301). 
b.	 Ensure that DHCP who handle and dispose 
of regulated medical waste are trained in 
appropriate handling and disposal methods 
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and informed of the possible health and operative unit, ultrasonic scaler, or other 
safety hazards (IC) (13). dental equipment that uses the public water 
2. Management of Regulated Medical Waste in system (IB, IC) (341,342,346,349,350). 
Dental Health-Care Facilities b. Do not use water from the public water sys­
a. Use a color-coded or labeled container that tem for dental treatment, patient rinsing, or 
prevents leakage (e.g., biohazard bag) to con­ handwashing (IB, IC) (341,342,346,349, 
tain nonsharp regulated medical waste (IC) 350). 
(13). c. For handwashing, use antimicrobial-
b. Place sharp items (e.g., needles, scalpel containing products that do not require 
blades, orthodontic bands, broken metal water for use (e.g., alcohol-based hand rubs). 
instruments, and burs) in an appropriate If hands are visibly contaminated, use bottled 
sharps container (e.g., puncture resistant, water, if available, and soap for handwashing 
color-coded, and leakproof). Close container or an antiseptic towelette (IB, IC) (13,122). 
immediately before removal or replacement 2. The following apply when the boil-water 
to prevent spillage or protrusion of contents advisory is cancelled: 
during handling, storage, transport, or ship- a. Follow guidance given by the local water 
ping (IC) (2,8,13,113,115). utility regarding adequate flushing of water-
c. Pour blood, suctioned fluids or other liquid lines. If no guidance is provided, flush den-
waste carefully into a drain connected to a tal waterlines and faucets for 1–5 minutes 
sanitary sewer system, if local sewage dis­ before using for patient care (IC) (244,346, 
charge requirements are met and the state 351,352). 
has declared this an acceptable method of b. Disinfect dental waterlines as recommended 
disposal. Wear appropriate PPE while per- by the dental unit manufacturer (II). 
forming this task (IC) (7,9,13). IX. Special Considerations 
VIII. Dental Unit Waterlines, Biofilm, and Water Quality A. Dental Handpieces and Other Devices Attached 
A. General Recommendations to Air and Waterlines 
1. Use water that meets EPA regulatory standards 1. Clean and heat-sterilize handpieces and other 
for drinking water (i.e., <500 CFU/mL of het­ intraoral instruments that can be removed from 
erotrophic water bacteria) for routine dental the air and waterlines of dental units between 
treatment output water (IB, IC) (341,342). patients (IB, IC) (2,246,275,356,357,360,407). 
2. Consult with the dental unit manufacturer for 2. Follow the manufacturer’s instructions for clean-
appropriate methods and equipment to main­ ing, lubrication, and sterilization of handpieces 
tain the recommended quality of dental water and other intraoral instruments that can be 
(II) (339). removed from the air and waterlines of dental 
3. Follow recommendations for monitoring water units (IB) (361–363). 
quality provided by the manufacturer of the unit 3. Do not surface-disinfect, use liquid chemical ste­
or waterline treatment product (II). rilants, or ethylene oxide on handpieces and 
4. Discharge water and air for a minimum of 20– other intraoral instruments that can be removed 
30 seconds after each patient, from any device from the air and waterlines of dental units (IC) 
connected to the dental water system that enters (2,246,250,275). 
the patient’s mouth (e.g., handpieces, ultrasonic 4. Do not advise patients to close their lips tightly 
scalers, and air/water syringes) (II) (2,311,344). around the tip of the saliva ejector to evacuate 
5. Consult with the dental unit manufacturer on oral fluids (II) (364–366). 
the need for periodic maintenance of B. Dental Radiology 
antiretraction mechanisms (IB) (2,311). 1. Wear gloves when exposing radiographs and 
B. Boil-Water Advisories handling contaminated film packets. Use other 
1. The following apply while a boil-water advisory PPE (e.g., protective eyewear, mask, and gown) 
is in effect: as appropriate if spattering of blood or other 
a. Do not deliver water from the public water body fluids is likely (IA, IC) (11,13). 
system to the patient through the dental 
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2.	 Use heat-tolerant or disposable intraoral devices 
whenever possible (e.g., film-holding and posi­
tioning devices). Clean and heat-sterilize heat-
tolerant devices between patients. At a 
minimum, high-level disinfect semicritical heat-
sensitive devices, according to manufacturer’s 
instructions (IB) (243). 
3.	 Transport and handle exposed radiographs in an 
aseptic manner to prevent contamination of 
developing equipment (II). 
4.	 The following apply for digital radiography 
sensors: 
a.	 Use FDA-cleared barriers (IB) (243). 
b.	 Clean and heat-sterilize, or high-level disin­
fect, between patients, barrier-protected 
semicritical items. If the item cannot toler­
ate these procedures then, at a minimum, 
protect with an FDA-cleared barrier and 
clean and disinfect with an EPA-registered 
hospital disinfectant with intermediate-level 
(i.e., tuberculocidal claim) activity, between 
patients. Consult with the manufacturer for 
methods of disinfection and sterilization of 
digital radiology sensors and for protection 
of associated computer hardware (IB) (243). 
C. Aseptic Technique for Parenteral Medications 
1.	 Do not administer medication from a syringe to 
multiple patients, even if the needle on the 
syringe is changed (IA) (378). 
2.	 Use single-dose vials for parenteral medications 
when possible (II) (376,377). 
3.	 Do not combine the leftover contents of single-
use vials for later use (IA) (376,377). 
4.	 The following apply if multidose vials are used: 
a.	 Cleanse the access diaphragm with 70% 
alcohol before inserting a device into the vial 
(IA) (380,381). 
b.	 Use a sterile device to access a multiple-dose 
vial and avoid touching the access diaphragm. 
Both the needle and syringe used to access 
the multidose vial should be sterile. Do not 
reuse a syringe even if the needle is changed 
(IA) (380,381). 
c.	 Keep multidose vials away from the imme­
diate patient treatment area to prevent inad­
vertent contamination by spray or spatter 
(II). 
d.	 Discard the multidose vial if sterility is com­
promised (IA) (380,381). 
5.	 Use fluid infusion and administration sets (i.e., 
IV bags, tubings and connections) for one 
patient only and dispose of appropriately (IB) 
(378). 
D. Single-Use (Disposable) Devices 
1.	 Use single-use devices for one patient only and 
dispose of them appropriately (IC) (383). 
E.	 Preprocedural Mouth Rinses 
1.	 No recommendation is offered regarding use of 
preprocedural antimicrobial mouth rinses to 
prevent clinical infections among DHCP or pa­
tients. Although studies have demonstrated that 
a preprocedural antimicrobial rinse (e.g., 
chlorhexidine gluconate, essential oils, or povi­
done-iodine) can reduce the level of oral micro­
organisms in aerosols and spatter generated 
during routine dental procedures and can 
decrease the number of microorganisms intro­
duced in the patient’s bloodstream during inva­
sive dental procedures (391–399), the scientific 
evidence is inconclusive that using these rinses 
prevents clinical infections among DHCP or 
patients (see discussion, Preprocedural Mouth 
Rinses) (Unresolved issue). 
F.	 Oral Surgical Procedures 
1.	 The following apply when performing oral sur­
gical procedures: 
a.	 Perform surgical hand antisepsis by using an 
antimicrobial product (e.g., antimicrobial 
soap and water, or soap and water followed 
by alcohol-based hand scrub with persistent 
activity) before donning sterile surgeon’s 
gloves (IB) (127–132,137). 
b.	 Use sterile surgeon’s gloves (IB) (2,7,121, 
123,137). 
c.	 Use sterile saline or sterile water as a cool­
ant/irrigatant when performing oral surgi­
cal procedures. Use devices specifically 
designed for delivering sterile irrigating flu­
ids (e.g., bulb syringe, single-use disposable 
products, and sterilizable tubing) (IB) 
(2,121). 
G.	 Handling of Biopsy Specimens 
1.	 During transport, place biopsy specimens in a 
sturdy, leakproof container labeled with the bio­
hazard symbol (IC) (2,13,14). 
2.	 If a biopsy specimen container is visibly con­
taminated, clean and disinfect the outside of a 
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container or place it in an impervious bag 
labeled with the biohazard symbol, (IC) (2,13). 
H. Handling of Extracted Teeth 
1.	 Dispose of extracted teeth as regulated medical 
waste unless returned to the patient (IC) (13,14). 
2.	 Do not dispose of extracted teeth containing 
amalgam in regulated medical waste intended 
for incineration (II). 
3.	 Clean and place extracted teeth in a leakproof 
container, labeled with a biohazard symbol, and 
maintain hydration for transport to educational 
institutions or a dental laboratory (IC) (13,14). 
4.	 Heat-sterilize teeth that do not contain amal­
gam before they are used for educational pur­
poses (IB) (403,405,406). 
I.	 Dental Laboratory 
1.	 Use PPE when handling items received in the 
laboratory until they have been decontaminated 
(IA, IC) (2,7,11,13,113). 
2.	 Before they are handled in the laboratory, clean, 
disinfect, and rinse all dental prostheses and 
prosthodontic materials (e.g., impressions, bite 
registrations, occlusal rims, and extracted teeth) 
by using an EPA-registered hospital disinfectant 
having at least an intermediate-level (i.e., tuber­
culocidal claim) activity (IB) (2,249,252,407). 
3.	 Consult with manufacturers regarding the sta­
bility of specific materials (e.g., impression 
materials) relative to disinfection procedures (II). 
4.	 Include specific information regarding disinfec­
tion techniques used (e.g., solution used and 
duration), when laboratory cases are sent off-
site and on their return (II) (2,407,409). 
5.	 Clean and heat-sterilize heat-tolerant items used 
in the mouth (e.g., metal impression trays and 
face-bow forks) (IB) (2,407). 
6.	 Follow manufacturers’ instructions for cleaning 
and sterilizing or disinfecting items that become 
contaminated but do not normally contact the 
patient (e.g., burs, polishing points, rag wheels, 
articulators, case pans, and lathes). If manufac­
turer instructions are unavailable, clean and heat-
sterilize heat-tolerant items or clean and disinfect 
with an EPA-registered hospital disinfectant with 
low- (HIV, HBV effectiveness claim) to inter­
mediate-level (tuberculocidal claim) activity, 
depending on the degree of contamination (II). 
J.	 Laser/Electrosurgery Plumes/Surgical Smoke 
1.	 No recommendation is offered regarding prac­
tices to reduce DHCP exposure to laser plumes/ 
surgical smoke when using lasers in dental prac­
tice. Practices to reduce HCP exposure to laser 
plumes/surgical smoke have been suggested, 
including use of a) standard precautions (e.g., 
high-filtration surgical masks and possibly full 
face shields) (437); b) central room suction units 
with in-line filters to collect particulate matter 
from minimal plumes; and c) dedicated 
mechanical smoke exhaust systems with a high-
efficiency filter to remove substantial amounts 
of laser-plume particles. The effect of the expo­
sure (e.g., disease transmission or adverse respi­
ratory effects) on DHCP from dental 
applications of lasers has not been adequately 
evaluated (see previous discussion, Laser/ 
Electrosurgery Plumes or Surgical Smoke) 
(Unresolved issue). 
K.	 Mycobacterium tuberculosis 
1.	 General Recommendations 
a.	 Educate all DHCP regarding the recogni­
tion of signs, symptoms, and transmission 
of TB (IB) (20,21). 
b.	 Conduct a baseline TST, preferably by 
using a two-step test, for all DHCP who 
might have contact with persons with sus­
pected or confirmed active TB, regardless of 
the risk classification of the setting (IB) (20). 
c.	 Assess each patient for a history of TB as well 
as symptoms indicative of TB and document 
on the medical history form (IB) (20,21). 
d.	 Follow CDC recommendations for 1) 
developing, maintaining, and implementing 
a written TB infection-control plan; 2) man­
aging a patient with suspected or active TB; 
3) completing a community risk-assessment 
to guide employee TSTs and follow-up; and 
4) managing DHCP with TB disease (IB) 
(2,21). 
2.	 The following apply for patients known or sus­
pected to have active TB: 
a.	 Evaluate the patient away from other patients 
and DHCP. When not being evaluated, the 
patient should wear a surgical mask or be 
instructed to cover mouth and nose when 
coughing or sneezing (IB) (20,21). 
b.	 Defer elective dental treatment until the 
patient is noninfectious (IB) (20,21). 
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c.	 Refer patients requiring urgent dental treat­
ment to a previously identified facility with 
TB engineering controls and a respiratory 
protection program (IB) (20,21). 
L.	 Creutzfeldt-Jakob Disease (CJD) and Other Prion 
Diseases 
1.	 No recommendation is offered regarding use of 
special precautions in addition to standard pre­
cautions when treating known CJD or vCJD 
patients. Potential infectivity of oral tissues in 
CJD or vCJD patients is an unresolved issue. 
Scientific data indicate the risk, if any, of spo­
radic CJD transmission during dental and oral 
surgical procedures is low to nil. Until additional 
information exists regarding the transmissibility 
of CJD or vCJD during dental procedures, spe­
cial precautions in addition to standard precau­
tions might be indicated when treating known 
CJD or vCJD patients; a list of such precau­
tions is provided for consideration without rec­
ommendation (see Creutzfeldt-Jakob Disease 
and Other Prion Diseases) (Unresolved issue). 
M. Program Evaluation 
1.	 Establish routine evaluation of the infection-
control program, including evaluation of per­
formance indicators, at an established frequency 
(II) (470-471). 
Infection-Control Internet Resources 
Advisory Committee on Immunization Practices 
http://www.cdc.gov/nip/ACIP/default.htm 
American Dental Association 
http://www.ada.org 
American Institute of Architects Academy of Architec­
ture for Health 
http://www.aahaia.org 
American Society of Heating, Refrigeration, Air-condi­
tioning Engineers 
http://www.ashrae.org 
Association for Professionals in Infection Control and 
Epidemiology, Inc. 
http://www.apic.org/resc/guidlist.cfm 
CDC, Division of Healthcare Quality Promotion 
http://www.cdc.gov/ncidod/hip 
CDC, Division of Oral Health, Infection Control 
http://www.cdc.gov/OralHealth/infectioncontrol/index.htm 
CDC, Morbidity and Mortality Weekly Report 
http://www.cdc.gov/mmwr 
CDC, NIOSH 
http://www.cdc.gov/niosh/homepage.html 
CDC Recommends, Prevention Guidelines System 
http://www.phppo.cdc.gov/cdcRecommends/AdvSearchV.asp 
EPA, Antimicrobial Chemicals 
http://www.epa.gov/oppad001/chemregindex.htm 
FDA 
http://www.fda.gov 
Immunization Action Coalition 
http://www.immunize.org/acip 
Infectious Diseases Society of America 
http://www.idsociety.org/PG/toc.htm 
OSHA, Dentistry, Bloodborne Pathogens 
http://www.osha.gov/SLTC/dentistry/index.html 
http://www.osha.gov/SLTC/bloodbornepathogens/index.html 
Organization for Safety and Asepsis Procedures 
http://www.osap.org 
Society for Healthcare Epidemiology of America, Inc., 
Position Papers 
http://www.shea-online.org/PositionPapers.html 
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Appendix A

Regulatory Framework for Disinfectants and Sterilants

When using the guidance provided in this report 
regarding use of liquid chemical disinfectants and sterilants, 
dental health-care personnel (DHCP) should be aware of fed­
eral laws and regulations that govern the sale, distribution, 
and use of these products. In particular, DHCPs should know 
what requirements pertain to them when such products are 
used. Finally, DHCP should understand the relative roles of 
the U.S. Environmental Protection Agency (EPA), the U.S. 
Food and Drug Administration (FDA), the Occupational 
Safety and Health Administration (OSHA) and CDC. 
The choice of specific cleaning or disinfecting agents is largely 
a matter of judgment, guided by product label claims and 
instructions and government regulations. A single liquid chemi­
cal germicide might not satisfy all disinfection requirements 
in a given dental practice or facility. Realistic use of liquid 
chemical germicides depends on consideration of multiple fac­
tors, including the degree of microbial killing required; the 
nature and composition of the surface, item, or device to be 
treated; and the cost, safety, and ease of use of the available 
agents. Selecting one appropriate product with a higher de­
gree of potency to cover all situations might be more conve­
nient. 
In the United States, liquid chemical germicides (disinfec­
tants) are regulated by EPA and FDA (A-1–A-3). In health-
care settings, EPA regulates disinfectants that are used on 
environmental surfaces (housekeeping and clinical contact 
surfaces), and FDA regulates liquid chemical sterilants/ 
high-level disinfectants (e.g., glutaraldehyde, hydrogen perox­
ide, and peracetic acid) used on critical and semicritical patient-
care devices. Disinfectants intended for use on clinical contact 
surfaces (e.g., light handles, radiographic-ray heads, or drawer 
knobs) or housekeeping surfaces (e.g., floors, walls, or sinks) 
are regulated in interstate commerce by the Antimicrobials 
Division, Office of Pesticide Programs, EPA, under the 
authority of the Federal Insecticide, Fungicide, and 
Rodenticide Act (FIFRA) of 1947, as amended in 1996 (A-4). 
Under FIFRA, any substance or mixture of substances intended 
to prevent, destroy, repel, or mitigate any pest, including 
microorganisms but excluding those in or on living man or 
animals, must be registered before sale or distribution. To 
obtain a registration, a manufacturer must submit specific data 
regarding the safety and the effectiveness of each product. 
EPA requires manufacturers to test formulations by using 
accepted methods for microbicidal activity, stability, and tox­
icity to animals and humans. Manufacturers submit these data 
to EPA with proposed labeling. If EPA concludes a product 
may be used without causing unreasonable adverse effects, the 
product and its labeling are given an EPA registration num­
ber, and the manufacturer may then sell and distribute the 
product in the United States. FIFRA requires users of prod­
ucts to follow the labeling directions on each product explicitly. 
The following statement appears on all EPA-registered prod­
uct labels under the Directions for Use heading: “It is a viola­
tion of federal law to use this product inconsistent with its 
labeling.” This means that DHCP must follow the safety pre­
cautions and use directions on the labeling of each registered 
product. Not following the specified dilution, contact time, 
method of application, or any other condition of use is con­
sidered misuse of the product. 
FDA, under the authority of the 1976 Medical Devices 
Amendment to the Food, Drug, and Cosmetic Act, regulates 
chemical germicides if they are advertised and marketed for 
use on specific medical devices (e.g., dental unit waterline or 
flexible endoscope). A liquid chemical germicide marketed for 
use on a specific device is considered, for regulatory purposes, 
a medical device itself when used to disinfect that specific medi­
cal device. Also, this FDA regulatory authority over a particu­
lar instrument or device dictates that the manufacturer is 
obligated to provide the user with adequate instructions for 
the safe and effective use of that device. These instructions 
must include methods to clean and disinfect or sterilize the 
item if it is to be marketed as a reusable medical device. 
OSHA develops workplace standards to help ensure safe and 
healthful working conditions in places of employment. OSHA 
is authorized under Pub. L. 95-251, and as amended, to en­
force these workplace standards. In 1991, OSHA published 
Occupational Exposure to Bloodborne Pathogens; final rule 
[29 CFR Part 1910.1030] (A-5). This standard is designed to 
help prevent occupational exposures to blood or other poten­
tially infectious substances. Under this standard, OSHA has 
interpreted that, to decontaminate contaminated work sur­
faces, either an EPA-registered hospital tuberculocidal disin­
fectant or an EPA-registered hospital disinfectant labeled as 
effective against human immunodeficiency virus (HIV) and 
hepatitis B virus (HBV) is appropriate. Hospital disinfectants 
with such HIV and HBV claims can be used, provided sur­
faces are not contaminated with agents or concentration of 
agents for which higher level (i.e., intermediate-level) disin­
fection is recommended. In addition, as with all disinfectants, 
effectiveness is governed by strict adherence to the label 
instructions for intended use of the product. 
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CDC is not a regulatory agency and does not test, evaluate, 
or otherwise recommend specific brand-name products of 
chemical germicides. This report is intended to provide over­
all guidance for providers to select general classifications of 
products based on certain infection-control principles. In this 
report, CDC provides guidance to practitioners regarding 
appropriate application of EPA- and FDA-registered liquid 
chemical disinfectants and sterilants in dental health-care set­
tings. 
CDC recommends disinfecting environmental surfaces or 
sterilizing or disinfecting medical equipment, and DHCP 
should use products approved by EPA and FDA unless no 
such products are available for use against certain microorgan­
isms or sites. However, if no registered or approved products 
are available for a specific pathogen or use situation, DHCP 
are advised to follow the specific guidance regarding unregis­
tered or unapproved (e.g., off-label) uses for various chemical 
germicides. For example, no antimicrobial products are regis­
tered for use specifically against certain emerging pathogens 
(e.g., Norwalk virus), potential terrorism agents (e.g., variola 
major or Yersinia pestis), or Creutzfeldt-Jakob disease agents. 
One point of clarification is the difference in how EPA and 
FDA classify disinfectants. FDA adopted the same basic ter­
minology and classification scheme as CDC to categorize 
medical devices (i.e., critical, semicritical, and noncritical) and 
to define antimicrobial potency for processing surfaces (i.e., 
sterilization, and high-, intermediate- and low-level disinfec­
tion) (A-6). EPA registers environmental surface disinfectants 
based on the manufacturer’s microbiological activity claims 
when registering its disinfectant. This difference has led to con­
fusion on the part of users because the EPA does not use the 
terms intermediate- and low-level disinfectants as used in CDC 
guidelines. 
CDC designates any EPA-registered hospital disinfectant 
without a tuberculocidal claim as a low-level disinfectant and 
any EPA-registered hospital disinfectant with a tuberculocidal 
claim as an intermediate-level disinfectant. To understand this 
comparison, one needs to know how EPA registers disinfec­
tants. First, to be labeled as an EPA hospital disinfectant, the 
product must pass Association of Official Analytical Chemists 
(AOAC) effectiveness tests against three target organisms: Sal­
monella choleraesuis for effectiveness against gram-negative 
bacteria; Staphylococcus aureus for effectiveness against gram-
positive bacteria; and Pseudomonas aeruginosa for effectiveness 
against a primarily nosocomial pathogen. Substantiated label 
claims of effectiveness of a disinfectant against specific micro­
organisms other than the test microorganisms are permitted, 
but not required, provided that the test microorganisms are 
likely to be present in or on the recommended use areas and 
surfaces. Therefore, manufacturers might also test specifically 
against organisms of known concern in health-care practices 
(e.g., HIV, HBV, hepatitis C virus [HCV], and herpes) al­
though it is considered likely that any product satisfying AOAC 
tests for hospital disinfectant designation will also be effective 
against these relatively fragile organisms when the product is 
used as directed by the manufacturer. 
Potency against Mycobacterium tuberculosis has been recog­
nized as a substantial benchmark. However, the tuberculocidal 
claim is used only as a benchmark to measure germicidal 
potency. Tuberculosis is not transmitted via environmental sur­
faces but rather by the airborne route. Accordingly, use of such 
products on environmental surfaces plays no role in prevent­
ing the spread of tuberculosis. However, because mycobacte­
ria have among the highest intrinsic levels of resistance among 
the vegetative bacteria, viruses, and fungi, any germicide with 
a tuberculocidal claim on the label is considered capable of 
inactivating a broad spectrum of pathogens, including such 
less-resistant organisms as bloodborne pathogens (e.g., HBV, 
HCV, and HIV). It is this broad-spectrum capability, rather 
than the product’s specific potency against mycobacteria, that 
is the basis for protocols and regulations dictating use of 
tuberculocidal chemicals for surface disinfection. 
EPA also lists disinfectant products according to their 
labeled use against these organisms of interest as follows: 
•	 List B. Tuberculocide products effective against Mycobac­
terium species. 
•	 List C. Products effective against human HIV-1 virus. 
•	 List D. Products effective against human HIV-1 virus and 
HBV. 
•	 List E. Products effective against Mycobacterium species, 
human HIV-1 virus, and HBV. 
•	 List F. Products effective against HCV. 
Microorganisms vary in their resistance to disinfection and 
sterilization, enabling CDC’s designation of disinfectants as 
high-, intermediate-, and low-level, when compared with EPA’s 
designated organism spectrum (Figure). However, exceptions 
to this general guide exist, and manufacturer’s label claims and 
instructions should always be followed. 
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FIGURE. Decreasing order of resistance of microorganisms to germicidal chemicals 
Organism Processing Level Required 
Sterilization 
Bacterial spores FDA sterilant/high-level disinfectant 
Geobacillus stearothermophilus (= CDC sterilant/high-level disinfectant) 
 Bacillus atrophaeus 
Mycobacteria EPA hospital disinfectant with 
 Mycobacterium tuberculosis tuberculocidal claim 
Nonlipid or small viruses (= CDC intermediate-level disinfectant) 
Polio virus
 Coxsackle virus
 Rhinovirus 
Fungi
 Aspergillus
 Candida 
Vegetative bacteria
 Staphylococcus species

 Pseudomonus species

 Salmonella species

Lipid or medium-sized viruses 
Human immunodeficiency virus 
Herpes simplex virus 
Hepatitis B and hepatitis C
 Coronavirus 
EPA hospital disinfectant

(= CDC low-level disinfectant)

Source: Adapted from Bond WW, Ott BJ, Franke K, McCracken JE. Effective use of liquid chemical germicides on medical devices; instrument design 
problems. In: Block SS, ed. Disinfection, sterilization and preservation. 4th ed. Philadelphia, PA: Lea & Gebiger, 1991:1100. 
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Appendix B

Immunizations Strongly Recommended for Health-Care Personnel (HCP)

Major precautions 
Vaccine Dose schedule Indications and contraindications Special considerations 
Hepatitis B Three-dose schedule Health-care personnel (HCP) History of anaphylactic reaction to No therapeutic or adverse effects on hepatitis 
recombinant administered intramuscularly at risk for exposure to blood common baker’s yeast. Pregnancy B virus (HBV)-infected persons; cost-
vaccine* (IM) in the deltoid; 0,1,6 ­ and body fluids. is not a contraindication. effectiveness of prevaccination screening for 
second dose administered 1 susceptibility to HBV depends on costs of 
month after first dose; third dose vaccination and antibody testing and 
administered 4 months after prevalence of immunity in the group of 
second. Booster doses are not potential vaccinees; health-care personnel who 
necessary for persons who have have ongoing contact with patients or blood 
developed adequate antibodies should be tested 1–2 months after completing 
to hepatitis B surface antigen the vaccination series to determine serologic 
(anti-HBs). response. If vaccination does not induce 
adequate anti-HBs (>10 mIU/mL), a second 
vaccine series should be administered. 
Influenza Annual single-dose vaccination HCP who have contact with History of anaphylactic hypersensi- Recommended for women who will be in the 
vaccine IM with current vaccine. patients at high risk or who tivity to eggs or to other compo- second or third trimesters of pregnancy during 
(inactivated)¶ work in chronic-care facilities; nents of the vaccine. the influenza season and women in any stage 
HCP aged >50 years or who of pregnancy who have chronic medical 
have high-risk medical conditions that are associated with an 
conditions. increased risk of influenza.§ 
Measles live- One dose administered HCP who were born during or Pregnancy; immunocompromised† Measles, mumps, rubella (MMR) is the 
virus vaccine subcutaneously (SC); second after 1957 without documenta­ state (including human immunode­ recommended vaccine, if recipients are also 
dose >4 weeks later. tion of 1) receipt of 2 doses of ficiency virus [HIV]-infected likely to be susceptible to rubella or mumps; 
live vaccine on or after their first persons with severe immunosup­ persons vaccinated during 1963–1967 with 
birthday, 2) physician-diagnosed pression); history of anaphylactic 1) measles killed-virus vaccine alone, 
measles, or 3) laboratory reactions after gelatin ingestion or 2) killed-virus vaccine followed by live-virus 
evidence of immunity. Vaccine receipt of neomycin; or recent vaccine, or 3) a vaccine of unknown type, 
should also be considered for receipt of antibody-containing should be revaccinated with two doses of 
all HCP who have no proof of blood products. live-virus measles vaccine. 
immunity, including those born 
before 1957. 
Mumps live- One dose SC; no booster. HCP believed susceptible can Pregnancy; immunocompromised† MMR is the recommended vaccine. 
virus vaccine be vaccinated; adults born state; history of anaphylactic 
before 1957 can be considered reaction after gelatin ingestion or 
immune. receipt of neomycin. 
Rubella live- One dose SC; no booster. HCP, both male and female, Pregnancy; immunocompromised† Women pregnant when vaccinated or who 
virus vaccine who lack documentation of state; history of anaphylactic become pregnant within 4 weeks of 
receipt of live vaccine on or reaction after receipt of neomycin. vaccination should be counseled regarding 
after their first birthday, or lack theoretic risks to the fetus; however, the risk 
of laboratory evidence of of rubella vaccine-associated malformations 
immunity can be vaccinated. among these women is negligible. MMR is the 
Adults born before 1957 can recommended vaccine. 
be considered immune, except 
women of childbearing age. 
Varicella-zoster Two 0.5 mL doses SC 4–8 HCP without reliable history of Pregnancy; immunocompromised† Because 71%–93% of U.S.-born persons 
live-virus weeks apart if aged >13 years. varicella or laboratory evidence state; history of anaphylactic without a history of varicella are immune, 
vaccine of varicella immunity. reaction after receipt of neomycin serologic testing before vaccination might be 
or gelatin; recent receipt of cost-effective. 
antibody-containing blood products; 
salicylate use should be avoided 
for 6 weeks after vaccination. 
Sources: Adapted from Bolyard EA, Hospital Infection Control Practices Advisory Committee. Guidelines for infection control in health care personnel, 1998. Am J Infect Control

1998;26:289–354.

CDC. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices

Advisory Committee (HICPAC). MMWR 1997;46(No. RR-18).

CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2003;52:1-34.

CDC. Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices

(ACIP). MMWR 2003;52(No. RR-13).

* A federal standard issued in December 1991 under the Occupational Safety and Health Act mandates that hepatitis B vaccine be made available at the employer’s expense to 
all HCP occupationally exposed to blood or other potentially infectious materials. The Occupational Safety and Health Administration requires that employers make available 
hepatitis B vaccinations, evaluations, and follow-up procedures in accordance with current CDC recommendations. † Persons immunocompromised because of immune deficiencies, HIV infection, leukemia, lymphoma, generalized malignancy; or persons receiving immunosuppressive therapy 
with corticosteroids, alkylating drugs, antimetabolites; or persons receiving radiation. § Vaccination of pregnant women after the first trimester might be preferred to avoid coincidental association with spontaneous abortions, which are most common during the first 
trimester. However, no adverse fetal effects have been associated with influenza vaccination. ¶ A live attenuated influenza vaccine (LAIV) is FDA-approved for healthy persons aged 5-49 years. Because of the possibility of transmission of vaccine viruses from recipients 
of LAIV to other persons and in the absence of data on the risk of illness and among immunocompromised persons infected with LAIV viruses, the inactivated influenza vaccine 
is preferred for HCP who have close contact with immunocompromised persons. 
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Appendix C 
Methods for Sterilizing and Disinfecting Patient-Care Items 
and Environmental Surfaces* 
Health-care application 
Process Result Method Examples 
Type of 
patient-care item 
Environmental 
surfaces 
Sterilization Destroys all microorgan­
isms, including bacterial 
spores. 
Heat-automated 
High temperature Steam, dry heat, unsaturated chemical vapor Heat-tolerant critical 
and semicritical 
Not applicable 
Low temperature Ethylene oxide gas, plasma sterilization Heat-sensitive critical 
and semicritical 
Liquid immersion† Chemical sterilants. Glutaraldehyde, 
glutaraldehydes with phenol, hydrogen 
peroxide, hydrogen peroxide with peracetic acid, 
peracetic acid 
Heat-sensitive critical 
and semicritical 
High-level 
disinfection 
Destroys all microorgan­
isms, but not necessarily 
high numbers of bacterial 
spores. 
Heat-automated 
Liquid immersion† 
Washer-disinfector 
Chemical sterilants/high-level disinfectants. 
Glutaraldehyde, glutaraldehyde with phenol, 
hydrogen peroxide, hydrogen peroxide with 
peracetic acid, ortho-phthalaldehyde 
Heat-sensitive 
semicritical 
Not applicable 
Intermediate-
level 
disinfection 
Destroys vegetative bacteria 
and the majority of fungi and 
viruses. Inactivates 
Mycobacterium bovis.§ Not 
necessarily capable of killing 
bacterial spores. 
Liquid contact U.S. Environmental Protection Agency (EPA)­
registered hospital disinfectant with label claim 
of tuberculocidal activity (e.g., chlorine-
containing products, quaternary ammonium 
compounds with alcohol, phenolics, iodophors, 
EPA-registered chlorine-based product¶) 
Noncritical with visible 
blood 
Clinical contact 
surfaces; blood 
spills on 
housekeeping 
surfaces 
Low-level 
disinfection 
Destroys the majority of 
vegetative bacteria, certain 
fungi, and viruses. Does not 
inactivate Mycobacterium 
bovis .§ 
Liquid contact EPA-registered hospital disinfectant with no 
label claim regarding tuberculocidal activity.** 
The Occupational Safety and Health Administra­
tion also requires label claims of human 
immunodeficiency virus (HIV) and hepatitis B 
virus (HBV) potency for clinical contact surfaces 
(e.g., quaternary ammonium compounds, some 
phenolics, some iodophors) 
Noncritical without 
visible blood 
Clinical contact 
surfaces; 
housekeeping 
surfaces 
*	 EPA and the Food and Drug Administration (FDA) regulate chemical germicides used in health-care settings. FDA regulates chemical sterilants used on critical and semicritical 
medical devices, and the EPA regulates gaseous sterilants and liquid chemical disinfectants used on noncritical surfaces. FDA also regulates medical devices, including 
sterilizers. More information is available at 1) http://www.epa.gov/oppad001/chemregindex.htm, 2) http://www.fda.gov/cdrh/index.html, and 3) http://www.fda.gov/cdrh/ode/ 
germlab.html. 
†	 Contact time is the single critical variable distinguishing the sterilization process from high-level disinfection with FDA-cleared liquid chemical sterilants. FDA defines a high-level 
disinfectant as a sterilant used under the same contact conditions as sterilization except for a shorter immersion time (C-1). 
§	 The tuberculocidal claim is used as a benchmark to measure germicidal potency. Tuberculosis (TB) is transmitted via the airborne route rather than by environmental surfaces 
and, accordingly, use of such products on environmental surfaces plays no role in preventing the spread of TB. Because mycobacteria have among the highest intrinsic levels of 
resistance among vegetative bacteria, viruses, and fungi, any germicide with a tuberculocidal claim on the label (i.e., an intermediate-level disinfectant) is considered capable of 
inactivating a broad spectrum of pathogens, including much less resistant organisms, including bloodborne pathogens (e.g., HBV, hepatitis C virus [HCV], and HIV). It is this 
broad-spectrum capability, rather than the product’s specific potency against mycobacteria, that is the basis for protocols and regulations dictating use of tuberculocidal 
chemicals for surface disinfection. 
¶	 Chlorine-based products that are EPA-registered as intermediate-level disinfectants are available commercially. In the absence of an EPA-registered chlorine-based product, a 
fresh solution of sodium hypochlorite (e.g., household bleach) is an inexpensive and effective intermediate-level germicide. Concentrations ranging from 500 ppm to 800 ppm of 
chlorine (1:100 dilution of 5.25% bleach and tap water, or approximately ¼ cup of 5.25% bleach to 1 gallon of water) are effective on environmental surfaces that have been 
cleaned of visible contamination. Appropriate personal protective equipment (e.g., gloves and goggles) should be worn when preparing hypochlorite solutions (C-2,C-3). Caution 
should be exercised, because chlorine solutions are corrosive to metals, especially aluminum. 
**	 Germicides labeled as “hospital disinfectant” without a tuberculocidal claim pass potency tests for activity against three representative microorganisms: Pseudomonas aeruginosa, 
Staphylococcus aureus, and Salmonella choleraesuis. 
References	 pathogens; needlesticks and other sharps injuries; final rule. Federal 
C-1. Food and Drug Administration. Guidance for industry and FDA Register 2001;66:5317–25. As amended from and includes 29 CFR 
reviewers: content and format of premarket notification [510(k)] sub- Part 1910.1030. Occupational exposure to bloodborne pathogens; fi­
missions for liquid chemical sterilants/high level disinfectants. Rockville, nal rule. Federal Register 1991;56:64174–82. Available at http://www. 
MD: US Department of Health and Human Services, Food and Drug osha.gov/SLTC/dentistry/index.html. 
Administration, 2000. Available at http://www.fda.gov/cdrh/ode/ C-3. CDC. Guidelines for environmental infection control in health-care 
397.pdf. facilities: recommendations of CDC and the Healthcare Infection Con-
C-2. US Department of Labor, Occupational Safety and Health Adminis- trol Practices Advisory Committee (HICPAC). MMWR 2003;52(No. 
tration. 29 CFR Part 1910.1030. Occupational exposure to bloodborne RR-10). 
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Dental Help Feature 

(Revised January 2004) 
Appendix D. Dental Help Feature 
The Dental Help Feature is designed to provide the examiner with an on-line reference 
document for the examination and recording procedures specific for this study as well as color slides of 
oral conditions that may be used to assist the examiner in making appropriate assessment calls.  This 
section of the manual provides basic instructions on using the system.  Detailed instructions are found 
within the program itself. 
Accessing the Program:  The Dental Help Feature can be accessed by using the mouse to 
double click on the NHANES Protocols folder located on the main menu screen and then double clicking 
on the “HANES IV Protocols” icon within the folder. If the Dental Examination program is running, it 
should be minimized by clicking on the minimize box (-) in the upper right corner of the screen. 
D-1 (Revised January 2004) 
Movement within the Program:  Navigation through the system is done with the mouse 
only.  No key strokes have been defined for this program.  An arrow is used as the cursor in this program. 
Navigational buttons appear on the bottom of the screen and are clearly labeled to direct the 
user through the system.  In addition, buttons are used on the menu option screens to direct the user to 
different segments of the program. 
D-2 (Revised January 2004) 
Assessment Screens:  There is a separate menu option for each assessment (see sample 
above). The first screen displayed for each assessment is an outline of the key discussion points of that 
assessment.  Several features may appear on the screens as follows: 
 Blue phrases:  Additional information on these topics is available by accessing the 
associated dialog box as discussed below. 
 “ISIS” button:  Clicking on this button displays a copy of the ISIS screen used to 
record data for the assessment.  Clicking on the “recording procedures” button on the 
ISIS screen will pull up specific information on the allowable codes for the 
assessment.  Note there is no data entry allowed on these ISIS screens. 
 “Slide” button:  Clicking on this button allows the user to view slides related to this 
assessment.  Note: there is a significant pause in the system while the program 
accesses the slides. 
D-3 (Revised January 2004) 
Dialog Boxes:  Additional information on certain topics can be pulled up by clicking on 
phrases written in blue.  (Note: the arrow will change to a pointing finger on these phrases.)  Dialog boxes 
are displayed in the top portion of the screen.  Use the mouse to click on the <PgDn> button to proceed to 
the next box in the series and the <PgUp> button to proceed to the previous box in the series.  Clicking on 
the <PgDn> button on the last box in the series closes the dialog box.  Clicking on the <PgUp> button on 
the first screen in the series does not cause a change to the box. 
D-4 (Revised January 2004) 
Oral Health Slides:  The oral health slides are accessed when the user clicks on the “slide” 
buttons displayed on the various assessment screens. A significant pause occurs while the program 
accesses the slides.  In the upper right corner of each slide are navigation buttons to aid the user in 
moving from slide to slide as follows: 
 Next:  Moves the user to the next slide in the series. 
 Previous:  Moves the user to the previous slide in the series. 
 Go to:  Sends the user to the menu screen for that slide series so that the user may 
choose to go to any slide in that series without cycling through all of the previous 
slides. 
D-5 (Revised January 2004) 
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MEC Network & Coordinator Overview 

Network  Overv iew 
The illustration below depicts how the MEC subsystems are connected to 
the FO and HO to supply the SP data necessary to conduct the multitude 
of examinations.  The Field Office manages the Interview Teams that 
conduct the footwork of identifying and gathering detailed data on 
prospective SPs and transmits the information to the FO and HO for 
processing. This information is stored in databases and retrieved by the 
MEC subsystems in preparation for examinations.  The results of FO 
surveys and MEC examinations are collected, analyzed, and prepared for 
dissemination for public, research, and examination participates in various 
forms. 
Figure 1: NHANES Network Connectivity 
Each ISIS workstation is integral component of a sophisticated network 
that links the MEC workstations together with utility and database servers, 
and the Home Office.  Continual status communications between the 
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workstations and the Coordinator station enable orchestration of activities 

and personnel flow. 

A simplified Intranet schematic is illustrated below: 

Figure 2: Network Connectivity Scheme 
Each workstation connects to both the office automation server (NT 
Server) and the database server (Sybase) through a series of hubs.  These 
hubs connect the servers and workstations (operating on Windows NT) 
within the MEC trailers to form part of the ISIS system.  The MEC 
network communicates with both the Field Office (FO) and Home Office 
(HO) using primary and backup data links.  The data links synchronize 
operational activities and transfer examination and other data as 
scheduled. 
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MEC Coordinator  
The MEC Coordinator subsystem is designed to efficiently orchestrate the 
flow of Sample Persons (SPs) throughout the MEC examination process.  
Continual interaction between each workstation and the Coordinator 
enables smooth passing of SPs from one workstation to another.  Each 
component examination program automatically transmits the status of the 
examination to the Coordinator to assist in synchronizing the next 
component assignment.  Exams cannot be performed without specific 
assignment of a technician and an SP. 
The MEC Coordinator subsystem receives appointments scheduled by the 
Field Office’s Appointment Management subsystem.  The Coordinator 
subsystem determines the appropriate examination program, called a 
‘profile’, based on gender and age at the time of the Household Interview. 
During the conduct of the session operations, the Coordinator subsystem 
provides a graphical representation of the location of SPs in the MEC, the 
status of exam components, the availability of examiners, and the 
availability of exam stations.   
T h e  C o o r d i n a t o r  S c r e e n  C o n f i g u r a t i o n  
The Coordinator station is the nerve center for the MEC.  All functions of 
the Coordinator are executed with the graphical interface designed to 
assign, monitor, and manage all activities within the MEC.  The 
Coordinator screen, illustrated below, is organized into three major panes 
and a menu bar: 
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SP Exam Profile 
and Monitoring 
MEC Examination 
Rooms Layout 
Menu Bar 
Examiner & 
Technician 
List 
Figure 3: The Coordinator Screen 
The Menu Bar provides access to options detailed in the following section. 
The SP Exam Profile and Monitoring pane displays each SP exam profile, 
current status, and examination progress. (The actual screen shows all 10 
scheduled SPs).  The Examination Profile pane is designed to assist the 
Coordinator to rapidly assess the availability of examination components 
against the required examination profiles for each SP, and to manage the 
movement of SPs and staff.   
The MEC Examination Rooms Layout visually portrays the floor plan of 
the MEC, availability of each examination room, assigned examiner and 
technician, the location of SPs, and examination status for each room. 
The Examiner and Technician List shows available examiners and 
technicians along with their status. 
A s s i g n i n g  a n  S P  t o  a n  E x a m  
After check-in and after completion of individual examinations, the MEC 
Coordinator assigns the SP to new components.  Assignments are based on 
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a list of the SP's remaining required exams, available examiners, and 
available exam components. 
Examiners are notified by a system-generated message when an SP is 
assigned to their component.  When the examination is complete, the 
Coordinator system advises the examiner of the SP’s next component for 
the SP. 
S ys t e m  B l o c k i n g  a n d  E x c l u s i o n s  
Specified examinations are “blocked” or excluded for SP assignment or 
continuation of an examination due to medical, SP non-consent, or safety 
considerations.  Some examinations become “unblocked” when medical 
conditions are verified, such as a negative pregnancy test result from the 
lab. 
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MEC Workstation 

Workstat ion  Star tup 
The workstation startup procedures are rarely necessary since the 
workstations will remain powered and running the Windows NT operating 
systems for the stand duration.  However, at times the workstation must be 
completely shutdown and restarted to resolve connectivity and other 
operating issues. 
In the event that you must startup a workstation, follow these simple 
procedures: 
  To Startup the Workstation: 
•	 Locate and press the power button 

as shown on the right; 

•	 Then turn on the monitor. 
  To Turn On the Monitor: 
•	 Locate and press the power button as 
shown. 
•	 A small green light located near the 
power button will light if the 
monitor’s power line is connected. 
The MEC Desktop 
After workstation startup, the MEC desktop appears. The desktop is 
specially tailored to support the specific MEC examination or station.  An 
illustration of the desktop and components are shown below. 
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Tray 
Figure 4:  MEC Workstation Desktop 
The desktop is similar to a real desktop, except perhaps a little neater.  The 
desktop holds “shortcuts” to frequently used programs, such as the 
examination programs.  Shortcuts are icons that represent a file or program 
located within the computer or network.  The shortcuts provide a rapid 
means to open the program or file it represents.  When an application 
opens, it displays on the desktop, as well as most other system activities. 
Descriptions of the items that appear on all examination workstations are 
below. 
The Start button, when clicked, displays a menu containing everything 
you need to begin using Windows.  The menu options include:   
Shut Down  – Shut down menu options. 
Help – Starts Windows NT Help. 
Documents – Displays a list of previously opened documents. 
Programs – Displays a list of programs you can start. 
The Start button menu expands as programs are added to the system.  The 
graphic below illustrates how the MEC desktop menu expands. 
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Figure 5: Start Button Menus 
Note the highlighted selections. The menu expands when a small black 
arrow is shown on the menu’s right margin.  The main Start menu, the 
menu with the Windows NT banner on the first menu’s left margin, is set 
by the development team.  You may be asking yourself “Where is all the 
fun stuff?”  The Explorer and many other Windows functions are disabled 
to discourage any modifications to the desktop, Start menus, and files.  
Inadvertent moving or deletions of files could and would cause havoc. 
My Computer icon views and manages your files.  Double-clicking the 
icon will open a window view of your computer and connected resources. 
Network Neighborhood provides a view of all available resources on the 
network. 
Examination Program icons (with shortcuts indicators) reside on the 
desktop to easily start an examination.  Each examination has its own 
tailored icon. Double-click on the icon to open the examination program. 
The Taskbar, located at the bottom of the Desktop, displays the Start 
button on the left side and the System Tray on the right side of the bar.  By 
default, the system tray displays the current time and shows special system 
icons for programs that run in the background.  The Physician button, 
shown to the right of the Start button, indicates the Physician examination 
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component is currently running.  Programs running but minimized are 
also shown as a button on the Taskbar. 
The System Tray  Icons 
The System Tray holds icons that represent the programs for displaying 
time and a screen capture utility.   
Clock Time 
PrintKey Sceen 
Capture Utility 
The PrintKey screen capture utility operates automatically in the 
background. This feature enables you to capture items for documentation 
and database or program error messages.  See Appendix A, Using 
PrintKey, for directions on how this feature can help you. 
Right  Mouse But ton Menus 
The right mouse button provides a short menu of common actions when 

clicked on a desktop icon, the desktop itself, or System Tray icons.  The 

Task Bar menu is disabled. 

The right mouse menu for the Desktop Icons appears as shown below: 

Open will open the program or file with associated application. 

Send To provides an option to send the selected program o r file to either 

the A:\ drive (floppy) or Mail. 

Cut removes the icon from the desktop and places it on the system

clipboard. 

Copy places the contents of the clipboard to the desktop. 

Create Shortcut makes another Shortcut on the desktop. 

Delete permanently removes the selected item. 

Rename highlights the item's name for editing. 

Properties displays information on the application the icon represents and 

shows the path and working area of the actual application. 

The right mouse menu for the Desktop appears when right-clicked 

anywhere on the desktop, as shown below: 
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Arrange Icons provide options to display the icons. 

Line Up Icons automatically rearranges your desktop in a manner you 

will not like.

Paste will place the contents of the clipboard onto the desktop. 

Paste Shortcut places a shortcut of the item in the clipboard on the 

desktop. 

Undo Copy will clear the clipboard of the last copied item. 

New provides a menu of items from which you can create, such as a new 

folder or document. 

Properties display the Display Properties window to view and change 

several properties, such as window appearance, background, and colors.  

Some, if not all properties, will be disabled to ensure consistent 

appearance of all MEC workstations. 

If the System Tray menu appears as shown on the left, you have clicked 

in the wrong area of the Task Bar. 

Restore brings the program to the last used or default window size on the 

desktop. 

Minimize will reduce the program to an icon on the Task Bar.  The Tray 

Utility program will reduce the connectivity applications back into the 

System Tray. 

Maximize opens the program in a window that fills the screen. 

Close will terminate the program. 

Note: 	 In the event you activate this menu from the System Tray, press 
the ESC key to escape the menu.  DO NOT select Close! You 
will lose the background applications. 
End of  Day Procedures  
The current procedure is to leave your workstation operational when 
departing the MEC. Examinations are closed and the programs in the 
system tray left running. 
There will be times when the system malfunctions, such as failure to 
respond to keyboard or mouse commands or “hangs”, you may be directed 
to shut down or restart the workstation. 
To Shut Down or Restart the Workstation: 
• Click on the Start button on the Taskbar. 
• Select Shutdown from the Start Menu. 
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•	 The dialog box, shown below, appears. 
•	 To shut down the system completely, select Shut down the 
computer. 
•	 Wait for the message indicating that it is safe to turn off the 
computer. 
•	 To restart the system without shutting down, select Restart the 
computer. 
•	 The system will restart automatically. 
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MEC Exam Application’s Common Features 
MEC applications are custom built for each specific component but share 
a common design. This commonality provides all component applications 
the same “look and feel” which minimizes reorienting technicians that 
rotate from component to component. These features and characteristics 
are described below. 
Examiner  Logon 
There are currently several types of examiner logon procedures.  The 
logon procedure for an examination component is determined by whether 
the examiner is static or rotates through other components throughout a 
session. Static examiners include components such as Physician, 
Phlebotomy, Dietary, and MEC Interviewers that remain logged on 
throughout the session. Health technicians, such as Vision and CV 
Fitness, are not assigned to rooms but rotate through several examination 
components.  These technicians are required to logon and logoff for each 
examination.  Other examinations, such as Dental and Body 
Measurements, have slightly different requirements and are addressed in 
their specific User’s Manual. The two basic approaches to logon are 
outlined below.   
Static Examiner Logon: 
•	 The logon screen, shown above, appears after the Coordinator 
assigns the examiner to the component and the assigned 
examiner starts the examination program. 
•	 The User ID (Last Name_First Initial) will automatically appear 
and cannot be changed. 
•	 Type in the Password and press OK 
•	 Examiner logoff is automatic at the end of the session. 
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Rotating Examiner Logon: 
•	 The logon screen appears when the Coordinator assigns an SP to 
an exam component.   
•	 If the component involves both an examiner and a recorder, the 
examiner logon screens appear first, followed by the recorder 
logon screen. 
•	 The User IDs will automatically appear and cannot be changed.  
Both exam technicians must logon. 
•	 Type in the Password. 
•	 Press OK. 
•	 Logoff is automatic upon completion of the SP examination. 
NOTE:Your password is your safeguard.  All examination actions 
within the MEC are traced with the logon User ID and 
Password. Unauthorized entry and malicious actions to the ISIS 
system are prevented by a simple act of not ever, for any reason, 
give your password to another.  You could jeopardize much 
more than study data. 
After entering your password and prior to pressing 
OK, you can change your password by clicking 
on the Change Password button. The Change 
Password dialog box appears. 
Enter your current password for access verification, 
followed by your new password. Confirm your 
new password and press OK. 
Figure 6: Change Password Dialog Box 
SP Logon 
The MEC Coordinator checks-in each SP upon arrival and assigns the SP 
to an initial examination component. The action of assigning the SP to a 
component automatically triggers a message from the Coordinator to alert 
the technician that an SP is assigned. 
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When the examiner selects File | Open to 
begin the exam, the SP logon screen appears. 
•	 Acquire the SP ID through the wand 

device or manually enter the ID 

imprinted on the SP bracelet. 

•	 Verify that the SP information is 

correct. 

•	 Click OK to proceed with the examination. 
•	 The Message button opens a dialog box for sending a message to 
the Coordinator. 
•	 Cancel stops the logon process. 
Examinat ion  Screen Overv iew 
The first examination screen appears after an SP is logged in or an existing 
record is opened. This example screen, shown on the next page and 
compressed for space, displays the basic visual appearance and design 
used throughout all MEC components.  
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Examination 
Slide 
Navigation Bar 
Menu Bar 
Tool Bar SP Title Bar 
Program Title 
Bar 
Figure 7: Sample Examination Screen 
Program Title Bar shows the component program title, stand, session, 
and date time information. 
Menu Bar displays the commands, functions, options, and information 
available during an examination. 
Tool Bars hold buttons that execute common commands and other actions 
available in the menu bar.  Buttons that are dimmed are not available. 
SP Title Bar displays SP information during the course of the 
examination. 
Examination Slide captures the measurements and other information.  
Navigation Bar is used to move forward or back in the examination and 
displays the examination’s relative location. 
Microhelp and Status Bar displays the status of the computer, 
completion percentage message to the coordinator, and other information 
triggered by events. 
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Menu Bar  Opt ions 
Each MEC application has tailored menu options to support the specific 
examination.  The menu options below list all available options.  The 
options marked with an asterisk appear on all MEC examination 
programs.  Options are grayed (inverted) or not present when they are not 
available for your subsystem. 
Note the underlined letters in both the Menu and Menu Option.  These 
underlined letters, used in conjunction with the Alt key, provide keyboard 
access to the menu selection without using the mouse.  For example, 
pressing Alt+F+O will open a file.  The Ctrl+keystroke, such as Ctrl+O , 
will also open a file. 
Asterisks (*) denotes menu options common to all MEC examination 
components. 
File* 
Open * 
Ctrl+O 
Review 
Close * 
Print * 
Ctrl+P 
Delete * 
Exit * 
Opens a new, Partial, or Not Done SP exam; must be 
assigned by Coordinator if not in standalone mode 
Opens any existing SP examination in read-only mode; 
Coordinator assignment not required; no status 
updates sent to the coordinator system in Review 
mode 
Closes the current examination 
Prints the current examination screen or report.  Note 
the Ctrl+P shortcut keys. 
Deletes current exam and any associated references. 
Used primarily to delete an examination that clearly is 
in error, such as the wrong SP. Only enabled if it is a 
new exam and the status is not done or partial. 
Exits the application. 
View * 
First * 
Next * 
Prior * 
Last * 
Returns examination screen to first slide 
Advances to next examination slide. 
Displays previous slide IN THE SKIP PATTERN 
Advances to last slide. 
Utilities * 
Quality 

Control 

Ctrl+Q 
Exam Pause * 
Opens the quality control dialog box to initiate 
quality control procedures. 
Used in case of an emergency in the MEC, such as 
an ill SP. Pauses the exam temporarily to stop the 
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Send 
Message * 
Ctrl+M 
Observation* 
IC Exclude 
Settings * 
Toolbars* Configures placement of toolbars. 
English Toggle option to set exam language to English. 
Ctrl+E 
Spanish 
Ctrl+S 
exam timer (in NH_Exam); sends “Exam paused” 
message to Coordinator. 
Opens a dialog box to send messages to the 
coordinator. 
Submits an observation to the Physician for 
possible referral. 
Posts an exclusion record for those SPs who do not 
want HIV, STD, Genetic Testing , or Future 
Research performed;  available only for 
Coordinator, Physician, & Phlebotomy. 
Allows user to view or modify subsystem settings, 
including the Coordinator connection. Modifying 
setting requires approval by the data manager. 
Toggle option to set exam language to Spanish. 
Reports* 
Session Lists all SPs in current session 
Preview* 
Room Log* Lists the SPs who have completed the component, 
including appt/exam and component status Ctrl+R 
Window* 
Cascade * 
Tile 
Horizontal* 
Tile Vertical * 
Layer * 
Minimize All 

Windows * 

Displays multiple windows overlapped and slightly 
offset as to show the title bar of each open window. 
Displays open windows on top of each other and 
sized to fit all in the main program window. 
Displays open windows next to each and sized to fit 
in the main program window. 
Displays open windows stacked over each other. 
Reduces all windows to a button in the lower portion 
of the main program window. 
Help* 
Help Topics * Displays ISIS system help contents. 
F1 
NHANES Displays component procedures manual. (not in 
Procedures * Pilot). 
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OMB 
Statement. 
Displays the OMB Confidentiality Statement. 
About * Displays the About dialog box. 
Tool  Bars  
Tools Bar buttons display when the program first opens to provide an easy 
way to access menu commands.  Buttons are dimmed to signify that the 
action is temporarily unavailable; such as a dimmed Print button when no 
examination is open.  
The Tool Bars, labeled FrameBar and FrameBar2, are customizable 
through the System | Customize Tool Bars… menu option or the Arrange 
Toolbars button. The Tool Bars buttons are: 
Opens a New Sample Person Examination. 
Opens an Existing Sample Person Examination. 
Prints the Current SP Examination. 
Arranges toolbar buttons. 
Modifies system configuration and settings. 
Sends message to coordinator. 
Quits the Exam Application. 
Performs Quality Control Procedures. 
Pauses the current SP examination. 
Logs an Emergency for the Current SP. 
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Enters a Referral for the Current SP. 
Displays NHANES Procedures. 
Displays program Help. 
SP T i t le  Bar  
The Title Bar appears with the first examination slide after the SP is 
logged on. The Title Bar remains visible throughout the examination 
process. The example above illustrates the actual information displayed, 
but is not as compressed along the bar. 
Exam Sl ide  Navigat ion  
The slide navigation bar provides a means to move forward and back 
through an examination.  The features of this bar are: 
View first slide in examination sequence.  Disabled (dimmed) 
if current slide is first in examination sequence. 
View previous slide in examination sequence. Disabled 
(dimmed) if current slide is first in examination sequence. 
View next slide in examination sequence.  Disabled 
(dimmed) if current slide is last slide in examination 
sequence. 
View last slide in examination sequence.  Disabled (dimmed) 
if current slide is last slide in examination sequence. 
View next slide in examination sequence.  An easy to click 
button. 
Note the slide counter between the previous and next slide buttons.  This 
counter aids in determining your current location in the slideshow 
sequence. 
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End of Section button advances the examination slide to the status slide for 
the current section or the end of the examination for single section 
examinations. 
Close button interrupts the examination and displays the Status screen for 
an appropriate status code and comment. 
Finish button is disabled (dimmed) until the examination is complete.  
Partial and Not Done examinations require a status code and comment to 
activate the Finish button.  The action completes the current examination. 
Qual i ty  Contro l  
Several examinations incorporate medical equipment that requires 
periodic maintenance and inspection.  These components have detailed 
procedures on conducting their specific inspection checks.  Each 
subsystem notifies the examiner that QC inspections have not been 
performed when the examination program is started. 
An example Quality Control window is shown below. 
Figure 8: Quality Control Screen Sample 
Included in the QC Checks are mandatory checks that must be completed 
prior to starting the examination program.  The types of QC Checks are 
listed: 
1. Start of Stand. 
2. Start of Session. 
3. Daily. 
4. Weekly. 
5. Middle of Stand. 
6. End of Stand. 
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Warning and Error  Messages 
Throughout the course of an examination, warning and error messages 
may appear when you attempt to perform an action the program can not 
execute or requires your confirmation to continue the action.  The message 
normally appears with statements explaining the error condition.  
Complying with the error message statement will normally remedy the 
error. When required to confirm an action, such as deleting records, be 
sure the action is necessary because in most cases the action is 
irreversible. Most “Oh #@%&” comments result from responding “Yes” 
when “No” was appropriate. 
Data entry fields may have limitations on the acceptable range of values.  
The limitations imposed on these values are called Hard and Soft Edits. 
Hard edits impose a strict 
limitation on values entered 
in a data field. A data 
value entered outside of the 
hard edit range is not 
accepted and a program 
warning displays. For 
example, if a vision hard edit limitation is 20/500, an entry of 20/520 will 
not be accepted. 
Soft edits are flexible limitations on values but prompts you for 
confirmation if a value exceeds the limit.  For example, if a vision soft edit 
limitation is 20/400, an entry of 20/435 will prompt a confirmation dialog 
box. 
Buttons and Boxes and L is ts  
The examination slides use a variety of methods to capture acquired data.  
The methods include the following data control devices. 
The radio buttons require a single response out of the responses displayed. 
The responses are mutually exclusive, but may have more than two 
displayed responses. To select a response, simply click on the appropriate 
button. The selected button will appear with a black dot in the center of 
the circle. 
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The drop list, or drop-down list, provides a rapid means of selecting a 
desired response from a fixed set of possible responses.  The drop-down 
list window may initially appear blank, as shown in the top example 
above. To drop down the list of possible responses, click on the down 
arrow button. A scroll bar may appear on the windows right side to enable 
you to scroll down the list.  Click to select the desired response.  Your 
selection will appear in the upper list window. 
The check boxes enable selection to all responses that apply.  The 
responses are not mutually exclusive. To select a response, simply click 
on the appropriate box.  The selected box will appear with a black check 
in the center of the box. Click on a selected box to deselect. 
The ellipsis button indicates additional action is available, such as 
browsing for records or additional information.   
The spin box accepts a limited set of discrete responses.  The “spin” name 
is derived from the up-down arrow buttons that can be used to “spin” the 
set of responses up or down. To select a response, simply click on the 
appropriate up or down arrow button to increment the responses.  You 
may also type the response value in the spin window, if known. 
Sect ion  or  Component  Status  
The Section or Component Status screen displays the relative completion 
of the examination – Complete, Partial, or Not Complete. This is the last 
exam slide at the end of a section or a component if there are multiple 
sections. The status automatically displays and is not editable.  
Interruptions, emergencies, refusals, and other events that prematurely 
stop the examination will trigger this screen for appropriate incomplete 
comment codes. Comments are not recorded for Complete 
examinations. 
Comment codes: 
Component status codes indicate the degree of component examination 
completion.  The three standard codes are: 
Complete: All sections of the component were completed or attempted. 
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Partial: At least one section of the component was not completed or attempted. 
Not Done: No part of the component was done or attempted. 
Comment codes are used to explain Partial complete or Not Done status 
codes. The Comment Codes defined below are common to all exams.  
There are other specific components and sections comment codes which 
are not defined here. 
Safety The examinee was excluded from the component for safety reasons as 
Exclusion: defined by the protocol for the component.   
SP Refusal: 	 This is an SP initiated response due to refusal.  The SP refuses the 
component for any reason other than an illness or emergency.  If the SP 
refuses in the reception area, the Coordinator can code the exam.  If the 
SP refuses after starting the exam, the examiner will code the refusal. 
No Time: 	 The SP comes on time and stays for the entire session, there is adequate 
staff in the MEC but at the end of the session there is no time to do the 
examination. 
Physical SP is unable to have the test due to physical problems.  For example, the 
Limitations: SP is unable to lie flat for the total body composition scan. 
Communication SP is unable to understand and follow the instructions for the component 
Problems: due to language, cognitive impairment or other problem, and is unable to 
complete the test. 
Equipment The component equipment malfunctioned and the test could not be 
Failure: performed on the SP. 
SP Ill/ The SP became ill or an emergency occurred and the test was not 

Emergency: performed on the SP. 

Interrupted: 	 An exam is interrupted, usually for a MEC-wide emergency, and cannot 
be completed by the SP. 
Other, specify: 	 If the above reason for a Status Code of Partial or Not Done is not 
explained by one of the above Comment Codes, the examiner must 
choose Other, specify and record a comment in the text field. 
Examinations closed prior to completion are automatically assigned a 
Partial status and the examiner is prompted for an appropriate comment. 
Select the comment from the Comments drop-down list and press OK. 
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The Messaging Subsystem 
Read Flag 
Urgent Flag 
Messages Received 
Message Response 
New Message Text Box 
Message Counter 
The Messaging subsystem is the communication nerve center that 
continually informs the Coordinator on the status of each component 
examination progress, assigned examiner(s), components available for 
SPs, and other management information. 
Communication between the Coordinator and examination components is 
readily available through the Utilities menu or the Send Message button 
on the toolbar. 
To Send a Message to the Coordinator: 
• Click on the Send Message button on the toolbar. 
Or, 
• Press Ctrl+M keystroke combination. 
Or, 
• Select Send Message from the Utilities menu. 
• The Message Center transmittal box appears. 
Messages sent to the Coordinator appear in the Message Center window 
on the Coordinator screen. Messages received from the Coordinator will 
remain visible on your screen for approximately 30 seconds.   
Messages that have been flagged as “Read” (click the Read Flag column 
next to the read message) will be removed from the Messages Received 
pane during the system update, usually every 30 seconds.   
• Received messages appear in the upper pane. 
• Message responses are constructed in the lower pane. 
Send Button 

Close Button 
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•	 To respond to a message, select the message in the upper pane by 
clicking the “Read” flag. 
•	 The Coordinator automatically appears in the “To” message 
response pane. 
•	 Type your message in the Message text box. 
•	 Click the Send button to send the message. 
•	 Clicking the send button without including a text message 
automatically sends an “Ok”. 
•	 Click the Close button to close the Message Center 
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Sample Reports 
The Reports menu options include the Session Preview, Room Log, and 
Results reports. Most reports display on screen and all reports can be 
printed. 
To Pr in t  a  Repor t  
Default printers are designated for each workstation and cannot be 
changed with the examination program. 
  To Print a Report or Window: 
• Open the report. 
• Select File | Print from the menu bar. 
The report or print capable window is automatically sent to the default 
printer. 
Session Prev iew Report  
This report can be viewed one day in advance.  The report shows SPs 
scheduled for the scheduled sessions with special considerations and 
comments to notify the team in advance. 
Figure 9: Session Preview Report 
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Room Log 
The Room Log displays SPs that have completed the component and other 
comments. 
Figure 10: Room Log 
Resul ts  Report  
The Result Report displays a detailed listing of the examination results.  
Each component application is tailored to the examination.  However all 
reports reflect the itemized results in tabular form in a style consistent with 
the sample below. 
Figure 11: Result Report 
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Appendix A: Using PrintKey 

PR I N T KE Y OV E R V I E W
The PrintKey screen capture utility allows you to capture whole or partial 
screen images for immediate printing or saving to a file. Use this feature 
to capture any error messages that appear on the screen. Capturing the 
error message as it appears will enable the data manager to quickly 
determine the appropriate actions needed to correct the error. 
PrintKey automatically loads whenever you logon a MEC workstation. 
It’s icon appears in the system tray in the lower right corner of the screen 
next to the clock (looks like a little hand pushing a button). Full Screen 
and Window Only are two available options to capture various parts of a 
screen image. Full Screen captures the entire monitor screen, and 
Window Only captures the currently active window only, such as an error 
message window. 
Ful l  Screen Capture  
Full screen captures are used when the entire monitor image is needed. Each 
image will require approximately 1.5 Megabytes of space, which is more than 
what 1 floppy disk can hold. 
•	 Press the Print Scrn key, a screen shot of the full screen is taken and 
the PrintKey utility window pops up: 
Print Setup 
Button 
Copies 
Image Preview 
Window 
Print Button 
Minimize Button 
• Now you can print the image or save the image to a file. 
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Window Only  Capture  
Window only captures are used when only the current window image is 
needed. The window can be an error message, dialog box, or a window 
within an application.  Image sizes will very depending on the area the 
window covers on the monitor.  If you want to capture information in a 
program without the distraction of toolbars and other graphics, this method 
works best. 
•	 Press and hold the Alt key, then press the Print Scrn key. The 
capture of the open window is taken and the PrintKey utility window 
pops up: 
Image Preview 
Window 
Print Button 
Minimize Button 
• Now you can print the image or save the image to a file. 
Saving Images to  a  F i le  
Images captured using any technique discussed below can be saved to a file 
for later use. This is how you do it: 
•	 Click Image on the menu bar. 
•	 Select Save… or press Ctrl+S keys. 
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• The Save dialog box appears. 
•	 In the Save in drop-down list, select the destination directory/folder. 
•	 The selected directory/folder, shown below, opens and displays 
individual subdirectories to store your files. 
Create a New 
Directory 
• Double-click to select your subdirectory if available, or make a new 
directory is you do not see one with your name. 
• Name your image in the File name field. 
• Select BMP from the Save as type drop down list. 
• Click Save. 
• Click Minimize on the PrintKey window. 
Pr int ing  a  Screen Capture  
To print the image 
•	 Click on Print in the lower left corner to print to the default printer.  
•	 The capture will print at your designated printer. 
•	 Click Minimize to hide the PrintKey window. 
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Dental Reference Sheets 
- Summary Dental Reference Sheet 
- Summary Dental Question Reference Sheet 
- Medical Exclusion Questionnaire 
APPENDIX F. SUMMARY DENTAL REFERENCE SHEET 

F-1 (REVISED April  2003) 
APPENDIX F. SUMMARY DENTAL REFERENCE SHEET (continued) 
F-2 (REVISED April  2003) 
APPENDIX F. SUMMARY DENTAL QUESTION REFERENCE SHEET 

F-3 (REVISED April  2003) 
APPENDIX F. MEDICAL EXCLUSION QUESTIONNAIRE 
NHANES Oral Health Component 
Medical Exclusion Questionnaire 
1. Has the doctor or dentist ever told you that you must ALWAYS take 
antibiotics (e.g., penicillin) before you get a dental check-up or care? 
Before we begin, I'd like to read you a list of health conditions that some 
people have. As I read off each condition, please tell me whether or not a 
doctor has ever told you that you have the condition.   
2. Has a doctor ever told you that you have a heart problem?  
Was the heart problem due to: 
3. Congenital heart murmurs; 
4. A heart valve problem; 
5. Congenital heart disease; or 
6. Bacterial endocarditis? 
Has a doctor ever told you that you have: 
7. Rheumatic fever; or 
8. Kidney disease requiring renal dialysis? 
Do you have: 
9. Hemophilia; 
10. A pacemaker or automatic defibrillator; 
11. Other artificial material in your heart, veins, or arteries; or 
12. A hip, bone, or joint replacement?  
F-4 (REVISED April  2003) 
Appendix G 

Dental Room Teardown Diagram 

(Revised January 2004) 
Appendix G.  Dental Room Teardown Diagram 
G-1 (Revised January 2004) 
